
<html lang="en"     class="pb-page"  data-request-id="c87442d8-9c1a-46ec-bf9c-03d8deee50de"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm200401v;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2011.54.issue-13;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery and Characterization of 6-{4-[3-(R)-2-Methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, Irdabisant): A Potent, Selective Histamine H3 Receptor Inverse Agonist" /></meta><meta name="dc.Creator" content="Robert L.  Hudkins" /></meta><meta name="dc.Creator" content="Rita  Raddatz" /></meta><meta name="dc.Creator" content="Ming  Tao" /></meta><meta name="dc.Creator" content="Joanne R.  Mathiasen" /></meta><meta name="dc.Creator" content="Lisa D.  Aimone" /></meta><meta name="dc.Creator" content="Nadine C.  Becknell" /></meta><meta name="dc.Creator" content="Catherine P.  Prouty" /></meta><meta name="dc.Creator" content="Lars J. S.  Knutsen" /></meta><meta name="dc.Creator" content="Mehran  Yazdanian" /></meta><meta name="dc.Creator" content="Gilbert  Moachon" /></meta><meta name="dc.Creator" content="Mark A.  Ator" /></meta><meta name="dc.Creator" content="John P.  Mallamo" /></meta><meta name="dc.Creator" content="Michael J.  Marino" /></meta><meta name="dc.Creator" content="Edward R.  Bacon" /></meta><meta name="dc.Creator" content="Michael  Williams" /></meta><meta name="dc.Description" content="Optimization of a novel series of pyridazin-3-one histamine H3 receptor (H3R) antagonists/inverse agonists identified 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (8a, CEP..." /></meta><meta name="Description" content="Optimization of a novel series of pyridazin-3-one histamine H3 receptor (H3R) antagonists/inverse agonists identified 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (8a, CEP..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 2, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm200401v" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm200401v" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm200401v" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm200401v" /></link>
        
    
    

<title>Discovery and Characterization of 6-{4-[3-(R)-2-Methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, Irdabisant): A Potent, Selective Histamine H3 Receptor Inverse Agonist | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm200401v" /></meta><meta property="og:title" content="Discovery and Characterization of 6-{4-[3-(R)-2-Methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, Irdabisant): A Potent, Selective Histamine H3 Receptor Inverse Agonist" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0007.jpeg" /></meta><meta property="og:description" content="Optimization of a novel series of pyridazin-3-one histamine H3 receptor (H3R) antagonists/inverse agonists identified 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (8a, CEP-26401; irdabisant) as a lead candidate for potential use in the treatment of attentional and cognitive disorders. 8a had high affinity for both human (Ki = 2.0 nM) and rat (Ki = 7.2 nM) H3Rs with greater than 1000-fold selectivity over the hH1R, hH2R, and hH4R histamine receptor subtypes and against an in vitro panel of 418 G-protein-coupled receptors, ion channels, transporters, and enzymes. 8a demonstrated ideal pharmaceutical properties for a CNS drug in regard to water solubility, permeability and lipophilicity and had low binding to human plasma proteins. It weakly inhibited recombinant cytochrome P450 isoforms and human ether-a-go-go-related gene. 8a metabolism was minimal in rat, mouse, dog, and human liver microsomes, and it had good interspecies pharmacokinetic properties. 8a dose-dependently inhibited H3R agonist-induced dipsogenia in the rat (ED50 = 0.06 mg/kg po). On the basis of its pharmacological, pharmaceutical, and safety profiles, 8a was selected for preclinical development. The clinical portions of the single and multiple ascending dose studies assessing safety and pharmacokinetics have been completed allowing for the initiation of a phase IIa for proof of concept." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm200401v"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm200401v">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm200401v&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm200401v&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm200401v&amp;href=/doi/10.1021/jm200401v" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 4781-4792</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm200400m" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm2004078" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Characterization of 6-{4-[3-(<i>R</i>)-2-Methylpyrrolidin-1-yl)propoxy]phenyl}-2<i>H</i>-pyridazin-3-one (CEP-26401, Irdabisant): A Potent, Selective Histamine H<sub>3</sub> Receptor Inverse Agonist</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+L.++Hudkins">Robert L. Hudkins</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rita++Raddatz">Rita Raddatz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ming++Tao">Ming Tao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joanne+R.++Mathiasen">Joanne R. Mathiasen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lisa+D.++Aimone">Lisa D. Aimone</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nadine+C.++Becknell">Nadine C. Becknell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Catherine+P.++Prouty">Catherine P. Prouty</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lars+J.+S.++Knutsen">Lars J. S. Knutsen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mehran++Yazdanian">Mehran Yazdanian</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gilbert++Moachon">Gilbert Moachon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+A.++Ator">Mark A. Ator</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+P.++Mallamo">John P. Mallamo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+J.++Marino">Michael J. Marino</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edward+R.++Bacon">Edward R. Bacon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Williams">Michael Williams</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Worldwide Discovery Research and Development, Cephalon, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States</span></div><div class="aff-info" id="aff2"><span class="aff-text">Cephalon, Inc., 19 Rue Prof. Cadieux, Maisons Alfort, France</span></div><div class="corresp-info">Phone: 610-738-6283. Fax: 610-738-6558. E-mail: <a href="/cdn-cgi/l/email-protection#23514b5647484a4d50634046534b424f4c4d0d404c4e"><span class="__cf_email__" data-cfemail="03716b7667686a6d70436066736b626f6c6d2d606c6e">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm200401v&amp;href=/doi/10.1021%2Fjm200401v" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 4781â4792</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 2, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 April 2011</li><li><span class="item_label"><b>Published</b> online</span>2 June 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 July 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm200401v" title="DOI URL">https://doi.org/10.1021/jm200401v</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4781%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRobert%2BL.%2BHudkins%252C%2BRita%2BRaddatz%252C%2BMing%2BTao%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D13%26contentID%3Djm200401v%26title%3DDiscovery%2Band%2BCharacterization%2Bof%2B6-%257B4-%255B3-%2528R%2529-2-Methylpyrrolidin-1-yl%2529propoxy%255Dphenyl%257D-2H-pyridazin-3-one%2B%2528CEP-26401%252C%2BIrdabisant%2529%253A%2BA%2BPotent%252C%2BSelective%2BHistamine%2BH3%2BReceptor%2BInverse%2BAgonist%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4792%26publicationDate%3DJuly%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm200401v"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1875</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">58</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm200401v" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Characterization of 6-{4-[3-(R)-2-Methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, Irdabisant): A Potent, Selective Histamine H3 Receptor Inverse Agonist&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;L. Hudkins&quot;},{&quot;first_name&quot;:&quot;Rita&quot;,&quot;last_name&quot;:&quot;Raddatz&quot;},{&quot;first_name&quot;:&quot;Ming&quot;,&quot;last_name&quot;:&quot;Tao&quot;},{&quot;first_name&quot;:&quot;Joanne&quot;,&quot;last_name&quot;:&quot;R. Mathiasen&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;D. Aimone&quot;},{&quot;first_name&quot;:&quot;Nadine&quot;,&quot;last_name&quot;:&quot;C. Becknell&quot;},{&quot;first_name&quot;:&quot;Catherine&quot;,&quot;last_name&quot;:&quot;P. Prouty&quot;},{&quot;first_name&quot;:&quot;Lars&quot;,&quot;last_name&quot;:&quot;J. S. Knutsen&quot;},{&quot;first_name&quot;:&quot;Mehran&quot;,&quot;last_name&quot;:&quot;Yazdanian&quot;},{&quot;first_name&quot;:&quot;Gilbert&quot;,&quot;last_name&quot;:&quot;Moachon&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;A. Ator&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;P. Mallamo&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;J. Marino&quot;},{&quot;first_name&quot;:&quot;Edward&quot;,&quot;last_name&quot;:&quot;R. Bacon&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Williams&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;4781-4792&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm200401v&quot;},&quot;abstract&quot;:&quot;Optimization of a novel series of pyridazin-3-one histamine H3 receptor (H3R) antagonists/inverse agonists identified 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (8a, CEP-26401; irdabisant) as a lead candidate for potential use in the treatment of attentional and cognitive disorders. 8a had high affinity for both human (Ki = 2.0 nM) and rat (Ki = 7.2 nM) H3Rs with greater than 1000-fold selectivity over the hH1R, hH2R, and hH4R histamine receptor subtypes and against an in vitro panel of 418 G-protein-coupled receptors, ion channels, transporters, and enzymes. 8a demonstrated ideal pharmaceutical properties for a CNS drug in regard to water solubility, permeability and lipophilicity and had low binding to human plasma proteins. It weakly inhibited recombinant cytochrome P450 isoforms and human ether-a-go-go-related gene. 8a metabolism was minimal in rat, mouse, dog, and human liver microsomes, and it had good interspecies pharmacokinetic properties. 8a dose-dependently inhibited H3R&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200401v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200401v" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200401v&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200401v" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200401v&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200401v" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm200401v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200401v&amp;href=/doi/10.1021/jm200401v" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm200401v" /></input><a href="/doi/pdf/10.1021/jm200401v" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm200401v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm200401v%26sid%3Dliteratum%253Aachs%26pmid%3D21634396%26genre%3Darticle%26aulast%3DHudkins%26date%3D2011%26atitle%3DDiscovery%2Band%2BCharacterization%2Bof%2B6-%257B4-%255B3-%2528R%2529-2-Methylpyrrolidin-1-yl%2529propoxy%255Dphenyl%257D-2H-pyridazin-3-one%2B%2528CEP-26401%252C%2BIrdabisant%2529%253A%2BA%2BPotent%252C%2BSelective%2BHistamine%2BH3%2BReceptor%2BInverse%2BAgonist%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D13%26spage%3D4781%26epage%3D4792%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jmcmar.2011.54.issue-13/production/jmcmar.2011.54.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/medium/jm-2011-00401v_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200401v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Optimization of a novel series of pyridazin-3-one histamine H<sub>3</sub> receptor (H<sub>3</sub>R) antagonists/inverse agonists identified 6-{4-[3-(<i>R</i>)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2<i>H</i>-pyridazin-3-one (<b>8a</b>, CEP-26401; irdabisant) as a lead candidate for potential use in the treatment of attentional and cognitive disorders. <b>8a</b> had high affinity for both human (<i>K</i><sub>i</sub> = 2.0 nM) and rat (<i>K</i><sub>i</sub> = 7.2 nM) H<sub>3</sub>Rs with greater than 1000-fold selectivity over the hH<sub>1</sub>R, hH<sub>2</sub>R, and hH<sub>4</sub>R histamine receptor subtypes and against an in vitro panel of 418 G-protein-coupled receptors, ion channels, transporters, and enzymes. <b>8a</b> demonstrated ideal pharmaceutical properties for a CNS drug in regard to water solubility, permeability and lipophilicity and had low binding to human plasma proteins. It weakly inhibited recombinant cytochrome P450 isoforms and human ether-a-go-go-related gene. <b>8a</b> metabolism was minimal in rat, mouse, dog, and human liver microsomes, and it had good interspecies pharmacokinetic properties. <b>8a</b> dose-dependently inhibited H<sub>3</sub>R agonist-induced dipsogenia in the rat (ED<sub>50</sub> = 0.06 mg/kg po). On the basis of its pharmacological, pharmaceutical, and safety profiles, <b>8a</b> was selected for preclinical development. The clinical portions of the single and multiple ascending dose studies assessing safety and pharmacokinetics have been completed allowing for the initiation of a phase IIa for proof of concept.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>Â§</span>Â Author Present Address</h4><p class="last">Department of Molecular Pharmacology and Biological Chemistry, Feinberg School of Medicine, Northwestern University, Chicago, IL.</p></div><div class="extra-info-sec articleNote"><h4><span>â¥</span>Â Author Present Address</h4><p class="last">Merck & Co. Inc., West Point, PA.</p></div><div class="extra-info-sec articleNote"><h4><span>â¥</span>Â Author Present Address</h4><p class="last">Discovery Pharma, LLC, West Chester, PA.</p></div><div class="extra-info-sec articleNote"><h4><span>#</span>Â Author Present Address</h4><p class="last">Department of Pharmaceutical Sciences, School of Pharmacy, Thomas Jefferson University, Philadelphia, PA.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22065" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22065" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Many drug discovery efforts in the histamine (HIS) G-protein-coupled receptor (GPCR) receptor family, now some 75 years old, are currently focused on the H<sub>3</sub> receptor (H<sub>3</sub>R), identified in 1983<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and finally cloned in 1999.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The four receptors (H<sub>1</sub>âH<sub>4</sub>) that comprise the HIS GPCR family represent one of the more successful drug target classes over the past 50 years, yielding the antihistamines (H<sub>1</sub> blockers) and the H<sub>2</sub>-blockers cimetidine and ranitidine. The recently discovered H<sub>4</sub> receptor is expressed mainly in mast cells, eosinophils, and tissues involved in the immune response and may play a role in inflammation and pain.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> H<sub>3</sub>Rs are expressed predominantly on the presynaptic terminals of CNS neurons, and agonist signaling inhibits adenylyl and guanylyl cyclases.<a onclick="showRef(event, 'ref2 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref4">(2, 4)</a> H<sub>3</sub>Rs function as autoreceptors to modulate HIS release<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and as inhibitory heteroreceptors, regulating the release of key neurotransmitters including acetylcholine, dopamine, norepinephrine, and serotonin that are involved in attention, vigilance, and cognition.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Thus, H<sub>3</sub> antagonists may have potential utility in addressing a variety of CNS disorders associated with attention and cognitive deficits, including deficits in wakefulness, attention-deficit hyperactivity disorder (ADHD), Alzheimerâs disease (AD), mild cognitive impairment, and schizophrenia.</div><div class="NLM_p">An important aspect in understanding the role of the H<sub>3</sub>R and its ligands is the high degree of constitutive activity in vitro and in vivo.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Native and heterologously expressed cloned H<sub>3</sub>Rs signal constitutively,<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> tonically suppressing neuronal activities, e.g., HIS release, to baseline levels.<a onclick="showRef(event, 'ref6 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref8">(6, 8)</a> Agonist-induced signaling in the presence of elevated HIS levels further suppresses HIS release. As opposed to H<sub>3</sub> antagonists, which would interfere with HIS-mediated negative feedback, inverse agonists decrease constitutive signaling and suppress tonic inhibition of release, further potentiating histaminergic effects. It has been proposed that H<sub>3</sub>R antagonist/inverse agonists may be desirable as therapeutics because of their ability to reverse constitutive activity.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">The advancement of new chemical entities (NCEs) in the H<sub>3</sub>R field over the past 25 years has been confounded by species differences, interactions with the human ether-a-go-go-related gene (hERG) potassium channel (potential for QTc prolongation and torsade de pointes), and pharmacokinetic (PK) hurdles that include high brain and tissue levels with long residence times, reflecting the potential for tolerance (CNS) and phospholipidosis.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Initial work in the field focused on imidazole analogues of the natural ligand, HIS, producing several tool compounds that helped advance the biology, e.g., thioperamide and ciproxifan.<a onclick="showRef(event, 'cit5e ref11'); return false;" href="javascript:void(0);" class="ref cit5e ref11">(5e, 11)</a> To date, however, imidazole-based H<sub>3</sub> antagonists have not successfully advanced through the drug development process because of numerous liabilities and poor druglike properties, including metabolic degradation by histamine <i>N</i>-methyltransferase (HNMT), poor selectivity, cytochrome P450 (CYP) inhibition, and importantly issues with bloodâbrain barrier penetration. The search for H<sub>3</sub> antagonists with druglike properties has focused exclusively on amine-based cores. These compounds exhibited reduced side effect liabilities and advanced into clinical evaluation. The phenoxypropylamine pharmacophore is a common H<sub>3</sub> chemotype that had been optimized by several research groups, with substitution of the central phenyl core providing potency and accessory functionality to modulate pharmacokinetics, selectivity, and physical properties.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> Early biphenylphenoxypropylamine candidates, e.g., {4â²-[3-((2<i>R</i>,5<i>R</i>)-2,5-dimethylpyrrolidin-1-yl)propoxy]biphenyl-4-yl}morpholin-4-ylmethanone (<b>1a</b>, A-349821) had cognitive enhancing activity in animal models but had low brain permeability and cardiovascular liabilities,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and 4â²-[3-((<i>S</i>)-3-dimethylaminopyrrolidin-1-yl)propoxy]biphenyl-4-carbonitrile (<b>1b</b>, A-331440) was positive in an in vitro micronucleus test.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> A design strategy to rigidify the skeleton to enhance the overall druglike properties and selectivity produced 4-{2-[2-((<i>R</i>)-2-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl}benzonitrile (<b>1c</b>, ABT-239).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a><b>1c</b> had an impressive in vivo profile for cognition enhancement but had high plasma protein binding, high brain to plasma partitioning, and the potential to induce phospholipidosis.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Its development was ultimately halted because of hERG and cardiovascular liabilities.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Merck & Co. advanced 2-methyl-3-[4-(3-pyrrolidin-1-ylpropoxy)phenyl]-5-trifluoromethyl-3<i>H</i>-quinazolin-4-one (<b>2</b>, MK-0249) as a clinical candidate.<a onclick="showRef(event, 'cit17a cit17b'); return false;" href="javascript:void(0);" class="ref cit17a cit17b">(17a, 17b)</a><b>2</b> had high affinity (hH<sub>3</sub><i>K</i><sub>i</sub> = 1.7 nM) and a good safety profile, but it had poor brain permeability in rodents due to P-glycoprotein (P-gp) mediated efflux.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Preclinically, <b>2</b> was only effective in promoting histamine release in rat at 30 g/kg po.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a><b>2</b> completed three phase II trails (adult ADHD, treatment of AD, and the cognitive domain of schizophrenia (CDS)); however, it failed to improve cognition in schizophrenia patients dosed for 4 weeks and also failed to improve adult ADHD at 10 mg.<a onclick="showRef(event, 'cit5g'); return false;" href="javascript:void(0);" class="ref cit5g">(5g)</a> Merck & Co. has advanced a second compound (MK-3134, undisclosed structure) into the clinic for cognition.<a onclick="showRef(event, 'cit5g'); return false;" href="javascript:void(0);" class="ref cit5g">(5g)</a> 1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine (<b>3</b>, BF2.649, pitrolisant) reportedly is in late stage clinical trials for a number of potential indications, including cognitive enhancement, schizophrenia, and antiepileptic activity.<a onclick="showRef(event, 'cit5e cit5g ref18'); return false;" href="javascript:void(0);" class="ref cit5e cit5g ref18">(5e, 5g, 18)</a> However, its development and drugability have been questioned, since <b>3</b> had limited oral bioavailability, was a potent inhibitor of CYP2D6 and hERG, and had the potential for inducing phospholipidosis.<a onclick="showRef(event, 'cit5d'); return false;" href="javascript:void(0);" class="ref cit5d">(5d)</a> 6-(3-Cyclobutyl-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>d</i>]azepin-7-yloxy)-<i>N</i>-methylnicotinamide (<b>4</b>, GSK189254) enhanced cognitive performance preclinically and advanced to phase II for narcolepsy and was in early clinical trials for AD.<a onclick="showRef(event, 'ref19 cit5d cit5e cit5g'); return false;" href="javascript:void(0);" class="ref ref19 cit5d cit5e cit5g">(19, 5d, 5e, 5g)</a> Reports indicate clinical development on <b>4</b> was terminated, and GlaxoSmithKline advanced a second candidate (GSK239512, undisclosed structure) into phase II for treatment of cognitive deficits in AD.<a onclick="showRef(event, 'cit5d cit5e cit5f cit5g cit5h cit5i'); return false;" href="javascript:void(0);" class="ref cit5d cit5e cit5f cit5g cit5h cit5i">(5d-5i)</a> Pfizer advanced 3-fluoro-3-(3-fluoro-4-pyrrolidin-1-ylmethylphenyl)cyclobutanecarboxylic acid ethylamide (<b>1d</b>, PF-3654746). However, it failed in a phase II ADHD trial and was discontinued.<a onclick="showRef(event, 'cit5g'); return false;" href="javascript:void(0);" class="ref cit5g">(5g)</a> Early diamine compounds from Johnson & Johnson had exceptionally long bio-half-life and brain residency time and induced phospholipidosis.<a onclick="showRef(event, 'cit5e'); return false;" href="javascript:void(0);" class="ref cit5e">(5e)</a> The diamine (4-cyclopropylpiperazin-1-yl)-(4-morpholin-4-ylmethylphenyl)methanone (<b>1e</b>, JNJ-31001074, bavisant) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) completed a phase II ADHD trial, but no results have not been reported.<a onclick="showRef(event, 'cit5k'); return false;" href="javascript:void(0);" class="ref cit5k">(5k)</a></div><div class="NLM_p">We have identified a novel class of pyridazin-3-one H<sub>3</sub>R antagonists/inverse agonists with excellent drug properties, safety, and in vivo profile. Reported in this paper is the discovery, preliminary structureâactivity relationships (SARs), and profile of the potent pyridazin-3-one H<sub>3</sub>R clinical candidate 6-{4-[3-(<i>R</i>)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2<i>H</i>-pyridazin-3-one (<b>8a</b>, CEP-26401, irdabisant).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/medium/jm-2011-00401v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of representative H<sub>3</sub>R antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200401v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86682" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86682" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthetic routes for the 6-arylpyridazin-3-one derivatives reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> are outlined in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>â<a class="ref internalNav" href="#sch3" aria-label="3">3</a>. The 2<i>H</i>-pyridazin-3-one analogues were synthesized using two methods. Method A (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) utilizes an aldol/hydrazine cyclocondensation sequence to construct the pyridazinone ring.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In the scheme, the aminopropoxy side chain can be efficiently installed either before or after the pyridazinone ring synthesis. Alkylation of 4-hydroxyacetophenone with 3-bromo-1-chloropropane quantitatively produced <b>6</b>. Compound <b>6</b> was reacted with glyoxalic acid monohydrate in acetic acid at 100 Â°C, followed by cyclocondensation of the resulting Aldol adduct with hydrazine to give the 2<i>H</i>-pyridazin-3-one <b>7</b> in 57% yield. Alkylation of chloro <b>7</b> with (<i>R</i>)-2-methylpyrrolidine produced <b>8a</b> in high yield and purity. Analogues <b>8b</b>, <b>8c</b>, and <b>8d</b> were synthesized by first converting chloro <b>6</b> to aminoketones <b>9a</b>â<b>c</b>, which were then subjected to the glyoxalic acid/hydrazine procedure to produce the 2<i>H</i>-pyridizan-3-ones. In method B (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), a palladium catalyzed Suzuki cross-coupling reaction was used to install the pyridazine moiety. Commercially available 4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)phenol <b>10</b> was alkylated with 3-bromo-1-chloropropane (or 1,3-dibromopropane) to give the chlorodioxaborolane intermediate <b>11</b>, which was converted to the versatile aminoborolane reagent (<i>R</i>)-2-methyl-1-{3-[4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)phenoxyl]propyl}pyrrolidine <b>12</b> in high yield. Suzuki coupling of <b>12</b> with 3,6-dichloropyridazine produced 3-chloropyridazine <b>13</b>. Chloro displacement/hydrolysis using sodium acetate in acetic acid at 115 Â°C cleanly converted 3-chloro <b>13</b> to the 2<i>H</i>-pyridazin-3-one <b>8a</b>. The N<sup>2</sup>-substituted derivatives were synthesized as outlined in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> by cyclocondensation of 4-(4-methoxyphenyl)-4-oxobutyric acid <b>14</b> with various N-substituted hydrazine derivatives.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> For example, reaction of methylhydrazine and <b>14</b> in 2-propanol produced the 2-methyl-4,5-dihydropyridazin-3-one <b>15a</b>. Intermediate <b>15a</b> was oxidized to <b>16a</b> using MnO<sub>2</sub><a onclick="showRef(event, 'cit22a'); return false;" href="javascript:void(0);" class="ref cit22a">(22a)</a> or CuCl<sub>2</sub> in acetonitrile,<a onclick="showRef(event, 'cit22b'); return false;" href="javascript:void(0);" class="ref cit22b">(22b)</a> then O-demethylated to phenol <b>17a</b> with BBr<sub>3</sub> in dichloromethane. The (<i>R</i>)-2-methylpyrrolidinylpropoxy side chain was installed by standard conditions via chloro <b>18a</b> to give 2-methylpyridazin-3-one <b>19a</b>. <b>19b</b>â<b>e</b> were synthesized in an analogous manner starting with the corresponding N-substituted hydrazine. Amine analogues <b>20a</b>â<b>c</b> were synthesized from <b>18a</b>â<b>c</b> as outlined in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. The 5-aryl-2<i>H</i>-pyridazinone regiomer <b>21</b> was synthesized using the Suzuki method coupling dioxaborolane <b>12</b> with 2-hydroxymethyl-5-iodo-2<i>H</i>-pyridazin-3-one (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Deprotection of the <i>N</i><sup>2</sup>-hydroxymethyl readily occurs in the workup. The <i>N</i><sup>2</sup>-arylpyridazinone regiomer <b>25</b> was synthesized by copper mediated coupling of (<i>R</i>)-1-[3-(4-bromophenoxy)propyl]-2-methylpyrrolidine <b>24</b> with 2<i>H</i>-pyridazin-3-one as outlined in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Pyridazin-3-one in Vitro and PK Data</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/medium/jm-2011-00401v_0009.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/medium/jm-2011-00401v_0010.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">See <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for methods. Administration at 1 mg/kg iv. <i>t</i><sub>1/2</sub> in h. CL in (mL/min)/kg.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Protocol as described in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">5 mg/kg po administration. Calculated from 6 h AUC values.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">10 mg/kg po administration. Calculated from 24 h AUC values.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Not tested.</p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last"><i>B</i>/<i>P</i> = brain to plasma ratio.</p></div><div class="footnote" id="t1fn7"><sup>Table g</sup><p class="last">Data in parentheses taken from ref <a onclick="showRef(event, 'cit15a'); return false;" href="javascript:void(0);" class="ref cit15a">15a</a>.</p></div></div><div></div></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/medium/jm-2011-00401v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200401v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, 3-bromo-1-chloropropane, acetone, 65 Â°C, 99%; (b) CHOCO<sub>2</sub>HÂ·H<sub>2</sub>O, HOAc, 100 Â°C; (c) N<sub>2</sub>H<sub>4</sub>âH<sub>2</sub>O, 35â66%, two steps; (d) (<i>R</i>)-2-methylpyrrolidine, NaI, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 80 Â°C, 41%; (e) <b>9a</b> (<i>S</i>)-2-methylpyrrolidine, NaI, CH<sub>3</sub>CN, reflux, 93%; <b>9b</b> pyrrolidine, NaI, CH<sub>3</sub>CN, reflux, 72%; <b>9c</b> morpholine, NaI, CH<sub>3</sub>CN, reflux, 85%.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/medium/jm-2011-00401v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200401v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-bromo-3-chloropropane, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN; (b) (<i>R</i>)-2-methylpyrrolidine, NaI, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 80 Â°C, 65%, two steps; (c) Pd(OAc)<sub>2</sub>, Ph<sub>3</sub>P, 3,6-dichloropyridazine, THF, EtOH, 80 Â°C, 90%; (d) HOAc, NaOAc 115 Â°C, 86%.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/medium/jm-2011-00401v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200401v&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>15a</b> MeNHNH<sub>2</sub>; <b>15b</b> EtNHNH<sub>2</sub>; <b>15c</b><i>i</i>-PrNHNH<sub>2</sub>; <b>15d</b> PhNHNH<sub>2</sub>; <b>15e</b> BnNHNH<sub>2</sub>, 2-propanol, reflux; (b) MnO<sub>2</sub>, xylenes, 155 Â°C; (c) Cu(II)Cl<sub>2</sub>, CH<sub>3</sub>CN, reflux, 71â94%, two steps; (d) BBr<sub>3</sub>, DCM, 5 Â°C â room temp, 92â98%; (e) K<sub>2</sub>CO<sub>3</sub>, 3-bromo-1-chloropropane, acetone, 65 Â°C, 78â92%; (f) (<i>R</i>)-2-methylpyrrolidine, NaI, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN 80 Â°C, 48â88%; (g) <b>20a</b> piperidine, 71%; <b>20b</b> (<i>S</i>)-1-pyrrolidin-2-yl-methanol, 53%; <b>20c</b> (<i>R</i>)-1-pyrrolidin-2-yl-methanol, 50%.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/medium/jm-2011-00401v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200401v&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (PPh<sub>3</sub>)<sub>4</sub>Pd(0), K<sub>2</sub>CO<sub>3</sub>, 2-hydroxymethyl-5-iodo-2<i>H</i>-pyridazin-3-one, DME, reflux 48 h, 63%.</p></p></figure><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/medium/jm-2011-00401v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200401v&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, 3-bromo-1-chloropropane, acetone, 65 Â°C, 92%; (b) (<i>R</i>)-2-methylpyrrolidine, NaI, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN 80 Â°C, 97%; (c) 2<i>H</i>-pyridazin-3-one, Cu(0), pyr, reflux 18 h, 36%.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10762" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10762" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the lead optimization processes particular attention was placed on issues early in the discovery flow that have plagued the H<sub>3</sub>R field, such as high lipophilicity, hERG, and PK, to accelerate the drug discovery process. While important for CNS penetration, lipophilicity contributes significantly to high plasma protein binding, hERG activity and the potential to induce phospholipidosis, a toxicity associated with cationic amphiphilic compounds that bind to and accumulate in phospholipid bilayers of cells, causing decreased turnover and accumulation of endosomal and lysosomal phospholipids as lamellar bodies.<a onclick="showRef(event, 'ref10 ref23'); return false;" href="javascript:void(0);" class="ref ref10 ref23">(10, 23)</a> A logâ<i>P</i> criterion of less than 3.0 was set for advancing compounds based on correlations established early in the program with hERG activity and also the propensity for high tissue distribution. In the discovery flow, compounds meeting binding affinity criteria (hH<sub>3</sub><i>K</i><sub>i</sub> < 15 nM, rH<sub>3</sub><i>K</i><sub>i</sub> < 50 nM) were screened for selectivity against hH<sub>1</sub>, hH<sub>2</sub>, and hH<sub>4</sub> receptor subtypes, for aqueous solubility (pH 2 and pH 7.4), in vitro liver microsomal stability (rat, mouse, dog, and human), and inhibition of CYP isoforms (1A2, 2C9, 2C19, 2D6, and 3A4). The selectivity profiles of compounds meeting criteria were further assessed for activity against GPCRs, ion channels, and enzymes. Compounds of interest at this stage were screened in in vivo rat PK experiments designed to evaluate the intrinsic intravenous (iv) PK parameters (<i>t</i><sub>1/2</sub>, CL, <i>V</i><sub>d</sub>), oral (po) bioavailability and brain partitioning. Those that met criteria for rat PK (and compounds of interest to develop structureâactivity relationships) were screened in a functional hERG patch clamp assay for initial assessment of potential QTc liabilities. High quality compounds were then prioritized and advanced into in vivo efficacy models and further PK and safety profiling.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> StructureâActivity Relationships</h3><div class="NLM_p">The H<sub>3</sub>R SAR was developed using in vitro binding assays by displacement of [<sup>3</sup>H]<i>N</i>-Î±-methylhistamine ([<sup>3</sup>H]NAMH) in membranes isolated from CHO cells transfected with cloned human H<sub>3</sub> or rat H<sub>3</sub> receptors.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> An H<sub>3</sub>R binding assay using membranes prepared from rat cortex was used to compare the recombinant rat assay to a native tissue. A summary of the pyridazin-3-one in vitro data in comparison to the reference compound <b>1c</b> is shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. The SAR for the N<sup>2</sup>âH series showed that the (<i>R</i>)-2-methylpyrrolidine <b>8a</b> had high affinity for both hH<sub>3</sub>Rs and rH<sub>3</sub>Rs (<i>K</i><sub>i</sub> = 2.0 and 7.2 nM) with a low clogP (2.3). Also, binding affinity of <b>8a</b> to rat cortical membranes (<i>K</i><sub>i</sub> = 2.7 Â± 0.2 nM) compared favorably to the recombinant rH<sub>3</sub>R data. The preference for the <i>R</i>-isomer was established early in the project, as the (<i>S</i>)-2-methylpyrrolidine isomer <b>8b</b> had weaker affinity for hH<sub>3</sub>R and rH<sub>3</sub>R with eudismic ratios of 8 and 7, respectively (hH<sub>3</sub><i>K</i><sub>i</sub> = 16 Â± 3 nM, rH<sub>3</sub><i>K</i><sub>i</sub> = 50 Â± 8 nM). It is interesting to note that the SAR with <b>1c</b> revealed little enantioselectivity between the (<i>R</i>)- and (<i>S</i>)-2-methylpyrrolidine isomers.<a onclick="showRef(event, 'cit15a ref17'); return false;" href="javascript:void(0);" class="ref cit15a ref17">(15a, 17)</a> The SAR for the amine moiety was further evaluated with a series of amine replacements of the (<i>R</i>)-2-methylpyrrolidine. The des-2-methylpyrrolidine <b>8c</b> and the piperidine <b>8d</b> had 8-fold and 4-fold weaker hH<sub>3</sub>R affinity, respectively. The morpholine analogue <b>8e</b> had an hH<sub>3</sub><i>K</i><sub>i</sub> of 767 nM, potentially due to the lower p<i>K</i><sub>a</sub> (7.1) compared to that of <b>8a</b> (p<i>K</i><sub>a</sub> = 10.2). The effect of substitution of the <i>N</i><sup>2</sup>-pyridazin-3-one nitrogen showed that significant steric bulk could be accommodated without affecting binding affinity. Methyl <b>19a</b>, ethyl <b>19b</b>, isopropyl <b>19c</b>, and phenyl (<b>19d</b>) substitution had essentially equivalent binding affinity for both hH<sub>3</sub>R and rH<sub>3</sub>R compared to <b>8a</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Although the potency was unaffected, increasing the size of the R<sup>2</sup> group greater than methyl resulted in compounds with clogP values greater than 3, negatively affecting molecular weight and decreasing the ligand efficiency (LE)<a onclick="showRef(event, 'cit25a'); return false;" href="javascript:void(0);" class="ref cit25a">(25a)</a> and the ligand lipophilic efficiency (LLE).<a onclick="showRef(event, 'cit25b cit25c'); return false;" href="javascript:void(0);" class="ref cit25b cit25c">(25b, 25c)</a> The LLE values for <b>8a</b> and <b>19a</b> based on the measured logâ<i>D</i> at pH 7.4 were 8.1 and 8.0, respectively. The LE values were as follows: <b>8a</b> = 0.52, <b>19a</b> = 0.50, <b>19c</b> = 0.44, phenyl <b>19d</b> = 0.40, and benzyl <b>19e</b> = 0.37. The SAR trend for the amine in the <i>N</i><sup>2</sup>-Me series (<b>19a</b>) was consistent with the NH series. The piperidine analogue <b>20a</b> had 15-fold weaker affinity compared to the (<i>R</i>)-2-methylpyrrolidine <b>19a</b>. Incorporating an alcohol on the <i>R</i>-methylpyrrolidine (<b>20b</b>) reduced affinity 7-fold, with the <i>S</i>-isomer preferred over <i>R</i> (compare <b>20b</b> vs <b>20c</b>). The position of attachment of the pyridazin-3-one ring to the central phenoxy core was also explored. The 5-pyridazin-3-one regiomer <b>21</b> had high affinity (hH<sub>3</sub>R <i>K</i><sub>i</sub> = 2.8 nM, rH<sub>3</sub>R <i>K</i><sub>i</sub> = 8.5 nM) but lower bioavailability (<i>F</i> = 24%) compared to regiomer <b>8a</b>. The <i>N</i><sup>2</sup>-pyridazinone isomer <b>25</b> had over 40-fold weaker affinity.</div><div class="NLM_p">The pyridazin-3-ones were potent antagonists and displayed full inverse agonist activity in the guanosine 5â²-(Î³-thio)triphosphate ([<sup>35</sup>S]GTPÎ³S) binding assay<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Compounds <b>8a</b>, <b>19a</b>, and <b>21</b> potently inhibited <i>R</i>-Î±-methylhistamine (RAMH) induced [<sup>35</sup>S]GTPÎ³S binding at recombinant rH<sub>3</sub>R (<b>8a</b><i>K</i><sub>b</sub> = 1.0 Â± 0.2 nM) and hH<sub>3</sub>R (<b>8a</b><i>K</i><sub>b</sub> = 0.4 Â± 0.1 nM). Compound <b>8a</b> decreased basal activity with EC<sub>50</sub> of 2.0 Â± 0.8 and 1.1 Â± 0.0 nM for rat and human H<sub>3</sub>R, respectively. Inverse agonist data for analogues <b>19a</b> and <b>21</b> were comparable to data for <b>8a</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Functional and in Vivo Activity for Selected Pyridazin-3-ones</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="2" align="center">human GTPÎ³S</th><th class="rowsep1 colsep0" colspan="2" align="center">rat GTPÎ³S</th><th class="colsep0 rowsep0" align="center">Â </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>b</sub>, nM<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub>, nM<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>b</sub>, nM<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub>, nM<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">rat dispogenia<br /></br>ED<sub>50</sub>, mg/kg</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="left">0.4 Â± 0.1</td><td class="colsep0 rowsep0" align="left">1.1 Â± 0.0</td><td class="colsep0 rowsep0" align="left">1.1 Â± 0.2</td><td class="colsep0 rowsep0" align="left">2.0 Â± 0.8</td><td class="colsep0 rowsep0" align="left">0.06 (0.01â0.3)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">0.01 (0.001â0.08)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="left">0.5 Â± 0.1</td><td class="colsep0 rowsep0" align="left">1.0 Â± 0.1</td><td class="colsep0 rowsep0" align="left">1.1 Â± 0.3</td><td class="colsep0 rowsep0" align="left">2.2 Â± 0.6</td><td class="colsep0 rowsep0" align="left">0.14 (0.1â1.9)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">0.4 Â± 0.2</td><td class="colsep0 rowsep0" align="left">1.1 Â± 0.1</td><td class="colsep0 rowsep0" align="left">1.3 Â± 0.6</td><td class="colsep0 rowsep0" align="left">2.1 Â± 0.2</td><td class="colsep0 rowsep0" align="left">0.03 (0.02â0.05)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Antagonist.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Inverse agonist.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">po administration.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">ip administration.</p></div></div></div><div class="NLM_p last">Compounds meeting H<sub>3</sub>R affinity and in vitro metabolic stability criteria (<i>t</i><sub>1/2</sub> > 40 min) in liver microsomes (data not shown) were screened for pharmacokinetic properties in the rat (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The N<sup>2</sup>-H <b>8a</b> showed a <i>t</i><sub>1/2</sub> of 2.6 h following iv administration, high systemic clearance, high oral bioavailability (<i>F</i> = 83%), and good brain exposure in the rat (brain to plasma ratio <i>B</i>/<i>P</i> = 2.6). The piperidine <b>8d</b> had significantly lower oral bioavailability (<i>F</i> = 11%). The N<sup>2</sup>-Me <b>19a</b> showed acceptable oral bioavailability (<i>F</i> = 39%) with good brain exposure in the rat (<i>B</i>/<i>P</i> = 3.5). Extensive in vivo PK experiments in rat, dog, and monkey following administration of <b>19a</b> showed N-demethylation to the N<sup>2</sup>H compound <b>8a</b>. On the basis of the presence of the active metabolite <b>8a</b>, compound <b>19a</b> was not further advanced in discovery and <b>8a</b> was selective for advanced testing. The in vivo rat PK SAR indicated that although <b>19b</b>â<b>d</b> showed acceptable in vitro metabolic stability (<i>t</i><sub>1/2</sub> > 40 min in rat liver microsomes), R<sup>2</sup> substituents larger than methyl had poor pharmacokinetics following iv administration with short <i>t</i><sub>1/2</sub> and high CL (<b>19b</b> and <b>19c</b>) or low oral bioavailability (<b>19d</b> and <b>19e</b>). The <i>F</i> values were based on 6 h of oral AUCs and may be reflective of the high tissue distribution due to the high clogP.</div></div><div id="sec3_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Selectivity of <b>8a</b></h3><div class="NLM_p last">Compound <b>8a</b> had greater than 1000-fold selectivity versus histamine hH<sub>1</sub>, hH<sub>2</sub>, and hH<sub>4</sub> receptor subtypes (<11% inhibition at 10 Î¼M) and against a panel of 176 GPCRs, ion channels and enzymes (MDS Pharma Services, Seattle, WA). In this panel <b>8a</b> had only modest activity at muscarinic M<sub>2</sub> (<i>K</i><sub>i</sub> = 3.7 Â± 0.0 Î¼M) and adrenergic Î±<sub>1A</sub> (<i>K</i><sub>i</sub> = 9.8 Â± 0.3 Î¼M) receptors, dopamine (DAT, <i>K</i><sub>i</sub> = 11 Â± 2 Î¼M) and norepinephrine (NET, <i>K</i><sub>i</sub> = 10 Â± 1 Î¼M) transporters, and phosphodiesterase PDE3 (IC<sub>50</sub> = 15 Â± 1 Î¼M). <b>8a</b> also showed negligible inhibition against 242 kinases (<20% inhibition at 1 Î¼M) and human PARP1 (IC<sub>50</sub> > 30 Î¼M).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Functional inhibition of recombinant human DAT (IC<sub>50</sub> = 9.4 Î¼M) and NET (IC<sub>50</sub> = 17.5 Î¼M) was determined, which confirmed weak inhibitory activity for these transporters.</div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Pharmaceutics Properties of <b>8a</b></h3><div class="NLM_p last">Both the hydrochloride salt and free base forms were crystalline as assessed by X-ray power diffraction. On the basis of its high water solubility (pH 2 and pH 7.4, >2 mg/mL), the HCl salt form was formulated in saline for in vivo pharmacokinetic and animal studies. The permeability of <b>8a</b> (free base) was also evaluated in the Caco-2 intestinal epithelial cell line where it showed high permeability (<i>P</i><sub>app</sub> = 13.5 Â± 0.9 Ã 10<sup>â6</sup> cm/s).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The permeability directional ratio (PDR) was less than 2, indicating minimal interaction with efflux transporters such as P-gp. A battery of physicochemical and ADME drug properties were calculated (Tripos, Schrodinger QikProp, ACD Labs) and monitored to aid in the design of NCEs. The logâ<i>D</i><sub>7.4</sub> and clogP calculations provided permeability information on the percent drug that distributed into a nonaqueous lipid layer. <b>8a</b> had a clogP of 2.3 (Tripos method) and measured logâ<i>D</i><sub>7.4</sub> of 0.6, in the ideal range for a CNS drug. <b>8a</b> was only minimally bound to plasma proteins of rat (39%), dog (32%), and human (44%) in vitro. The unbound fraction in rat brain homogenate,<a onclick="showRef(event, 'cit28a'); return false;" href="javascript:void(0);" class="ref cit28a">(28a)</a> an important property for CNS in vivo activity,<a onclick="showRef(event, 'cit28b'); return false;" href="javascript:void(0);" class="ref cit28b">(28b)</a> was also high (40%) and comparable with the unbound fraction found in rat plasma.</div></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Drug Metabolism and Pharmacokinetic Properties of <b>8a</b></h3><div class="NLM_p">The in vitro metabolic stability profile of <b>8a</b> following incubation with rat, mouse, dog, and human liver microsomes was consistent showing a <i>t</i><sub>1/2</sub> greater than 40 min (>98% remaining at 40 min) in each species.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Because of the high metabolic stability, an accurate in vitro intrinsic clearance could not be calculated. <b>8a</b> inhibited the cytochrome P450 enzymes CYP1A2, 2C9, 2C19, 2D6, and 3A4 with IC<sub>50</sub> values of greater than 30 Î¼M, indicating minimal potential for drugâdrug interactions. <b>8a</b> demonstrated low CYP3A4 induction (<2-fold) at concentrations up to 30 Î¼M (Puracyp, Carlsbad, CA).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p">The interspecies pharmacokinetic properties of <b>8a</b> were studied in rat, dog, and monkey (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The PK parameters for rat shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> were calculated from composite mean plasma concentrationâtime data from 12 rats following administration of 1 mg/kg iv and 3 mg/kg po. The PK parameters for dog (<i>n</i> = 3) and monkey (<i>n</i> = 4) were calculated using plasma concentrationâtime data for individual animals. Following administration of a single po dose, <b>8a</b> was rapidly absorbed with high oral bioavailability in rat and monkey (<i>F</i> = 83%), compared to dog (<i>F</i> = 22%). The iv terminal half-life was 2.6 h in rat, 2.9 h in dog, and 5.4 h in monkey, and <b>8a</b> had a moderate clearance in monkey and dog compared to the rat. <b>8a</b> was not extensively metabolized in vitro, and a potential explanation for the discrepancy between in vitro and in vivo clearance in rat is a high degree of renal excretion and the fact that the biliary excretion component across species is unknown. The volume of distribution (<i>V</i><sub>d</sub>) in monkey was 3.8 Â± 0.9 L/kg with a clearance rate of 7.7 Â± 1.8 (mL/min)/kg. The measured brain to plasma ratio was 2.6 in rat and 2.4 in dog. Dose related systemic exposure (<i>C</i><sub>max</sub> and AUC) to <b>8a</b> was observed after increasing oral doses in each species. Tissue distribution studies with <b>8a</b> in male SpragueâDawley rats were run to determine tissue clearance rate from brain, liver, lung, spleen, kidney, and heart and to evaluate the potential for accumulation as an early indication of phospholipidosis-inducing potential. A single 10 mg/kg po dose of <b>8a</b> was cleared in a parallel manner from all tissues and plasma by greater than 98% at 24 h, with low levels of <b>8a</b> remaining only in liver, kidney, and spleen.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Pharmacokinetic Properties of <b>8a</b> across Species</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">rat<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">dog<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">monkey<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv <i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">5.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>d</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">9.4</td><td class="colsep0 rowsep0" align="left">3.5 Â± 1.1</td><td class="colsep0 rowsep0" align="left">3.8 Â± 0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL ((mL/min)/kg)</td><td class="colsep0 rowsep0" align="left">42</td><td class="colsep0 rowsep0" align="left">13.2 Â± 1.5</td><td class="colsep0 rowsep0" align="left">7.7 Â± 1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po AUC (ngÂ·h/mL)</td><td class="colsep0 rowsep0" align="left">984</td><td class="colsep0 rowsep0" align="left">1190 Â± 180</td><td class="colsep0 rowsep0" align="left">1919 Â± 611</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="left">270</td><td class="colsep0 rowsep0" align="left">230 Â± 70</td><td class="colsep0 rowsep0" align="left">760 Â± 74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="left">5.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">83</td><td class="colsep0 rowsep0" align="left">22 Â± 2</td><td class="colsep0 rowsep0" align="left">83 Â± 18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>B</i>/<i>P</i></td><td class="colsep0 rowsep0" align="left">2.6 Â± 0.2</td><td class="colsep0 rowsep0" align="left">2.4 Â± 0.4<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Administered at 1 mg/kg iv and 3 mg/kg po. Parameters were calculated from composite mean plasma concentrationâtime data (<i>n</i> = 12).</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Administered at 1 mg/kg iv and 3 mg/kg po for dog and 1 mg/kg iv and po for monkey. Parameters were calculated using plasma concentrationâtime data for individual animals (dog <i>n</i> = 3; monkey <i>n</i> = 4).</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Calculated from 5 mg/kg po dose (<i>n</i> = 4).</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Not determined.</p></div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Drug Safety</h3><div class="NLM_p">As a class, the present H<sub>3</sub>R pyridazin-3-one inverse agonists displayed low inhibition of the hERG channel current, a surrogate for the rapidly activating delayed rectifier cardiac potassium current (<i>I</i><sub>kr</sub>). The hERG current IC<sub>50</sub> for <b>8a</b> was 13.8 Â± 0.8 Î¼M (Cerep, recombinant human hERG/HEK-293 cells). Analogues <b>19a</b> and <b>21</b> had IC<sub>50</sub> of 13 and 9.5 Î¼M, respectively. Interaction with the hERG cardiac potassium channel has been implicated in the development of acquired long QT syndrome and a potentially fatal form of ventricular arrhythmia known as torsade de pointes.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p last"><b>8a</b> was nonclastogenic and nonmutagenic and did not induce mutation in the Ames assay in the presence and absence of rat liver S9 metabolic activation. <b>8a</b> did not induce micronuclei in vitro in a micronucleus test in cultured human peripheral blood lymphocytes in the presence or absence of metabolic activation (<i>n</i> = 2). <b>8a</b> was well tolerated in nonclinical toxicology studies up to 28 days in rats and monkeys, and no issues were observed with cardiovascular safety and respiratory pharmacology in the monkey.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> In Vivo Activity in the Rat Dipsogenia Model</h3><div class="NLM_p last">The rat dipsogenia model was used as a measure of H<sub>3</sub>R blockade in the CNS following peripheral administration of NCEs. Histamine and the H<sub>3</sub>-selective agonist RAMH induce water drinking in the rat when administered either peripherally or centrally, an effect blocked by H<sub>3</sub>R antagonists.<a onclick="showRef(event, 'ref19 ref24 ref32'); return false;" href="javascript:void(0);" class="ref ref19 ref24 ref32">(19, 24, 32)</a> Activity in this model may be predictive of efficacy in cognitive models.<a onclick="showRef(event, 'ref13 cit15b cit15c ref33'); return false;" href="javascript:void(0);" class="ref ref13 cit15b cit15c ref33">(13, 15b, 15c, 33)</a><b>8a</b> dose-dependently (ED<sub>50</sub> = 0.01 (0.001â0.08) mg/kg ip; ED<sub>50</sub> = 0.06 (0.01â0.3) mg/kg po) inhibited RAMH-induced dipsogenia when administered 15 min prior to RAMH. Compounds <b>19a</b> and <b>21</b> had ED<sub>50</sub> of 0.01 (0.004â0.03) and 0.03 (0.02â0.05) mg/kg ip, respectively. <b>8a</b> was also efficacious in cognition models.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> CNS Therapeutic Index</h3><div class="NLM_p last">H<sub>3</sub>R antagonists/inverse agonists can induce hypothermia, piloerection, loss of righting reflex, irritability, hypoactivity, ptosis, tremors, and even seizures.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The CNS side effects of <b>8a (</b>10, 30, 100, and 300 mg/kg po) were assessed in the Irwin test, a systematic observational battery that comprehensively assesses behavioral responses to pharmacologic agents<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> at time points from 15 min through 6 h. <b>8a</b> was well tolerated and was without side effects at doses up to 100 mg/kg po. The estimated brain concentration at the highest tolerated dose of 100 mg/kg po 1 h postdose was 36 Î¼M, providing a therapeutic index (TI) of >1000 using rat dipsogenia as a quantitative H<sub>3</sub> efficacy model.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33853" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33853" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last"><b>8a</b> is a novel, orally active, high affinity antagonist/inverse agonist active at human H<sub>3</sub>Rs (hH<sub>3</sub>R <i>K</i><sub>i</sub> = 2.0 nM) that has potential for use in the treatment of attentional and cognitive disorders. <b>8a</b> had greater than 1000-fold selectivity for the hH<sub>3</sub>R over the hH<sub>1</sub>R, hH<sub>2</sub>R, and hH<sub>4</sub>R subtypes and against a panel of 418 GPCRs, ion channels, enzymes, and kinases. <b>8a</b> demonstrated âidealâ pharmaceutical properties in regard to water solubility, permeability, and lipophilicity and exhibited low binding to human plasma proteins and weakly inhibited recombinant cytochrome P450 isoforms (1A2, 2C9, 2C19, 2D6, and 3A4) with low induction of CYP3A4, suggesting a minimal potential for drugâdrug interactions. In the human hERG functional patch clamp assay, <b>8a</b> had an IC<sub>50</sub> of 14 Î¼M. Metabolism of <b>8a</b> was minimal in rat, mouse, dog, and human liver microsomes. <b>8a</b> had good pharmacokinetic properties, brain permeability, and safety profile for a CNS-active drug and was selected for full preclinical development. The clinical portions of the single and multiple ascending dose studies assessing safety and pharmacokinetics have been completed allowing for the initiation of a phase IIa proof of concept study.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80310" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80310" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chemistry: General Methods</h3><div class="NLM_p last">All reagents and anhydrous solvents were obtained from commercial sources and used as received. <sup>1</sup>H NMR was obtained on a Bruker 400 MHz instrument in the solvent indicated with tetramethylsilane as an internal standard. Coupling constants (<i>J</i>) are in hertz (Hz). Liquid chromatographyâmass spectrometry (LC/MS) were run on a Bruker Esquire 2000 ion trap LCMS. Compound purity was >96% determined by high pressure liquid chromatography (HPLC) using a Zorbax RX-C8, 5 mm Ã 150 mm column, eluting with a mixture of acetonitrile and water containing 0.1% trifluoroacetic acid with a gradient of 10â100%. Compounds were purified by silica gel chromatography using an ISCO apparatus and monitored at 254 and 290 nm. Melting points were determined using a MEL-TEMP II and are uncorrected. Preparative chromatography was run using silica gel GF 20 mm Ã 20 cm Ã 1000 Î¼m plates (Analtech).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Synthesis of <b>8a</b>. Method A</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 1-[4-(3-Chloropropoxy)phenyl]ethanone (<b>6</b>)</h4><div class="NLM_p last">A mixture of 1-(4-hydroxyphenyl)ethanone <b>5</b> (20.4 g, 150 mmol), K<sub>2</sub>CO<sub>3</sub> (62.1 g, 3.0 equiv), and 3-bromo-1-chloropropane (29.6 mL, 2.0 equiv) in acetone (200 mL) was heated to 65 Â°C overnight. The mixture was cooled to room temperature, filtered, washed with acetone, and concentrated to dryness. The crude product was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (150 mL) and washed with saturated NaHCO<sub>3</sub> solution, NaCl solution and dried over Na<sub>2</sub>SO<sub>4</sub> to give <b>6</b> (31.5 g, 99% as an oil). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> Î´): 2.20 (q, 2H, <i>J</i> = 6.2 Hz), 2.51 (s, 3H), 3.80 (t, 2H, <i>J</i> = 6.2 Hz), 4.19 (t, 2H, <i>J</i> = 6.2 Hz), 7.06 (d, 2H, <i>J</i> = 8.3 Hz), 7.93 (d, 2H, <i>J</i> = 8.3 Hz). LCMS <i>m</i>/<i>z</i>: 213 (M + 1).</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 6-[4-(3-Chloropropoxy)phenyl]-2<i>H</i>-pyridazin-3-one (<b>7</b>)</h4><div class="NLM_p last">A mixture of <b>6</b> (10.6 g, 50 mmol) and glyoxalic acid monohydrate (4.6 g, 1.0 equiv) was stirred in acetic acid (15 mL) at 100 Â°C for 2 h. The solvent was evaporated, 25 mL of water was added, and the mixture was cooled to 0 Â°C while concentrated NH<sub>4</sub>OH was added to pH 8. Hydrazine monohydrate (4.76 mL, 2.0 equiv) was added, and the mixture was heated to 100 Â°C for 1 h. The reaction was complete by HPLC analysis. The resulting solid was filtered and washed with water. The crude product was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (500 mL) and washed with H<sub>2</sub>O, 5% NaHCO<sub>3</sub> solution, saturated NaCl solution, dried over Na<sub>2</sub>SO<sub>4</sub>, and purified by ISCO silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub> to 9:1 CH<sub>2</sub>Cl<sub>2</sub>/MeOH) to give <b>7</b> (7.6 g, 57%) as a white solid. Mp 191â193 Â°C (CH<sub>2</sub>Cl<sub>2</sub>âMeOH). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> Î´): 2.16 (q, 2H, <i>J</i> = 6.4 Hz), 3.81 (t, 2H, <i>J</i> = 6.4 Hz), 4.15 (t, 2H, <i>J</i> = 6.4 Hz), 6.95 (1H, d, <i>J</i> = 9.9 Hz), 7.06 (2H, d, <i>J</i> = 7.9 Hz), 7.80 (2H, d, <i>J</i> = 7.8 Hz), 8.0 (1 Hz, d, <i>J</i> = 9.9 Hz). LCMS <i>m</i>/<i>z</i>: 265 (M + 1).</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 6-{4-[3-(<i>R</i>)-2-Methylpyrrolidin-1-yl)propoxy]phenyl}-2<i>H</i>-pyridazin-3-one (<b>8a</b>)</h4><div class="NLM_p last">A mixture of <b>7</b> (5.5 g, 21 mmol), K<sub>2</sub>CO<sub>3</sub> (10.1 g, 73.5 mmol), NaI (100 mg), and (<i>R</i>)-2-methylpyrrolidine hydrochloride (5.1 g, 42 mmol) in acetonitrile (250 mL) was heated at 80 Â°C for 3 days. The reaction was complete by HPLC analysis. The mixture was filtered, washed with CH<sub>2</sub>Cl<sub>2</sub> (2 Ã 50 mL), and concentrated. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (200 mL) and washed with saturated NaHCO<sub>3</sub>, saturated NaCl solution, dried with Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The product was purified by ISCO chromatography using 100% CH<sub>2</sub>Cl<sub>2</sub> to 9:1:05 CH<sub>2</sub>Cl<sub>2</sub>/MeOH/<i>i</i>-PrNH<sub>2</sub>. The pure product was dissolved in MeOH (15 mL), filtered through 0.45 Î¼m filter, and then 30 mL of 0.5 N HCl in EtOH was added. The solvent was concentrated and the product crystallized from MeOHâether to give <b>8a</b>Â·HCl (2.65 g, 41%, 99% purity). Mp 240â242 Â°C (MeOHâether). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> Î´): 1.39 (d, 3H, <i>J</i> = 6.8 Hz), 1.64 (m, 1H), 1.95 (m, 2H), 2.17 (m, 5H), 3.07 (m, 2H), 3.40 (m, 2H), 3.61 (m, 1H), 4.15 (m, 2H), 6.96 (d, 1H, <i>J</i> = 10.0 Hz), 7.05 (d, 2H, <i>J</i> = 8.64 Hz), 7.81 (d, 2H, <i>J</i> = 8.64 Hz), 8.0 (d, 1H, <i>J</i> = 10.0 Hz), 10.52 (bs, 1H), 13.08 (s, 1H). LCMS <i>m</i>/<i>z</i>: 314 (M + 1). Anal. (C<sub>18</sub>H<sub>23</sub>ClN<sub>3</sub>O<sub>2</sub>Â·0.4H<sub>2</sub>O) C, H, N.</div></div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Synthesis of 6-{4-[3-(<i>R</i>)-2-Methylpyrrolidin-1-yl)propoxy]phenyl}-2<i>H</i>-pyridazin-3-one (<b>8a</b>). Method B</h3><div class="NLM_p last">3-Chloro-6-{4-[3-((<i>R</i>)-2-methylpyrrolodin-1-yl)propoxy]phenylpyridazine <b>13</b> (0.1 g 0.3 mmol) in 3 mL of glacial acetic acid and sodium acetate (0.027 g, 0.33 mmol) was heated to 115 Â°C for 2 h. The mixture was cooled to room temperature and then concentrated. The residue was dissolved in EtOAc and washed with saturated NaHCO<sub>3</sub>, saturated NaCl solution and dried over Na<sub>2</sub>SO<sub>4</sub>. The product was purified using ISCO silica gel chromatography (EtOAc/EtOH/NH<sub>4</sub>OH 9:1:0.5) to give <b>8a</b> an off white solid (0.081 g, 86% yield, 98% purity). This compound was identical in its physical and spectral properties to that synthesized by method A.</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 6-{4-[3-(<i>S</i>)-2-Methylpyrrolidin-1-yl)propoxy]phenyl}-2<i>H</i>-pyridazin-3-one (<b>8b</b>)</h3><div class="NLM_p last">To a round-bottom flask was added <b>9a</b> (1.8 g, 6.8 mmol), glyoxalic acid hydrate (1.3 g, 13.6 mmol), and acetic acid (10 mL). The mixture was heated at 110 Â°C for 3 h, cooled to 0 Â°C, and then diluted with water (25 mL) and NH<sub>4</sub>OH solution until pH â¼7 was obtained. To this solution was added hydrazine hydrate (1.0 mL, 20.4 mmol). Then the mixture was heated at 100 Â°C for 17 h. The mixture was cooled to room temperature, concentrated and the product purified by column chromatography (10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to give 750 mg (35% yield, >99% purity) of <b>8b</b>. Mp 156â158 Â°C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, Î´): 0.99 (d, 3H, <i>J</i> = 6 Hz), 1.23â1.32 (m, 1H), 1.59â1.67 (m, 2H), 1.80â1.96 (m, 3H), 2.00â2.14 (m, 2H), 2.20â2.28 (m, 1H), 2.87â2.94 (m, 1H), 3.05â3.10 (m, 1H), 4.07 (t, 2H, <i>J</i> = 5 Hz), 6.95 (d, 1H, <i>J</i> = 10 Hz), 7.02 (d, 2H, <i>J</i> = 8 Hz), 7.78 (d, 2H, <i>J</i> = 9 Hz), 7.98 (d, 1H, <i>J</i> = 10 Hz), 13.0 (s, 1H). LCMS <i>m</i>/<i>z</i>: 314 (M + 1).</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 6-[4-(3-Pyrrolidin-1-yl-propoxy)phenyl]-2<i>H</i>-pyridazin-3-one (<b>8c</b>)</h3><div class="NLM_p last">To a round-bottom flask was added <b>9b</b> (1.3 g, 5.1 mmol), glyoxalic acid hydrate (0.93 g, 10.1 mmol), and acetic acid (8 mL). The reaction was heated at 110 Â°C for 2 h, cooled to 0 Â°C, and then diluted with water (25 mL) and NH<sub>4</sub>OH solution until pH â¼7 was obtained. To this solution was added hydrazine hydrate (1.0 mL, 20.6 mmol). Then the mixture was heated at 100 Â°C for 21 h. The mixture was cooled to room temperature, concentrated and the product purified by column chromatography (10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to give 1.0 g (66% yield, 97% purity) of <b>8c</b>. Mp 154â157 Â°C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, Î´): 1.68 (broad s, 4H), 1.90 (m, 2H), 2.44 (broad s, 4H), 2.52 (m, 2H), 4.06 (m, 2H), 6.95 (d, 1H, <i>J</i> = 8 Hz), 7.02 (d, 2H, <i>J</i> = 9 Hz), 7.78 (d, 2H, <i>J</i> = 8 Hz), 7.99 (d, 1H, <i>J</i> = 9 Hz), 13.0 (s, 1H). LCMS <i>m</i>/<i>z</i>: 300 (M + 1).</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 6-[4-(3-Piperidin-1-yl-propoxy)phenyl]-2<i>H</i>-pyridazin-3-one (<b>8d</b>)</h3><div class="NLM_p last">This compound was synthesized by the procedure for <b>8a</b>, method B. Yield 54%, purity 98%. Mp 183â184 Â°C (EtOAcâMeOH). <sup>1</sup>H NMR (CDCl<sub>3</sub>, Î´): 1.45 (m, 2H), 1.63 (m, 6H), 2.00 (m, 2H), 2.41 (m, 2H), 2.49 (t, 2H, <i>J</i> = 7.0), 4.06 (t, 2H, <i>J</i> = 7.0), 6.97 (d, 2H, <i>J</i> = 10), 7.03 (d, 1H, <i>J</i> = 10), 7.70 (m, 3H), 11.10 (broad s,1H). LCMS <i>m</i>/<i>z</i>: 314 (M + 1).</div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 6-[4-(3-Morpholin-4-yl-propoxy)phenyl]-2<i>H</i>-pyridazin-3-one (<b>8e</b>)</h3><div class="NLM_p last">To a round-bottom flask was added <b>9c</b> (5.0 g, 19.0 mmol), glyoxalic acid hydrate (3.5 g, 47.5 mmol), and acetic acid (15 mL). The mixture was heated at 110 Â°C for 2.5 h, cooled to 0 Â°C, and then diluted with water (25 mL) and NH<sub>4</sub>OH solution until pH â¼6 was obtained. To this solution was added hydrazine hydrate (2.8 mL, 57.0 mmol). Then the mixture was heated at reflux for 20 h (during which time an additional 3 equiv of hydrazine hydrate was added). The mixture was cooled to room temperature, concentrated and the product purified by column chromatography (20% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to give 2.53 g (42% yield, 99% purity) of <b>8e</b>. Mp 156â159 Â°C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, Î´): 1.89 (m, 2H), 2.37 (broad s, 4H), 2.42 (t, 2H, <i>J</i> = 7 Hz), 3.57 (m, 4H), 4.06 (t, 2H, <i>J</i> = 6 Hz), 6.95 (d, 1H, <i>J</i> = 10 Hz), 7.02 (d, 2H, <i>J</i> = 8 Hz), 7.79 (d, 2H, <i>J</i> = 10 Hz), 7.99 (d, 1H, <i>J</i> = 9 Hz), 13.0 (s, 1H). LCMS <i>m</i>/<i>z</i>: 316 (M + 1).</div></div><div id="sec5_2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 1-{4-[3-((<i>S</i>)-2-Methylpyrrolidin-1-yl)propoxy]phenyl}ethanone (<b>9a</b>)</h3><div class="NLM_p last">To a round-bottom flask was added 4â²-hydroxyacetophenone <b>5</b> (2.0 g, 14.7 mmol), 1-bromo-3-chloropropane (1.5 mL, 15.4 mmol), potassium carbonate (6.1 g, 44.1 mmol), and acetonitrile (50 mL). After the reaction mixture was heated at reflux for 19 h, (<i>S</i>)-2-methylpyrrolidine hydrochloride (2.7 g, 22.0 mmol), sodium iodide (2.2 g, 14.7 mmol), and acetonitrile (30 mL) were added. The mixture was stirred at reflux for 24 h and then cooled to room temperature, diluted with CH<sub>2</sub>Cl<sub>2</sub> (100 mL), and filtered through a pad of Celite. The filtrate was concentrated and the residue was purified by column chromatography (5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to give <b>9a</b> (3.55 g, 93%) as an oil. LCMS <i>m</i>/<i>z</i>: 262 (M + 1).</div></div><div id="sec5_2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 1-[4-(3-Pyrrolidin-1-yl-propoxy)phenyl]ethanone (<b>9b</b>)</h3><div class="NLM_p last">To a round-bottom flask was added 4â²-hydroxyacetophenone <b>5</b> (2.0 g, 14.7 mmol), 1-bromo-3-chloropropane (1.52 mL, 15.4 mmol), potassium carbonate (6.1 g, 44.1 mmol), and acetonitrile (50 mL). After the reaction mixture was heated at 90 Â°C for 24 h, pyrrolidine (1.84 mL, 22.0 mmol), sodium iodide (2.2 g, 14.7 mmol), and acetonitrile (30 mL) were added. The mixture was stirred at reflux for 24 h, cooled to room temperature, diluted with CH<sub>2</sub>Cl<sub>2</sub> (100 mL), and filtered through a pad of Celite. The filtrate was concentrated and the residue was purified by column chromatography (5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to give <b>9b</b> (2.60 g, 72%). Mp 146â148 Â°C. LCMS <i>m</i>/<i>z</i>: 248 (M + 1).</div></div><div id="sec5_2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 1-[4-(3-Morpholin-4-yl-propoxy)phenyl]ethanone (<b>9c</b>)</h3><div class="NLM_p last">To a round-bottom flask was added 1-[4-(3-chloropropoxy)phenyl]ethanone (10.0 g, 47.0 mmol), morpholine (6.2 mL, 70.5 mmol), sodium iodide (7.1 g. 47.0 mmol), potassium carbonate (19.5 g, 141 mmol), and acetonitrile (100 mL). The reaction mixture was heated at reflux for 23 h, cooled to room temperature, and diluted with methylene chloride (100 mL). The mixture was then filtered and the filtrate was concentrated and the product purified by column chromatography (2% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to give <b>9c</b> (10.5 g, 85%) as an off-white solid. Mp 48â51 Â°C. LCMS <i>m</i>/<i>z</i>: 264 (M + 1).</div></div><div id="sec5_2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2-[4-(3-Chloropropoxy)phenyl]-4,4,5,5,-tetramethyl[1,3,2]dioxaborolane (<b>11</b>)</h3><div class="NLM_p last">To a round-bottom flask were added 4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)phenol <b>10</b> (11.0 g, 50 mmol), 1-bromo-3-chloropropane (9.9 mL, 100 mmol), potassium carbonate (20.7 g, 150 mmol), and acetonitrile (100 mL). The reaction mixture was heated at reflux for 24 h, cooled to room temperature, and was filtered. The filtrate was concentrated to give <b>11</b>. This material was used further without purification.</div></div><div id="sec5_2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (<i>R</i>)-2-Methyl-1-{3-[4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)phenoxyl]-propyl}pyrrolidine (<b>12</b>)</h3><div class="NLM_p last">To a round-bottom flask were added <b>11</b>, (<i>R</i>)-2-methylpyrrolidine, benzenesulfonic acid salt (24.3 g, 100 mmol), sodium iodide (7.5 g, 50 mmol), potassium carbonate (20.7 g, 150 mmol), and acetonitrile (100 mL). The mixture was heated at reflux for 2.5 days and was cooled to room temperature. The mixture was diluted with methylene chloride (100 mL), filtered, and concentrated. The residue was purified by column chromatography (5% MeOH in CH<sub>2</sub>CH<sub>2</sub>) to give 11.3 g (65%, two steps) of <b>12</b>. Mp 148â150 Â°C.</div></div><div id="sec5_2_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 3-Chloro-6-{4-[3-((<i>R</i>)-2-methylpyrrolidin-1-yl)propoxy]phenyl}pyridazine (<b>13</b>)</h3><div class="NLM_p last">Pd(OAc)<sub>2</sub> (2.0 g, 9.0 mmol) and Ph<sub>3</sub>P (9.4 g, 35.6 mmol) were suspended in anhydrous THF (300 mL) and stirred vigorously under a nitrogen atmosphere for 10 min. 3,6-Dichloropyridazine (26.8 g, 180 mmol) was added and stirred for 10 min. Then <b>12</b> (11.8 g, 34 mmol) in THF (200 mL) and EtOH (100 mL) were added dropwise followed by addition of saturated NaHCO<sub>3</sub> solution (360 mL). The reaction mixture was heated at 80 Â°C for 15 h, cooled to room temperature, and evaporated to a solid. This material was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (300 mL), washed with water and saturated NaHCO<sub>3</sub> solution, then dried (Na<sub>2</sub>SO<sub>4</sub>) and evaporated. The product was purified by ISCO silica gel chromatography (EtOAc to EtOAc/CH<sub>3</sub>OH (9:1) to give <b>13</b> (10.2 g, 90%) as an off-white solid. Mp 107â108.5 Â°C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, Î´): 1.10 (d, 3H), 2.99 (m, 2H), 3.18 (m, 2H), 4.10 (m, 2H), 7.04 (d, 2H), 7.50 (d, 1H), 7.78 (d, 1H), 7.99 (d, 2H).</div></div><div id="sec5_2_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 6-(4-Methoxyphenyl)-2-methyl-4,5-dihydro-2<i>H</i>-pyridazin-3-one (<b>15a</b>)</h3><div class="NLM_p last">4-(4-Methoxyphenyl)-4-oxobutyric acid <b>14</b> (27 g, 132 mmol) and methylhydrazine (7.3 g, 8.5 mL, 159 mmol) in 2-propanol (150 mL) were stirred at reflux 12 h. The solvent was concentrated to about 50 mL, and ether was added (â¼50 mL). The product was collected by filtration, washed with ether, and dried under vacuum to give <b>15a</b> (27 g, 94%, purity >96%). Mp 133â135 Â°C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, Î´): 2.57 (m, 2H), 2.9 (m, 2H), 3.4 (s, 3H), 3.8 (s, 3H), 6.9 (d, 2H), 7.6 (d, 2H). LCMS <i>m</i>/<i>z</i>: 218 (M + 1).</div></div><div id="sec5_2_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 6-(4-Methoxyphenyl)-2-methyl-2<i>H</i>-pyridazin-3-one (<b>16a</b>)</h3><div id="secy" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Method A</h4><div class="NLM_p last">In a 1 L round-bottom flask, <b>15a</b> (27 g, 124 mmol) and MnO<sub>2</sub> (30 g, 345 mmol) in xylene (250 mL) were stirred at vigorous reflux for 14 h. The mixture was cooled to room temperature and filtered through a pad of Celite. The xylene was concentrated and the resulting yellow solid was triturated with ether/hexane (1:2) and collected to produce 20 g (75%, 98% purity) of product. The Celite/MnO<sub>2</sub> pad was washed with CHCl<sub>3</sub>/MeOH 9:1 (2 Ã 100 mL), filtered, and concentrated. The residue was triturated with ether/hexane (1:2) and collected to give a second crop (4 g, 15%, 96% purity). Total yield of <b>16a</b>, 24 g (90%). Mp 109â110 Â°C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, Î´): 3.75 (s, 3H), 3.85 (s, 3H), 7.00â7.05 (m, 3H), 7.82 (d, 2H, <i>J</i> = 9.6 Hz), 8.01 (d, 1H, <i>J</i> = 8.8 Hz). LCMS <i>m</i>/<i>z</i>: 216 (M + 1).</div></div><div id="secz" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Method B</h4><div class="NLM_p last">A mixture of <b>15a</b> (3.3 g, 15 mmol) and anhydrous Cu(II)Cl<sub>2</sub> (4.0 g, 2 equiv) in 45 mL of acetonitrile was stirred at reflux for 2 h. The mixture was cooled to room temperature and poured into iceâwater (â¼100 mL). The acetonitrile was removed at reduced pressure, and the resulting off-white solid was collected, washed with water, and crystallized from EtOHâether to give <b>16a</b> (2.5 g, 76%).</div></div></div><div id="sec5_2_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 6-(4-Hydroxyphenyl)-2-methyl-2<i>H</i>-pyridazin-3-one (<b>17a</b>)</h3><div class="NLM_p last">To <b>16a</b> (10 g, 46.3 mmol) in 15 mL DCM cooled on an iceâwater bath at â¼5 Â°C was added 93 mL of BBr<sub>3</sub> (1 M solution in DCM) over 5 min. The ice bath was removed and the solution stirred at room temperature for 4 h. The mixture was cooled on an ice bath, and saturated NH<sub>4</sub>Cl solution (100 mL) was added slowly. After the addition was complete, the DCM was removed under reduced pressure, excess water added, and the product collected, washed with MeOH (20 mL), and dried to give <b>17a</b> (9.2 g, 98%). Mp 242â245 Â°C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, Î´): 3.8 (s, 3H), 6.85 (d, 2H), 7.0 (d, 1H), 7.7 (d, 2H), 7.95 (d, 1H), 9.8 (s, 1H). LCMS <i>m</i>/<i>z</i>: 203 (M + 1).</div></div><div id="sec5_2_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 6-[4-(3-Chloropropoxy)phenyl]-2-methyl-2<i>H</i>-pyridazin-3-one (<b>18a</b>)</h3><div class="NLM_p last">Phenol <b>17a</b> (0.5 g, 2.3 mmol), 3-bromo-1-chloropropane (0.7 g, 4.6 mmol), and K<sub>2</sub>CO<sub>3</sub> (1.0 g) in CH<sub>3</sub>CN (25 mL) was stirred at reflux 20 h. The mixture was filtered and concentrated. The resulting oil was dissolved in Et<sub>2</sub>O and washed with water, NaCl solution, dried (MgSO<sub>4</sub>), and concentrated. The product was triturated with Et<sub>2</sub>Oâhexanes to yield <b>18a</b> (0.6 g, 91%). Mp 186â187 Â°C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, Î´): 2.2 (m, 2H, <i>J</i> = 7 Hz), 3.7 (s, 3H), 3.8 (t, 2H, <i>J</i> = 7 Hz), 4.15 (t, 2H, <i>J</i> = 7 Hz), 7.0â7.1 (m, 3H), 7.8 (d, 2H, <i>J</i> = 7.8 Hz), 8.0 (d, 1H). LCMS <i>m</i>/<i>z</i>: 279 (M + 1).</div></div><div id="sec5_2_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 2-Methyl-6-{4-[3-((<i>R</i>)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2<i>H</i>-pyridazin-3-one (<b>19a</b>)</h3><div class="NLM_p">A mixture of <b>18a</b> (1.5 g, 5.4 mmol), K<sub>2</sub>CO<sub>3</sub> (2.2 g 16.2 mmol), NaI (0.8 g, 5.4 mmol), (<i>R</i>)-2-methylpyrrolidineâHCl (1.3 g, 10.8 mmol) in CH<sub>3</sub>CN (30 mL) was heated under N<sub>2</sub> at 90 Â°C for 2 days. The mixture was filtered and concentrated. The residue was dissolved in EtOAc and washed with 2 N Na<sub>2</sub>CO<sub>3</sub>, NaCl solution, dried (MgSO<sub>4</sub>), and concentrated. The product was purified by ISCO silica gel chromatography (95:5 DCM/MeOH). The fractions were combined and concentrated to yield <b>19a</b> (0.85 g, 48%, free base). The HCl salt was prepared by adding a 1 N HClâether solution to the base in ether. The white solid was collected and crystallized from CH<sub>3</sub>CNâether. Mp 183â185 Â°C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, Î´): 1.38 (d, 3H, <i>J</i> = 5.2 Hz), 1.62 (m, 1H), 1.92â1.97 (m, 2H), 2.1â2.3 (m, 3H), 3.1 (m, 2H), 3.4 (m, 2H), 3.6 (m, 1H), 3.7 (m, 1H), 3.7 (s, 3H), 4.15 (m, 2H), 7.0â7.17 (m, 3H), 7.8 (d, 2H, <i>J</i> = 8.6 Hz), 8.0 (d, 1H, <i>J</i> = 9.6 Hz), 10.1 (s, 1H). LCMS <i>m</i>/<i>z</i>: 328 (M + 1).</div><div class="NLM_p last">Compounds <b>19b</b>-<b>e</b> and <b>20a</b>â<b>c</b> were synthesized using the methods for <b>19a</b>.</div></div><div id="sec5_2_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 2-Ethyl-6-{4-[3-((<i>R</i>)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2<i>H</i>-pyridazin-3-one (<b>19b</b>)</h3><div class="NLM_p last">Yield 96% free base, purity 97%. Mp 58â62 Â°C (<span class="smallcaps smallerCapital">l</span>-tartrate salt, acetoneâether). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> Î´): 1.19 (d, 3H, <i>J</i> = 5.6 Hz), 1.29â1.33 (t, 3H, <i>J</i> = 7.1 Hz), 1.4 (m, 1H), 1.7 (m, 2H), 2.0 (m, 4H), 2.8 (m, 2H), 3.0 (broad, 1H), 3.2 (broad, 1H), 6.99â7.06 (m, 3H), 7.84 (d, 1H, <i>J</i> = 8.9 Hz), 7.99 (d, 2H, <i>J</i> = 9 Hz). LCMS <i>m</i>/<i>z</i>: 342 (M + 1).</div></div><div id="sec5_2_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 2-Isopropyl-6-{4-[3-((<i>R</i>)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2<i>H</i>-pyridazin-3-one (<b>19c</b>)</h3><div class="NLM_p last">Yield 88% free base, purity 98%. Mp 60â64 Â°C (<span class="smallcaps smallerCapital">l</span>-tartrate salt, CHCl<sub>3</sub>âetherâhexane). <sup>1</sup>H NMR (CDCl<sub>3</sub>, Î´): 1.09 (d, 3H, <i>J</i> = 5.8 Hz), 1.43 (d, 6H, <i>J</i> = 6.6 Hz), 1.7â1.9 (m, 2H), 1.9â2.4 (m, 7H), 2.8 (m, 1H), 3.0 (broad, 1H), 4.06â4.1 (m, 2H), 5.37 (m, 1H), 6.94â6.99 (m, 3H), 7.59 (d, 1H, <i>J</i> = 9.7 Hz), 7.73 (d, 2H, <i>J</i> = 8.7 Hz). LCMS <i>m</i>/<i>z</i>: 358 (M + 1).</div></div><div id="sec5_2_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 2-Phenyl 6-{4-[3-((<i>R</i>)-2-Methylpyrrolidin-1-yl)propoxy]phenyl}-2<i>H</i>-pyridazin-3-one (<b>19d</b>)</h3><div class="NLM_p last">Yield 88% purity 96%. Mp 82â86 Â°C (CH<sub>2</sub>Cl<sub>2</sub>). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, Î´): 1.36 (m, 3H), 1.59 (m, 1H), 1.91 (m, 2H), 2.14 (m, 3H), 3.09 (m, 2H), 3.39 (m, 2H), 3.59 (m, 1H), 4.13 (t, 2H, <i>J</i> = 4.5 Hz), 7.06 (d, 2H, <i>J</i> = 8.5 Hz,), 7.16 (d, 1H, <i>J</i> = 9.8 Hz,), 7.44 (t, 1H, <i>J</i> = 6.9 Hz,), 7.53 (t, 2H, <i>J</i> = 7.9 Hz,), 7.65 (d, 2H, <i>J</i> = 8.3 Hz,), 7.88 (d, 2H, <i>J</i> = 8.5 Hz,), 8.13 (d, 1H, <i>J</i> = 9.8 Hz,). LCMS <i>m</i>/<i>z</i>: 390 (M + 1).</div></div><div id="sec5_2_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-Benzyl-6-{4-[3-((<i>R</i>)-2-Methylpyrrolidin-1-yl)propoxy]phenyl}-2<i>H</i>-pyridazin-3-one (<b>19e</b>)</h3><div class="NLM_p last">Yield 88% free base, purity 96%. Mp 228â230 Â°C (HCl salt, MeOHâether). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, Î´): 1.37 (d, 3H, <i>J</i> = 6.2 Hz), 1.62 (m, 1H), 1.94 (m, 2H), 2.15 (m, 3H), 3.12 (m, 2H), 3.44 (m, 2H), 3.62 (m, 1H), 4.13 (t, 2H, <i>J</i> = 5.8 Hz), 5.31 (s, 2H), 7.07 (m, 3H), 7.31 (m, 3H), 7.35 (d, 2H, <i>J</i> = 4.1 Hz), 7.85 (d, 2H, <i>J</i> = 8.7 Hz), 8.04 (d, 1H, <i>J</i> = 9.5 Hz), 9.53 (broad s, 1H). LCMS <i>m</i>/<i>z</i>: 404 (M + 1).</div></div><div id="sec5_2_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 2-Methyl-6-[4-(3-piperidin-1-yl-propoxy)phenyl]-2<i>H</i>-pyridazin-3-one (<b>20a</b>)</h3><div class="NLM_p last">Yield 71%, purity 98%. Mp 200â201 Â°C (HCl salt, MeOHâether). <sup>1</sup>H NMR (CDCl<sub>3</sub>, Î´): 1.58â161 (br m, 6H), 2.00â2.04 (m, 2H), 2.4 (b, 4H), 2.47â2.51 (m, 2H), 3.86 (s, 3H), 4.06 (m, 2H), 6.95â7.0 (m, 3H), 7.63 (d, 1H, <i>J</i> = 9.7 Hz), 7.70 (d, 2H, <i>J</i> = 7 Hz). LCMS <i>m</i>/<i>z</i>: 328 (M + 1).</div></div><div id="sec5_2_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 6-{4-[3-((<i>S</i>)-2-Hydroxymethyl-pyrrolidin-1-yl)propoxy]phenyl}-2-methyl-2<i>H</i>-pyridazin-3-one Hydrochloride (<b>20b</b>)</h3><div class="NLM_p last">Yield 53%, purity 99%. Mp 169 Â°C (HCl salt, acetonitrileâhexanes). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> Î´): 1.78 (broad m, 1H), 1.90 (broad m, 1H), 2.07 (broad m, 1H), 2.10 (broad m, 1H), 2.25 (broad m, 2H), 3.09â3.20 (broad m, 2H), 3.58 (broad m, 3 H), 3.68 (m, 1H), 3.72 (s, 3H), 3.78 (m, 1H), 4.14 (t, 2H, <i>J</i> = 5.9 Hz), 5.45 (br s, 1H), 7.06 (m, 3H), 7.85 (d, 2H, <i>J</i> = 8.4 Hz), 8.03 (d, 1H, <i>J</i> = 9.7 Hz), 10.09 (br s, 1H). LCMS <i>m</i>/<i>z</i>: 344 (M + 1).</div></div><div id="sec5_2_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 6-{4-[3-((<i>R</i>)-2-Hydroxymethylpyrrolidin-1-yl)propoxy]phenyl}-2-methyl-2<i>H</i>-pyridazin-3-one Hydrochloride (<b>20c</b>)</h3><div class="NLM_p last">Yield 50%, purity 99%. Mp 166â167 Â°C (HCl salt, acetonitrileâhexanes). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> Î´): 1.78 (broad m, 1H), 1.90 (broad m, 1H), 2.07 (broad m, 1H), 2.10 (broad m, 1H), 2.24 (broad m, 2H), 3.12â3.20 (broad m, 2H), 3.59 (broad m, 3H), 3.68 (m, 1H), 3.72 (s, 3H), 3.75 (m, 1H), 4.14 (t, 2H, <i>J</i> = 5.9 Hz), 5.45 (broad s, 1H), 7.06 (m, 3H), 7.85 (d, 2H, <i>J</i> = 8.7 Hz), 8.03 (d, 1H, <i>J</i> = 9.7 Hz), 10.09 (broad s, 1H). LCMS <i>m/z:</i> 344 (M + 1).</div></div><div id="sec5_2_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 5-{4-[3-((<i>R</i>)-2-Methylpyrrolidin-1-yl)propoxy]phenyl}-2<i>H</i>-pyridazin-3-one (<b>21</b>)</h3><div class="NLM_p last">To a round-bottom flask was added <b>12</b> (3.3 g, 9.5 mmol), 2-hydroxymethyl-5-iodo-2<i>H</i>-pyridazin-3-one (2.3 g, 9.1 mmol), tetrakis(triphenylphosphine)palladium(0) (2.1 g, 1.8 mmol), potassium carbonate (6.3 g, 45.2 mmol), 1,2-dimethoxyethane (80 mL), and water (40 mL). The reaction mixture was flushed with nitrogen for 30 min and was heated at reflux for 48 h. The mixture was cooled to room temperature, filtered, and concentrated. The residue was purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/<i>i</i>-PrNH<sub>2</sub>, 9:1:0.1) to give <b>21</b> (3.3 g, 63% yield, 98% purity). Mp 166â169 Â°C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, Î´): 1.00 (d, 3H, <i>J</i> = 4 Hz), 1.27â1.3.6 (m, 1H), 1.56â1.72 (m, 1H), 1.87 (m, 3H), 1.98â2.29 (m, 3H), 2.84â2.98 (m, 1H), 3.03â3.13 (m, 1H), 4.09 (t, 2H, <i>J</i> = 6 Hz), 7.06 (m, 2H), 7.78 (m, 3H), 8.29 (m, 2H), 13.0 (s, 1H). LCMS <i>m</i>/<i>z</i>: 314 (M + 1).</div></div><div id="sec5_2_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 1-Bromo-4-(3-chloropropoxy)benzene (<b>23</b>)</h3><div class="NLM_p last">4-Bromophenol <b>22</b> (10 g, 57.8 mmol), 3-bromo-1-chloropropane (9.6 g, 60.7 mmol), and K<sub>2</sub>CO<sub>3</sub> (8.0 g, 63.6 mmol) in acetone was stirred at reflux for 18 h. The mixture was cooled to room temperature, filtered, and concentrated at reduced pressure. The resulting oil was dissolved in ether (100 mL) and washed with 1 N NaOH solution (2 Ã 25 mL), water, NaCl solution and dried over MgSO<sub>4</sub> to give <b>23</b> (13.3 g, 92%) as a clear oil that solidified on standing. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, Î´): 2.21 (m, 2H), 3.73 (t, 2H, <i>J</i> = 6.1 Hz), 4.08 (t, 2H, <i>J</i> = 5.7 Hz), 6.78 (d, 2H, <i>J</i> = 8 Hz), 7.37 (d, 2H, <i>J</i> = 8 Hz). LCMS <i>m</i>/<i>z</i>: 250 (M + 1).</div></div><div id="sec5_2_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (<i>R</i>)-1-[3-(4-Bromophenoxy)propyl]-2-methylpyrrolidine (<b>24</b>)</h3><div class="NLM_p last">A mixture of <b>22</b> (2.0 g, 8.0 mmol), (<i>R</i>)-2-methylpyrrolidineâHCl (1.2 g, 9.6 mmol), K<sub>2</sub>CO<sub>3</sub> (2.2 g, 16 mmol), and NaI (0.6 g, 4 mmol) in acetonitrile (35 mL) was stirred at reflux 48 h. The mixture was cooled to room temperature. Water was added and the solution extracted with ether (3 Ã 25 mL). The ether layer was washed with water, NaCl solution and dried over MgSO<sub>4</sub> to give <b>23</b> (2.3 g, 97%) as a clear oil. The HCl salt was prepared by adding a 1 N HClâether solution to the base in ether. Mp 157â159 C (HCl salt, MeOHâether). <sup>1</sup>H NMR (CDCl<sub>3</sub>, Î´): 1.07 (d, 3H, <i>J</i> = 6 Hz), 1.39â1.43 (m, 1H), 1.66â1.79 (m, 2H), 1.87â2.00 (m, 3H), 2.06â2.21 (m, 2H), 2.26â2.31 (m, 1H), 2.92â2.99 (m, 1H), 3.14â3.18 (m, 1H), 3.97â4.0 (m, 2H), 6.77 (d, 2H, <i>J</i> = 8 Hz), 7.35 (d, 2H, <i>J</i> = 8 Hz). LCMS <i>m</i>/<i>z</i>: 299 (M + 1).</div></div><div id="sec5_2_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 2-{4-[3-((<i>R</i>)-2-Methylpyrrolidin-1-yl)propoxy]phenyl}-2<i>H</i>-pyridazin-3-one (<b>25</b>)</h3><div class="NLM_p last">A mixture of <b>24</b> (560 mg, 1.87 mmol), 2<i>H</i>-pyridazin-3-one (180 mg, 1.87 mmol), K<sub>2</sub>CO<sub>3</sub> (775 mg, 5.61 mmol), copper powder (120 mg, 1.87 mmol) in pyridine (75 mL) was stirred at reflux under nitrogen for 18 h. The mixture was cooled to room temperature and concentrated at reduced pressure. The residue was absorbed onto Fluorosil for elution and purification by ISCO silica gel chromatography (95:5:1/DCM, MeOH, <i>i</i>-PrNH<sub>2</sub>). The fractions containing pure product were collected and concentrated. The solid was crystallized from Et<sub>2</sub>Oâhexanes to give <b>25</b> (210 mg, 36%, 97% purity) as a white solid. Mp 106â107 Â°C. The HCl salt was prepared by dissolving the base in MeOH and adding 1 N Et<sub>2</sub>OâHCl. After concentration the product was crystallized using MeOHâether. Mp 175â177 Â°C (MeOHâEt<sub>2</sub>O). <sup>1</sup>H NMR (CDCl<sub>3</sub>, Î´): 1.10 (d, 3H, <i>J</i> = 5.2 Hz), 1.42 (m, 1H), 1.70â1.79 (m, 2H), 1.79â1.92 (m, 3H), 2.11â2.30 (m, 3H), 2.98 (m, 1H), 3.18 (m, 1H), 4.06 (m, 2H), 6.98 (d, 2H, <i>J</i> = 8 Hz), 7.04 (d, 1H, <i>J</i> = 9 Hz), 7.21â7.24 (m, 1H), 7.50 (d, 2H, <i>J</i> = 8 Hz), 7.87 (s, 1H). LCMS <i>m</i>/<i>z</i>: 314 (M + 1).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Pharmacokinetics</h3><div class="NLM_p">Adult male SpragueâDawley rats (275â350 g; Charles River, Kingston, NY), male beagle dogs (9â14 kg, Cephalon, Inc., Maisons Alfort, France), and male cynomolgus monkeys (2â4 kg, Covance Laboratories, Alice, TX) were used in the experiments. All animal usage was approved by the Cephalon IUCAC. For routine compound screening rats were dosed via the lateral tail vein at the indicated dose for iv administration (3% DMSO, 30% Solutol, 67% phosphate buffered saline or 100% saline) or via oral gavage (50% Tween 80, 40% propylene carbonate, and 10% propylene glycol, saline, or 2% HClâwater) at the indicated dose. Rats were fasted overnight prior to po administration. Serial blood samples were collected from the lateral tail vein into heparinized collection tubes (approximately 0.25 mL) at seven sampling times over a 6 or 24 h period as indicated. The plasma was separated by centrifugation, and the sample was prepared for analysis HPLC/MS by protein precipitation with acetonitrile. The plasma samples were analyzed for drug and internal standard via LCâMS/MS protocol. The pharmacokinetic parameters were calculated by a noncompartmental method using WinNonlin software (Professional version 4.1, Pharsight Corporation, Palo Alto, CA, 1997). For experiments to determine detailed rat PK parameters, rats were administered 1 mg/kg iv and 3 mg/kg po in saline and parameters calculated from composite mean plasma concentrationâtime data (<i>n</i> = 12).</div><div class="NLM_p last">Dogs were administered at 1 mg/kg iv and 3 mg/kg po and monkeys at 1 mg/kg iv and po. Parameters were calculated using plasma concentrationâtime data for individual animals (dog <i>n</i> = 3; monkey <i>n</i> = 4).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Plasma Protein Binding</h3><div class="NLM_p last">Test compounds were dissolved in DMSO and spiked into plasma from rat, dog, and human, as well as phosphate-buffered saline (pH 7.4). The final concentration in plasma or PBS was 5 Î¼M. The mixtures were incubated in a 37 Â°C water bath with gentle shaking for 1 h and then were loaded into the MultiScreen Ultracell-PPB plate (Millipore Inc., Billerica, MA) that was centrifuged at 2000<i>g</i> for 45 min at 37 Â°C. The amount of compound present in the ultrafiltrate was determined using LC/MS/MS. The percentage of drug bound to plasma was calculated using mean peak area of test compound in plasma ultrafiltrate (as free) and mean peak area of compound in PBS buffer (as total). The results are the mean of duplicate determinations.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Rat Dipsogenia Model</h3><div class="NLM_p last">Rat dipsogenia was conducted as previously described.<a onclick="showRef(event, 'ref24 ref32'); return false;" href="javascript:void(0);" class="ref ref24 ref32">(24, 32)</a> RAMH-induced water intake was measured in Harlan Long Evans rats (>300 g; Harlan, Dublin, VA, or Indianapolis, IN) for 30 min beginning 20 min after administration of RAMH (10 mg/kg ip). Test compound (in saline) was administered at the indicated times prior to the initiation of the drinking trial period. Percent inhibition of RAMH-induced drinking was calculated for each rat based on normalization to the group mean RAMH-induced drinking using the following equation: [100 â (Dr/(Dg<sub>RAMH</sub>)) Ã 100], where Dr is the amount of water an individual rat drinks and Dg<sub>RAMH</sub> is the group mean for the amount of water consumed by the RAMH-treated group. Group mean values for percent inhibition were then calculated for each dosage group together with the associated standard deviation and standard error of the mean. Treatment effects for percent inhibition vs RAMH-induced dipsogenia were evaluated using a one-way ANOVA (GraphPad Prism 4). Dunnettâs post hoc analysis was performed for multiple comparisons with the RAMH group set as the control comparator.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-5"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58"><a href="/doi/suppl/10.1021/jm200401v">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25462" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25462" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis results of <b>8a</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200401v/suppl_file/jm200401v_si_001.pdf">jm200401v_si_001.pdf (19.02 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm200401v" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65207" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65207" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert L. Hudkins</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research and Development, Cephalon, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3e4c564b5a5557504d7e5d5b4e565f525150105d5153"><span class="__cf_email__" data-cfemail="4b39233e2f202225380b282e3b232a27242565282426">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rita Raddatz</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research and Development, Cephalon, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ming Tao</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research and Development, Cephalon, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joanne R. Mathiasen</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research and Development, Cephalon, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa D. Aimone</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research and Development, Cephalon, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nadine C. Becknell</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research and Development, Cephalon, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Catherine P. Prouty</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research and Development, Cephalon, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lars J. S. Knutsen</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research and Development, Cephalon, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mehran Yazdanian</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research and Development, Cephalon, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gilbert Moachon</span> - <span class="hlFld-Affiliation affiliation">Cephalon, Inc., 19 Rue Prof. Cadieux, Maisons Alfort, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark A. Ator</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research and Development, Cephalon, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John P. Mallamo</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research and Development, Cephalon, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael J. Marino</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research and Development, Cephalon, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edward R. Bacon</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research and Development, Cephalon, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Williams</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research and Development, Cephalon, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74288" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74288" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors acknowledge the support and contributions from VÃ©ronique Agathon, Brad Barnes, Bob Bendesky, Nathalie Bourrit, Donna Bozyczko-Coyne, Amy Decamillo, Debra Galinis, SÃ©bastien Girault, John Gruner, Ed Hellriegel, Zeqi Huang, Kurt Josef, Isabelle Kanmacher, Siyuan Le, Nicole Lepallec, Brigitte Lesur, Jackie Lyons, Val Marcy, Phil Robertson, Xiu Ping Wang, and Allison Zulli.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i59" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i59"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i60" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i60"> Abbreviations Used</h2><tr><td class="NLM_term">hH<sub>1</sub>R</td><td class="NLM_def"><p class="first last">human H<sub>1</sub> receptor</p></td></tr><tr><td class="NLM_term">hH<sub>2</sub>R</td><td class="NLM_def"><p class="first last">human H<sub>2</sub> receptor</p></td></tr><tr><td class="NLM_term">hH<sub>4</sub>R</td><td class="NLM_def"><p class="first last">human H<sub>4</sub> receptor</p></td></tr><tr><td class="NLM_term">H<sub>3</sub>R</td><td class="NLM_def"><p class="first last">H<sub>3</sub> receptor</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">HIS</td><td class="NLM_def"><p class="first last">histamine</p></td></tr><tr><td class="NLM_term">ADHD</td><td class="NLM_def"><p class="first last">attention-deficit hyperactivity disorder</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimerâs disease</p></td></tr><tr><td class="NLM_term">NCE</td><td class="NLM_def"><p class="first last">new chemical entities</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">HNMT</td><td class="NLM_def"><p class="first last">histamine <i>N</i>-methyltransferase</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structureâactivity relationship</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">[<sup>3</sup>H]NAMH</td><td class="NLM_def"><p class="first last">[<sup>3</sup>H]<i>N</i>-Î±-methylhistamine</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">ligand lipophilic efficiency</p></td></tr><tr><td class="NLM_term">[<sup>35</sup>S]GTPÎ³S</td><td class="NLM_def"><p class="first last">guanosine 5â²-(Î³-thio)triphosphate</p></td></tr><tr><td class="NLM_term">RAMH</td><td class="NLM_def"><p class="first last"><i>R</i>-Î±-methylhistamine</p></td></tr><tr><td class="NLM_term">TI</td><td class="NLM_def"><p class="first last">therapeutic index</p></td></tr><tr><td class="NLM_term">CDS</td><td class="NLM_def"><p class="first last">cognitive domain of schizophrenia</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i61">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18738" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18738" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 35 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Arrang, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbarg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J. C.</span><span> </span><span class="NLM_article-title">Auto-inhibition of brain histamine release mediated by a novel class (H<sub>3</sub>) of histamine receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">832</span><span class="NLM_x">â</span> <span class="NLM_lpage">837</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1038%2F302832a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=6188956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADyaL3sXitFSmsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=1983&pages=832-837&author=J.+M.+Arrangauthor=M.+Garbargauthor=J.+C.+Schwartz&title=Auto-inhibition+of+brain+histamine+release+mediated+by+a+novel+class+%28H3%29+of+histamine+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Autoinhibition of brain histamine release mediated by a novel class (H3) of histamine receptor</span></div><div class="casAuthors">Arrang, Jean Michel; Garbarg, Monique; Schwartz, Jean Charles</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5911</span>),
    <span class="NLM_cas:pages">832-7</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The K+-induced release of 3H-labeled histamine (I)  [51-45-6] from rat cerebral cortex slices was inhibited by exogenous I, suggesting the presence of histaminic receptors by which this compd. can control its own release.  Although NÎ±-methylhistamine  [673-50-7] and NÎ±,NÎ±-dimethylhistamine  [673-46-1] also inhibited [3H]-I release, a no. of compds. known to exhibit agonist activities of H1 or H2 receptors had no significant effect.  Consequently, autoinhibition of I release by the brain is apparently mediated by a type of receptor (histaminic H3) that is clearly different from H1 and H2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpu3HYACgLprVg90H21EOLACvtfcHk0lgCdBj4N31-jg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXitFSmsbc%253D&md5=891b1e95467aa9213317c930f12bf3b7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F302832a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F302832a0%26sid%3Dliteratum%253Aachs%26aulast%3DArrang%26aufirst%3DJ.%2BM.%26aulast%3DGarbarg%26aufirst%3DM.%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26atitle%3DAuto-inhibition%2520of%2520brain%2520histamine%2520release%2520mediated%2520by%2520a%2520novel%2520class%2520%2528H3%2529%2520of%2520histamine%2520receptor%26jtitle%3DNature%26date%3D1983%26volume%3D302%26spage%3D832%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roland, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyati, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huvar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlander, M. G.</span><span> </span><span class="NLM_article-title">Cloning and functional expression of the human histamine H<sub>3</sub> receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1101</span><span class="NLM_x">â</span> <span class="NLM_lpage">1107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1124%2Fmol.55.6.1101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=10347254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADyaK1MXjsVOksb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=1101-1107&author=T.+W.+Lovenbergauthor=B.+L.+Rolandauthor=S.+J.+Wilsonauthor=X.+Jiangauthor=J.+Pyatiauthor=A.+Huvarauthor=M.+R.+Jacksonauthor=M.+G.+Erlander&title=Cloning+and+functional+expression+of+the+human+histamine+H3+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and functional expression of the human histamine H3 receptor</span></div><div class="casAuthors">Lovenberg, Timothy W.; Roland, Barbara L.; Wilson, Sandy J.; Jiang, Xiaoxia; Pyati, Jayashree; Huvar, Arne; Jackson, Michael R.; Erlander, Mark G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1101-1107</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Histamine regulates neurotransmitter release in the central and peripheral nervous systems through H3 presynaptic receptors.  The existence of the histamine H3 receptor was demonstrated pharmacol. 15 yr ago, yet despite intensive efforts, its mol. identity has remained elusive.  As part of a directed effort to discover novel G protein-coupled receptors through homol. searching of expressed sequence tag databases, we identified a partial clone (GPCR97) that had significant homol. to biogenic amine receptors.  The GPCR97 clone was used to probe a human thalamus library, which resulted in the isolation of a full-length clone encoding a putative G protein-coupled receptor.  Homol. anal. showed the highest similarity to MV muscarinic acetylcholine receptors and overall low homol. to all other biogenic amine receptors.  Transfection of GPCR97 into a variety of cell lines conferred an ability to inhibit forskolin-stimulated cAMP formation in response to histamine, but not to acetylcholine or any other biogenic amine.  Subsequent anal. revealed a pharmacol. profile practically indistinguishable from that for the histamine H3 receptor.  In situ hybridization in rat brain revealed high levels of mRNA in all neuronal systems (such as the cerebral cortex, the thalamus, and the caudate nucleus) previously assocd. with H3 receptor function.  Its widespread and abundant neuronal expression in the brain highlights the significance of histamine as a general neurotransmitter modulator.  The availability of the human H3 receptor cDNA should greatly aid in the development of chem. and biol. reagents, allowing a greater appreciation of the role of histamine in brain function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokl8o0_LbHs7Vg90H21EOLACvtfcHk0limdsTBide8-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjsVOksb8%253D&md5=62250ade28417ca835b6a85be5bebec2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fmol.55.6.1101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.55.6.1101%26sid%3Dliteratum%253Aachs%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DRoland%26aufirst%3DB.%2BL.%26aulast%3DWilson%26aufirst%3DS.%2BJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DPyati%26aufirst%3DJ.%26aulast%3DHuvar%26aufirst%3DA.%26aulast%3DJackson%26aufirst%3DM.%2BR.%26aulast%3DErlander%26aufirst%3DM.%2BG.%26atitle%3DCloning%2520and%2520functional%2520expression%2520of%2520the%2520human%2520histamine%2520H3%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D1999%26volume%3D55%26spage%3D1101%26epage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chazot, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenton, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J.</span><span> </span><span class="NLM_article-title">Molecular and biochemical pharmacology of the histamine H4 receptor</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="NLM_x">â</span> <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1111%2Fj.1476-5381.2009.00250.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=19413568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVWlsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2009&pages=14-23&author=R.+Leursauthor=P.+L.+Chazotauthor=F.+C.+Shentonauthor=H.+D.+Limauthor=I.+J.+de+Esch&title=Molecular+and+biochemical+pharmacology+of+the+histamine+H4+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular and biochemical pharmacology of the histamine H4 receptor</span></div><div class="casAuthors">Leurs, Rob; Chazot, Paul L.; Shenton, Fiona C.; Lim, Herman D.; de Esch, Iwan J. P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-23</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The elucidation of the human genome has had a major impact on histamine receptor research.  The identification of the human H4 receptor by several groups has been instrumental for a new appreciation of the role of histamine in the modulation of immune function.  In this review, we summarize the historical developments and the mol. and biochem. pharmacol. of the H4 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPKXOJ1f6Ka7Vg90H21EOLACvtfcHk0limdsTBide8-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVWlsrc%253D&md5=a091124eaeae2a088845cd64da627293</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00250.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00250.x%26sid%3Dliteratum%253Aachs%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DChazot%26aufirst%3DP.%2BL.%26aulast%3DShenton%26aufirst%3DF.%2BC.%26aulast%3DLim%26aufirst%3DH.%2BD.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%26atitle%3DMolecular%2520and%2520biochemical%2520pharmacology%2520of%2520the%2520histamine%2520H4%2520receptor%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D157%26spage%3D14%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_contrib-group">Zampeli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiligada, E.</span><span> </span><span class="NLM_article-title">The role of histamine H4 receptor in immune and inflammatory disorders</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">â</span> <span class="NLM_lpage">33</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1111%2Fj.1476-5381.2009.00151.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=19309354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVWls74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2009&pages=24-33&author=E.+Zampeliauthor=E.+Tiligada&title=The+role+of+histamine+H4+receptor+in+immune+and+inflammatory+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The role of histamine H4 receptor in immune and inflammatory disorders</span></div><div class="casAuthors">Zampeli, E.; Tiligada, E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-33</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Since its discovery at the beginning of the 20th century, histamine has been established to play a pathophysiol. regulatory role in cellular events through binding to four types of G-protein-coupled histamine receptors that are differentially expressed in various cell types.  The discovery, at the turn of the millennium, that the histamine H4 receptor is largely expressed in hemopoietic cells as well as its chemotactic properties designate its regulatory role in the immune system.  H4 receptors modulate eosinophil migration and selective recruitment of mast cells leading to amplification of histamine-mediated immune responses and eventually to chronic inflammation.  H4 receptor involvement in dendritic cell activation and T cell differentiation documents its immunomodulatory function.  The characterization of the H4 as the immune system histamine receptor directed growing attention towards its therapeutic exploitation in inflammatory disorders, such as allergy, asthma, chronic pruritus and autoimmune diseases.  The efficacy of a no. of H4 receptor ligands has been evaluated in in vivo and in vitro animal models of disease and in human biol. samples.  However, before reaching decisive conclusions on H4 receptor pathophysiol. functions and therapeutic exploitation, identification of genetic polymorphisms and interspecies differences in its relative actions and pharmacol. profile need to be addressed and taken into consideration.  Despite certain variations in the reported findings, the available data strongly point to the H4 receptor as a novel target for the pharmacol. modulation of histamine-transferred immune signals and offer an optimistic perspective for the therapeutic exploitation of this promising new drug target in inflammatory disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAW6UpRFCXFLVg90H21EOLACvtfcHk0limdsTBide8-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVWls74%253D&md5=e850c2e825c0c62b59927854ccfb35c2</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00151.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00151.x%26sid%3Dliteratum%253Aachs%26aulast%3DZampeli%26aufirst%3DE.%26aulast%3DTiligada%26aufirst%3DE.%26atitle%3DThe%2520role%2520of%2520histamine%2520H4%2520receptor%2520in%2520immune%2520and%2520inflammatory%2520disorders%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D157%26spage%3D24%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_contrib-group">Oda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morikawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuho, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, S.</span><span> </span><span class="NLM_article-title">Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">36781</span><span class="NLM_x">â</span> <span class="NLM_lpage">36786</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1074%2Fjbc.M006480200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=10973974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD3cXoslWlsrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=36781-36786&author=T.+Odaauthor=N.+Morikawaauthor=Y.+Saitoauthor=Y.+Masuhoauthor=S.+Matsumoto&title=Molecular+cloning+and+characterization+of+a+novel+type+of+histamine+receptor+preferentially+expressed+in+leukocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes</span></div><div class="casAuthors">Oda, Tamaki; Morikawa, Noriyuki; Saito, Yoko; Masuho, Yasuhiko; Matsumoto, Shun-Ichiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">36781-36786</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Recently cDNA encoding the histamine H3 receptor was isolated after 15 yr of considerable research.  However, several studies have proposed heterogeneity of the H3 receptor.  We report here the mol. cloning and characterization of a novel type of histamine receptor.  A novel orphan G-protein-coupled receptor named GPRv53 was obtained through a search of the human genomic DNA data base and analyzed by rapid amplification of cDNA ends (RACE).  GPRv53 possessed the features of biol. amine receptors and had the highest homol. with H3 receptor among known G-protein-coupled receptors.  Mammalian cells expressing GPRv53 were demonstrated to bind and respond to histamine in a concn.-dependent manner.  In functional assays, not only an H3 receptor agonist, R-(Î±)-methylhistamine, but also a H3 receptor antagonist, clobenpropit, and a neuroleptic, clozapine, activated GPRv53-expressing cells.  Tissue distribution anal. revealed that expression of GPRv53 is localized in the peripheral blood leukocytes, spleen, thymus, and colon, which was totally different from the H3 receptor, whose expression was restricted to the brain.  The discovery of the GPRv53 receptor will open a new phase of research on the physiol. role of histamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDi7OAeZ5Y9bVg90H21EOLACvtfcHk0limdsTBide8-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXoslWlsrs%253D&md5=1c5ef920f061561b6cc2dcf920d1f259</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M006480200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M006480200%26sid%3Dliteratum%253Aachs%26aulast%3DOda%26aufirst%3DT.%26aulast%3DMorikawa%26aufirst%3DN.%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DMasuho%26aufirst%3DY.%26aulast%3DMatsumoto%26aufirst%3DS.%26atitle%3DMolecular%2520cloning%2520and%2520characterization%2520of%2520a%2520novel%2520type%2520of%2520histamine%2520receptor%2520preferentially%2520expressed%2520in%2520leukocytes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D36781%26epage%3D36786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3d"><span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keseru, G. M.</span><span> </span><span class="NLM_article-title">Histamine H4 receptor ligands and their potential therapeutic applications</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">â</span> <span class="NLM_lpage">135</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1517%2F13543770802691085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=19441913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVClu7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=119-135&author=R.+Kissauthor=G.+M.+Keseru&title=Histamine+H4+receptor+ligands+and+their+potential+therapeutic+applications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3dR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Histamine H4 receptor ligands and their potential therapeutic applications</span></div><div class="casAuthors">Kiss, Robert; Keseru, Gyorgy M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-135</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The histamine H4 receptor (H4R) was first cloned in 2000.  As a new member of the histamine receptor family it was of great interest and a promising drug target for the treatment of inflammatory diseases.  Recent studies suggest that H4 antagonists have therapeutic potential, even in several pain conditions.  Initially, pharmacol. processes mediated by H4R were analyzed primarily by non-selective H4 ligands.  Since then, some highly potent and selective H4 antagonists have been reported by different groups.  Several companies are working on the development of potent H4 antagonists, although the no. of published patent applications is still low.  This review aims to give an overview of the ligands acting on H4R, this is drawn from published in papers and patent applications.  Anal. of scaffolds possessing significant H4 activity and review of their therapeutic potential.  The pharmacol. of currently available selective H4 ligands suggests therapeutic utility for H4 antagonists in inflammatory conditions as well as in chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6vhvbflM7ZLVg90H21EOLACvtfcHk0liYFihwgTFc6g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVClu7s%253D&md5=ee1ede069edacbe85f30f111ab438e1c</span></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=10.1517%2F13543770802691085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770802691085%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DHistamine%2520H4%2520receptor%2520ligands%2520and%2520their%2520potential%2520therapeutic%2520applications%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D119%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_contrib-group">Bongers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span> </span><span class="NLM_article-title">Molecular aspects of the histamine H<sub>3</sub> receptor</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1195</span><span class="NLM_x">â</span> <span class="NLM_lpage">1204</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2007&pages=1195-1204&author=G.+Bongersauthor=R.+A.+Bakkerauthor=R.+Leurs&title=Molecular+aspects+of+the+histamine+H3+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBongers%26aufirst%3DG.%26aulast%3DBakker%26aufirst%3DR.%2BA.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DMolecular%2520aspects%2520of%2520the%2520histamine%2520H3%2520receptor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D73%26spage%3D1195%26epage%3D1204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_contrib-group">Wulff, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastrup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimvall, K.</span><span> </span><span class="NLM_article-title">Characteristics of recombinantly expressed rat and human histamine H<sub>3</sub> receptors</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">453</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">â</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1016%2FS0014-2999%2802%2902382-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=12393057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVChtL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=453&publication_year=2002&pages=33-41&author=B.+S.+Wulffauthor=S.+Hastrupauthor=K.+Rimvall&title=Characteristics+of+recombinantly+expressed+rat+and+human+histamine+H3+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Characteristics of recombinantly expressed rat and human histamine H3 receptors</span></div><div class="casAuthors">Wulff, Birgitte S.; Hastrup, Sven; Rimvall, Karin</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">453</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-41</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Human and rat histamine H3 receptors were recombinantly expressed and characterized using receptor binding and a functional cAMP assay.  Seven of nine agonists had similar affinities and potencies at the rat and human histamine H3 receptor.  S-Î±-methylhistamine had a significantly higher affinity and potency at the human than rat receptor, and for 4-[(1R*,2R*)-2-(5,5-dimethyl-1-hexynyl)cyclopropyl]-1H-imidazole (Perceptin) the preference was the reverse.  Only two of six antagonists had similar affinities and potencies at the human and the rat histamine H3 receptor.  Ciproxifan, thioperamide and ((1R*,2R*)-trans-2-imidazol-4-ylcyclopropyl) (cyclohexylmethoxy) carboxamide (GT2394) had significantly higher affinities and potencies at the rat than at the human histamine H3 receptor, while for N-(4-chlorobenzyl)-N-(7-pyrrolodin-1-ylheptyl)guanidine (JB98064) the preference was the reverse.  All antagonists also showed potent inverse agonism properties.  Iodoproxyfan, Perceptin, proxyfan and GR175737, compds. previously described as histamine H3 receptor antagonists, acted as full or partial agonists at both the rat and the human histamine H3 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopMFBIvhcSgbVg90H21EOLACvtfcHk0liYFihwgTFc6g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVChtL0%253D&md5=1abed9da8f107ceaa8f2dbd094a9e186</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2902382-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252902382-8%26sid%3Dliteratum%253Aachs%26aulast%3DWulff%26aufirst%3DB.%2BS.%26aulast%3DHastrup%26aufirst%3DS.%26aulast%3DRimvall%26aufirst%3DK.%26atitle%3DCharacteristics%2520of%2520recombinantly%2520expressed%2520rat%2520and%2520human%2520histamine%2520H3%2520receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D453%26spage%3D33%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="note"><p class="first last">Reviews: </p></div><div class="NLM_citation" id="cit5a"><span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmerman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J.</span><span> </span><span class="NLM_article-title">The histamine H<sub>3</sub> receptor: from gene cloning to H<sub>3</sub> receptor drugs</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">â</span> <span class="NLM_lpage">120</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1038%2Fnrd1631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=15665857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpt1Wlsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=107-120&author=R.+Leursauthor=R.+A.+Bakkerauthor=H.+Timmermanauthor=I.+J.+de+Esch&title=The+histamine+H3+receptor%3A+from+gene+cloning+to+H3+receptor+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The histamine H3 receptor: from gene cloning to H3 receptor drugs</span></div><div class="casAuthors">Leurs, Rob; Bakker, Remko A.; Timmerman, Henk; de Esch, Iwan J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-120</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the cloning of the histamine H3 receptor cDNA in 1999 by Lovenberg and coworkers, this histamine receptor has gained the interest of many pharmaceutical companies as a potential drug target for the treatment of various important disorders, including obesity, attention-deficit hyperactivity disorder, Alzheimer's disease, schizophrenia, as well as for myocardial ischemia, migraine and inflammatory diseases.  Here, the authors discuss relevant information on this target protein and describe the development of various H3 receptor agonists and antagonists, and their effects in preclin. animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS284dYZ2NqrVg90H21EOLACvtfcHk0liYFihwgTFc6g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpt1Wlsw%253D%253D&md5=78f1127c7e8fb9abd416dae666f5bcfe</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1038%2Fnrd1631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1631%26sid%3Dliteratum%253Aachs%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DBakker%26aufirst%3DR.%2BA.%26aulast%3DTimmerman%26aufirst%3DH.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%26atitle%3DThe%2520histamine%2520H3%2520receptor%253A%2520from%2520gene%2520cloning%2520to%2520H3%2520receptor%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D107%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_contrib-group">Wijtmans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I.</span><span> </span><span class="NLM_article-title">Histamine H<sub>3</sub> receptor ligands break ground in a remarkable plethora of therapeutic areas</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">â</span> <span class="NLM_lpage">985</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=967-985&author=M.+Wijtmansauthor=R.+Leursauthor=I.+de+Esch&title=Histamine+H3+receptor+ligands+break+ground+in+a+remarkable+plethora+of+therapeutic+areas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWijtmans%26aufirst%3DM.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3Dde%2BEsch%26aufirst%3DI.%26atitle%3DHistamine%2520H3%2520receptor%2520ligands%2520break%2520ground%2520in%2520a%2520remarkable%2520plethora%2520of%2520therapeutic%2520areas%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2007%26volume%3D16%26spage%3D967%26epage%3D985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowart, M. D.</span><span> </span><span class="NLM_article-title">Histamine H<sub>3</sub> receptor antagonists: preclinical promise for treating obesity and cognitive disorders</span> <span class="citation_source-journal">Mol. Interventions</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">â</span> <span class="NLM_lpage">88</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=77-88&author=T.+A.+Esbenshadeauthor=G.+B.+Foxauthor=M.+D.+Cowart&title=Histamine+H3+receptor+antagonists%3A+preclinical+promise+for+treating+obesity+and+cognitive+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DFox%26aufirst%3DG.%2BB.%26aulast%3DCowart%26aufirst%3DM.%2BD.%26atitle%3DHistamine%2520H3%2520receptor%2520antagonists%253A%2520preclinical%2520promise%2520for%2520treating%2520obesity%2520and%2520cognitive%2520disorders%26jtitle%3DMol.%2520Interventions%26date%3D2006%26volume%3D6%26spage%3D77%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browman, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strakhova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowart, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brioni, J. D.</span><span> </span><span class="NLM_article-title">The histamine H<sub>3</sub> receptor: an attractive target for the treatment of cognitive disorders</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">1166</span><span class="NLM_x">â</span> <span class="NLM_lpage">1181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1038%2Fbjp.2008.147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=18469850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVCjtL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2008&pages=1166-1181&author=T.+A.+Esbenshadeauthor=K.+E.+Browmanauthor=R.+S.+Bitnerauthor=M.+Strakhovaauthor=M.+D.+Cowartauthor=J.+D.+Brioni&title=The+histamine+H3+receptor%3A+an+attractive+target+for+the+treatment+of+cognitive+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The histamine H3 receptor: an attractive target for the treatment of cognitive disorders</span></div><div class="casAuthors">Esbenshade, T. A.; Browman, K. E.; Bitner, R. S.; Strakhova, M.; Cowart, M. D.; Brioni, J. D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1166-1181</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The histamine H3 receptor, first described in 1983 as a histamine autoreceptor and later shown to also function as a heteroreceptor that regulates the release of other neurotransmitters, has been the focus of research by numerous labs. as it represents an attractive drug target for a no. of indications including cognition.  The purpose of this review is to acquaint the reader with the current understanding of H3 receptor localization and function as a modulator of neurotransmitter release and its effects on cognitive processes, as well as to provide an update on selected H3 antagonists in various states of preclin. and clin. advancement.  Blockade of centrally localized H3 receptors by selective H3 receptor antagonists has been shown to enhance the release of neurotransmitters such as histamine, ACh, dopamine and norepinephrine, among others, which play important roles in cognitive processes.  The cognitive-enhancing effects of H3 antagonists across multiple cognitive domains in a wide no. of preclin. cognition models also bolster confidence in this therapeutic approach for the treatment of attention deficit hyperactivity disorder, Alzheimer's disease and schizophrenia.  However, although a no. of clin. studies examg. the efficacy of H3 receptor antagonists for a variety of cognitive disorders are currently underway, no clin. proof of concept for an H3 receptor antagonist has been reported to date.  The discovery of effective H3 antagonists as therapeutic agents for the novel treatment of cognitive disorders will only be accomplished through continued research efforts that further our insights into the functions of the H3 receptor.  British Journal of Pharmacol. (2008) 154, 1166-1181; doi:10.1038/bjp.2008.147; published online 12 May 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2N2Dg3cdZfrVg90H21EOLACvtfcHk0lj75LlBP3dBlA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVCjtL4%253D&md5=05bcda7b1140e9d16b4ca4072902d925</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.147%26sid%3Dliteratum%253Aachs%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DBrowman%26aufirst%3DK.%2BE.%26aulast%3DBitner%26aufirst%3DR.%2BS.%26aulast%3DStrakhova%26aufirst%3DM.%26aulast%3DCowart%26aufirst%3DM.%2BD.%26aulast%3DBrioni%26aufirst%3DJ.%2BD.%26atitle%3DThe%2520histamine%2520H3%2520receptor%253A%2520an%2520attractive%2520target%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D154%26spage%3D1166%26epage%3D1181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5e"><span><span class="NLM_contrib-group">Hudkins, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raddatz, R.</span><span> </span><span class="NLM_article-title">Recent advances in drug discovery of histamine H<sub>3</sub> antagonist</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">â</span> <span class="NLM_lpage">63</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=49-63&author=R.+L.+Hudkinsauthor=R.+Raddatz&title=Recent+advances+in+drug+discovery+of+histamine+H3+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26aulast%3DRaddatz%26aufirst%3DR.%26atitle%3DRecent%2520advances%2520in%2520drug%2520discovery%2520of%2520histamine%2520H3%2520antagonist%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2007%26volume%3D42%26spage%3D49%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5f"><span><span class="NLM_contrib-group">Sander, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kottke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, H.</span><span> </span><span class="NLM_article-title">Histamine H<sub>3</sub> receptor antagonists go to clinics</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2163</span><span class="NLM_x">â</span> <span class="NLM_lpage">2181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1248%2Fbpb.31.2163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=19043195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Kmsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=2163-2181&author=K.+Sanderauthor=T.+Kottkeauthor=H.+Stark&title=Histamine+H3+receptor+antagonists+go+to+clinics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5fR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Histamine H3 receptor antagonists go to clinics</span></div><div class="casAuthors">Sander, Kerstin; Kottke, Tim; Stark, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2163-2181</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A review.  Within the recent years novel lead optimizations for histamine H3 receptor antagonists made their way from bench to bedside.  Structure-activity relationships, cross-affinities and side effects as well as pharmacokinetic profiling will be discussed on selected promising compd. series.  Due to diversity in potential therapeutic applications and in some cases a controversial debate, different indications will be highlighted with the potential and the problems of the test compds., e.g. sleep-wake disorders, attention-deficient hyperactivity disorder, epilepsy, cognitive impairment, schizophrenia, obesity and neuropathic pain.  First data published on clin. trials phase II (IIb) are presented showing proof of concept of H3 receptor antagonists in narcolepsy and photoinduced epilepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJWogrOu3mmbVg90H21EOLACvtfcHk0lj75LlBP3dBlA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Kmsbs%253D&md5=b816371be0c006bef83d279a426fee45</span></div><a href="/servlet/linkout?suffix=cit5f&amp;dbid=16384&amp;doi=10.1248%2Fbpb.31.2163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.31.2163%26sid%3Dliteratum%253Aachs%26aulast%3DSander%26aufirst%3DK.%26aulast%3DKottke%26aufirst%3DT.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DHistamine%2520H3%2520receptor%2520antagonists%2520go%2520to%2520clinics%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2008%26volume%3D31%26spage%3D2163%26epage%3D2181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5g"><span><span class="NLM_contrib-group">Brioni, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrison, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitner, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowart, M. D.</span><span> </span><span class="NLM_article-title">Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimerâs disease</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">â</span> <span class="NLM_lpage">46</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1124%2Fjpet.110.166876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=20864505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1ektw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=38-46&author=J.+D.+Brioniauthor=T.+A.+Esbenshadeauthor=T.+R.+Garrisonauthor=S.+R.+Bitnerauthor=M.+D.+Cowart&title=Discovery+of+histamine+H3+antagonists+for+the+treatment+of+cognitive+disorders+and+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5gR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer's disease</span></div><div class="casAuthors">Brioni, Jorge D.; Esbenshade, Tim A.; Garrison, Tiffany Runyan; Bitner, Scott R.; Cowart, Marlon D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-46</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  H3 antagonists increase the release of brain histamine, acetylcholine, noradrenaline, and dopamine, neurotransmitters that are known to modulate cognitive processes.  The ability to release brain histamine supports the effect on attention and vigilance, but histamine also modulates other cognitive domains such as short-term and long-term memory.  A no. of H3 antagonists, including 1-{3-[3-(4-chlorophenyl)propoxy]propyl}piperidine hydrochloride (BF2.649), (1R,3R)-N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]cyclobutane-1-carboxamide (PF-03654746), 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-pyridinecarboxamide hydrochloride (GSK189254), MK-0249 (structure not yet disclosed), JNJ-17216498 (structure not yet disclosed), and ABT-288 (structure not yet disclosed), have advanced to the clin. area for the potential treatment of human cognitive disorders.  H3 antagonists exhibited wake-promoting effects in humans and efficacy in narcoleptic patients, indicating target engagement, but some of them were not efficacious in patients suffering from attention-deficit hyperactivity disorder and schizophrenic patients.  Preclin. studies have also shown that H3 antagonists activate intracellular signaling pathways that may improve cognitive efficacy and disease-modifying effects in Alzheimer's disease.  Ongoing clin. studies will be able to det. the utility of H3 antagonists for the treatment of cognitive disorders in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHvanX-UatFbVg90H21EOLACvtfcHk0lj75LlBP3dBlA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1ektw%253D%253D&md5=d8f3f6997a6b9c96be5e6eb836bd2951</span></div><a href="/servlet/linkout?suffix=cit5g&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.166876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.166876%26sid%3Dliteratum%253Aachs%26aulast%3DBrioni%26aufirst%3DJ.%2BD.%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DGarrison%26aufirst%3DT.%2BR.%26aulast%3DBitner%26aufirst%3DS.%2BR.%26aulast%3DCowart%26aufirst%3DM.%2BD.%26atitle%3DDiscovery%2520of%2520histamine%2520H3%2520antagonists%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26spage%3D38%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5h"><span><span class="NLM_contrib-group">Raddatz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudkins, R. L.</span><span> </span><span class="NLM_article-title">Histamine H3 antagonists for treatment of cognitive deficits in CNS diseases</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">â</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5h&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.2174%2F156802610790411027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5h&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=20166960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5h&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFajsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=153-169&author=R.+Raddatzauthor=M.+Taoauthor=R.+L.+Hudkins&title=Histamine+H3+antagonists+for+treatment+of+cognitive+deficits+in+CNS+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5hR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Histamine H3 antagonists for treatment of cognitive deficits in CNS diseases</span></div><div class="casAuthors">Raddatz, Rita; Tao, Ming; Hudkins, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-169</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The H3 histamine receptor is expressed in many brain regions, including those involved in sleep/wake regulation and cognitive functions.  Inhibition of the H3 receptor leads to increased release of multiple neurotransmitters in these regions, making this receptor an ideal target for the potential enhancement of arousal and/or cognitive processes.  The high interest level by several pharmaceutical companies in H3 receptors as potential drug targets has produced rapid advancement in novel compd. series with different properties, providing a variety of preclin. tools as well as advancing several candidates into clin. trials.  Multiple chemotypes have demonstrated efficacy in preclin. models covering a range of cognitive deficits, suggesting the potential value of H3 antagonists as cognition enhancers in a variety of disease states.  These studies have revealed the actions of this class of compds. at the cellular, neuronal systems and behavioral levels.  Recently, compds. with improved selectivity, pharmacokinetics and preclin. safety profiles have advanced into clin. trials for a no. of potential indications.  The results of these clin. trials are eagerly awaited and will increase our understanding of the properties of H3 receptor antagonists that will provide therapeutic value.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5LHkk08wu0rVg90H21EOLACvtfcHk0lgZsw4slwXDDw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFajsro%253D&md5=c0168541e8407860144a7266a7555acd</span></div><a href="/servlet/linkout?suffix=cit5h&amp;dbid=16384&amp;doi=10.2174%2F156802610790411027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610790411027%26sid%3Dliteratum%253Aachs%26aulast%3DRaddatz%26aufirst%3DR.%26aulast%3DTao%26aufirst%3DM.%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26atitle%3DHistamine%2520H3%2520antagonists%2520for%2520treatment%2520of%2520cognitive%2520deficits%2520in%2520CNS%2520diseases%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D153%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5i"><span><span class="NLM_contrib-group">Berlin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lera Ruiz, M.</span><span> </span><span class="NLM_article-title">Histamine H(3) receptor as a drug discovery target</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">â</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100064d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=26-53&author=M.+Berlinauthor=C.+W.+Boyceauthor=M.+de+Lera+Ruiz&title=Histamine+H%283%29+receptor+as+a+drug+discovery+target"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5i&amp;dbid=16384&amp;doi=10.1021%2Fjm100064d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100064d%26sid%3Dliteratum%253Aachs%26aulast%3DBerlin%26aufirst%3DM.%26aulast%3DBoyce%26aufirst%3DC.%2BW.%26aulast%3Dde%2BLera%2BRuiz%26aufirst%3DM.%26atitle%3DHistamine%2520H%25283%2529%2520receptor%2520as%2520a%2520drug%2520discovery%2520target%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D26%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5j"><span><span class="NLM_contrib-group">Celanire, F.; Lebon, F.; Stark, H.</span><span> </span><span class="NLM_article-title">Drug Discovery: From Hits to Clinical Candidates</span>. In  <span class="citation_source-book">The Third Histamine Receptor: Selective Ligands as Potential Therapeutic Agents in CNS Disorders</span>; <span class="NLM_contrib-group">Vohora, D.</span>, Ed.; <span class="NLM_publisher-name">CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=F.+Celanire&author=F.+Lebon&author=H.+Starkauthor=D.+Vohora&title=The+Third+Histamine+Receptor%3A+Selective+Ligands+as+Potential+Therapeutic+Agents+in+CNS+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCelanire%26aufirst%3DF.%26atitle%3DDrug%2520Discovery%253A%2520From%2520Hits%2520to%2520Clinical%2520Candidates%26btitle%3DThe%2520Third%2520Histamine%2520Receptor%253A%2520Selective%2520Ligands%2520as%2520Potential%2520Therapeutic%2520Agents%2520in%2520CNS%2520Disorders%26aulast%3DVohora%26aufirst%3DD.%26pub%3DCRC%2520Press%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5k"><span> Thompson Reuters Integrity, Bavisant, Entry 470497,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Thompson+Reuters+Integrity%2C+Bavisant%2C+Entry+470497%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5k&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5l"><span> See trials NCT00675090, NCT00420420, NCT00506077, NCT00531752; <a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+See+trials+NCT00675090%2C+NCT00420420%2C+NCT00506077%2C+NCT00531752%3B+www.clinicaltrials.gov."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Arrang, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morisset, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gbahou, F.</span><span> </span><span class="NLM_article-title">Constitutive activity of the histamine H<sub>3</sub> receptor</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">â</span> <span class="NLM_lpage">357</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=350-357&author=J.+M.+Arrangauthor=S.+Morissetauthor=F.+Gbahou&title=Constitutive+activity+of+the+histamine+H3+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArrang%26aufirst%3DJ.%2BM.%26aulast%3DMorisset%26aufirst%3DS.%26aulast%3DGbahou%26aufirst%3DF.%26atitle%3DConstitutive%2520activity%2520of%2520the%2520histamine%2520H3%2520receptor%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D350%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Morisset, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouleau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligneau, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gbahou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tardivel-Lacombe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schunack, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganellin, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrang, J. M.</span><span> </span><span class="NLM_article-title">High constitutive activity of native H<sub>3</sub> receptors regulates histamine neurons in brain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">860</span><span class="NLM_x">â</span> <span class="NLM_lpage">864</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1038%2F35048583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=11130725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtl2lsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=860-864&author=S.+Morissetauthor=A.+Rouleauauthor=X.+Ligneauauthor=F.+Gbahouauthor=J.+Tardivel-Lacombeauthor=H.+Starkauthor=W.+Schunackauthor=C.+R.+Ganellinauthor=J.+C.+Schwartzauthor=J.+M.+Arrang&title=High+constitutive+activity+of+native+H3+receptors+regulates+histamine+neurons+in+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">High constitutive activity of native H3 receptors regulates histamine neurons in brain</span></div><div class="casAuthors">Morisset, Severine; Rouleau, Agnes; Lineau, Xavier; Gbahou, Florence; Tardivel-Lacombe, Joil; Stark, Holger; Schunack, Walter; Ganellin, C. Robin; Schwartz, Jean-Charles; Arrang, Jean-Michel</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6814</span>),
    <span class="NLM_cas:pages">860-864</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Some G-protein-coupled receptors display 'constitutive activity', i.e., spontaneous activity in the absence of agonist.  This means that a proportion of the receptor population spontaneously undergoes an allosteric transition, leading to a conformation that can bind G proteins.  The process has been shown to occur with recombinant receptors expressed at high d., and/or mutated, but also non-mutated recombinant receptors expressed at physiol. concns.  Transgenic mice that express a constitutively active mutant of the Î²2-adrenergic receptor display cardiac anomalies; and spontaneous receptor mutations leading to constitutive activity are at the origin of some human disease.  Nevertheless, this process has not previously been found to occur in animal expressing normal levels of receptor.  Here we show that two isoforms of the recombinant rat H3 receptor display high constitutive activity.  Using drugs that abrogate this activity ('inverse antagonists') and a drug that opposes both agonists and inverse agonists ('neutral antagonist'), we show that constitutive activity of native H3 receptors is present in rodent brain and that it controls histaminergic neuron activity in vivo.  Inverse agonists may therefore find therapeutic applications, even in the case of diseases involving non-mutated receptors expressed at normal levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ND0ffL4qKLVg90H21EOLACvtfcHk0lh4VuMM2KzYNQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtl2lsw%253D%253D&md5=8d2a24b002e41a6e1d8fca67707e86d6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F35048583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35048583%26sid%3Dliteratum%253Aachs%26aulast%3DMorisset%26aufirst%3DS.%26aulast%3DRouleau%26aufirst%3DA.%26aulast%3DLigneau%26aufirst%3DX.%26aulast%3DGbahou%26aufirst%3DF.%26aulast%3DTardivel-Lacombe%26aufirst%3DJ.%26aulast%3DStark%26aufirst%3DH.%26aulast%3DSchunack%26aufirst%3DW.%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26aulast%3DArrang%26aufirst%3DJ.%2BM.%26atitle%3DHigh%2520constitutive%2520activity%2520of%2520native%2520H3%2520receptors%2520regulates%2520histamine%2520neurons%2520in%2520brain%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D860%26epage%3D864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Wieland, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bongers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamatodani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menge, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmerman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span> </span><span class="NLM_article-title">Constitutive activity of histamine h(3) receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H(3) antagonists</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">â</span> <span class="NLM_lpage">914</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=11714875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovVCktrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2001&pages=908-914&author=K.+Wielandauthor=G.+Bongersauthor=Y.+Yamamotoauthor=T.+Hashimotoauthor=A.+Yamatodaniauthor=W.+M.+Mengeauthor=H.+Timmermanauthor=T.+W.+Lovenbergauthor=R.+Leurs&title=Constitutive+activity+of+histamine+h%283%29+receptors+stably+expressed+in+SK-N-MC+cells%3A+display+of+agonism+and+inverse+agonism+by+H%283%29+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Constitutive activity of histamine H3 receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H3 antagonists</span></div><div class="casAuthors">Wieland, Kerstin; Bongers, Gerold; Yamamoto, Yumiko; Hashimoto, Takeshi; Yamatodani, Atsushi; Menge, Wiro M. B. P.; Timmerman, Henk; Lovenberg, Timothy W.; Leurs, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">908-914</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Agonist-independent activity of G-protein-coupled receptor, also referred to as constitutive activity, is a well-documented phenomenon and has been reported recently for both the histamine H1 and H2 receptors.  Using SK-N-MC cell lines stably expressing the human and rat H3 receptors at physiol. receptor densities (500-600 fmol/mg of protein), we show that both the rat and human H3 receptors show a high degree of constitutive activity.  The forskolin-mediated cAMP prodn. in SK-N-MC cells is inhibited strongly upon expression of the G1-coupled H3 receptor.  The cAMP prodn. can be further inhibited upon agonist stimulation of the H3 receptor and can be enhanced by a variety of H3 antagonists acting as inverse agonists at the H3 receptor.  Thioperamide, clobenpropit, and iodophenpropit raise the cAMP levels in SK-N-MC cells with potencies that match their receptor binding affinities.  Surprisingly, impentamine and burimamide act as effective H3 agonists.  Modification of the amine group of impentamine dramatically affected the pharmacol. activity of the ligand.  Receptor affinity was reduced slightly for most impentamine analogs, but the functional activity of the ligands varied from agonist to neutral antagonist and inverse agonist, indicating that subtle changes in the chem. structures of impentamine analogs have major impact on the (de)activation steps of the H3 receptor.  In conclusion, upon stable expression of the rat and human H3 receptor in SK-N-MC cells constitutive receptor activity is detected.  In this exptl. system, H3 receptors ligands, previously identified as H3 antagonists, cover the whole spectrum of pharmacol. activities, ranging from full inverse agonists to agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQLJVmRiEDBrVg90H21EOLACvtfcHk0lh4VuMM2KzYNQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovVCktrk%253D&md5=1a3268a54761aa35466cd46908212311</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWieland%26aufirst%3DK.%26aulast%3DBongers%26aufirst%3DG.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DT.%26aulast%3DYamatodani%26aufirst%3DA.%26aulast%3DMenge%26aufirst%3DW.%2BM.%26aulast%3DTimmerman%26aufirst%3DH.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DConstitutive%2520activity%2520of%2520histamine%2520h%25283%2529%2520receptors%2520stably%2520expressed%2520in%2520SK-N-MC%2520cells%253A%2520display%2520of%2520agonism%2520and%2520inverse%2520agonism%2520by%2520H%25283%2529%2520antagonists%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D299%26spage%3D908%26epage%3D914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Schwartz, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morisset, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouleau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligneau, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gbahou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tardivel-Lacombe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schunack, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganellin, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrang, J. M.</span><span> </span><span class="NLM_article-title">Therapeutic implications of constitutive activity of receptors: the example of the histamine H<sub>3</sub> receptor</span> <span class="citation_source-journal">J. Neural Transm., Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1007%2F978-3-7091-6020-6_1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=12830926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1ClsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=1-16&author=J.+C.+Schwartzauthor=S.+Morissetauthor=A.+Rouleauauthor=X.+Ligneauauthor=F.+Gbahouauthor=J.+Tardivel-Lacombeauthor=H.+Starkauthor=W.+Schunackauthor=C.+R.+Ganellinauthor=J.+M.+Arrang&title=Therapeutic+implications+of+constitutive+activity+of+receptors%3A+the+example+of+the+histamine+H3+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic implications of constitutive activity of receptors: the example of the histamine H3 receptor</span></div><div class="casAuthors">Schwartz, J.-C.; Morisset, S.; Rouleau, A.; Ligneau, X.; Gbahou, F.; Tardivel-Lacombe, J.; Stark, H.; Schunack, W.; Ganellin, C. R.; Arrang, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neural Transmission, Supplement</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">Neuropsychopharmacology</span>),
    <span class="NLM_cas:pages">1-16</span>CODEN:
                <span class="NLM_cas:coden">JNTSD4</span>;
        ISSN:<span class="NLM_cas:issn">0303-6995</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag Wien</span>)
        </div><div class="casAbstract">A review.  Some G-protein-coupled receptors display constitutive activity, that is spontaneous activity in the absence of agonist: a proportion of the receptor population adopts a conformation that can bind and activate G proteins.  Whereas this was mainly shown to occur with recombinant or pathol. mutated receptors, the physiol. relevance of the process has remained debated.  We have addressed this question in the case of the histamine H3 receptor, a presynaptic inhibitory receptor regulating histamine release in brain.  Having identified a neutral antagonist and inverse agonists with variable intrinsic activity, we show that the native H3 receptor in brain displays high constitutive activity in vitro and, in vivo, controls the release of endogenous histamine.  This implies that inverse agonists with high intrinsic activity should be preferred for therapeutic application as "cognitive enhancers" in several psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL7nl3ktp80rVg90H21EOLACvtfcHk0lh4VuMM2KzYNQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1ClsrY%253D&md5=1469b883ec83b60f59be86791e45b359</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2F978-3-7091-6020-6_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-7091-6020-6_1%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26aulast%3DMorisset%26aufirst%3DS.%26aulast%3DRouleau%26aufirst%3DA.%26aulast%3DLigneau%26aufirst%3DX.%26aulast%3DGbahou%26aufirst%3DF.%26aulast%3DTardivel-Lacombe%26aufirst%3DJ.%26aulast%3DStark%26aufirst%3DH.%26aulast%3DSchunack%26aufirst%3DW.%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26aulast%3DArrang%26aufirst%3DJ.%2BM.%26atitle%3DTherapeutic%2520implications%2520of%2520constitutive%2520activity%2520of%2520receptors%253A%2520the%2520example%2520of%2520the%2520histamine%2520H3%2520receptor%26jtitle%3DJ.%2520Neural%2520Transm.%252C%2520Suppl.%26date%3D2003%26volume%3D64%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Reasor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastings, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, R. G.</span><span> </span><span class="NLM_article-title">Drug-induced phospholipidosis: issues and future directions</span> <span class="citation_source-journal">Expert Opin. Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">â</span> <span class="NLM_lpage">583</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1517%2F14740338.5.4.567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=16774494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD28XmslSksL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=567-583&author=M.+J.+Reasorauthor=K.+L.+Hastingsauthor=R.+G.+Ulrich&title=Drug-induced+phospholipidosis%3A+issues+and+future+directions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced phospholipidosis: issues and future directions</span></div><div class="casAuthors">Reasor, Mark J.; Hastings, Kenneth L.; Ulrich, Roger G.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Safety</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">567-583</span>CODEN:
                <span class="NLM_cas:coden">EODSA9</span>;
        ISSN:<span class="NLM_cas:issn">1474-0338</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Numerous drugs contg. a cationic amphiphilic structure are capable of inducing phospholipidosis in cells under conditions of in vivo administration or ex vivo incubation.  The principal characteristics of this condition include the reversible accumulation of polar phospholipids in assocn. with the development of unicentric or multicentric lamellated bodies within cells.  There is an abundance of data providing an understanding of potential mechanisms for the induction of phospholipidosis; however, the process is likely to be complex and may differ from one drug to another.  The functional consequences of the presence of this condition on cellular or tissue function are not well understood.  The general consensus is that the condition is an adaptive response rather than a toxicol. manifestation; however, addnl. studies to examine this question are needed.  Until this issue is resolved, concerns about phospholipidosis will continue to exist at regulatory agencies.  Procedures for the screening of potential phospholipogenic candidate compds. are available.  In contrast, a clear need exists for the identification of valid biomarkers to assess the development of phospholipidosis in preclin. and clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwYtmd7pqUebVg90H21EOLACvtfcHk0lh4VuMM2KzYNQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmslSksL8%253D&md5=a2801d85bc4f1730f69272eaea3ce17b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1517%2F14740338.5.4.567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14740338.5.4.567%26sid%3Dliteratum%253Aachs%26aulast%3DReasor%26aufirst%3DM.%2BJ.%26aulast%3DHastings%26aufirst%3DK.%2BL.%26aulast%3DUlrich%26aufirst%3DR.%2BG.%26atitle%3DDrug-induced%2520phospholipidosis%253A%2520issues%2520and%2520future%2520directions%26jtitle%3DExpert%2520Opin.%2520Drug%2520Saf.%26date%3D2006%26volume%3D5%26spage%3D567%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_contrib-group">Stark, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kathmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlicker, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schunack, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlegel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span> </span><span class="NLM_article-title">Medicinal chemical and pharmacological aspects of imidazole-containing histamine H<sub>3</sub> receptor antagonists</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">965</span><span class="NLM_x">â</span> <span class="NLM_lpage">977</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=965-977&author=H.+Starkauthor=M.+Kathmannauthor=E.+Schlickerauthor=W.+Schunackauthor=B.+Schlegelauthor=W.+Sippl&title=Medicinal+chemical+and+pharmacological+aspects+of+imidazole-containing+histamine+H3+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStark%26aufirst%3DH.%26aulast%3DKathmann%26aufirst%3DM.%26aulast%3DSchlicker%26aufirst%3DE.%26aulast%3DSchunack%26aufirst%3DW.%26aulast%3DSchlegel%26aufirst%3DB.%26aulast%3DSippl%26aufirst%3DW.%26atitle%3DMedicinal%2520chemical%2520and%2520pharmacological%2520aspects%2520of%2520imidazole-containing%2520histamine%2520H3%2520receptor%2520antagonists%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D965%26epage%3D977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span> </span><span class="NLM_article-title">Recent medicinal chemistry of the histamine H<sub>3</sub> receptor</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">â</span> <span class="NLM_lpage">206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1016%2FS0079-6468%2805%2944405-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=16697898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktVShtb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2006&pages=181-206&author=M.+A.+Letavicauthor=A.+J.+Barbierauthor=C.+A.+Dvorakauthor=N.+I.+Carruthers&title=Recent+medicinal+chemistry+of+the+histamine+H3+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Recent medicinal chemistry of the histamine H3 receptor</span></div><div class="casAuthors">Letavic, Michael A.; Barbier, Ann J.; Dvorak, Curt A.; Carruthers, Nicholas I.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">181-206</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review on the new biol. insights on H3 receptor, its clin. applications, the histamine H3 receptor antagonists/inverse agonists and its mol. modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNLHHd2A-5RrVg90H21EOLACvtfcHk0lg4RBHfGbp0-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktVShtb0%253D&md5=c891bdacacb2ca1f14254bff9c5b8432</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2805%2944405-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252805%252944405-7%26sid%3Dliteratum%253Aachs%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DBarbier%26aufirst%3DA.%2BJ.%26aulast%3DDvorak%26aufirst%3DC.%2BA.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26atitle%3DRecent%2520medicinal%2520chemistry%2520of%2520the%2520histamine%2520H3%2520receptor%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D44%26spage%3D181%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_contrib-group">Stocking, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Histamine H<sub>3</sub> antagonists as wake-promoting and pro-cognitive agents</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">988</span><span class="NLM_x">â</span> <span class="NLM_lpage">1002</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.2174%2F156802608784936728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=18673168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1OhtLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=988-1002&author=E.+M.+Stockingauthor=M.+A.+Letavic&title=Histamine+H3+antagonists+as+wake-promoting+and+pro-cognitive+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Histamine H3 antagonists as wake-promoting and pro-cognitive agents</span></div><div class="casAuthors">Stocking, Emily M.; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">988-1002</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The histamine H3 receptor is a pre-synaptic auto- and hetero-receptor that controls the release of histamine and a variety of other neurotransmitters in the brain.  As such, modulation of the histamine H3 receptor is expected to affect wake via control of the release of histamine and to affect cognition via regulation of several other neurotransmitters including acetylcholine and norepinephrine.  Over the last several years numerous pre-clin. studies have shown that histamine H3 antagonists promote wakefulness, improve cognition, and in some cases affect food intake.  Based on the interest level generated from these early pharmacol. studies, and following the cloning and expression of the human histamine H3 receptor, many pharmaceutical companies began drug discovery programs aimed at the identification of histamine H3 antagonists suitable for human clin. trials.  These efforts have led to many new chemotypes, and several promising compds. have recently entered the clinic for a variety of conditions, including ADHD, Narcolepsy, EDS assocd. with Narcolepsy, Cognitive disorders and Schizophrenia.  Recent efforts towards the identification and pharmacol. characterization of novel histamine H3 antagonists will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3QHZ_tij6x7Vg90H21EOLACvtfcHk0lg4RBHfGbp0-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1OhtLg%253D&md5=278487f221ed3b58c2467ccd181c4032</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.2174%2F156802608784936728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608784936728%26sid%3Dliteratum%253Aachs%26aulast%3DStocking%26aufirst%3DE.%2BM.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DHistamine%2520H3%2520antagonists%2520as%2520wake-promoting%2520and%2520pro-cognitive%2520agents%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D988%26epage%3D1002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_contrib-group">Cowart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altenbach, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faghih, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, A. A.</span><span> </span><span class="NLM_article-title">Medicinal chemistry and biological properties of non-imidazole histamine H<sub>3</sub> antagonists</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">â</span> <span class="NLM_lpage">992</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=979-992&author=M.+Cowartauthor=R.+Altenbachauthor=L.+Blackauthor=R.+Faghihauthor=C.+Zhaoauthor=A.+A.+Hancock&title=Medicinal+chemistry+and+biological+properties+of+non-imidazole+histamine+H3+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCowart%26aufirst%3DM.%26aulast%3DAltenbach%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DL.%26aulast%3DFaghih%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DHancock%26aufirst%3DA.%2BA.%26atitle%3DMedicinal%2520chemistry%2520and%2520biological%2520properties%2520of%2520non-imidazole%2520histamine%2520H3%2520antagonists%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D979%26epage%3D992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_contrib-group">Berlin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, C. W.</span><span> </span><span class="NLM_article-title">Recent advances in the development of histamine H<sub>3</sub> antagonists</span> <span class="citation_source-journal">Exp. Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">â</span> <span class="NLM_lpage">687</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1517%2F13543776.17.6.675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=20144064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntFWqt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=675-687&author=M.+Berlinauthor=C.+W.+Boyce&title=Recent+advances+in+the+development+of+histamine+H3+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the development of histamine H3 antagonists</span></div><div class="casAuthors">Berlin, Michael; Boyce, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">675-687</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The histamine H3 receptor is involved in the central and peripheral regulation of levels of histamine and other neurotransmitters (e.g., acetylcholine, noradrenaline, dopamine, serotonin and GABA), which sets it up as a target in the treatment of various CNS (e.g., depression, schizophrenia, ADHD, dementia, neuropathic pain and sleep disorders), metabolic syndrome (e.g., obesity) and allergic disorders.  Novel chem. series from the most recent 2 years of patent literature have been reviewed.  While overall structural diversity is moderate, these represent or relate to some of the compds. progressing through clin. trials (e.g., GSK-189254).  However, an H3 receptor drug still has yet to reach the market.  Patenting activity is likely to remain high in the near future, bolstered by the com. promise of potential H3 receptor drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyL2NJ-m4DTbVg90H21EOLACvtfcHk0lg4RBHfGbp0-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntFWqt7k%253D&md5=28f8904ef061f9660e7e1fb890cde061</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1517%2F13543776.17.6.675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.17.6.675%26sid%3Dliteratum%253Aachs%26aulast%3DBerlin%26aufirst%3DM.%26aulast%3DBoyce%26aufirst%3DC.%2BW.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520histamine%2520H3%2520antagonists%26jtitle%3DExp.%2520Opin.%2520Ther.%2520Pat.%26date%3D2007%26volume%3D17%26spage%3D675%26epage%3D687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baranowski, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witte, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faghih, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennani, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, A. A.</span><span> </span><span class="NLM_article-title">Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H<sub>3</sub> receptor antagonist</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">â</span> <span class="NLM_lpage">945</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2004&pages=933-945&author=T.+A.+Esbenshadeauthor=G.+B.+Foxauthor=K.+M.+Kruegerauthor=J.+L.+Baranowskiauthor=T.+R.+Millerauthor=C.+H.+Kangauthor=L.+I.+Dennyauthor=D.+G.+Witteauthor=B.+B.+Yaoauthor=J.+B.+Panauthor=R.+Faghihauthor=Y.+L.+Bennaniauthor=M.+Williamsauthor=A.+A.+Hancock&title=Pharmacological+and+behavioral+properties+of+A-349821%2C+a+selective+and+potent+human+histamine+H3+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DFox%26aufirst%3DG.%2BB.%26aulast%3DKrueger%26aufirst%3DK.%2BM.%26aulast%3DBaranowski%26aufirst%3DJ.%2BL.%26aulast%3DMiller%26aufirst%3DT.%2BR.%26aulast%3DKang%26aufirst%3DC.%2BH.%26aulast%3DDenny%26aufirst%3DL.%2BI.%26aulast%3DWitte%26aufirst%3DD.%2BG.%26aulast%3DYao%26aufirst%3DB.%2BB.%26aulast%3DPan%26aufirst%3DJ.%2BB.%26aulast%3DFaghih%26aufirst%3DR.%26aulast%3DBennani%26aufirst%3DY.%2BL.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DHancock%26aufirst%3DA.%2BA.%26atitle%3DPharmacological%2520and%2520behavioral%2520properties%2520of%2520A-349821%252C%2520a%2520selective%2520and%2520potent%2520human%2520histamine%2520H3%2520receptor%2520antagonist%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2004%26volume%3D68%26spage%3D933%26epage%3D945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Hancock, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faghih, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowart, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, P. B.</span><span> </span><span class="NLM_article-title">In vitro optimization of structure activity relationships of analogues of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H<sub>3</sub> receptor antagonists</span> <span class="citation_source-journal">Basic Clin. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">â</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1111%2Fj.1742-7843.2004.950307.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=15447739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosFyiu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2004&pages=144-152&author=A.+A.+Hancockauthor=M.+S.+Diehlauthor=R.+Faghihauthor=E.+N.+Bushauthor=K.+M.+Kruegerauthor=G.+Krishnaauthor=T.+R.+Millerauthor=D.+M.+Wilcoxauthor=P.+Nguyenauthor=J.+K.+Prattauthor=M.+D.+Cowartauthor=T.+A.+Esbenshadeauthor=P.+B.+Jacobson&title=In+vitro+optimization+of+structure+activity+relationships+of+analogues+of+A-331440+combining+radioligand+receptor+binding+assays+and+micronucleus+assays+of+potential+antiobesity+histamine+H3+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro optimization of structure activity relationships of analogs of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H3 receptor antagonists</span></div><div class="casAuthors">Hancock, Arthur A.; Diehl, Marilyn S.; Faghih, Ramin; Bush, Eugene N.; Krueger, Kathleen M.; Krishna, Gopala; Miller, Thomas R.; Wilcox, Denise M.; Nguyen, Phong; Pratt, John K.; Cowart, Marlon D.; Eshenshade, Timothy A.; Jacobson, Peer B.</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">144-152</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A-331440 {4'-[3-(3(R)-(dimethylamino)-pyrrolidin-1-yl)-propoxy]-biphenyl-4-carbonitrile}, a potent and selective antagonist of histamine H3 receptors, yielded pos. results in an in vitro micronucleus assay, predictive of genotoxicity in vivo.  Because this compd. has highly favorable properties and potential as an antiobesity agent, new compds. of this general chem. class were sought that would retain or improve upon the high potency and selectivity of A-331440 for H3 receptors, but would lack the potential for genotoxicity obtained with that compd.  Our working hypothesis was that the biphenyl rings in A-331440 might contribute to interactions with DNA and thereby predispose toward genotoxicity.  Toward this end, several analogs were prepd., with substituents introduced onto the biaryl ring to alter the orientation, electronegativity, and polarity of this moiety, and were tested for their radioligand binding potency and selectivity and their propensity to induce genotoxicity in the in vitro micronucleus assay.  Using this strategy, novel compds. were discovered that retained or improved upon the potency and selectivity of A-331440 for H3 receptors and were devoid of genotoxicity in vitro.  Of these, the simple mono- and di-fluorinated analogs (A-417022 [4'-{3-[(3R)-3-(dimethylamino)-1-pyrrolidinyl]propoxy}-3'-fluoro-1,1'-biphenyl-4-carbonitrile] and A-423579 [4'-{3-[(3R)-3-(dimethylamino)-1-pyrrolidinyl]-propoxy}-3',5'-difluoro-1,1'-biphenyl-4-carbonitrile] resp.) were found to bind to H3 receptors at least as potently as A-331440, while lacking genotoxicity in the micronucleus assay.  The reason of the lack of genotoxicity of the fluorinated analogs is unclear, but is esp. noteworthy in light of the general principle that fluorine and hydrogen are very similar in size.  Therefore, these fluorinated analogs of A-331440 represented the most potent and potentially safest compds. for further evaluation as antiobesity leads.  Preliminary findings with one of these examples, A-417022, in a mouse model of obesity are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsB-CdUg04qLVg90H21EOLACvtfcHk0lg98I1qHVnLsQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosFyiu7o%253D&md5=dd639fa35ed75d531d83b6fc8f662087</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-7843.2004.950307.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-7843.2004.950307.x%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DA.%2BA.%26aulast%3DDiehl%26aufirst%3DM.%2BS.%26aulast%3DFaghih%26aufirst%3DR.%26aulast%3DBush%26aufirst%3DE.%2BN.%26aulast%3DKrueger%26aufirst%3DK.%2BM.%26aulast%3DKrishna%26aufirst%3DG.%26aulast%3DMiller%26aufirst%3DT.%2BR.%26aulast%3DWilcox%26aufirst%3DD.%2BM.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DPratt%26aufirst%3DJ.%2BK.%26aulast%3DCowart%26aufirst%3DM.%2BD.%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DJacobson%26aufirst%3DP.%2BB.%26atitle%3DIn%2520vitro%2520optimization%2520of%2520structure%2520activity%2520relationships%2520of%2520analogues%2520of%2520A-331440%2520combining%2520radioligand%2520receptor%2520binding%2520assays%2520and%2520micronucleus%2520assays%2520of%2520potential%2520antiobesity%2520histamine%2520H3%2520receptor%2520antagonists%26jtitle%3DBasic%2520Clin.%2520Pharmacol.%2520Toxicol.%26date%3D2004%26volume%3D95%26spage%3D144%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_contrib-group">Cowart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faghih, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gfesser, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennani, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, A. A.</span><span> </span><span class="NLM_article-title">4-(2-[2-(2(<i>R</i>)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H<sub>3</sub> receptor antagonists potently enhance cognition and attention</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">â</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040118g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=38-55&author=M.+Cowartauthor=R.+Faghihauthor=M.+P.+Curtisauthor=G.+A.+Gfesserauthor=Y.+L.+Bennaniauthor=L.+A.+Blackauthor=L.+Panauthor=K.+C.+Marshauthor=J.+P.+Sullivanauthor=T.+A.+Esbenshadeauthor=G.+B.+Foxauthor=A.+A.+Hancock&title=4-%282-%5B2-%282%28R%29-methylpyrrolidin-1-yl%29ethyl%5Dbenzofuran-5-yl%29benzonitrile+and+related+2-aminoethylbenzofuran+H3+receptor+antagonists+potently+enhance+cognition+and+attention"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1021%2Fjm040118g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040118g%26sid%3Dliteratum%253Aachs%26aulast%3DCowart%26aufirst%3DM.%26aulast%3DFaghih%26aufirst%3DR.%26aulast%3DCurtis%26aufirst%3DM.%2BP.%26aulast%3DGfesser%26aufirst%3DG.%2BA.%26aulast%3DBennani%26aufirst%3DY.%2BL.%26aulast%3DBlack%26aufirst%3DL.%2BA.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DFox%26aufirst%3DG.%2BB.%26aulast%3DHancock%26aufirst%3DA.%2BA.%26atitle%3D4-%25282-%255B2-%25282%2528R%2529-methylpyrrolidin-1-yl%2529ethyl%255Dbenzofuran-5-yl%2529benzonitrile%2520and%2520related%25202-aminoethylbenzofuran%2520H3%2520receptor%2520antagonists%2520potently%2520enhance%2520cognition%2520and%2520attention%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D38%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witte, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennani, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowart, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, A. A.</span><span> </span><span class="NLM_article-title">Pharmacological properties of ABT-239 [4-(2-{2-[(2<i>R</i>)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H<sub>3</sub> receptor antagonist with drug-like properties</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">â</span> <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1124%2Fjpet.104.078303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=15608078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlSnsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2005&pages=165-175&author=T.+A.+Esbenshadeauthor=G.+B.+Foxauthor=K.+M.+Kruegerauthor=T.+R.+Millerauthor=C.+H.+Kangauthor=L.+I.+Dennyauthor=D.+G.+Witteauthor=B.+B.+Yaoauthor=L.+Panauthor=J.+Wetterauthor=K.+Marshauthor=Y.+L.+Bennaniauthor=M.+D.+Cowartauthor=J.+P.+Sullivanauthor=A.+A.+Hancock&title=Pharmacological+properties+of+ABT-239+%5B4-%282-%7B2-%5B%282R%29-2-Methylpyrrolidinyl%5Dethyl%7D-benzofuran-5-yl%29benzonitrile%5D%3A+I.+Potent+and+selective+histamine+H3+receptor+antagonist+with+drug-like+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties</span></div><div class="casAuthors">Esbenshade, Timothy A.; Fox, Gerard B.; Krueger, Kathleen M.; Miller, Thomas R.; Kang, Chae Hee; Denny, Lynne I.; Witte, David G.; Yao, Betty B.; Pan, Liping; Wetter, Jill; Marsh, Kennan; Bennani, Youssef L.; Cowart, Marlon D.; Sullivan, James P.; Hancock, Arthur A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">165-175</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Histamine H3 receptor antagonists are being developed to treat a variety of neurol. and cognitive disorders that may be ameliorated by enhancement of central neurotransmitter release.  Here, we present the in vitro pharmacol. and in vivo pharmacokinetic profiles for the nonimidazole, benzofuran ligand ABT-239 [4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile] and compare it with several previously described imidazole and nonimidazole H3 receptor antagonists.  ABT-239 binds to recombinant human and rat H3 receptors with high affinity, with pKi values of 9.4 and 8.9, resp., and is over 1000-fold selective vs. human H1, H2, and H4 histamine receptors.  ABT-239 is a potent H3 receptor antagonist at recombinant human and rat receptors, reversing agonist-induced changes in cAMP formation (pKb = 7.9 and 7.6, resp.), guanosine 5'-O-(3-[35S]thio) triphosphate ([35S]GTPÎ³S) binding (pKb = 9.0 and 8.3, resp.), and calcium mobilization (human pKb = 7.9).  ABT-239 also competitively reversed histamine-mediated inhibition of [3H]histamine release from rat brain cortical synaptosomes (pKb = 7.7) and agonist-induced inhibition of contractile responses in elec. field stimulated guinea pig ileal segments (pA2 = 8.7).  Addnl., ABT-239 is a potent inverse agonist, inhibiting constitutive [35S]GTPÎ³S binding at both rat and human H3 receptors with resp. pEC50 values of 8.9 and 8.2.  ABT-239 demonstrates good pharmacokinetic characteristics in rat, dog, and monkey with t1/2 values ranging from 4 to 29 h, corresponding with clearance values and metabolic turnover in liver microsomes from these species, and good oral bioavailability ranging from 52 to 89%.  Thus, ABT-239 is a selective, nonimidazole H3 receptor antagonist/inverse agonist with similar high potency in both human and rat and favorable drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowcC95NH2bcLVg90H21EOLACvtfcHk0lg98I1qHVnLsQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlSnsL0%253D&md5=33248c15c96745da445a14853461c019</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.078303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.078303%26sid%3Dliteratum%253Aachs%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DFox%26aufirst%3DG.%2BB.%26aulast%3DKrueger%26aufirst%3DK.%2BM.%26aulast%3DMiller%26aufirst%3DT.%2BR.%26aulast%3DKang%26aufirst%3DC.%2BH.%26aulast%3DDenny%26aufirst%3DL.%2BI.%26aulast%3DWitte%26aufirst%3DD.%2BG.%26aulast%3DYao%26aufirst%3DB.%2BB.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DWetter%26aufirst%3DJ.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DBennani%26aufirst%3DY.%2BL.%26aulast%3DCowart%26aufirst%3DM.%2BD.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DHancock%26aufirst%3DA.%2BA.%26atitle%3DPharmacological%2520properties%2520of%2520ABT-239%2520%255B4-%25282-%257B2-%255B%25282R%2529-2-Methylpyrrolidinyl%255Dethyl%257D-benzofuran-5-yl%2529benzonitrile%255D%253A%2520I.%2520Potent%2520and%2520selective%2520histamine%2520H3%2520receptor%2520antagonist%2520with%2520drug-like%2520properties%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D313%26spage%3D165%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15c"><span><span class="NLM_contrib-group">Fox, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radek, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browman, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komater, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faghih, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drescher, K. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porsolt, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennani, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowart, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, A. A.</span><span> </span><span class="NLM_article-title">Pharmacological properties of ABT-239 [4-(2-{2-[(2<i>R</i>)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H<sub>3</sub> receptor antagonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">176</span><span class="NLM_x">â</span> <span class="NLM_lpage">190</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1124%2Fjpet.104.078402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=15608077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlSnsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2005&pages=176-190&author=G.+B.+Foxauthor=T.+A.+Esbenshadeauthor=J.+B.+Panauthor=R.+J.+Radekauthor=K.+M.+Kruegerauthor=B.+B.+Yaoauthor=K.+E.+Browmanauthor=M.+J.+Buckleyauthor=M.+E.+Ballardauthor=V.+A.+Komaterauthor=H.+Minerauthor=M.+Zhangauthor=R.+Faghihauthor=L.+E.+Rueterauthor=R.+S.+Bitnerauthor=K.+U.+Drescherauthor=J.+Wetterauthor=K.+Marshauthor=M.+Lemaireauthor=R.+D.+Porsoltauthor=Y.+L.+Bennaniauthor=J.+P.+Sullivanauthor=M.+D.+Cowartauthor=M.+W.+Deckerauthor=A.+A.+Hancock&title=Pharmacological+properties+of+ABT-239+%5B4-%282-%7B2-%5B%282R%29-2-methylpyrrolidinyl%5Dethyl%7D-benzofuran-5-yl%29benzonitrile%5D%3A+II.+neurophysiological+characterization+and+broad+preclinical+efficacy+in+cognition+and+schizophrenia+of+a+potent+and+selective+histamine+H3+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15cR"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist</span></div><div class="casAuthors">Fox, Gerard B.; Esbenshade, Timothy A.; Pan, Jia Bao; Radek, Richard J.; Krueger, Kathleen M.; Yao, Betty B.; Browman, Kaitlin E.; Buckley, Michael J.; Ballard, Michael E.; Komater, Victoria A.; Miner, Holly; Zhang, Min; Faghih, Ramin; Rueter, Lynne E.; Bitner, R. Scott; Drescher, Karla U.; Wetter, Jill; Marsh, Kennan; Lemaire, Martine; Porsolt, Roger D.; Bennani, Youssef L.; Sullivan, James P.; Cowart, Marlon D.; Decker, Michael W.; Hancock, Arthur A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">176-190</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Acute pharmacol. blockade of central histamine H3 receptors (H3Rs) enhances arousal/attention in rodents.  However, there is little information available for other behavioral domains or for repeated administration using selective compds.  ABT-239 [4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile] exemplifies such a selective, nonimidazole H3R antagonist with high affinity for rat (pKi = 8.9) and human (pKi = 9.5) H3Rs.  Acute functional blockade of central H3Rs was demonstrated by blocking the dipsogenia response to the selective H3R agonist (R)-Î±-methylhistamine in mice.  In cognition studies, acquisition of a five-trial, inhibitory avoidance test in rat pups was improved with ABT-239 (0.1-1.0 mg/kg), a 10- to 150-fold gain in potency, with similar efficacy, over previous antagonists such as thioperamide, ciproxifan, A-304121 [(4-(3-(4-((2R)-2-aminopropanoyl)-1-piperazinyl)propoxy)phenyl)(cyclopropyl) methanone], A-317920 [N-((1R)-2-(4-(3-(4-(cyclopropylcarbonyl)phenoxy)propyl)-1-piperazinyl)-1-methyl-2-oxoethyl)-2-furamide], and A-349821 [(4'-(3-((R,R)2,5-dimethyl-pyrrolidin-1-yl)-propoxy)-biphenyl-4-yl)- morpholin-4-yl-methanone].  Efficacy in this model was maintained for 3 to 6 h and following repeated dosing with ABT-239.  Social memory was also improved in adult (0.01-0.3 mg/kg) and aged (0.3-1.0 mg/kg) rats.  In schizophrenia models, ABT-239 improved gating deficits in DBA/2 mice using prepulse inhibition of startle (1.0-3.0 mg/kg) and N40 (1.0-10.0 mg/kg).  Furthermore, ABT-239 (1.0 mg/kg) attenuated methamphetamine-induced hyperactivity in mice.  In freely moving rat microdialysis studies, ABT-239 enhanced acetylcholine release (0.1-3.0 mg/kg) in adult rat frontal cortex and hippocampus and enhanced dopamine release in frontal cortex (3.0 mg/kg), but not striatum.  In summary, broad efficacy was obsd. with ABT-239 across animal models such that potential clin. efficacy may extend beyond disorders such as ADHD to include Alzheimer's disease and schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5hD1Q0ydnubVg90H21EOLACvtfcHk0lj1fgq3_Eq70g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlSnsLo%253D&md5=437e154a172071e4c5d31e44134ab1b5</span></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.078402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.078402%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DG.%2BB.%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DPan%26aufirst%3DJ.%2BB.%26aulast%3DRadek%26aufirst%3DR.%2BJ.%26aulast%3DKrueger%26aufirst%3DK.%2BM.%26aulast%3DYao%26aufirst%3DB.%2BB.%26aulast%3DBrowman%26aufirst%3DK.%2BE.%26aulast%3DBuckley%26aufirst%3DM.%2BJ.%26aulast%3DBallard%26aufirst%3DM.%2BE.%26aulast%3DKomater%26aufirst%3DV.%2BA.%26aulast%3DMiner%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DFaghih%26aufirst%3DR.%26aulast%3DRueter%26aufirst%3DL.%2BE.%26aulast%3DBitner%26aufirst%3DR.%2BS.%26aulast%3DDrescher%26aufirst%3DK.%2BU.%26aulast%3DWetter%26aufirst%3DJ.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DLemaire%26aufirst%3DM.%26aulast%3DPorsolt%26aufirst%3DR.%2BD.%26aulast%3DBennani%26aufirst%3DY.%2BL.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DCowart%26aufirst%3DM.%2BD.%26aulast%3DDecker%26aufirst%3DM.%2BW.%26aulast%3DHancock%26aufirst%3DA.%2BA.%26atitle%3DPharmacological%2520properties%2520of%2520ABT-239%2520%255B4-%25282-%257B2-%255B%25282R%2529-2-methylpyrrolidinyl%255Dethyl%257D-benzofuran-5-yl%2529benzonitrile%255D%253A%2520II.%2520neurophysiological%2520characterization%2520and%2520broad%2520preclinical%2520efficacy%2520in%2520cognition%2520and%2520schizophrenia%2520of%2520a%2520potent%2520and%2520selective%2520histamine%2520H3%2520receptor%2520antagonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D313%26spage%3D176%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Hancock, A. A.</span><span> </span><span class="NLM_article-title">The challenge of drug discovery of a GPCR target: analysis of preclinical pharmacology of histamine H<sub>3</sub> antagonists/inverse agonists</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1103</span><span class="NLM_x">â</span> <span class="NLM_lpage">1113</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=1103-1113&author=A.+A.+Hancock&title=The+challenge+of+drug+discovery+of+a+GPCR+target%3A+analysis+of+preclinical+pharmacology+of+histamine+H3+antagonists%2Finverse+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DA.%2BA.%26atitle%3DThe%2520challenge%2520of%2520drug%2520discovery%2520of%2520a%2520GPCR%2520target%253A%2520analysis%2520of%2520preclinical%2520pharmacology%2520of%2520histamine%2520H3%2520antagonists%252Finverse%2520agonists%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2006%26volume%3D71%26spage%3D1103%26epage%3D1113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_contrib-group">Nagase, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitobe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takenaga, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, N.</span><span> </span><span class="NLM_article-title">Synthesis, structureâactivity relationships, and biological profiles of a quinazolinone class of histamine H<sub>3</sub> receptor inverse agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4780</span><span class="NLM_x">â</span> <span class="NLM_lpage">4789</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8003834" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4780-4789&author=T.+Nagaseauthor=T.+Mizutaniauthor=S.+Ishikawaauthor=E.+Sekinoauthor=T.+Sasakiauthor=T.+Fujimuraauthor=S.+Itoauthor=Y.+Mitobeauthor=Y.+Miyamotoauthor=R.+Yoshimotoauthor=T.+Tanakaauthor=A.+Ishiharaauthor=N.+Takenagaauthor=S.+Tokitaauthor=T.+Fukamiauthor=N.+Sato&title=Synthesis%2C+structure%E2%80%93activity+relationships%2C+and+biological+profiles+of+a+quinazolinone+class+of+histamine+H3+receptor+inverse+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Fjm8003834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8003834%26sid%3Dliteratum%253Aachs%26aulast%3DNagase%26aufirst%3DT.%26aulast%3DMizutani%26aufirst%3DT.%26aulast%3DIshikawa%26aufirst%3DS.%26aulast%3DSekino%26aufirst%3DE.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DFujimura%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DS.%26aulast%3DMitobe%26aufirst%3DY.%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DYoshimoto%26aufirst%3DR.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DIshihara%26aufirst%3DA.%26aulast%3DTakenaga%26aufirst%3DN.%26aulast%3DTokita%26aufirst%3DS.%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DN.%26atitle%3DSynthesis%252C%2520structure%25E2%2580%2593activity%2520relationships%252C%2520and%2520biological%2520profiles%2520of%2520a%2520quinazolinone%2520class%2520of%2520histamine%2520H3%2520receptor%2520inverse%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4780%26epage%3D4789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span>Thompson Reuters Integrity, MK-0249, Entry 433171,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Thompson+Reuters+Integrity%2C+MK-0249%2C+Entry+433171%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_contrib-group">Ligneau, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landais, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piriou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uguen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anaclet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burban, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrang, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J. C.</span><span> </span><span class="NLM_article-title">Brain histamine and schizophrenia: potential therapeutic applications of H<sub>3</sub> receptor inverse agonists studied with BF2.649</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1215</span><span class="NLM_x">â</span> <span class="NLM_lpage">1224</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2007&pages=1215-1224&author=X.+Ligneauauthor=L.+Landaisauthor=D.+Perrinauthor=J.+Piriouauthor=M.+Uguenauthor=E.+Denisauthor=P.+Robertauthor=R.+Parmentierauthor=C.+Anacletauthor=J.+S.+Linauthor=A.+Burbanauthor=J.+M.+Arrangauthor=J.+C.+Schwartz&title=Brain+histamine+and+schizophrenia%3A+potential+therapeutic+applications+of+H3+receptor+inverse+agonists+studied+with+BF2.649"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLigneau%26aufirst%3DX.%26aulast%3DLandais%26aufirst%3DL.%26aulast%3DPerrin%26aufirst%3DD.%26aulast%3DPiriou%26aufirst%3DJ.%26aulast%3DUguen%26aufirst%3DM.%26aulast%3DDenis%26aufirst%3DE.%26aulast%3DRobert%26aufirst%3DP.%26aulast%3DParmentier%26aufirst%3DR.%26aulast%3DAnaclet%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DJ.%2BS.%26aulast%3DBurban%26aufirst%3DA.%26aulast%3DArrang%26aufirst%3DJ.%2BM.%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26atitle%3DBrain%2520histamine%2520and%2520schizophrenia%253A%2520potential%2520therapeutic%2520applications%2520of%2520H3%2520receptor%2520inverse%2520agonists%2520studied%2520with%2520BF2.649%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D73%26spage%3D1215%26epage%3D1224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_contrib-group">Ligneau, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landais, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camelin, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calmels, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrebi-Bertrand, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecomte, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anaclet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertaina-Anglade, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">la Rochelle, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">dâAniello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouleau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gbahou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrang, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganellin, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schunack, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J. C.</span><span> </span><span class="NLM_article-title">BF2.649 [1-{3-[3-(4-chlorophenyl)-propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H<sub>3</sub> receptor: preclinical pharmacology</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">â</span> <span class="NLM_lpage">75</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1124%2Fjpet.106.111039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=17005916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsFChsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=365-75&author=X.+Ligneauauthor=D.+Perrinauthor=L.+Landaisauthor=J.+C.+Camelinauthor=T.+P.+Calmelsauthor=I.+Berrebi-Bertrandauthor=J.+M.+Lecomteauthor=R.+Parmentierauthor=C.+Anacletauthor=J.+S.+Linauthor=V.+Bertaina-Angladeauthor=C.+D.+la+Rochelleauthor=F.+d%E2%80%99Anielloauthor=A.+Rouleauauthor=F.+Gbahouauthor=J.+M.+Arrangauthor=C.+R.+Ganellinauthor=H.+Starkauthor=W.+Schunackauthor=J.+C.+Schwartz&title=BF2.649+%5B1-%7B3-%5B3-%284-chlorophenyl%29-propoxy%5Dpropyl%7Dpiperidine%2C+hydrochloride%5D%2C+a+nonimidazole+inverse+agonist%2Fantagonist+at+the+human+histamine+H3+receptor%3A+preclinical+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">BF2.649 [1-{3-[3-(4-chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: preclinical pharmacology</span></div><div class="casAuthors">Ligneau, X.; Perrin, D.; Landais, L.; Camelin, J.-C.; Calmels, T. P. G.; Berrebi-Bertrand, I.; Lecomte, J.-M.; Parmentier, R.; Anaclet, C.; Lin, J.-S.; Bertaina-Anglade, V.; la Rochelle, C. Drieu; d'Aniello, F.; Rouleau, A.; Gbahou, F.; Arrang, J.-M.; Ganellin, C. R.; Stark, H.; Schunack, W.; Schwartz, J.-C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">365-375</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Histamine H3 receptor inverse agonists are known to enhance the activity of histaminergic neurons in brain and thereby promote vigilance and cognition.  1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride (BF2.649) is a novel, potent, and selective nonimidazole inverse agonist at the recombinant human H3 receptor.  On the stimulation of guanosine 5'-O-(3-[35S]thio)triphosphate binding to this receptor, BF2.649 behaved as a competitive antagonist with a Ki value of 0.16 nM and as an inverse agonist with an EC50 value of 1.5 nM and an intrinsic activity â¼50% higher than that of ciproxifan.  Its in vitro potency was â¼6 times lower at the rodent receptor.  In mice, the oral bioavailability coeff., i.e., the ratio of plasma areas under the curve after oral and i.v. administrations, resp., was 84%.  BF2.649 dose dependently enhanced tele-methylhistamine levels in mouse brain, an index of histaminergic neuron activity, with an ED50 value of 1.6 mg/kg p.o., a response that persisted after repeated administrations for 17 days.  In rats, the drug enhanced dopamine and acetylcholine levels in microdialyzates of the prefrontal cortex.  In cats, it markedly enhanced wakefulness at the expense of sleep states and also enhanced fast cortical rhythms of the EEG, known to be assocd. with improved vigilance.  On the two-trial object recognition test in mice, a promnesiant effect was shown regarding either scopolamine-induced or natural forgetting.  These preclin. data suggest that BF2.649 is a valuable drug candidate to be developed in wakefulness or memory deficits and other cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKmA7knKGrp7Vg90H21EOLACvtfcHk0lhPXRl3iL1rmQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsFChsA%253D%253D&md5=592d569ec46591850fcd1dde58be3ff7</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.111039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.111039%26sid%3Dliteratum%253Aachs%26aulast%3DLigneau%26aufirst%3DX.%26aulast%3DPerrin%26aufirst%3DD.%26aulast%3DLandais%26aufirst%3DL.%26aulast%3DCamelin%26aufirst%3DJ.%2BC.%26aulast%3DCalmels%26aufirst%3DT.%2BP.%26aulast%3DBerrebi-Bertrand%26aufirst%3DI.%26aulast%3DLecomte%26aufirst%3DJ.%2BM.%26aulast%3DParmentier%26aufirst%3DR.%26aulast%3DAnaclet%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DJ.%2BS.%26aulast%3DBertaina-Anglade%26aufirst%3DV.%26aulast%3Dla%2BRochelle%26aufirst%3DC.%2BD.%26aulast%3Dd%25E2%2580%2599Aniello%26aufirst%3DF.%26aulast%3DRouleau%26aufirst%3DA.%26aulast%3DGbahou%26aufirst%3DF.%26aulast%3DArrang%26aufirst%3DJ.%2BM.%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26aulast%3DStark%26aufirst%3DH.%26aulast%3DSchunack%26aufirst%3DW.%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26atitle%3DBF2.649%2520%255B1-%257B3-%255B3-%25284-chlorophenyl%2529-propoxy%255Dpropyl%257Dpiperidine%252C%2520hydrochloride%255D%252C%2520a%2520nonimidazole%2520inverse%2520agonist%252Fantagonist%2520at%2520the%2520human%2520histamine%2520H3%2520receptor%253A%2520preclinical%2520pharmacology%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D365%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_contrib-group">Medhurst, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkins, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresford, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brackenborough, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calver, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cilia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluderay, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crook, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gartlon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heslop, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacroix, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martyn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ociepka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schogger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southam, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stean, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trail, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadsworth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wald, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolley, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. M.</span><span> </span><span class="NLM_article-title">GSK189254, a novel H<sub>3</sub> receptor antagonist that binds to histamine H3 receptors in Alzheimerâs disease brain and improves cognitive performance in preclinical models</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">1032</span><span class="NLM_x">â</span> <span class="NLM_lpage">1045</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1124%2Fjpet.107.120311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=17327487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFeqs74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=1032-1045&author=A.+D.+Medhurstauthor=A.+R.+Atkinsauthor=I.+J.+Beresfordauthor=K.+Brackenboroughauthor=M.+A.+Briggsauthor=A.+R.+Calverauthor=J.+Ciliaauthor=J.+E.+Cluderayauthor=B.+Crookauthor=J.+B.+Davisauthor=R.+K.+Davisauthor=R.+P.+Davisauthor=L.+A.+Dawsonauthor=A.+G.+Foleyauthor=J.+Gartlonauthor=M.+I.+Gonzalezauthor=T.+Heslopauthor=W.+D.+Hirstauthor=C.+Jenningsauthor=D.+N.+Jonesauthor=L.+P.+Lacroixauthor=A.+Martynauthor=S.+Ociepkaauthor=A.+Rayauthor=C.+M.+Reganauthor=J.+C.+Robertsauthor=J.+Schoggerauthor=E.+Southamauthor=T.+O.+Steanauthor=B.+K.+Trailauthor=N.+Uptonauthor=G.+Wadsworthauthor=J.+A.+Waldauthor=T.+Whiteauthor=J.+Witheringtonauthor=M.+L.+Woolleyauthor=A.+Worbyauthor=D.+M.+Wilson&title=GSK189254%2C+a+novel+H3+receptor+antagonist+that+binds+to+histamine+H3+receptors+in+Alzheimer%E2%80%99s+disease+brain+and+improves+cognitive+performance+in+preclinical+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models</span></div><div class="casAuthors">Medhurst, Andrew D.; Atkins, Alan R.; Beresford, Isabel J.; Brackenborough, Kim; Briggs, Michael A.; Calver, Andrew R.; Cilia, Jackie; Cluderay, Jane E.; Crook, Barry; Davis, John B.; Davis, Rebecca K.; Davis, Robert P.; Dawson, Lee A.; Foley, Andrew G.; Gartlon, Jane; Gonzalez, M. Isabel; Heslop, Teresa; Hirst, Warren D.; Jennings, Carol; Jones, Declan N. C.; Lacroix, Laurent P.; Martyn, Abbe; Ociepka, Sandrine; Ray, Alison; Regan, Ciaran M.; Roberts, Jennifer C.; Schogger, Joanne; Southam, Eric; Stean, Tania O.; Trail, Brenda K.; Upton, Neil; Wadsworth, Graham; Wald, Jeffrey A.; White, Trevor; Witherington, Jason; Woolley, Marie L.; Worby, Angela; Wilson, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1032-1045</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">6[(3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-pyridinecarboxamide hydrochloride (GSK189254) is a novel histamine H3 receptor antagonist with high affinity for human (pKi = 9.59-9.90) and rat (pKi = 8.51-9.17) H3 receptors.  GSK189254 is >10,000-fold selective for human H3 receptors vs. other targets tested, and it exhibited potent functional antagonism (pA2 = 9.06 vs. agonist-induced changes in cAMP) and inverse agonism [pIC50 = 8.20 vs. basal guanosine 5'-O-(3-[35S]thio)triphosphate binding] at the human recombinant H3 receptor.  In vitro autoradiog. demonstrated specific [3H]GSK189254 binding in rat and human brain areas, including cortex and hippocampus.  In addn., dense H3 binding was detected in medial temporal cortex samples from severe cases of Alzheimer's disease, suggesting for the first time that H3 receptors are preserved in late-stage disease.  After oral administration, GSK189254 inhibited cortical ex vivo R-(-)-Î±-methyl[imidazole-2,5(n)-3H]histamine dihydrochloride ([3H]R-Î±-methylhistamine) binding (ED50 = 0.17 mg/kg) and increased c-Fos immunoreactivity in prefrontal and somatosensory cortex (3 mg/kg).  Microdialysis studies demonstrated that GSK189254 (0.3-3 mg/kg p.o.) increased the release of acetylcholine, noradrenaline, and dopamine in the anterior cingulate cortex and acetylcholine in the dorsal hippocampus.  Functional antagonism of central H3 receptors was demonstrated by blockade of R-Î±-methylhistamine-induced dipsogenia in rats (ID50 = 0.03 mg/kg p.o.).  GSK189254 significantly improved performance of rats in diverse cognition paradigms, including passive avoidance (1 and 3 mg/kg p.o.), water maze (1 and 3 mg/kg p.o.), object recognition (0.3 and 1 mg/kg p.o.), and attentional set shift (1 mg/kg p.o.).  These data suggest that GSK189254 may have therapeutic potential for the symptomatic treatment of dementia in Alzheimer's disease and other cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1RSEKGEQaDbVg90H21EOLACvtfcHk0lhgc1O2xs8HtA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFeqs74%253D&md5=c72dfbcb1db4f56cda723eff6b0f0e85</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.120311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.120311%26sid%3Dliteratum%253Aachs%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DAtkins%26aufirst%3DA.%2BR.%26aulast%3DBeresford%26aufirst%3DI.%2BJ.%26aulast%3DBrackenborough%26aufirst%3DK.%26aulast%3DBriggs%26aufirst%3DM.%2BA.%26aulast%3DCalver%26aufirst%3DA.%2BR.%26aulast%3DCilia%26aufirst%3DJ.%26aulast%3DCluderay%26aufirst%3DJ.%2BE.%26aulast%3DCrook%26aufirst%3DB.%26aulast%3DDavis%26aufirst%3DJ.%2BB.%26aulast%3DDavis%26aufirst%3DR.%2BK.%26aulast%3DDavis%26aufirst%3DR.%2BP.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DFoley%26aufirst%3DA.%2BG.%26aulast%3DGartlon%26aufirst%3DJ.%26aulast%3DGonzalez%26aufirst%3DM.%2BI.%26aulast%3DHeslop%26aufirst%3DT.%26aulast%3DHirst%26aufirst%3DW.%2BD.%26aulast%3DJennings%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DD.%2BN.%26aulast%3DLacroix%26aufirst%3DL.%2BP.%26aulast%3DMartyn%26aufirst%3DA.%26aulast%3DOciepka%26aufirst%3DS.%26aulast%3DRay%26aufirst%3DA.%26aulast%3DRegan%26aufirst%3DC.%2BM.%26aulast%3DRoberts%26aufirst%3DJ.%2BC.%26aulast%3DSchogger%26aufirst%3DJ.%26aulast%3DSoutham%26aufirst%3DE.%26aulast%3DStean%26aufirst%3DT.%2BO.%26aulast%3DTrail%26aufirst%3DB.%2BK.%26aulast%3DUpton%26aufirst%3DN.%26aulast%3DWadsworth%26aufirst%3DG.%26aulast%3DWald%26aufirst%3DJ.%2BA.%26aulast%3DWhite%26aufirst%3DT.%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DWoolley%26aufirst%3DM.%2BL.%26aulast%3DWorby%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26atitle%3DGSK189254%252C%2520a%2520novel%2520H3%2520receptor%2520antagonist%2520that%2520binds%2520to%2520histamine%2520H3%2520receptors%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520brain%2520and%2520improves%2520cognitive%2520performance%2520in%2520preclinical%2520models%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D321%26spage%3D1032%26epage%3D1045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span> Thompson Reuters Integrity, GSK-189254, Entry 376370,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Thompson+Reuters+Integrity%2C+GSK-189254%2C+Entry+376370%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_contrib-group">Wermuth, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlewer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourguignon, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maghioros, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouchet, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moire, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worms, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biziere, K.</span><span> </span><span class="NLM_article-title">3-Aminopyridazine derivatives with atypical antidepressant, serotonergic, and dopaminergic activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">528</span><span class="NLM_x">â</span> <span class="NLM_lpage">537</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00123a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=528-537&author=C.+G.+Wermuthauthor=G.+Schlewerauthor=J.+J.+Bourguignonauthor=G.+Maghiorosauthor=M.+J.+Bouchetauthor=C.+Moireauthor=J.+P.+Kanauthor=P.+Wormsauthor=K.+Biziere&title=3-Aminopyridazine+derivatives+with+atypical+antidepressant%2C+serotonergic%2C+and+dopaminergic+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1021%2Fjm00123a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00123a004%26sid%3Dliteratum%253Aachs%26aulast%3DWermuth%26aufirst%3DC.%2BG.%26aulast%3DSchlewer%26aufirst%3DG.%26aulast%3DBourguignon%26aufirst%3DJ.%2BJ.%26aulast%3DMaghioros%26aufirst%3DG.%26aulast%3DBouchet%26aufirst%3DM.%2BJ.%26aulast%3DMoire%26aufirst%3DC.%26aulast%3DKan%26aufirst%3DJ.%2BP.%26aulast%3DWorms%26aufirst%3DP.%26aulast%3DBiziere%26aufirst%3DK.%26atitle%3D3-Aminopyridazine%2520derivatives%2520with%2520atypical%2520antidepressant%252C%2520serotonergic%252C%2520and%2520dopaminergic%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D528%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_contrib-group">Coates, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKillop, A.</span><span> </span><span class="NLM_article-title">One-pot preparation of 6-substituted 3(2<i>H</i>)-pyridazinones from ketones</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_fpage">334</span><span class="NLM_x">â</span> <span class="NLM_lpage">342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1055%2Fs-1993-25861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADyaK3sXisFCrt7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&pages=334-342&author=W.+J.+Coatesauthor=A.+McKillop&title=One-pot+preparation+of+6-substituted+3%282H%29-pyridazinones+from+ketones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">One-pot preparation of 6-substituted 3(2H)-pyridazinones from ketones</span></div><div class="casAuthors">Coates, W. J.; McKillop, A.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">334-42</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">A one-pot process for the prepn. of 6-phenyl-3(2H)-pyridazinone from acetophenone and glyoxylic acid has been investigated and shown to have wide utility in the prepn. of 6- and 5,6-substituted 3(2H)-pyridazinones.  Limitations to the process encountered with 2'-hydroxyacetophenone and with basic heteroarom. ketones have been overcome, and the processes described offer the rapid and efficient synthesis of many 6-substituted pyridazinones from readily available ketones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUXtHqDnNY2LVg90H21EOLACvtfcHk0lhgc1O2xs8HtA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXisFCrt7w%253D&md5=7fa145eb5b58dd9f6b1700cd961336e4</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1055%2Fs-1993-25861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1993-25861%26sid%3Dliteratum%253Aachs%26aulast%3DCoates%26aufirst%3DW.%2BJ.%26aulast%3DMcKillop%26aufirst%3DA.%26atitle%3DOne-pot%2520preparation%2520of%25206-substituted%25203%25282H%2529-pyridazinones%2520from%2520ketones%26jtitle%3DSynthesis%26date%3D1993%26spage%3D334%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Curran, W. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, A.</span><span> </span><span class="NLM_article-title">6-Phenyl-4,5-dihydro-3(2<i>H</i>)-pyridazinones. A series of hypotensive agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">â</span> <span class="NLM_lpage">281</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00249a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1974&pages=273-281&author=W.+V.+Curranauthor=A.+Ross&title=6-Phenyl-4%2C5-dihydro-3%282H%29-pyridazinones.+A+series+of+hypotensive+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm00249a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00249a004%26sid%3Dliteratum%253Aachs%26aulast%3DCurran%26aufirst%3DW.%2BV.%26aulast%3DRoss%26aufirst%3DA.%26atitle%3D6-Phenyl-4%252C5-dihydro-3%25282H%2529-pyridazinones.%2520A%2520series%2520of%2520hypotensive%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1974%26volume%3D17%26spage%3D273%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_contrib-group">Sircar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duell, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristol, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. B.</span><span> </span><span class="NLM_article-title">Cardiotonic agents. 2. Synthesis and structureâactivity relationships of 4,5-dihydro-6-[4-(1<i>H</i>-imidazol-1-yl)phenyl]-3(2<i>H</i>)-pyridazinones: a new class of positive inotropic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1405</span><span class="NLM_x">â</span> <span class="NLM_lpage">1413</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00148a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=1405-1413&author=I.+Sircarauthor=B.+L.+Duellauthor=G.+Bobowskiauthor=J.+A.+Bristolauthor=D.+B.+Evans&title=Cardiotonic+agents.+2.+Synthesis+and+structure%E2%80%93activity+relationships+of+4%2C5-dihydro-6-%5B4-%281H-imidazol-1-yl%29phenyl%5D-3%282H%29-pyridazinones%3A+a+new+class+of+positive+inotropic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fjm00148a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00148a006%26sid%3Dliteratum%253Aachs%26aulast%3DSircar%26aufirst%3DI.%26aulast%3DDuell%26aufirst%3DB.%2BL.%26aulast%3DBobowski%26aufirst%3DG.%26aulast%3DBristol%26aufirst%3DJ.%2BA.%26aulast%3DEvans%26aufirst%3DD.%2BB.%26atitle%3DCardiotonic%2520agents.%25202.%2520Synthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%25204%252C5-dihydro-6-%255B4-%25281H-imidazol-1-yl%2529phenyl%255D-3%25282H%2529-pyridazinones%253A%2520a%2520new%2520class%2520of%2520positive%2520inotropic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1985%26volume%3D28%26spage%3D1405%26epage%3D1413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_contrib-group">Sotelo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravina, E.</span><span> </span><span class="NLM_article-title">Efficient aromatization of 4,5-dihydro-3(2<i>H</i>)-pyridazinone substituted at 5 position by using anhydrous copper chloride</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">7</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1080%2F00397910008087285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtVSrtb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2000&pages=1-7&author=E.+Soteloauthor=E.+Ravina&title=Efficient+aromatization+of+4%2C5-dihydro-3%282H%29-pyridazinone+substituted+at+5+position+by+using+anhydrous+copper+chloride"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient aromatization of 4,5-dihydro-3(2H)-pyridazinones substituted at 5 position by using anhydrous copper(II) chloride</span></div><div class="casAuthors">Sotelo, Eddy; Ravina, Enrique</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">An efficient conversion of 5-substituted-4,5-dihydro-3(2H)-pyridazinones, e.g. I, into their corresponding dehydrogenated derivs. was achieved by treatment with anhyd. copper(II) chloride in acetonitrile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1-dh7DTR7fLVg90H21EOLACvtfcHk0ljxzZFidS6T5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtVSrtb0%253D&md5=fa6bf2391659d2b8c6ae80dfc8e9fa7c</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1080%2F00397910008087285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910008087285%26sid%3Dliteratum%253Aachs%26aulast%3DSotelo%26aufirst%3DE.%26aulast%3DRavina%26aufirst%3DE.%26atitle%3DEfficient%2520aromatization%2520of%25204%252C5-dihydro-3%25282H%2529-pyridazinone%2520substituted%2520at%25205%2520position%2520by%2520using%2520anhydrous%2520copper%2520chloride%26jtitle%3DSynth.%2520Commun.%26date%3D2000%26volume%3D30%26spage%3D1%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_contrib-group">Kodavanti, U. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehendale, H. M.</span><span> </span><span class="NLM_article-title">Cationic amphiphilic drugs and phospholipid storage disorder</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">â</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=2080227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADyaK3MXksVWjtbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1990&pages=327-354&author=U.+P.+Kodavantiauthor=H.+M.+Mehendale&title=Cationic+amphiphilic+drugs+and+phospholipid+storage+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Cationic amphiphilic drugs and phospholipid storage disorder</span></div><div class="casAuthors">Kodavanti, Urmila P.; Mehendale, Harihara M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">327-54</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    </div><div class="casAbstract">A review with â¼300 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeDCq1uXj7fLVg90H21EOLACvtfcHk0ljxzZFidS6T5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXksVWjtbk%253D&md5=2025601b772b06756c57559565810c73</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKodavanti%26aufirst%3DU.%2BP.%26aulast%3DMehendale%26aufirst%3DH.%2BM.%26atitle%3DCationic%2520amphiphilic%2520drugs%2520and%2520phospholipid%2520storage%2520disorder%26jtitle%3DPharmacol.%2520Rev.%26date%3D1990%26volume%3D42%26spage%3D327%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_contrib-group">Ploemen, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Sandt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Burgsteden, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saleminki, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Esch, E.</span><span> </span><span class="NLM_article-title">Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines</span> <span class="citation_source-journal">Exp. Toxicol. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">â</span> <span class="NLM_lpage">355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=15088636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFGltL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=347-355&author=J.+P.+Ploemenauthor=J.+Kelderauthor=T.+Hafmansauthor=H.+van+de+Sandtauthor=J.+A.+van+Burgstedenauthor=P.+J.+Saleminkiauthor=E.+van+Esch&title=Use+of+physicochemical+calculation+of+pKa+and+CLogP+to+predict+phospholipidosis-inducing+potential%3A+a+case+study+with+structurally+related+piperazines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines</span></div><div class="casAuthors">Ploemen, Jan-Peter H. T. M.; Kelder, Jan; Hafmans, Theo; van de Sandt, Han; van Burgsteden, Johan A.; Salemink, Paul J. M.; van Esch, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">347-355</span>CODEN:
                <span class="NLM_cas:coden">ETPAEK</span>;
        ISSN:<span class="NLM_cas:issn">0940-2993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Several cationic amphiphilic compds. are known to induce phospholipidosis, a condition primarily characterized by excessive accumulation of phospholipids in different cell types, giving the affected cells a finely foamy appearance.  Excessive storage of lamellar membranous intralysosomal inclusion bodies is the hallmark for phospholipidosis on the electron microscopic level.  In case of alveolar phospholipidosis, foamy macrophages accumulate within the alveolar spaces of the lung.  Based on such findings in a one-year toxicity study with gepirone in rats, we studied the mol. properties of this compd. and compds. suspected of being phospholipidosis inducers by means of physicochem. calcns.  Physicochem. mol. calcns. of mol. wt., ClogP (partition coeff. octanol/water), logD at pH 7.4, and pKa were performed, for the cationic amphiphilic compds. chlorpromazine, amiodarone, imipramine, propranolol and fluoxetine, and for the structurally related compds. 1-phenylpiperazine (1-PHP), gepirone (and its major metabolites, 3-OH-gepirone and 1-pyrimidinylpiperazine [1-PP]), and buspirone.  ClogP and calcd. pKa cluster differently for the amphiphilic drugs compared to the chem. series of piperazines.  In line with this anal., lamellar inclusion bodies were found in an in vitro validation expt. in the human monoblastoid cell line U-937, incubated for 96 h at 10 Î¼g/mL with cationic amphiphilic drugs (amiodarone, imipramine, or propranolol).  No such lamellar inclusion bodies were seen for any of the compds. from the chem. series of piperazines including gepirone and its metabolites.  The data presented support the use of simple physicochem. calcns. of ClogP and pKa to discriminate rapidly between compds. suspected of being phospholipidosis inducers.  Finally, the discriminative power of these physicochem. ClogP and pKa calcns. to predict phospholipidosis-inducing potential was further validated by extension of the set of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-qnA3_zghvbVg90H21EOLACvtfcHk0ljxzZFidS6T5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFGltL0%253D&md5=caf5e68d3d5356dfef1cc29dbaf5ca87</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPloemen%26aufirst%3DJ.%2BP.%26aulast%3DKelder%26aufirst%3DJ.%26aulast%3DHafmans%26aufirst%3DT.%26aulast%3Dvan%2Bde%2BSandt%26aufirst%3DH.%26aulast%3Dvan%2BBurgsteden%26aufirst%3DJ.%2BA.%26aulast%3DSaleminki%26aufirst%3DP.%2BJ.%26aulast%3Dvan%2BEsch%26aufirst%3DE.%26atitle%3DUse%2520of%2520physicochemical%2520calculation%2520of%2520pKa%2520and%2520CLogP%2520to%2520predict%2520phospholipidosis-inducing%2520potential%253A%2520a%2520case%2520study%2520with%2520structurally%2520related%2520piperazines%26jtitle%3DExp.%2520Toxicol.%2520Pathol.%26date%3D2004%26volume%3D55%26spage%3D347%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Bacon, E. R.; Bailey, T. R.; Becknell, N. C.; Chatterjee, S.; Dunn, D.; Hostetler, G. A.; Hudkins, R. L.; Josef, K. A.; Knutsen, L.; Tao, M.; Zulli, A. L.</span>US2010273779,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bacon%2C+E.+R.%3B+Bailey%2C+T.+R.%3B+Becknell%2C+N.+C.%3B+Chatterjee%2C+S.%3B+Dunn%2C+D.%3B+Hostetler%2C+G.+A.%3B+Hudkins%2C+R.+L.%3B+Josef%2C+K.+A.%3B+Knutsen%2C+L.%3B+Tao%2C+M.%3B+Zulli%2C+A.+L.US2010273779%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBacon%26aufirst%3DE.%2BR.%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">â</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eb5UL3-pwz6w7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25b"><span><span class="NLM_contrib-group">Lesson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concept on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">â</span> <span class="NLM_lpage">890</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Lessonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concept+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLesson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concept%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25c"><span><span class="NLM_contrib-group">Perola, E.</span><span> </span><span class="NLM_article-title">An analysis of the binding efficiencies of drugs and their leads in successful drug discovery program</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2986</span><span class="NLM_x">â</span> <span class="NLM_lpage">2997</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100118x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2986-2997&author=E.+Perola&title=An+analysis+of+the+binding+efficiencies+of+drugs+and+their+leads+in+successful+drug+discovery+program"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=10.1021%2Fjm100118x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100118x%26sid%3Dliteratum%253Aachs%26aulast%3DPerola%26aufirst%3DE.%26atitle%3DAn%2520analysis%2520of%2520the%2520binding%2520efficiencies%2520of%2520drugs%2520and%2520their%2520leads%2520in%2520successful%2520drug%2520discovery%2520program%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2986%26epage%3D2997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_contrib-group">Menear, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adcock, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockcroft, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copsey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cranston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillon, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drzewiecki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javaid, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerrigan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knights, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, V. M.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâConnor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M.</span><span> </span><span class="NLM_article-title">4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2<i>H</i>-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6581</span><span class="NLM_x">â</span> <span class="NLM_lpage">6591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8001263" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6581-6591&author=K.+A.+Menearauthor=C.+Adcockauthor=R.+Boulterauthor=X.+L.+Cockcroftauthor=L.+Copseyauthor=A.+Cranstonauthor=K.+J.+Dillonauthor=J.+Drzewieckiauthor=S.+Garmanauthor=S.+Gomezauthor=H.+Javaidauthor=F.+Kerriganauthor=C.+Knightsauthor=A.+Lauauthor=V.+M.+Lohauthor=I.+T.+Matthewsauthor=S.+Mooreauthor=M.+J.+O%E2%80%99Connorauthor=G.+C.+Smithauthor=N.+M.+Martin&title=4-%5B3-%284-Cyclopropanecarbonylpiperazine-1-carbonyl%29-4-fluorobenzyl%5D-2H-phthalazin-1-one%3A+a+novel+bioavailable+inhibitor+of+poly%28ADP-ribose%29+polymerase-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1021%2Fjm8001263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8001263%26sid%3Dliteratum%253Aachs%26aulast%3DMenear%26aufirst%3DK.%2BA.%26aulast%3DAdcock%26aufirst%3DC.%26aulast%3DBoulter%26aufirst%3DR.%26aulast%3DCockcroft%26aufirst%3DX.%2BL.%26aulast%3DCopsey%26aufirst%3DL.%26aulast%3DCranston%26aufirst%3DA.%26aulast%3DDillon%26aufirst%3DK.%2BJ.%26aulast%3DDrzewiecki%26aufirst%3DJ.%26aulast%3DGarman%26aufirst%3DS.%26aulast%3DGomez%26aufirst%3DS.%26aulast%3DJavaid%26aufirst%3DH.%26aulast%3DKerrigan%26aufirst%3DF.%26aulast%3DKnights%26aufirst%3DC.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DLoh%26aufirst%3DV.%2BM.%26aulast%3DMatthews%26aufirst%3DI.%2BT.%26aulast%3DMoore%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DG.%2BC.%26aulast%3DMartin%26aufirst%3DN.%2BM.%26atitle%3D4-%255B3-%25284-Cyclopropanecarbonylpiperazine-1-carbonyl%2529-4-fluorobenzyl%255D-2H-phthalazin-1-one%253A%2520a%2520novel%2520bioavailable%2520inhibitor%2520of%2520poly%2528ADP-ribose%2529%2520polymerase-1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6581%26epage%3D6591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_contrib-group">Hoelder, S.; Mueller, G.; Schoenafinger, K.; Will, D. W.; Matter, H.; Bossart, M.</span><span> </span><span class="NLM_article-title">Preparation of Pyridazinones as Glycogen Synthase Kinase-3 Beta Inhibitors for Pharmaceutical Uses</span>. WO2005111018,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=S.+Hoelder&author=G.+Mueller&author=K.+Schoenafinger&author=D.+W.+Will&author=H.+Matter&author=M.+Bossart&title=Preparation+of+Pyridazinones+as+Glycogen+Synthase+Kinase-3+Beta+Inhibitors+for+Pharmaceutical+Uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DPreparation%2520of%2520Pyridazinones%2520as%2520Glycogen%2520Synthase%2520Kinase-3%2520Beta%2520Inhibitors%2520for%2520Pharmaceutical%2520Uses%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Yazdanian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glynn, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawi, A.</span><span> </span><span class="NLM_article-title">Correlating partitioning and caco-2 cell permeability of structurally diverse small molecular weight compounds</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1490</span><span class="NLM_x">â</span> <span class="NLM_lpage">1494</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1023%2FA%3A1011930411574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=9755906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADyaK1cXmtFyhu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1998&pages=1490-1494&author=M.+Yazdanianauthor=S.+L.+Glynnauthor=J.+L.+Wrightauthor=A.+Hawi&title=Correlating+partitioning+and+caco-2+cell+permeability+of+structurally+diverse+small+molecular+weight+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds</span></div><div class="casAuthors">Yazdanian, Mehran; Glynn, Susan L.; Wright, James L.; Hawi, Amale</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1490-1494</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Plenum Publishing Corp.</span>)
        </div><div class="casAbstract">Caco-2 cell permeability coeffs. for 51 structurally diverse small mol. wt. compds. were measured and correlated to distribution coeffs. in three distinct solvent systems: octanol, hexadecane, and propylene glycol dipelargonate (PGDP).  There were no simple math. correlations between Caco-2 cell permeability coeffs. and partitioning values for all solvent systems.  In general, however, the more lipophilic compds. had higher cellular permeability coeffs.  It was possible to det. an approx. distribution coeff. value above which all compds. were highly cell permeable for all the solvent systems.  These were in logarithmic units 0.5, -1.0, and 0 for octanol, hexadecane, and PGDP solvent systems, resp.  Below these distribution coeffs., as the compds. became more hydrophilic, there was absolutely no trend in the data.  This study reinforces the tenet that single phys. parameters such as partitioning values can only be used to quant. det. Caco-2 cell permeability, and cannot be used as surrogate markers of in vivo intestinal permeability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4HU14sQxafLVg90H21EOLACvtfcHk0lhIMSm6r56RQg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtFyhu7c%253D&md5=08831ac873445016aa618a112202af15</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1023%2FA%3A1011930411574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1011930411574%26sid%3Dliteratum%253Aachs%26aulast%3DYazdanian%26aufirst%3DM.%26aulast%3DGlynn%26aufirst%3DS.%2BL.%26aulast%3DWright%26aufirst%3DJ.%2BL.%26aulast%3DHawi%26aufirst%3DA.%26atitle%3DCorrelating%2520partitioning%2520and%2520caco-2%2520cell%2520permeability%2520of%2520structurally%2520diverse%2520small%2520molecular%2520weight%2520compounds%26jtitle%3DPharm.%2520Res.%26date%3D1998%26volume%3D15%26spage%3D1490%26epage%3D1494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_contrib-group">Summerfield, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Carmen Osuna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalding, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span> </span><span class="NLM_article-title">Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">1282</span><span class="NLM_x">â</span> <span class="NLM_lpage">1290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1124%2Fjpet.105.092916" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=16330496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1SgsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2006&pages=1282-1290&author=S.+G.+Summerfieldauthor=A.+J.+Stevensauthor=L.+Cutlerauthor=M.+del+Carmen+Osunaauthor=B.+Hammondauthor=S.+P.+Tangauthor=A.+Herseyauthor=D.+J.+Spaldingauthor=P.+Jeffrey&title=Improving+the+in+vitro+prediction+of+in+vivo+central+nervous+system+penetration%3A+integrating+permeability%2C+P-glycoprotein+efflux%2C+and+free+fractions+in+blood+and+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain</span></div><div class="casAuthors">Summerfield, Scott G.; Stevens, Alexander J.; Cutler, Leanne; Osuna, Maria del Carmen; Hammond, Beverley; Tang, Sac-Pham; Hersey, Ann; Spalding, David J.; Jeffrey, Phil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1282-1290</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">This work examines the inter-relationship between the unbound drug fractions in blood and brain homogenate, passive membrane permeability, P-glycoprotein (Pgp) efflux ratio, and log octanol/water partition coeffs. (cLogP) in detg. the extent of central nervous system (CNS) penetration obsd. in vivo.  The present results demonstrate that compds. often considered to be Pgp substrates in rodents (efflux ratio greater than 5 in multidrug resistant Madin-Darby canine kidney cells) with poor passive permeability may still exhibit reasonable CNS penetration in vivo; i.e., where the unbound fractions and non-specific tissue binding act as a compensating force.  In these instances, the efflux ratio and in vitro blood-brain partition ratio may be used to predict the in vivo blood-brain ratio.  This relationship may be extended to account for the differences in CNS penetration obsd. in vivo between mdr1a/b wild type and knockout mice.  In some instances, cross-species differences that might initially seem to be related to differing transporter expression can be rationalized from knowledge of unbound fractions alone.  The results presented in this article suggest that the information exists to provide a coherent picture of the nature of CNS penetration in the drug discovery setting, allowing the focus to be shifted away from understanding CNS penetration toward the more important aspect of understanding CNS efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZMb2mL7xQC7Vg90H21EOLACvtfcHk0lhIMSm6r56RQg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1SgsL0%253D&md5=02b6cbbcde6738e7f6802d223b889261</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.092916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.092916%26sid%3Dliteratum%253Aachs%26aulast%3DSummerfield%26aufirst%3DS.%2BG.%26aulast%3DStevens%26aufirst%3DA.%2BJ.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3Ddel%2BCarmen%2BOsuna%26aufirst%3DM.%26aulast%3DHammond%26aufirst%3DB.%26aulast%3DTang%26aufirst%3DS.%2BP.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DSpalding%26aufirst%3DD.%2BJ.%26aulast%3DJeffrey%26aufirst%3DP.%26atitle%3DImproving%2520the%2520in%2520vitro%2520prediction%2520of%2520in%2520vivo%2520central%2520nervous%2520system%2520penetration%253A%2520integrating%2520permeability%252C%2520P-glycoprotein%2520efflux%252C%2520and%2520free%2520fractions%2520in%2520blood%2520and%2520brain%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D316%26spage%3D1282%26epage%3D1290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28b"><span><span class="NLM_contrib-group">Kalvass, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassidy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollack, G. M.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and pharmacodynamics of seven opioids in P-glycoprotein-competent mice: assessment of unbound brain EC50, u and correlation of in vitro, preclinical, and clinical data</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">323</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">â</span> <span class="NLM_lpage">355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1124%2Fjpet.107.119560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=17646430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFahsb%252FN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2007&pages=346-355&author=J.+C.+Kalvassauthor=E.+R.+Olsonauthor=M.+P.+Cassidyauthor=D.+E.+Selleyauthor=G.+M.+Pollack&title=Pharmacokinetics+and+pharmacodynamics+of+seven+opioids+in+P-glycoprotein-competent+mice%3A+assessment+of+unbound+brain+EC50%2C+u+and+correlation+of+in+vitro%2C+preclinical%2C+and+clinical+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28bR"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and pharmacodynamics of seven opioids in P-glycoprotein-competent mice: assessment of unbound brain EC50,u and correlation of in vitro, preclinical, and clinical data</span></div><div class="casAuthors">Kalvass, J. Cory; Olson, Emily R.; Cassidy, Michael P.; Selley, Dana E.; Pollack, Gary M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">346-355</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">This study was conducted to assess the utility of unbound brain EC50 (EC50,u) as a measure of in vivo potency for centrally active drugs.  Seven Î¼-opioid agonists (alfentanil, fentanyl, loperamide, methadone, meperidine, morphine, and sufentanil) were selected as model central nervous system drugs because they elicit a readily measurable central effect (antinociception) and their clin. pharmacokinetics/pharmacodynamics are well understood.  Mice received an equipotent s.c. dose of one of the model opioids.  The time course of antinociception and the serum and brain concns. were detd.  A pharmacokinetic/pharmacodynamic model was used to est. relevant parameters.  In vitro measures of opioid binding affinity (Ki) and functional activity [EC50 for agonist stimulated guanosine 5'-O-(3-[35S]thio)triphosphate binding] and relevant clin. parameters were obtained to construct in vitro-to-preclin. and preclin.-to-clin. correlations.  The strongest in vitro-to-in vivo correlation was obsd. between Ki and unbound brain EC50,u (r2 â¼ 0.8).  A strong correlation between mouse serum and human plasma EC50 was obsd. (r2 = 0.949); the correlation was improved when cor. for protein binding (r2 = 0.995).  Clin. equipotent i.v. dose was only moderately related to Ki.  However, ests. of ED50 and EC50 (total serum, unbound serum, total brain, and unbound brain) were significant predictors of clin. equipotent i.v. dose; the best correlation was obsd. for brain EC50,u (r2 = 0.982).  For each opioid, brain equilibration half-life in mice was almost identical to the plasma effect-site equilibration half-life measured clin.  These results indicate that the mouse is a good model for opioid human brain disposition and clin. pharmacol. and that superior in vitro-to-preclin. and preclin.-to-clin. correlations can be achieved with relevant unbound concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_E2A6_UTPA7Vg90H21EOLACvtfcHk0lhIMSm6r56RQg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFahsb%252FN&md5=589fda7ce9d453d14f428c599a3640e5</span></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.119560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.119560%26sid%3Dliteratum%253Aachs%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DOlson%26aufirst%3DE.%2BR.%26aulast%3DCassidy%26aufirst%3DM.%2BP.%26aulast%3DSelley%26aufirst%3DD.%2BE.%26aulast%3DPollack%26aufirst%3DG.%2BM.%26atitle%3DPharmacokinetics%2520and%2520pharmacodynamics%2520of%2520seven%2520opioids%2520in%2520P-glycoprotein-competent%2520mice%253A%2520assessment%2520of%2520unbound%2520brain%2520EC50%252C%2520u%2520and%2520correlation%2520of%2520in%2520vitro%252C%2520preclinical%252C%2520and%2520clinical%2520data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D323%26spage%3D346%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silber, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rance, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wastall, P.</span><span> </span><span class="NLM_article-title">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">â</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=9336307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=46-58&author=R.+S.+Obachauthor=J.+G.+Baxterauthor=T.+E.+Listonauthor=B.+M.+Silberauthor=B.+C.+Jonesauthor=F.+MacIntyreauthor=D.+J.+Ranceauthor=P.+Wastall&title=The+prediction+of+human+pharmacokinetic+parameters+from+preclinical+and+in+vitro+metabolism+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span></div><div class="casAuthors">Obach, R. Scott; Baxter, James G.; Liston, Theodore E.; Silber, B. Michael; Jones, Barry C.; Macintyre, Flona; Rance, David J.; Wastall, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-58</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 35 refs.  We describe a comprehensive retrospective anal. in which the abilities of several methods by which human pharmacokinetic parameters are predicted from preclin. pharmacokinetic data and/or in vitro metab. data were assessed.  The prediction methods examd. included both methods from the scientific literature as well as some described in this report for the first time.  Four methods were examd. for their ability to predict human vol. of distribution.  Three were highly predictive, yielding, on av., predictions that were within 60% to 90% of actual values.  Twelve methods were assessed for their utility in predicting clearance.  The most successful allometric scaling method yielded clearance predictions that were, on av., within 80% of actual values.  The best methods in which in vitro metab. data from human liver microsomes were scaled to in vivo clearance values yielded predicted clearance values that were, on av., within 70% to 80% of actual values.  Human t1/2 was predicted by combining predictions of human vol. of distribution and clearance.  The best t1/2 prediction methods successfully assigned compds. to appropriate dosing regimen categories (e.g., once daily, twice daily and so forth) 70% to 80% of the time.  In addn., correlations between human t1/2 and t1/2 values from preclin. species were also generally successful (72-87%) when used to predict human dosing regimens.  In summary, this retrospective anal. has identified several approaches by which human pharmacokinetic data can be predicted from preclin. data.  Such approaches should find utility in the drug discovery and development processes in the identification and selection of compds. that will possess appropriate pharmacokinetic characteristics in humans for progression to clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAngniZ4izLVg90H21EOLACvtfcHk0lhT998QizEMnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D&md5=68d1910d925e26ec4a8ef23043ffb1ed</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DBaxter%26aufirst%3DJ.%2BG.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DJones%26aufirst%3DB.%2BC.%26aulast%3DMacIntyre%26aufirst%3DF.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26aulast%3DWastall%26aufirst%3DP.%26atitle%3DThe%2520prediction%2520of%2520human%2520pharmacokinetic%2520parameters%2520from%2520preclinical%2520and%2520in%2520vitro%2520metabolism%2520data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D46%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Raucy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warfe, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yueh, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S. W.</span><span> </span><span class="NLM_article-title">A cell-based reporter gene assay for determining induction of CYP3A4 in a high-volume system</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">412</span><span class="NLM_x">â</span> <span class="NLM_lpage">423</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1124%2Fjpet.102.038653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=12235278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsV2qtrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=412-423&author=J.+Raucyauthor=L.+Warfeauthor=M.+F.+Yuehauthor=S.+W.+Allen&title=A+cell-based+reporter+gene+assay+for+determining+induction+of+CYP3A4+in+a+high-volume+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A cell-based reporter gene assay for determining induction of CYP3A4 in a high-volume system</span></div><div class="casAuthors">Raucy, Judy; Warfe, Lyndon; Yueh, Mei-Fei; Allen, Scott W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">412-423</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Assessing the inducibility of CYP3A4 by various xenobiotics can predict potential drug interactions.  In the present investigation, human hepatoma cells were stably integrated with either the CYP3A4 enhancer region and a luciferase reporter gene or the CYP3A4-luciferase construct and the human pregnane X receptor (PXR).  Several colonies contg. one to three copies of luciferase per cell were identified by Southern blot anal.  Those transformants producing high luciferase activity in response to rifampicin were used to standardize a 96-well plate screening system with minimal inter- and intraplate variability.  Standardization also consisted of assessing viability of cells cultured in medium contg. various serum concns.  In cells maintained for 48 h in medium with less than 5% serum, a significant (p < 0.01) decline was obsd. in viability accompanied by altered induction.  A defined serum-free medium also produced less viable cells but did not alter the inductive response.  Treatment of transformants with various concns. of rifampicin produced a dose-response curve with maximal induction at 10 Î¼M (5.6Â±0.18- and 2.1Â±0.3-fold above DMSO (DMSO)-treated cells in transformants with and without PXR, resp.).  Of addnl. agents examd. for their ability to induce CYP3A4, omeprazole (200 Î¼M) was the most potent inducer (12.8Â±1.9- and 2.4Â±0.2-fold above DMSO-treated cells in transformants with and without PXR, resp.).  Mifepristone and mevastatin produced modest induction (â¼3-fold) in the cell line contg. exogenous PXR, but produced less than 1.2-fold increases in cells lacking PXR.  Thus, only potent inducers can be identified in the cell line without PXR.  In contrast, cells contg. the receptor can be used to rank CYP3A4 induction.  Because a high vol. of chems. can be readily and accurately screened for their ability to induce CYP3A4 with this format, such a system could be valuable in the initial stages of preclin. drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodZyXqBDWRWLVg90H21EOLACvtfcHk0lhT998QizEMnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsV2qtrc%253D&md5=433cb89b72745771e8df9c07df65632f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.038653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.038653%26sid%3Dliteratum%253Aachs%26aulast%3DRaucy%26aufirst%3DJ.%26aulast%3DWarfe%26aufirst%3DL.%26aulast%3DYueh%26aufirst%3DM.%2BF.%26aulast%3DAllen%26aufirst%3DS.%2BW.%26atitle%3DA%2520cell-based%2520reporter%2520gene%2520assay%2520for%2520determining%2520induction%2520of%2520CYP3A4%2520in%2520a%2520high-volume%2520system%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D412%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Lagrutta, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepakova, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salata, J. J.</span><span> </span><span class="NLM_article-title">The hERG channel and risk of drug-acquired cardiac arrhythmia: an overview</span> <span class="citation_source-journal">Curr. Top Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1102</span><span class="NLM_x">â</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.2174%2F156802608785700016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=18782006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsrjK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1102-1112&author=A.+A.+Lagruttaauthor=E.+S.+Trepakovaauthor=J.+J.+Salata&title=The+hERG+channel+and+risk+of+drug-acquired+cardiac+arrhythmia%3A+an+overview"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The hERG channel and risk of drug-acquired cardiac arrhythmia: an overview</span></div><div class="casAuthors">Lagrutta, Armando A.; Trepakova, Elena S.; Salata, Joseph J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1102-1112</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">This review summarizes current knowledge of the cardiac rapidly activating delayed rectifier potassium current (IKr), and its connection to drug-acquired QT prolongation and the assocd. risk of ventricular arrhythmia and fibrillation.  The mol. characterization of hERG as the structural correlate of IKr and the link between inherited long QT and the KCNH2 gene (hERG), have facilitated mechanistic studies of drug-acquired QT prolongation.  The development of high throughput assays to evaluate drug effects on hERG has provided an avenue to det. structure-activity relations (SAR) within chem. series.  More than 10 years of collective data and structural considerations support the notion that hERG is an unusually promiscuous target among potassium channels, but that defining SAR within a chem. series is a viable strategy to reduce or eliminate hERG activity.  Despite a crit. need to minimize drug effects on hERG, one should always keep in mind that hERG is not the only structural correlate of QT prolongation, and that QT prolongation is a sub-optimal biomarker for ventricular arrhythmia and fibrillation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoixN90Myu6bVg90H21EOLACvtfcHk0lhT998QizEMnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsrjK&md5=31c03ae1d1c67bf8f85d804c7b2fe2d2</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F156802608785700016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608785700016%26sid%3Dliteratum%253Aachs%26aulast%3DLagrutta%26aufirst%3DA.%2BA.%26aulast%3DTrepakova%26aufirst%3DE.%2BS.%26aulast%3DSalata%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520hERG%2520channel%2520and%2520risk%2520of%2520drug-acquired%2520cardiac%2520arrhythmia%253A%2520an%2520overview%26jtitle%3DCurr.%2520Top%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1102%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Clapham, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilpatrick, G. J.</span><span> </span><span class="NLM_article-title">Histamine H<sub>3</sub> receptor-mediated modulation of water consumption in the rat</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">232</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">â</span> <span class="NLM_lpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1016%2F0014-2999%2893%2990733-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=8384565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADyaK3sXhvVCit7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=1993&pages=99-103&author=J.+Claphamauthor=G.+J.+Kilpatrick&title=Histamine+H3+receptor-mediated+modulation+of+water+consumption+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Histamine H3 receptor-mediated modulation of water consumption in the rat</span></div><div class="casAuthors">Clapham, Jane; Kilpatrick, Gavin J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-103</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The effect of the selective H3 receptor agonist (R)-Î±-methylhistamine and antagonist thioperamide on water consumption in the rat were examd.  (R)-Î±-Methylhistamine (0.1-20 mg/kg, i.p.) evoked a dose-dependent increase in water consumption, the max. effect being 310% above the vehicle control response.  Thioperamide (0.2, 2, and 10 mg/kg, i.p.) alone had no effect on water consumption.  However, the stimulatory effect of (R)-Î±-methylhistamine on water consumption was antagonized by thioperamide in a dose-dependent manner, whereas the H1 receptor antagonist mepyramine and the H2 receptor antagonist loxtidine were without effect.  Thus, the H3 receptor may play a role in the regulation of water consumption in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWYx3RqmLBR7Vg90H21EOLACvtfcHk0lhT998QizEMnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhvVCit7w%253D&md5=1e1caf0a00bcccbc9f32e2ff157325f7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2893%2990733-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252893%252990733-X%26sid%3Dliteratum%253Aachs%26aulast%3DClapham%26aufirst%3DJ.%26aulast%3DKilpatrick%26aufirst%3DG.%2BJ.%26atitle%3DHistamine%2520H3%2520receptor-mediated%2520modulation%2520of%2520water%2520consumption%2520in%2520the%2520rat%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D232%26spage%3D99%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Fox, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radek, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faghih, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennani, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, A. A.</span><span> </span><span class="NLM_article-title">Two novel and selective nonimidazole H<sub>3</sub> receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterization</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">â</span> <span class="NLM_lpage">908</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1124%2Fjpet.102.047241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=12606600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1SnsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2003&pages=897-908&author=G.+B.+Foxauthor=J.+B.+Panauthor=R.+J.+Radekauthor=A.+M.+Lewisauthor=R.+S.+Bitnerauthor=T.+A.+Esbenshadeauthor=R.+Faghihauthor=Y.+L.+Bennaniauthor=M.+Williamsauthor=B.+B.+Yaoauthor=M.+W.+Deckerauthor=A.+A.+Hancock&title=Two+novel+and+selective+nonimidazole+H3+receptor+antagonists+A-304121+and+A-317920%3A+II.+In+vivo+behavioral+and+neurophysiological+characterization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterization</span></div><div class="casAuthors">Fox, Gerard B.; Pan, Jia Bao; Radek, Richard J.; Lewis, Angela M.; Bitner, R. Scott; Esbenshade, Timothy A.; Faghih, Ramin; Bennani, Youssef L.; Williams, Michael; Yao, Betty B.; Decker, Michael W.; Hancock, Arthur A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">897-908</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Pharmacol. blockade of central histamine H3 receptors (H3Rs) enhances cognition in rodents and offers promise for the clin. treatment of neurol. disorders.  However, many previously characterized H3R antagonists are either not selective for H3Rs or have potentially significant tolerability issues.  Here, we present in vivo behavioral and neurophysiol. data for two novel and selective H3R antagonists with improved safety indexes.  Functional blockade of central H3Rs was first demonstrated for A-304121 [(4-(3-(4-((2R)-2-aminopropanoyl)-1-piperazinyl)propoxy)phenyl)cyclopropylmethanone] (1 mg/kg) and A-317920 [N-((1R)-2-(4-(3-(4-(cyclopropylcarbonyl)phenoxy)propyl) -1-piperazinyl)-1-methyl-2-oxo-ethyl)-2-furamide] (0.45 mg/kg) by significantly attenuating an acute dipsogenia response to the selective H3R agonist (R)-Î±-methylhistamine [(R)-Î±-MeHA].  Cognitive performance was improved in a five-trial rat pup avoidance test following administration of A-304121 (10 mg/kg) or A-317920 (3 mg/kg), with efficacy comparable with previously published observations for ref. H3R antagonists thioperamide (10 mg/kg), ciproxifan (3 mg/kg), and GT-2331 [(1R,2R)-4-(2-(5,5-dimethylhex-1-ynyl)cyclopropyl)imidazole] (1 mg/kg).  Social memory was also significantly enhanced in the adult rat with A-304121 (3, 10 mg/kg) and A-317920 (1, 3 mg/kg) at doses that produced no significant change in EEG slow-wave amplitude activity.  Relative therapeutic indexes (Tls) of 30 and 42 were estd. for A-304121 and A-317920, resp., by comparing doses producing adverse effects in general observation studies with potency in inhibitory avoidance, which were superior to Tls of 8, 10, and 18 obsd. for the ref. antagonists thioperamide, ciproxifan, and GT-2331, resp.  A-304121 and A-317920 represent a series of novel, H3R-selective piperazine amides that enhance cognition in vivo, which could offer advantages over existing H3R antagonists or cognition-enhancing agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-leHeQZ5WiLVg90H21EOLACvtfcHk0lgOZeg0dpWWJw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1SnsL0%253D&md5=359e981ceb5c192d61e0029bacb0f817</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.047241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.047241%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DG.%2BB.%26aulast%3DPan%26aufirst%3DJ.%2BB.%26aulast%3DRadek%26aufirst%3DR.%2BJ.%26aulast%3DLewis%26aufirst%3DA.%2BM.%26aulast%3DBitner%26aufirst%3DR.%2BS.%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DFaghih%26aufirst%3DR.%26aulast%3DBennani%26aufirst%3DY.%2BL.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DYao%26aufirst%3DB.%2BB.%26aulast%3DDecker%26aufirst%3DM.%2BW.%26aulast%3DHancock%26aufirst%3DA.%2BA.%26atitle%3DTwo%2520novel%2520and%2520selective%2520nonimidazole%2520H3%2520receptor%2520antagonists%2520A-304121%2520and%2520A-317920%253A%2520II.%2520In%2520vivo%2520behavioral%2520and%2520neurophysiological%2520characterization%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D305%26spage%3D897%26epage%3D908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Raddatz, R.; Hudkins, R. L.; Mathiasen, J. R.; Gruner, J. A.; Le, S.; Schaffhauser, H.; Bozyczko-Coyne, D.; Marino, M. J.; Ator, M. A.; Bacon, E. R.; Mallamo, J. P.; Williams, M.</span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Raddatz%2C+R.%3B+Hudkins%2C+R.+L.%3B+Mathiasen%2C+J.+R.%3B+Gruner%2C+J.+A.%3B+Le%2C+S.%3B+Schaffhauser%2C+H.%3B+Bozyczko-Coyne%2C+D.%3B+Marino%2C+M.+J.%3B+Ator%2C+M.+A.%3B+Bacon%2C+E.+R.%3B+Mallamo%2C+J.+P.%3B+Williams%2C+M.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DRaddatz%26aufirst%3DR." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Irwin, S.</span><span> </span><span class="NLM_article-title">Comprehensive observational assessment: Ia. A systematic quantitative procedure for assessing the behavioural and physiologic state of the mouse</span> <span class="citation_source-journal">Psychopharmacologia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">â</span> <span class="NLM_lpage">257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1007%2FBF00401402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=5679627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A280%3ADyaF1M%252FgtlCiuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1968&pages=222-257&author=S.+Irwin&title=Comprehensive+observational+assessment%3A+Ia.+A+systematic+quantitative+procedure+for+assessing+the+behavioural+and+physiologic+state+of+the+mouse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse</span></div><div class="casAuthors">Irwin S</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacologia</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">222-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQae8F3n8PRtf6AExegM5LLfW6udTcc2eavnBUnYQgMjrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF1M%252FgtlCiuw%253D%253D&md5=37ab1a9fa105ba776dbd68650fd9edbf</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1007%2FBF00401402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00401402%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DS.%26atitle%3DComprehensive%2520observational%2520assessment%253A%2520Ia.%2520A%2520systematic%2520quantitative%2520procedure%2520for%2520assessing%2520the%2520behavioural%2520and%2520physiologic%2520state%2520of%2520the%2520mouse%26jtitle%3DPsychopharmacologia%26date%3D1968%26volume%3D13%26spage%3D222%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3a','cit3b','cit3c','cit3d'],'ref4':['cit4a','cit4b'],'ref5':['cit5a','cit5b','cit5c','cit5d','cit5e','cit5f','cit5g','cit5h','cit5i','cit5j','cit5k','cit5l'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11a','cit11b'],'ref12':['cit12a','cit12b','cit12c'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15a','cit15b','cit15c'],'ref16':['cit16'],'ref17':['cit17a','cit17b'],'ref18':['cit18a','cit18b'],'ref19':['cit19a','cit19b'],'ref20':['cit20a','cit20b'],'ref21':['cit21'],'ref22':['cit22a','cit22b'],'ref23':['cit23a','cit23b'],'ref24':['cit24'],'ref25':['cit25a','cit25b','cit25c'],'ref26':['cit26a','cit26b'],'ref27':['cit27'],'ref28':['cit28a','cit28b'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 58 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Junda Wang, Yuanjun Zhu, Lingfei Yang, Hui Liu, Tongliang Zhou, Fengrong Xu, Ping Xu, Lan Yuan, <span class="NLM_string-name hlFld-ContribAuthor">Lei Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Early Diagnosis of Cerebral Ischemia Reperfusion Injury and Revelation of Its Regional Development by a H3R Receptor-Directed Probe. </span><span class="cited-content_cbyCitation_journal-name">ACS Sensors</span><span> <strong>2021,</strong> <em>6 </em>
                                    (3)
                                     , 1330-1338. <a href="https://doi.org/10.1021/acssensors.0c02667" title="DOI URL">https://doi.org/10.1021/acssensors.0c02667</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acssensors.0c02667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facssensors.0c02667%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sensors%26atitle%3DEarly%252BDiagnosis%252Bof%252BCerebral%252BIschemia%252BReperfusion%252BInjury%252Band%252BRevelation%252Bof%252BIts%252BRegional%252BDevelopment%252Bby%252Ba%252BH3R%252BReceptor-Directed%252BProbe%26aulast%3DWang%26aufirst%3DJunda%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D22122020%26date%3D25022021%26date%3D03032021%26volume%3D6%26issue%3D3%26spage%3D1330%26epage%3D1338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Liang</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Fengrong  Xu</span>, <span class="hlFld-ContribAuthor ">Yan  Niu</span>, <span class="hlFld-ContribAuthor ">Qi  Sun</span>, and <span class="hlFld-ContribAuthor ">Ping  Xu</span>  . </span><span class="cited-content_cbyCitation_article-title">Relay Catalysis by a Multifunctional Cu Catalyst in a Tandem Dehydro-/Dehalogenation Sequence along with N-Arylation. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2013,</strong> <em>15 </em>
                                    (11)
                                     , 2770-2773. <a href="https://doi.org/10.1021/ol401105x" title="DOI URL">https://doi.org/10.1021/ol401105x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol401105x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol401105x%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRelay%252BCatalysis%252Bby%252Ba%252BMultifunctional%252BCu%252BCatalyst%252Bin%252Ba%252BTandem%252BDehydro-%25252FDehalogenation%252BSequence%252Balong%252Bwith%252BN-Arylation%26aulast%3DLiang%26aufirst%3DLei%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D21042013%26date%3D14052013%26date%3D07062013%26volume%3D15%26issue%3D11%26spage%3D2770%26epage%3D2773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi  Wang</span>, <span class="hlFld-ContribAuthor ">Katrin  Przyuski</span>, <span class="hlFld-ContribAuthor ">Renee C.  Roemmele</span>, <span class="hlFld-ContribAuthor ">Robert L.  Hudkins</span>, and <span class="hlFld-ContribAuthor ">Roger P.  Bakale</span>  . </span><span class="cited-content_cbyCitation_article-title">Development and Scale-Up of an Optimized Route to the Pyridazin-3-one Histamine H3 Receptor Antagonist CEP-32215. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2013,</strong> <em>17 </em>
                                    (5)
                                     , 846-853. <a href="https://doi.org/10.1021/op400039d" title="DOI URL">https://doi.org/10.1021/op400039d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op400039d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop400039d%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DDevelopment%252Band%252BScale-Up%252Bof%252Ban%252BOptimized%252BRoute%252Bto%252Bthe%252BPyridazin-3-one%252BHistamine%252BH3%252BReceptor%252BAntagonist%252BCEP-32215%26aulast%3DWang%26aufirst%3DYi%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D15022013%26date%3D12042013%26date%3D17052013%26date%3D21032013%26volume%3D17%26issue%3D5%26spage%3D846%26epage%3D853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dahui  Zhou</span>, <span class="hlFld-ContribAuthor ">Jonathan L.  Gross</span>, <span class="hlFld-ContribAuthor ">Adedayo B.  Adedoyin</span>, <span class="hlFld-ContribAuthor ">Suzan B.  Aschmies</span>, <span class="hlFld-ContribAuthor ">Julie  Brennan</span>, <span class="hlFld-ContribAuthor ">Mark  Bowlby</span>, <span class="hlFld-ContribAuthor ">Li  Di</span>, <span class="hlFld-ContribAuthor ">Katie  Kubek</span>, <span class="hlFld-ContribAuthor ">Brian J.  Platt</span>, <span class="hlFld-ContribAuthor ">Zheng  Wang</span>, <span class="hlFld-ContribAuthor ">Guoming  Zhang</span>, <span class="hlFld-ContribAuthor ">Nicholas  Brandon</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Comery</span>, and <span class="hlFld-ContribAuthor ">Albert J.  Robichaud</span>  . </span><span class="cited-content_cbyCitation_article-title">2-(Pyrrolidin-1-yl)ethyl-3,4-dihydroisoquinolin-1(2H)-one Derivatives as Potent and Selective Histamine-3 Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (5)
                                     , 2452-2468. <a href="https://doi.org/10.1021/jm300011d" title="DOI URL">https://doi.org/10.1021/jm300011d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300011d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300011d%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2-%252528Pyrrolidin-1-yl%252529ethyl-3%25252C4-dihydroisoquinolin-1%2525282H%252529-one%252BDerivatives%252Bas%252BPotent%252Band%252BSelective%252BHistamine-3%252BReceptor%252BAntagonists%26aulast%3DZhou%26aufirst%3DDahui%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D03012012%26date%3D28022012%26date%3D08032012%26date%3D07022012%26volume%3D55%26issue%3D5%26spage%3D2452%26epage%3D2468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming  Tao</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Aimone</span>, <span class="hlFld-ContribAuthor ">Zeqi  Huang</span>, <span class="hlFld-ContribAuthor ">Joanne  Mathiasen</span>, <span class="hlFld-ContribAuthor ">Rita  Raddatz</span>, <span class="hlFld-ContribAuthor ">Jacquelyn  Lyons</span>, and <span class="hlFld-ContribAuthor ">Robert L.  Hudkins</span>  . </span><span class="cited-content_cbyCitation_article-title">Optimization of 5-Pyridazin-3-one Phenoxypropylamines as Potent, Selective Histamine H3 Receptor Antagonists with Potent Cognition Enhancing Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (1)
                                     , 414-423. <a href="https://doi.org/10.1021/jm201295j" title="DOI URL">https://doi.org/10.1021/jm201295j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201295j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201295j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252B5-Pyridazin-3-one%252BPhenoxypropylamines%252Bas%252BPotent%25252C%252BSelective%252BHistamine%252BH3%252BReceptor%252BAntagonists%252Bwith%252BPotent%252BCognition%252BEnhancing%252BActivity%26aulast%3DTao%26aufirst%3DMing%26date%3D2012%26date%3D2011%26date%3D2011%26date%3D28092011%26date%3D21122011%26date%3D12012012%26date%3D22112011%26volume%3D55%26issue%3D1%26spage%3D414%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maxim G.  Vinogradov</span>, <span class="hlFld-ContribAuthor ">Olga V.  Turova</span>, <span class="hlFld-ContribAuthor ">Sergei G.  Zlotin</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Asymmetric AzaâDielsâAlder Reaction: Pivotal Milestones and Recent Applications to Synthesis of NitrogenâContaining Heterocycles. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2021,</strong> <em>363 </em>
                                    (6)
                                     , 1466-1526. <a href="https://doi.org/10.1002/adsc.202001307" title="DOI URL">https://doi.org/10.1002/adsc.202001307</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202001307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202001307%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DCatalytic%252BAsymmetric%252BAza%2525E2%252580%252590Diels%2525E2%252580%252590Alder%252BReaction%25253A%252BPivotal%252BMilestones%252Band%252BRecent%252BApplications%252Bto%252BSynthesis%252Bof%252BNitrogen%2525E2%252580%252590Containing%252BHeterocycles%26aulast%3DVinogradov%26aufirst%3DMaxim%2BG.%26date%3D2021%26date%3D2021%26volume%3D363%26issue%3D6%26spage%3D1466%26epage%3D1526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuxin  Du</span>, <span class="hlFld-ContribAuthor ">Hongcen  Hou</span>, <span class="hlFld-ContribAuthor ">Yongli  Zhao</span>, <span class="hlFld-ContribAuthor ">Shouri  Sheng</span>, <span class="hlFld-ContribAuthor ">Junmin  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Rhodium(III)-Catalyzed Alkynylation of 4-Arylphthalazin-1(2
              H
              )-one Scaffolds via C-H Bond Activation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (9)
                                     , 1100-1107. <a href="https://doi.org/10.1002/ejoc.201901731" title="DOI URL">https://doi.org/10.1002/ejoc.201901731</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201901731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201901731%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRhodium%252528III%252529-Catalyzed%252BAlkynylation%252Bof%252B4-Arylphthalazin-1%2525282%252BH%252B%252529-one%252BScaffolds%252Bvia%252BC-H%252BBond%252BActivation%26aulast%3DDu%26aufirst%3DXuxin%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D9%26spage%3D1100%26epage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">LÃ­dia M.  Lima</span>, <span class="hlFld-ContribAuthor ">Marina A.  Alves</span>, <span class="hlFld-ContribAuthor ">Daniel N.  do Amaral</span>. </span><span class="cited-content_cbyCitation_article-title">Homologation: A Versatile Molecular Modification Strategy to Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (19)
                                     , 1734-1750. <a href="https://doi.org/10.2174/1568026619666190808145235" title="DOI URL">https://doi.org/10.2174/1568026619666190808145235</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190808145235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190808145235%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DHomologation%25253A%252BA%252BVersatile%252BMolecular%252BModification%252BStrategy%252Bto%252BDrug%252BDiscovery%26aulast%3DLima%26aufirst%3DL%25C3%25ADdia%2BM.%26date%3D2019%26volume%3D19%26issue%3D19%26spage%3D1734%26epage%3D1750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nakisa  Ghamari</span>, <span class="hlFld-ContribAuthor ">Omid  Zarei</span>, <span class="hlFld-ContribAuthor ">JosÃ©-Antonio  Arias-MontaÃ±o</span>, <span class="hlFld-ContribAuthor ">David  Reiner</span>, <span class="hlFld-ContribAuthor ">Siavoush  Dastmalchi</span>, <span class="hlFld-ContribAuthor ">Holger  Stark</span>, <span class="hlFld-ContribAuthor ">Maryam  Hamzeh-Mivehroud</span>. </span><span class="cited-content_cbyCitation_article-title">Histamine H3 receptor antagonists/inverse agonists: Where do they go?. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2019,</strong> <em>200 </em>, 69-84. <a href="https://doi.org/10.1016/j.pharmthera.2019.04.007" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2019.04.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2019.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2019.04.007%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DHistamine%252BH3%252Breceptor%252Bantagonists%25252Finverse%252Bagonists%25253A%252BWhere%252Bdo%252Bthey%252Bgo%25253F%26aulast%3DGhamari%26aufirst%3DNakisa%26date%3D2019%26volume%3D200%26spage%3D69%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Troxler</span>, <span class="hlFld-ContribAuthor ">Dominik  Feuerbach</span>, <span class="hlFld-ContribAuthor ">Xuechun  Zhang</span>, <span class="hlFld-ContribAuthor ">Charles R.  Yang</span>, <span class="hlFld-ContribAuthor ">Bharat  Lagu</span>, <span class="hlFld-ContribAuthor ">Mark  Perrone</span>, <span class="hlFld-ContribAuthor ">TieâLin  Wang</span>, <span class="hlFld-ContribAuthor ">Karin  Briner</span>, <span class="hlFld-ContribAuthor ">Mark G.  Bock</span>, <span class="hlFld-ContribAuthor ">Yves P.  Auberson</span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery of LML134, a Histamine H3 Receptor Inverse Agonist for the Clinical Treatment of Excessive Sleep Disorders. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (13)
                                     , 1238-1247. <a href="https://doi.org/10.1002/cmdc.201900176" title="DOI URL">https://doi.org/10.1002/cmdc.201900176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900176%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DThe%252BDiscovery%252Bof%252BLML134%25252C%252Ba%252BHistamine%252BH3%252BReceptor%252BInverse%252BAgonist%252Bfor%252Bthe%252BClinical%252BTreatment%252Bof%252BExcessive%252BSleep%252BDisorders%26aulast%3DTroxler%26aufirst%3DThomas%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D13%26spage%3D1238%26epage%3D1247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei  Dou</span>, <span class="hlFld-ContribAuthor ">Xudong  Cao</span>, <span class="hlFld-ContribAuthor ">Peng  Jing</span>, <span class="hlFld-ContribAuthor ">Chunyan  Wu</span>, <span class="hlFld-ContribAuthor ">Yuxin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yin  Chen</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of histamine H3 receptor ligand based on lactam scaffold as agents for treating neuropathic pain. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (12)
                                     , 1492-1496. <a href="https://doi.org/10.1016/j.bmcl.2019.04.015" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.04.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.04.015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bhistamine%252BH3%252Breceptor%252Bligand%252Bbased%252Bon%252Blactam%252Bscaffold%252Bas%252Bagents%252Bfor%252Btreating%252Bneuropathic%252Bpain%26aulast%3DDou%26aufirst%3DFei%26date%3D2019%26volume%3D29%26issue%3D12%26spage%3D1492%26epage%3D1496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dorota  ÅaÅ¼ewska</span>, <span class="hlFld-ContribAuthor ">Katarzyna  KieÄ-Kononowicz</span>. </span><span class="cited-content_cbyCitation_article-title">Progress in the development of histamine H
              3
              receptor antagonists/inverse agonists: a patent review (2013-2017). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2018,</strong> <em>28 </em>
                                    (3)
                                     , 175-196. <a href="https://doi.org/10.1080/13543776.2018.1424135" title="DOI URL">https://doi.org/10.1080/13543776.2018.1424135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2018.1424135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2018.1424135%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DProgress%252Bin%252Bthe%252Bdevelopment%252Bof%252Bhistamine%252BH%252B3%252Breceptor%252Bantagonists%25252Finverse%252Bagonists%25253A%252Ba%252Bpatent%252Breview%252B%2525282013-2017%252529%26aulast%3D%25C5%2581a%25C5%25BCewska%26aufirst%3DDorota%26date%3D2018%26date%3D2018%26volume%3D28%26issue%3D3%26spage%3D175%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zi-Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Jin  Song</span>. </span><span class="cited-content_cbyCitation_article-title">An isothiourea-catalyzed asymmetric formal [4 + 2] cycloaddition of
              in situ
              generated azoalkenes with C1 ammonium enolates. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2018,</strong> <em>5 </em>
                                    (17)
                                     , 2578-2582. <a href="https://doi.org/10.1039/C8QO00657A" title="DOI URL">https://doi.org/10.1039/C8QO00657A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8QO00657A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8QO00657A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DAn%252Bisothiourea-catalyzed%252Basymmetric%252Bformal%252B%25255B4%252B%25252B%252B2%25255D%252Bcycloaddition%252Bof%252Bin%252Bsitu%252Bgenerated%252Bazoalkenes%252Bwith%252BC1%252Bammonium%252Benolates%26aulast%3DZhang%26aufirst%3DZi-Jing%26date%3D2018%26date%3D2018%26volume%3D5%26issue%3D17%26spage%3D2578%26epage%3D2582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Xin</span>, <span class="hlFld-ContribAuthor ">Min  Hu</span>, <span class="hlFld-ContribAuthor ">Qian  Liu</span>, <span class="hlFld-ContribAuthor ">Tian Tai  Zhang</span>, <span class="hlFld-ContribAuthor ">Dong Mei  Wang</span>, <span class="hlFld-ContribAuthor ">Song  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of novel iso-flavones derivatives as H
              3
              R antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2018,</strong> <em>33 </em>
                                    (1)
                                     , 1545-1553. <a href="https://doi.org/10.1080/14756366.2018.1509212" title="DOI URL">https://doi.org/10.1080/14756366.2018.1509212</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2018.1509212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2018.1509212%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Biso-flavones%252Bderivatives%252Bas%252BH%252B3%252BR%252Bantagonists%26aulast%3DXin%26aufirst%3DJian%26date%3D2018%26date%3D2018%26volume%3D33%26issue%3D1%26spage%3D1545%26epage%3D1553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dorota  ÅaÅ¼ewska</span>, <span class="hlFld-ContribAuthor ">Maria  Kaleta</span>, <span class="hlFld-ContribAuthor ">J. Stephan  Schwed</span>, <span class="hlFld-ContribAuthor ">Tadeusz  Karcz</span>, <span class="hlFld-ContribAuthor ">Szczepan  Mogilski</span>, <span class="hlFld-ContribAuthor ">Gniewomir  Latacz</span>, <span class="hlFld-ContribAuthor ">Agnieszka  Olejarz</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>, <span class="hlFld-ContribAuthor ">Monika  Kubacka</span>, <span class="hlFld-ContribAuthor ">Annamaria  Lubelska</span>, <span class="hlFld-ContribAuthor ">Ewelina  Honkisz</span>, <span class="hlFld-ContribAuthor ">Jadwiga  Handzlik</span>, <span class="hlFld-ContribAuthor ">Barbara  Filipek</span>, <span class="hlFld-ContribAuthor ">Holger  Stark</span>, <span class="hlFld-ContribAuthor ">Katarzyna  KieÄ-Kononowicz</span>. </span><span class="cited-content_cbyCitation_article-title">Biphenyloxy-alkyl-piperidine and azepane derivatives as histamine H3 receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (20)
                                     , 5341-5354. <a href="https://doi.org/10.1016/j.bmc.2017.07.058" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.07.058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.07.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.07.058%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DBiphenyloxy-alkyl-piperidine%252Band%252Bazepane%252Bderivatives%252Bas%252Bhistamine%252BH3%252Breceptor%252Bligands%26aulast%3D%25C5%2581a%25C5%25BCewska%26aufirst%3DDorota%26date%3D2017%26volume%3D25%26issue%3D20%26spage%3D5341%26epage%3D5354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tongliang  Zhou</span>, <span class="hlFld-ContribAuthor ">Lingfei  Yang</span>, <span class="hlFld-ContribAuthor ">Lei  Liang</span>, <span class="hlFld-ContribAuthor ">Hui  Liu</span>, <span class="hlFld-ContribAuthor ">Yuanjun  Zhu</span>, <span class="hlFld-ContribAuthor ">Mengyang  Shui</span>, <span class="hlFld-ContribAuthor ">Lan  Yuan</span>, <span class="hlFld-ContribAuthor ">Fengrong  Xu</span>, <span class="hlFld-ContribAuthor ">Yan  Niu</span>, <span class="hlFld-ContribAuthor ">Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Ping  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Rational Design of a Near-Infrared Fluorescent Probe Based on a Pyridazinone Scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>2017 </em>
                                    (22)
                                     , 3274-3281. <a href="https://doi.org/10.1002/ejoc.201700355" title="DOI URL">https://doi.org/10.1002/ejoc.201700355</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201700355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201700355%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRational%252BDesign%252Bof%252Ba%252BNear-Infrared%252BFluorescent%252BProbe%252BBased%252Bon%252Ba%252BPyridazinone%252BScaffold%26aulast%3DZhou%26aufirst%3DTongliang%26date%3D2017%26date%3D2017%26volume%3D2017%26issue%3D22%26spage%3D3274%26epage%3D3281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eleni  Pontiki</span>, <span class="hlFld-ContribAuthor ">Dimitra  Hadjipavlou-Litina</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR models on H
              4
              receptor antagonists associated with inflammation and anaphylaxis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2017,</strong> <em>35 </em>
                                    (5)
                                     , 968-1005. <a href="https://doi.org/10.1080/07391102.2016.1166986" title="DOI URL">https://doi.org/10.1080/07391102.2016.1166986</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2016.1166986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2016.1166986%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DQSAR%252Bmodels%252Bon%252BH%252B4%252Breceptor%252Bantagonists%252Bassociated%252Bwith%252Binflammation%252Band%252Banaphylaxis%26aulast%3DPontiki%26aufirst%3DEleni%26date%3D2017%26date%3D2016%26volume%3D35%26issue%3D5%26spage%3D968%26epage%3D1005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wasim  Akhtar</span>, <span class="hlFld-ContribAuthor ">M.  Shaquiquzzaman</span>, <span class="hlFld-ContribAuthor ">Mymoona  Akhter</span>, <span class="hlFld-ContribAuthor ">Garima  Verma</span>, <span class="hlFld-ContribAuthor ">Mohemmed Faraz  Khan</span>, <span class="hlFld-ContribAuthor ">M. Mumtaz  Alam</span>. </span><span class="cited-content_cbyCitation_article-title">The therapeutic journey of pyridazinone. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>123 </em>, 256-281. <a href="https://doi.org/10.1016/j.ejmech.2016.07.061" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.07.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.07.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.07.061%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Btherapeutic%252Bjourney%252Bof%252Bpyridazinone%26aulast%3DAkhtar%26aufirst%3DWasim%26date%3D2016%26volume%3D123%26spage%3D256%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bassem  Sadek</span>, <span class="hlFld-ContribAuthor ">Ali  Saad</span>, <span class="hlFld-ContribAuthor ">Adel  Sadeq</span>, <span class="hlFld-ContribAuthor ">Fakhreya  Jalal</span>, <span class="hlFld-ContribAuthor ">Holger  Stark</span>. </span><span class="cited-content_cbyCitation_article-title">Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases. </span><span class="cited-content_cbyCitation_journal-name">Behavioural Brain Research</span><span> <strong>2016,</strong> <em>312 </em>, 415-430. <a href="https://doi.org/10.1016/j.bbr.2016.06.051" title="DOI URL">https://doi.org/10.1016/j.bbr.2016.06.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbr.2016.06.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbr.2016.06.051%26sid%3Dliteratum%253Aachs%26jtitle%3DBehavioural%2520Brain%2520Research%26atitle%3DHistamine%252BH3%252Breceptor%252Bas%252Ba%252Bpotential%252Btarget%252Bfor%252Bcognitive%252Bsymptoms%252Bin%252Bneuropsychiatric%252Bdiseases%26aulast%3DSadek%26aufirst%3DBassem%26date%3D2016%26volume%3D312%26spage%3D415%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bassem  Sadek</span>, <span class="hlFld-ContribAuthor ">Nadia  Khan</span>, <span class="hlFld-ContribAuthor ">Fouad H.  Darras</span>, <span class="hlFld-ContribAuthor ">Steffen  Pockes</span>, <span class="hlFld-ContribAuthor ">Michael  Decker</span>. </span><span class="cited-content_cbyCitation_article-title">The dual-acting AChE inhibitor and H3 receptor antagonist UW-MD-72 reverses amnesia induced by scopolamine or dizocilpine in passive avoidance paradigm in rats. </span><span class="cited-content_cbyCitation_journal-name">Physiology & Behavior</span><span> <strong>2016,</strong> <em>165 </em>, 383-391. <a href="https://doi.org/10.1016/j.physbeh.2016.08.022" title="DOI URL">https://doi.org/10.1016/j.physbeh.2016.08.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.physbeh.2016.08.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.physbeh.2016.08.022%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysiology%2520%2526%2520Behavior%26atitle%3DThe%252Bdual-acting%252BAChE%252Binhibitor%252Band%252BH3%252Breceptor%252Bantagonist%252BUW-MD-72%252Breverses%252Bamnesia%252Binduced%252Bby%252Bscopolamine%252Bor%252Bdizocilpine%252Bin%252Bpassive%252Bavoidance%252Bparadigm%252Bin%252Brats%26aulast%3DSadek%26aufirst%3DBassem%26date%3D2016%26volume%3D165%26spage%3D383%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ofer  Spiegelstein</span>, <span class="hlFld-ContribAuthor ">Jasper  Stevens</span>, <span class="hlFld-ContribAuthor ">Joop  Van Gerven</span>, <span class="hlFld-ContribAuthor ">Pradeep J  Nathan</span>, <span class="hlFld-ContribAuthor ">James P  Maynard</span>, <span class="hlFld-ContribAuthor ">David W  Mayleben</span>, <span class="hlFld-ContribAuthor ">Edward  Hellriegel</span>, <span class="hlFld-ContribAuthor ">Ronghua  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics, pharmacodynamics and safety of CEP-26401, a high-affinity histamine-3 receptor antagonist, following single and multiple dosing in healthy subjects. </span><span class="cited-content_cbyCitation_journal-name">Journal of Psychopharmacology</span><span> <strong>2016,</strong> <em>30 </em>
                                    (10)
                                     , 983-993. <a href="https://doi.org/10.1177/0269881116645301" title="DOI URL">https://doi.org/10.1177/0269881116645301</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/0269881116645301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F0269881116645301%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Psychopharmacology%26atitle%3DPharmacokinetics%25252C%252Bpharmacodynamics%252Band%252Bsafety%252Bof%252BCEP-26401%25252C%252Ba%252Bhigh-affinity%252Bhistamine-3%252Breceptor%252Bantagonist%25252C%252Bfollowing%252Bsingle%252Band%252Bmultiple%252Bdosing%252Bin%252Bhealthy%252Bsubjects%26aulast%3DSpiegelstein%26aufirst%3DOfer%26date%3D2016%26date%3D2016%26volume%3D30%26issue%3D10%26spage%3D983%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroki  Yoneyama</span>, <span class="hlFld-ContribAuthor ">Daisuke  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Atsushi  Yamatodani</span>, <span class="hlFld-ContribAuthor ">Shinya  Harusawa</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Approaches to S-alkyl-N-alkylisothioureas and Application to Novel Histamine H3R Antagonists. </span><span class="cited-content_cbyCitation_journal-name">YAKUGAKU ZASSHI</span><span> <strong>2016,</strong> <em>136 </em>
                                    (9)
                                     , 1217-1232. <a href="https://doi.org/10.1248/yakushi.16-00023" title="DOI URL">https://doi.org/10.1248/yakushi.16-00023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/yakushi.16-00023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fyakushi.16-00023%26sid%3Dliteratum%253Aachs%26jtitle%3DYAKUGAKU%2520ZASSHI%26atitle%3DEfficient%252BApproaches%252Bto%252BS-alkyl-N-alkylisothioureas%252Band%252BApplication%252Bto%252BNovel%252BHistamine%252BH3R%252BAntagonists%26aulast%3DYoneyama%26aufirst%3DHiroki%26date%3D2016%26volume%3D136%26issue%3D9%26spage%3D1217%26epage%3D1232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingfei  Yang</span>, <span class="hlFld-ContribAuthor ">Yuanjun  Zhu</span>, <span class="hlFld-ContribAuthor ">Mengyang  Shui</span>, <span class="hlFld-ContribAuthor ">Tongliang  Zhou</span>, <span class="hlFld-ContribAuthor ">Yuanbo  Cai</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Fengrong  Xu</span>, <span class="hlFld-ContribAuthor ">Yan  Niu</span>, <span class="hlFld-ContribAuthor ">Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Jun-Long  Zhang</span>, <span class="hlFld-ContribAuthor ">Ping  Xu</span>, <span class="hlFld-ContribAuthor ">Lan  Yuan</span>, <span class="hlFld-ContribAuthor ">Lei  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Rational Design of Fluorescent Phthalazinone Derivatives for One- and Two-Photon Imaging. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2016,</strong> <em>22 </em>
                                    (35)
                                     , 12363-12370. <a href="https://doi.org/10.1002/chem.201601499" title="DOI URL">https://doi.org/10.1002/chem.201601499</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201601499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201601499%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DRational%252BDesign%252Bof%252BFluorescent%252BPhthalazinone%252BDerivatives%252Bfor%252BOne-%252Band%252BTwo-Photon%252BImaging%26aulast%3DYang%26aufirst%3DLingfei%26date%3D2016%26date%3D2016%26volume%3D22%26issue%3D35%26spage%3D12363%26epage%3D12370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert L.  Hudkins</span>, <span class="hlFld-ContribAuthor ">John A.  Gruner</span>, <span class="hlFld-ContribAuthor ">Rita  Raddatz</span>, <span class="hlFld-ContribAuthor ">Joanne R.  Mathiasen</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Aimone</span>, <span class="hlFld-ContribAuthor ">Michael J.  Marino</span>, <span class="hlFld-ContribAuthor ">Edward R.  Bacon</span>, <span class="hlFld-ContribAuthor ">Michael  Williams</span>, <span class="hlFld-ContribAuthor ">Mark A.  Ator</span>. </span><span class="cited-content_cbyCitation_article-title">3-(1â²-Cyclobutylspiro[4H-1,3-benzodioxine-2,4â²-piperidine]-6-yl)-5,5-dimethyl-1,4-dihydropyridazin-6-one (CEP-32215), a new wake-promoting histamine H3 antagonist/inverse agonist. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2016,</strong> <em>106 </em>, 37-45. <a href="https://doi.org/10.1016/j.neuropharm.2015.09.025" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2015.09.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2015.09.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2015.09.025%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3D3-%2525281%2525E2%252580%2525B2-Cyclobutylspiro%25255B4H-1%25252C3-benzodioxine-2%25252C4%2525E2%252580%2525B2-piperidine%25255D-6-yl%252529-5%25252C5-dimethyl-1%25252C4-dihydropyridazin-6-one%252B%252528CEP-32215%252529%25252C%252Ba%252Bnew%252Bwake-promoting%252Bhistamine%252BH3%252Bantagonist%25252Finverse%252Bagonist%26aulast%3DHudkins%26aufirst%3DRobert%2BL.%26date%3D2016%26volume%3D106%26spage%3D37%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bassem  Sadek</span>, <span class="hlFld-ContribAuthor ">Holger  Stark</span>. </span><span class="cited-content_cbyCitation_article-title">Cherry-picked ligands at histamine receptor subtypes. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2016,</strong> <em>106 </em>, 56-73. <a href="https://doi.org/10.1016/j.neuropharm.2015.11.005" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2015.11.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2015.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2015.11.005%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DCherry-picked%252Bligands%252Bat%252Bhistamine%252Breceptor%252Bsubtypes%26aulast%3DSadek%26aufirst%3DBassem%26date%3D2016%26volume%3D106%26spage%3D56%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingfei  Yang</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Qi  Sun</span>, <span class="hlFld-ContribAuthor ">Fengrong  Xu</span>, <span class="hlFld-ContribAuthor ">Yan  Niu</span>, <span class="hlFld-ContribAuthor ">Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Liang</span>, <span class="hlFld-ContribAuthor ">Ping  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Development of novel proteasome inhibitors based on phthalazinone scaffold. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (12)
                                     , 2801-2805. <a href="https://doi.org/10.1016/j.bmcl.2016.04.067" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.04.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.04.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.04.067%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252Bnovel%252Bproteasome%252Binhibitors%252Bbased%252Bon%252Bphthalazinone%252Bscaffold%26aulast%3DYang%26aufirst%3DLingfei%26date%3D2016%26volume%3D26%26issue%3D12%26spage%3D2801%26epage%3D2805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">B.  Sadek</span>, <span class="hlFld-ContribAuthor ">D.  ÅaÅ¼ewska</span>, <span class="hlFld-ContribAuthor ">S.  Hagenow</span>, <span class="hlFld-ContribAuthor ">K.  KieÄ-Kononowicz</span>, <span class="hlFld-ContribAuthor ">H.  Stark</span>. </span><span class="cited-content_cbyCitation_article-title">Histamine H3R Antagonists: From Scaffold Hopping to Clinical Candidates. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 109-155. <a href="https://doi.org/10.1007/978-3-319-40308-3_5" title="DOI URL">https://doi.org/10.1007/978-3-319-40308-3_5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-40308-3_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-40308-3_5%26sid%3Dliteratum%253Aachs%26atitle%3DHistamine%252BH3R%252BAntagonists%25253A%252BFrom%252BScaffold%252BHopping%252Bto%252BClinical%252BCandidates%26aulast%3DSadek%26aufirst%3DB.%26date%3D2016%26date%3D2016%26spage%3D109%26epage%3D155%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHistamine%252BReceptors%26aulast%3DBlandina%26aufirst%3DPatrizio%26date%3D2016%26volume%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert L.  Hudkins</span>, <span class="hlFld-ContribAuthor ">Nadine C.  Becknell</span>, <span class="hlFld-ContribAuthor ">Jacquelyn A.  Lyons</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Aimone</span>, <span class="hlFld-ContribAuthor ">Mark  Olsen</span>, <span class="hlFld-ContribAuthor ">R. Curtis  Haltiwanger</span>, <span class="hlFld-ContribAuthor ">Joanne R.  Mathiasen</span>, <span class="hlFld-ContribAuthor ">Rita  Raddatz</span>, <span class="hlFld-ContribAuthor ">John A.  Gruner</span>. </span><span class="cited-content_cbyCitation_article-title">3,4-Diaza-bicyclo[4.1.0]hept-4-en-2-one phenoxypropylamine analogs of irdabisant (CEP-26401) as potent histamine-3 receptor inverse agonists with robust wake-promoting activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>95 </em>, 349-356. <a href="https://doi.org/10.1016/j.ejmech.2015.03.054" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.03.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.03.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.03.054%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D3%25252C4-Diaza-bicyclo%25255B4.1.0%25255Dhept-4-en-2-one%252Bphenoxypropylamine%252Banalogs%252Bof%252Birdabisant%252B%252528CEP-26401%252529%252Bas%252Bpotent%252Bhistamine-3%252Breceptor%252Binverse%252Bagonists%252Bwith%252Brobust%252Bwake-promoting%252Bactivity%26aulast%3DHudkins%26aufirst%3DRobert%2BL.%26date%3D2015%26volume%3D95%26spage%3D349%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Liang</span>, <span class="hlFld-ContribAuthor ">Fengrong  Xu</span>, <span class="hlFld-ContribAuthor ">Wenjie  Huang</span>, <span class="hlFld-ContribAuthor ">Yan  Niu</span>, <span class="hlFld-ContribAuthor ">Qi  Sun</span>, <span class="hlFld-ContribAuthor ">Ping  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Ruthenium-Catalyzed Switchable N-H/C-H Alkenylation of 6-Phenyl(dihydro)pyridazinones with Alkynes. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>2014 </em>
                                    (31)
                                     , 6863-6867. <a href="https://doi.org/10.1002/ejoc.201402986" title="DOI URL">https://doi.org/10.1002/ejoc.201402986</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201402986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201402986%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRuthenium-Catalyzed%252BSwitchable%252BN-H%25252FC-H%252BAlkenylation%252Bof%252B6-Phenyl%252528dihydro%252529pyridazinones%252Bwith%252BAlkynes%26aulast%3DWang%26aufirst%3DWei%26date%3D2014%26date%3D2014%26volume%3D2014%26issue%3D31%26spage%3D6863%26epage%3D6867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert L.  Hudkins</span>, <span class="hlFld-ContribAuthor ">Kurt A.  Josef</span>, <span class="hlFld-ContribAuthor ">Nadine C.  Becknell</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Aimone</span>, <span class="hlFld-ContribAuthor ">Jacquelyn A.  Lyons</span>, <span class="hlFld-ContribAuthor ">Joanne R.  Mathiasen</span>, <span class="hlFld-ContribAuthor ">John A.  Gruner</span>, <span class="hlFld-ContribAuthor ">Rita  Raddatz</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of (1R,6S)-5-[4-(1-cyclobutyl-piperidin-4-yloxy)-phenyl]-3,4-diaza-bicyclo[4.1.0]hept-4-en-2-one (R,S-4a): Histamine H3 receptor inverse agonist demonstrating potent cognitive enhancing and wake promoting activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (5)
                                     , 1303-1306. <a href="https://doi.org/10.1016/j.bmcl.2014.01.061" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.01.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.01.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.01.061%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B%2525281R%25252C6S%252529-5-%25255B4-%2525281-cyclobutyl-piperidin-4-yloxy%252529-phenyl%25255D-3%25252C4-diaza-bicyclo%25255B4.1.0%25255Dhept-4-en-2-one%252B%252528R%25252CS-4a%252529%25253A%252BHistamine%252BH3%252Breceptor%252Binverse%252Bagonist%252Bdemonstrating%252Bpotent%252Bcognitive%252Benhancing%252Band%252Bwake%252Bpromoting%252Bactivity%26aulast%3DHudkins%26aufirst%3DRobert%2BL.%26date%3D2014%26volume%3D24%26issue%3D5%26spage%3D1303%26epage%3D1306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaofeng  Bao</span>, <span class="hlFld-ContribAuthor ">Yanyan  Jin</span>, <span class="hlFld-ContribAuthor ">Xiaolu  Liu</span>, <span class="hlFld-ContribAuthor ">Hong  Liao</span>, <span class="hlFld-ContribAuthor ">Luyong  Zhang</span>, <span class="hlFld-ContribAuthor ">Tao  Pang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of XB-1 analogues as novel histamine H3 receptor antagonists and neuroprotective agents. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2014,</strong> <em>4 </em>
                                    (13)
                                     , 6761. <a href="https://doi.org/10.1039/c3ra46392c" title="DOI URL">https://doi.org/10.1039/c3ra46392c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ra46392c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ra46392c%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BXB-1%252Banalogues%252Bas%252Bnovel%252Bhistamine%252BH3%252Breceptor%252Bantagonists%252Band%252Bneuroprotective%252Bagents%26aulast%3DBao%26aufirst%3DXiaofeng%26date%3D2014%26volume%3D4%26issue%3D13%26spage%3D6761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dorota  ÅaÅ¼ewska</span>, <span class="hlFld-ContribAuthor ">Katarzyna  KieÄ-Kononowicz</span>. </span><span class="cited-content_cbyCitation_article-title">New developments around histamine H
              3
              receptor antagonists/inverse agonists: a patent review (2010 â present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (1)
                                     , 89-111. <a href="https://doi.org/10.1517/13543776.2014.848197" title="DOI URL">https://doi.org/10.1517/13543776.2014.848197</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.848197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.848197%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DNew%252Bdevelopments%252Baround%252Bhistamine%252BH%252B3%252Breceptor%252Bantagonists%25252Finverse%252Bagonists%25253A%252Ba%252Bpatent%252Breview%252B%2525282010%252B%2525E2%252580%252593%252Bpresent%252529%26aulast%3D%25C5%2581a%25C5%25BCewska%26aufirst%3DDorota%26date%3D2014%26date%3D2013%26volume%3D24%26issue%3D1%26spage%3D89%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shinya  Harusawa</span>, <span class="hlFld-ContribAuthor ">Koichi  Sawada</span>, <span class="hlFld-ContribAuthor ">Takuji  Magata</span>, <span class="hlFld-ContribAuthor ">Hiroki  Yoneyama</span>, <span class="hlFld-ContribAuthor ">Lisa  Araki</span>, <span class="hlFld-ContribAuthor ">Yoshihide  Usami</span>, <span class="hlFld-ContribAuthor ">Kouta  Hatano</span>, <span class="hlFld-ContribAuthor ">Kouichi  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Daisuke  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Atsushi  Yamatodani</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of N-alkyl-S-[3-(piperidin-1-yl)propyl]isothioureas: High affinity and human/rat species-selective histamine H3 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (23)
                                     , 6415-6420. <a href="https://doi.org/10.1016/j.bmcl.2013.09.052" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.09.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.09.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.09.052%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252BN-alkyl-S-%25255B3-%252528piperidin-1-yl%252529propyl%25255Disothioureas%25253A%252BHigh%252Baffinity%252Band%252Bhuman%25252Frat%252Bspecies-selective%252Bhistamine%252BH3%252Breceptor%252Bantagonists%26aulast%3DHarusawa%26aufirst%3DShinya%26date%3D2013%26volume%3D23%26issue%3D23%26spage%3D6415%26epage%3D6420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Liang</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Jun  Wu</span>, <span class="hlFld-ContribAuthor ">Fengrong  Xu</span>, <span class="hlFld-ContribAuthor ">Yan  Niu</span>, <span class="hlFld-ContribAuthor ">Bo  Xu</span>, <span class="hlFld-ContribAuthor ">Ping  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Rational Design, Green Synthesis, and Initial Evaluation of a Series of Full-Color Tunable Fluorescent Dyes Enabled by the Copper-Catalyzed N-Arylation of 6-Phenyl Pyridazinones and Their Application in Cell Imaging. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2013,</strong> <em>19 </em>
                                    (41)
                                     , 13774-13782. <a href="https://doi.org/10.1002/chem.201302495" title="DOI URL">https://doi.org/10.1002/chem.201302495</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201302495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201302495%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DRational%252BDesign%25252C%252BGreen%252BSynthesis%25252C%252Band%252BInitial%252BEvaluation%252Bof%252Ba%252BSeries%252Bof%252BFull-Color%252BTunable%252BFluorescent%252BDyes%252BEnabled%252Bby%252Bthe%252BCopper-Catalyzed%252BN-Arylation%252Bof%252B6-Phenyl%252BPyridazinones%252Band%252BTheir%252BApplication%252Bin%252BCell%252BImaging%26aulast%3DLiang%26aufirst%3DLei%26date%3D2013%26date%3D2013%26volume%3D19%26issue%3D41%26spage%3D13774%26epage%3D13782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Tang</span>, <span class="hlFld-ContribAuthor ">Liying  Zhao</span>, <span class="hlFld-ContribAuthor ">Lingjuan  Hong</span>, <span class="hlFld-ContribAuthor ">Fenyan  Yang</span>, <span class="hlFld-ContribAuthor ">Rong  Sheng</span>, <span class="hlFld-ContribAuthor ">Jianzhong  Chen</span>, <span class="hlFld-ContribAuthor ">Ying  Shi</span>, <span class="hlFld-ContribAuthor ">Naimin  Zhou</span>, <span class="hlFld-ContribAuthor ">Yongzhou  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel 3-substituted-indole derivatives as selective H3 receptor antagonists and potent free radical scavengers. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (19)
                                     , 5936-5944. <a href="https://doi.org/10.1016/j.bmc.2013.07.051" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.07.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.07.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.07.051%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252B3-substituted-indole%252Bderivatives%252Bas%252Bselective%252BH3%252Breceptor%252Bantagonists%252Band%252Bpotent%252Bfree%252Bradical%252Bscavengers%26aulast%3DTang%26aufirst%3DLi%26date%3D2013%26volume%3D21%26issue%3D19%26spage%3D5936%26epage%3D5944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Liang</span>, <span class="hlFld-ContribAuthor ">Guanyu  Yang</span>, <span class="hlFld-ContribAuthor ">Fengrong  Xu</span>, <span class="hlFld-ContribAuthor ">Yan  Niu</span>, <span class="hlFld-ContribAuthor ">Qi  Sun</span>, <span class="hlFld-ContribAuthor ">Ping  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Aerobic Dehydrogenation of C-C to C=C Bonds in the Synthesis of Pyridazinones. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>2013 </em>
                                    (27)
                                     , 6130-6136. <a href="https://doi.org/10.1002/ejoc.201300640" title="DOI URL">https://doi.org/10.1002/ejoc.201300640</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201300640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201300640%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCopper-Catalyzed%252BAerobic%252BDehydrogenation%252Bof%252BC-C%252Bto%252BC%25253DC%252BBonds%252Bin%252Bthe%252BSynthesis%252Bof%252BPyridazinones%26aulast%3DLiang%26aufirst%3DLei%26date%3D2013%26date%3D2013%26volume%3D2013%26issue%3D27%26spage%3D6130%26epage%3D6136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Levoin</span>, <span class="hlFld-ContribAuthor ">Olivier  Labeeuw</span>, <span class="hlFld-ContribAuthor ">StÃ©phane  Krief</span>, <span class="hlFld-ContribAuthor ">Thierry  Calmels</span>, <span class="hlFld-ContribAuthor ">Olivia  Poupardin-Olivier</span>, <span class="hlFld-ContribAuthor ">Isabelle  Berrebi-Bertrand</span>, <span class="hlFld-ContribAuthor ">Jeanne-Marie  Lecomte</span>, <span class="hlFld-ContribAuthor ">Jean-Charles  Schwartz</span>, <span class="hlFld-ContribAuthor ">Marc  Capet</span>. </span><span class="cited-content_cbyCitation_article-title">Determination of the binding mode and interacting amino-acids for dibasic H3 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (15)
                                     , 4526-4529. <a href="https://doi.org/10.1016/j.bmc.2013.05.035" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.05.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.05.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.05.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDetermination%252Bof%252Bthe%252Bbinding%252Bmode%252Band%252Binteracting%252Bamino-acids%252Bfor%252Bdibasic%252BH3%252Breceptor%252Bantagonists%26aulast%3DLevoin%26aufirst%3DNicolas%26date%3D2013%26volume%3D21%26issue%3D15%26spage%3D4526%26epage%3D4529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhongli  Gao</span>, <span class="hlFld-ContribAuthor ">William J.  Hurst</span>, <span class="hlFld-ContribAuthor ">Etienne  Guillot</span>, <span class="hlFld-ContribAuthor ">Werngard  Czechtizky</span>, <span class="hlFld-ContribAuthor ">Ulrike  Lukasczyk</span>, <span class="hlFld-ContribAuthor ">Raisa  Nagorny</span>, <span class="hlFld-ContribAuthor ">Marie-Pierre  Pruniaux</span>, <span class="hlFld-ContribAuthor ">Lothar  Schwink</span>, <span class="hlFld-ContribAuthor ">Juan Antonio  Sanchez</span>, <span class="hlFld-ContribAuthor ">Siegfried  Stengelin</span>, <span class="hlFld-ContribAuthor ">Lei  Tang</span>, <span class="hlFld-ContribAuthor ">Irvin  Winkler</span>, <span class="hlFld-ContribAuthor ">James A.  Hendrix</span>, <span class="hlFld-ContribAuthor ">Pascal G.  George</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (Part I). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (11)
                                     , 3416-3420. <a href="https://doi.org/10.1016/j.bmcl.2013.03.080" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.03.080</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.03.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.03.080%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Baryl%252Bureas%252Band%252Baryl%252Bamides%252Bas%252Bpotent%252Band%252Bselective%252Bhistamine%252BH3%252Breceptor%252Bantagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Bobesity%252B%252528Part%252BI%252529%26aulast%3DGao%26aufirst%3DZhongli%26date%3D2013%26volume%3D23%26issue%3D11%26spage%3D3416%26epage%3D3420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhongli  Gao</span>, <span class="hlFld-ContribAuthor ">William J.  Hurst</span>, <span class="hlFld-ContribAuthor ">Etienne  Guillot</span>, <span class="hlFld-ContribAuthor ">Werngard  Czechtizky</span>, <span class="hlFld-ContribAuthor ">Ulrike  Lukasczyk</span>, <span class="hlFld-ContribAuthor ">Raisa  Nagorny</span>, <span class="hlFld-ContribAuthor ">Marie-Pierre  Pruniaux</span>, <span class="hlFld-ContribAuthor ">Lothar  Schwink</span>, <span class="hlFld-ContribAuthor ">Juan Antonio  Sanchez</span>, <span class="hlFld-ContribAuthor ">Siegfried  Stengelin</span>, <span class="hlFld-ContribAuthor ">Lei  Tang</span>, <span class="hlFld-ContribAuthor ">Irvin  Winkler</span>, <span class="hlFld-ContribAuthor ">James A.  Hendrix</span>, <span class="hlFld-ContribAuthor ">Pascal G.  George</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (Part II). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (11)
                                     , 3421-3426. <a href="https://doi.org/10.1016/j.bmcl.2013.03.081" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.03.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.03.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.03.081%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Baryl%252Bureas%252Band%252Baryl%252Bamides%252Bas%252Bpotent%252Band%252Bselective%252Bhistamine%252BH3%252Breceptor%252Bantagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Bobesity%252B%252528Part%252BII%252529%26aulast%3DGao%26aufirst%3DZhongli%26date%3D2013%26volume%3D23%26issue%3D11%26spage%3D3421%26epage%3D3426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Liang</span>, <span class="hlFld-ContribAuthor ">Guanyu  Yang</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Fengrong  Xu</span>, <span class="hlFld-ContribAuthor ">Yan  Niu</span>, <span class="hlFld-ContribAuthor ">Qi  Sun</span>, <span class="hlFld-ContribAuthor ">Ping  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">A Copper-Catalyzed Aerobic Cascade Dehydrogenative- Dehalogenative Reaction. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2013,</strong> <em>355 </em>
                                    (7)
                                     , 1284-1290. <a href="https://doi.org/10.1002/adsc.201300026" title="DOI URL">https://doi.org/10.1002/adsc.201300026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201300026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201300026%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DA%252BCopper-Catalyzed%252BAerobic%252BCascade%252BDehydrogenative-%252BDehalogenative%252BReaction%26aulast%3DLiang%26aufirst%3DLei%26date%3D2013%26date%3D2013%26volume%3D355%26issue%3D7%26spage%3D1284%26epage%3D1290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Derek  Dunn</span>, <span class="hlFld-ContribAuthor ">Rita  Raddatz</span>, <span class="hlFld-ContribAuthor ">Mark A.  Ator</span>, <span class="hlFld-ContribAuthor ">Edward R.  Bacon</span>, <span class="hlFld-ContribAuthor ">Sankar  Chatterjee</span>. </span><span class="cited-content_cbyCitation_article-title">From an Atypical Wake-promoting Agent to Potent Histamine-3 Receptor Inverse Agonists. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2013,</strong> <em>81 </em>
                                    (3)
                                     , 433-435. <a href="https://doi.org/10.1111/cbdd.12094" title="DOI URL">https://doi.org/10.1111/cbdd.12094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12094%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DFrom%252Ban%252BAtypical%252BWake-promoting%252BAgent%252Bto%252BPotent%252BHistamine-3%252BReceptor%252BInverse%252BAgonists%26aulast%3DDunn%26aufirst%3DDerek%26date%3D2013%26date%3D2013%26volume%3D81%26issue%3D3%26spage%3D433%26epage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Attila  TakÃ¡cs</span>, <span class="hlFld-ContribAuthor ">Andrea  Czompa</span>, <span class="hlFld-ContribAuthor ">GÃ¡bor  Krajsovszky</span>, <span class="hlFld-ContribAuthor ">PÃ©ter  MÃ¡tyus</span>, <span class="hlFld-ContribAuthor ">LÃ¡szlÃ³  KollÃ¡r</span>. </span><span class="cited-content_cbyCitation_article-title">Functionalization of the pyridazin-3(2H)-one ring via palladium-catalysed aminocarbonylation. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2012,</strong> <em>68 </em>
                                    (38)
                                     , 7855-7860. <a href="https://doi.org/10.1016/j.tet.2012.07.030" title="DOI URL">https://doi.org/10.1016/j.tet.2012.07.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2012.07.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2012.07.030%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DFunctionalization%252Bof%252Bthe%252Bpyridazin-3%2525282H%252529-one%252Bring%252Bvia%252Bpalladium-catalysed%252Baminocarbonylation%26aulast%3DTak%25C3%25A1cs%26aufirst%3DAttila%26date%3D2012%26volume%3D68%26issue%3D38%26spage%3D7855%26epage%3D7860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nadine C.  Becknell</span>, <span class="hlFld-ContribAuthor ">Jacquelyn A.  Lyons</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Aimone</span>, <span class="hlFld-ContribAuthor ">Zeqi  Huang</span>, <span class="hlFld-ContribAuthor ">John A.  Gruner</span>, <span class="hlFld-ContribAuthor ">Rita  Raddatz</span>, <span class="hlFld-ContribAuthor ">Robert L.  Hudkins</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of 4- and 5-pyridazin-3-one phenoxypropylamine analogues as histamine-3 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (12)
                                     , 3880-3886. <a href="https://doi.org/10.1016/j.bmc.2012.04.028" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.04.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.04.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.04.028%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252B4-%252Band%252B5-pyridazin-3-one%252Bphenoxypropylamine%252Banalogues%252Bas%252Bhistamine-3%252Breceptor%252Bantagonists%26aulast%3DBecknell%26aufirst%3DNadine%2BC.%26date%3D2012%26volume%3D20%26issue%3D12%26spage%3D3880%26epage%3D3886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kurt A.  Josef</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Aimone</span>, <span class="hlFld-ContribAuthor ">Jacquelyn  Lyons</span>, <span class="hlFld-ContribAuthor ">Rita  Raddatz</span>, <span class="hlFld-ContribAuthor ">Robert L.  Hudkins</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of constrained benzocinnolinone analogues of CEP-26401 (irdabisant) as potent, selective histamine H3 receptor inverse agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (12)
                                     , 4198-4202. <a href="https://doi.org/10.1016/j.bmcl.2012.04.001" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.04.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.04.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252Bconstrained%252Bbenzocinnolinone%252Banalogues%252Bof%252BCEP-26401%252B%252528irdabisant%252529%252Bas%252Bpotent%25252C%252Bselective%252Bhistamine%252BH3%252Breceptor%252Binverse%252Bagonists%26aulast%3DJosef%26aufirst%3DKurt%2BA.%26date%3D2012%26volume%3D22%26issue%3D12%26spage%3D4198%26epage%3D4202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Allison L.  Zulli</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Aimone</span>, <span class="hlFld-ContribAuthor ">Joanne R.  Mathiasen</span>, <span class="hlFld-ContribAuthor ">John A.  Gruner</span>, <span class="hlFld-ContribAuthor ">Rita  Raddatz</span>, <span class="hlFld-ContribAuthor ">Edward R.  Bacon</span>, <span class="hlFld-ContribAuthor ">Robert L.  Hudkins</span>. </span><span class="cited-content_cbyCitation_article-title">Substituted phenoxypropyl-(R)-2-methylpyrrolidine aminomethyl ketones as histamine-3 receptor inverse agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (8)
                                     , 2807-2810. <a href="https://doi.org/10.1016/j.bmcl.2012.02.081" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.02.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.02.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.02.081%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSubstituted%252Bphenoxypropyl-%252528R%252529-2-methylpyrrolidine%252Baminomethyl%252Bketones%252Bas%252Bhistamine-3%252Breceptor%252Binverse%252Bagonists%26aulast%3DZulli%26aufirst%3DAllison%2BL.%26date%3D2012%26volume%3D22%26issue%3D8%26spage%3D2807%26epage%3D2810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph R.  Andrews</span>, <span class="hlFld-ContribAuthor ">Crist N.  Filer</span>, <span class="hlFld-ContribAuthor ">Mario  Maniscalco</span>, <span class="hlFld-ContribAuthor ">Nadine C.  Becknell</span>, <span class="hlFld-ContribAuthor ">Robert L.  Hudkins</span>. </span><span class="cited-content_cbyCitation_article-title">High specific activity tritiation of the pyridazin-3-one histamine H3 receptor inverse agonist CEP-27088. </span><span class="cited-content_cbyCitation_journal-name">Applied Radiation and Isotopes</span><span> <strong>2012,</strong> <em>70 </em>
                                    (3)
                                     , 512-514. <a href="https://doi.org/10.1016/j.apradiso.2011.11.061" title="DOI URL">https://doi.org/10.1016/j.apradiso.2011.11.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apradiso.2011.11.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apradiso.2011.11.061%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Radiation%2520and%2520Isotopes%26atitle%3DHigh%252Bspecific%252Bactivity%252Btritiation%252Bof%252Bthe%252Bpyridazin-3-one%252Bhistamine%252BH3%252Breceptor%252Binverse%252Bagonist%252BCEP-27088%26aulast%3DAndrews%26aufirst%3DJoseph%2BR.%26date%3D2012%26volume%3D70%26issue%3D3%26spage%3D512%26epage%3D514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Reddeppa Reddy  Dandu</span>, <span class="hlFld-ContribAuthor ">Jacquelyn A.  Lyons</span>, <span class="hlFld-ContribAuthor ">Rita  Raddatz</span>, <span class="hlFld-ContribAuthor ">Zeqi  Huang</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Aimone</span>, <span class="hlFld-ContribAuthor ">Robert L.  Hudkins</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of a new series of 1â²-cyclobutyl-6-(4-piperidyloxy)spiro[benzopyran-2,4â²-piperidine] derivatives as high affinity and selective histamine-3 receptor (H3R) antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (6)
                                     , 2151-2153. <a href="https://doi.org/10.1016/j.bmcl.2012.01.139" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.01.139</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.01.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.01.139%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Ba%252Bnew%252Bseries%252Bof%252B1%2525E2%252580%2525B2-cyclobutyl-6-%2525284-piperidyloxy%252529spiro%25255Bbenzopyran-2%25252C4%2525E2%252580%2525B2-piperidine%25255D%252Bderivatives%252Bas%252Bhigh%252Baffinity%252Band%252Bselective%252Bhistamine-3%252Breceptor%252B%252528H3R%252529%252Bantagonists%26aulast%3DDandu%26aufirst%3DReddeppa%2BReddy%26date%3D2012%26volume%3D22%26issue%3D6%26spage%3D2151%26epage%3D2153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Babu G.  Sundar</span>, <span class="hlFld-ContribAuthor ">Thomas R.  Bailey</span>, <span class="hlFld-ContribAuthor ">Derek  Dunn</span>, <span class="hlFld-ContribAuthor ">Greg A.  Hostetler</span>, <span class="hlFld-ContribAuthor ">Sankar  Chatterjee</span>, <span class="hlFld-ContribAuthor ">Edward R.  Bacon</span>, <span class="hlFld-ContribAuthor ">Christoph  Yue</span>, <span class="hlFld-ContribAuthor ">Dominique  Schweizer</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Aimone</span>, <span class="hlFld-ContribAuthor ">John A.  Gruner</span>, <span class="hlFld-ContribAuthor ">Jacquelyn  Lyons</span>, <span class="hlFld-ContribAuthor ">Rita  Raddatz</span>, <span class="hlFld-ContribAuthor ">Brigitte  Lesur</span>. </span><span class="cited-content_cbyCitation_article-title">Novel morpholine ketone analogs as potent histamine H3 receptor inverse agonists with wake activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (4)
                                     , 1546-1549. <a href="https://doi.org/10.1016/j.bmcl.2012.01.004" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.01.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.01.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252Bmorpholine%252Bketone%252Banalogs%252Bas%252Bpotent%252Bhistamine%252BH3%252Breceptor%252Binverse%252Bagonists%252Bwith%252Bwake%252Bactivity%26aulast%3DSundar%26aufirst%3DBabu%2BG.%26date%3D2012%26volume%3D22%26issue%3D4%26spage%3D1546%26epage%3D1549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert L.  Hudkins</span>, <span class="hlFld-ContribAuthor ">Allison L.  Zulli</span>, <span class="hlFld-ContribAuthor ">Reddeppa reddy  Dandu</span>, <span class="hlFld-ContribAuthor ">Ming  Tao</span>, <span class="hlFld-ContribAuthor ">Kurt A.  Josef</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Aimone</span>, <span class="hlFld-ContribAuthor ">R.  Curtis Haltiwanger</span>, <span class="hlFld-ContribAuthor ">Zeqi  Huang</span>, <span class="hlFld-ContribAuthor ">Jacquelyn A.  Lyons</span>, <span class="hlFld-ContribAuthor ">Joanne R.  Mathiasen</span>, <span class="hlFld-ContribAuthor ">Rita  Raddatz</span>, <span class="hlFld-ContribAuthor ">John A.  Gruner</span>. </span><span class="cited-content_cbyCitation_article-title">4-Phenoxypiperidine pyridazin-3-one histamine H3 receptor inverse agonists demonstrating potent and robust wake promoting activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (4)
                                     , 1504-1509. <a href="https://doi.org/10.1016/j.bmcl.2012.01.026" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.01.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.01.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.01.026%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D4-Phenoxypiperidine%252Bpyridazin-3-one%252Bhistamine%252BH3%252Breceptor%252Binverse%252Bagonists%252Bdemonstrating%252Bpotent%252Band%252Brobust%252Bwake%252Bpromoting%252Bactivity%26aulast%3DHudkins%26aufirst%3DRobert%2BL.%26date%3D2012%26volume%3D22%26issue%3D4%26spage%3D1504%26epage%3D1509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert L.  Hudkins</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Aimone</span>, <span class="hlFld-ContribAuthor ">Reddeppa reddy  Dandu</span>, <span class="hlFld-ContribAuthor ">Derek  Dunn</span>, <span class="hlFld-ContribAuthor ">John A.  Gruner</span>, <span class="hlFld-ContribAuthor ">Zeqi  Huang</span>, <span class="hlFld-ContribAuthor ">Kurt A.  Josef</span>, <span class="hlFld-ContribAuthor ">Jacquelyn A.  Lyons</span>, <span class="hlFld-ContribAuthor ">Joanne R.  Mathiasen</span>, <span class="hlFld-ContribAuthor ">Ming  Tao</span>, <span class="hlFld-ContribAuthor ">Allison L.  Zulli</span>, <span class="hlFld-ContribAuthor ">Rita  Raddatz</span>. </span><span class="cited-content_cbyCitation_article-title">4,5-Dihydropyridazin-3-one derivatives as histamine H3 receptor inverse agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (1)
                                     , 194-198. <a href="https://doi.org/10.1016/j.bmcl.2011.11.037" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.11.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.11.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.11.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D4%25252C5-Dihydropyridazin-3-one%252Bderivatives%252Bas%252Bhistamine%252BH3%252Breceptor%252Binverse%252Bagonists%26aulast%3DHudkins%26aufirst%3DRobert%2BL.%26date%3D2012%26volume%3D22%26issue%3D1%26spage%3D194%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nadine C.  Becknell</span>, <span class="hlFld-ContribAuthor ">Reddeppa Reddy  Dandu</span>, <span class="hlFld-ContribAuthor ">Jacquelyn A.  Lyons</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Aimone</span>, <span class="hlFld-ContribAuthor ">Rita  Raddatz</span>, <span class="hlFld-ContribAuthor ">Robert L.  Hudkins</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of 4-alkoxy-[1â²-cyclobutyl-spiro(3,4-dihydrobenzopyran-2,4â²-piperidine)] analogues as histamine-3 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (1)
                                     , 186-189. <a href="https://doi.org/10.1016/j.bmcl.2011.11.038" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.11.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.11.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.11.038%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252B4-alkoxy-%25255B1%2525E2%252580%2525B2-cyclobutyl-spiro%2525283%25252C4-dihydrobenzopyran-2%25252C4%2525E2%252580%2525B2-piperidine%252529%25255D%252Banalogues%252Bas%252Bhistamine-3%252Breceptor%252Bantagonists%26aulast%3DBecknell%26aufirst%3DNadine%2BC.%26date%3D2012%26volume%3D22%26issue%3D1%26spage%3D186%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming  Tao</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Aimone</span>, <span class="hlFld-ContribAuthor ">John A.  Gruner</span>, <span class="hlFld-ContribAuthor ">Joanne R.  Mathiasen</span>, <span class="hlFld-ContribAuthor ">Zeqi  Huang</span>, <span class="hlFld-ContribAuthor ">Jacquelyn  Lyons</span>, <span class="hlFld-ContribAuthor ">Rita  Raddatz</span>, <span class="hlFld-ContribAuthor ">Robert L.  Hudkins</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structureâactivity relationship of 5-pyridazin-3-one phenoxypiperidines as potent, selective histamine H3 receptor inverse agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (2)
                                     , 1073-1077. <a href="https://doi.org/10.1016/j.bmcl.2011.11.118" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.11.118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.11.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.11.118%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bof%252B5-pyridazin-3-one%252Bphenoxypiperidines%252Bas%252Bpotent%25252C%252Bselective%252Bhistamine%252BH3%252Breceptor%252Binverse%252Bagonists%26aulast%3DTao%26aufirst%3DMing%26date%3D2012%26volume%3D22%26issue%3D2%26spage%3D1073%26epage%3D1077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rita  Raddatz</span>, <span class="hlFld-ContribAuthor ">Robert L.  Hudkins</span>, <span class="hlFld-ContribAuthor ">Joanne R.  Mathiasen</span>, <span class="hlFld-ContribAuthor ">John A.  Gruner</span>, <span class="hlFld-ContribAuthor ">Dorothy G.  Flood</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Aimone</span>, <span class="hlFld-ContribAuthor ">Siyuan  Le</span>, <span class="hlFld-ContribAuthor ">HervÃ©  Schaffhauser</span>, <span class="hlFld-ContribAuthor ">Emir  Duzic</span>, <span class="hlFld-ContribAuthor ">Maciej  Gasior</span>, <span class="hlFld-ContribAuthor ">Donna  Bozyczko-Coyne</span>, <span class="hlFld-ContribAuthor ">Michael J.  Marino</span>, <span class="hlFld-ContribAuthor ">Mark A.  Ator</span>, <span class="hlFld-ContribAuthor ">Edward R.  Bacon</span>, <span class="hlFld-ContribAuthor ">John P.  Mallamo</span>, <span class="hlFld-ContribAuthor ">Michael  Williams</span>. </span><span class="cited-content_cbyCitation_article-title">CEP-26401 (Irdabisant), a Potent and Selective Histamine H
              3
              Receptor Antagonist/Inverse Agonist with Cognition-Enhancing and Wake-Promoting Activities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2012,</strong> <em>340 </em>
                                    (1)
                                     , 124-133. <a href="https://doi.org/10.1124/jpet.111.186585" title="DOI URL">https://doi.org/10.1124/jpet.111.186585</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.111.186585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.111.186585%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DCEP-26401%252B%252528Irdabisant%252529%25252C%252Ba%252BPotent%252Band%252BSelective%252BHistamine%252BH%252B3%252BReceptor%252BAntagonist%25252FInverse%252BAgonist%252Bwith%252BCognition-Enhancing%252Band%252BWake-Promoting%252BActivities%26aulast%3DRaddatz%26aufirst%3DRita%26date%3D2012%26date%3D2011%26volume%3D340%26issue%3D1%26spage%3D124%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nadine C.  Becknell</span>, <span class="hlFld-ContribAuthor ">Jacquelyn A.  Lyons</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Aimone</span>, <span class="hlFld-ContribAuthor ">John A.  Gruner</span>, <span class="hlFld-ContribAuthor ">Joanne R.  Mathiasen</span>, <span class="hlFld-ContribAuthor ">Rita  Raddatz</span>, <span class="hlFld-ContribAuthor ">Robert L.  Hudkins</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of pyridone-phenoxypropyl-R-2-methylpyrrolidine analogues as histamine H3 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (23)
                                     , 7076-7080. <a href="https://doi.org/10.1016/j.bmcl.2011.09.091" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.09.091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.09.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.09.091%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bpyridone-phenoxypropyl-R-2-methylpyrrolidine%252Banalogues%252Bas%252Bhistamine%252BH3%252Breceptor%252Bantagonists%26aulast%3DBecknell%26aufirst%3DNadine%2BC.%26date%3D2011%26volume%3D21%26issue%3D23%26spage%3D7076%26epage%3D7080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Reddeppa reddy  Dandu</span>, <span class="hlFld-ContribAuthor ">John A.  Gruner</span>, <span class="hlFld-ContribAuthor ">Joanne R.  Mathiasen</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Aimone</span>, <span class="hlFld-ContribAuthor ">Greg  Hostetler</span>, <span class="hlFld-ContribAuthor ">Caitlyn  Benfield</span>, <span class="hlFld-ContribAuthor ">Robert J.  Bendesky</span>, <span class="hlFld-ContribAuthor ">Val R.  Marcy</span>, <span class="hlFld-ContribAuthor ">Rita  Raddatz</span>, <span class="hlFld-ContribAuthor ">Robert L.  Hudkins</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of pyridazinoneâphenethylamine derivatives as selective and orally bioavailable histamine H3 receptor antagonists with robust wake-promoting activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (21)
                                     , 6362-6365. <a href="https://doi.org/10.1016/j.bmcl.2011.08.104" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.08.104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.08.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.08.104%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bpyridazinone%2525E2%252580%252593phenethylamine%252Bderivatives%252Bas%252Bselective%252Band%252Borally%252Bbioavailable%252Bhistamine%252BH3%252Breceptor%252Bantagonists%252Bwith%252Brobust%252Bwake-promoting%252Bactivity%26aulast%3DDandu%26aufirst%3DReddeppa%2Breddy%26date%3D2011%26volume%3D21%26issue%3D21%26spage%3D6362%26epage%3D6365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming  Tao</span>, <span class="hlFld-ContribAuthor ">Rita  Raddatz</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Aimone</span>, <span class="hlFld-ContribAuthor ">Robert L.  Hudkins</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structureâactivity relationships of 4,5-fused pyridazinones as histamine H3 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (20)
                                     , 6126-6130. <a href="https://doi.org/10.1016/j.bmcl.2011.08.045" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.08.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.08.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.08.045%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationships%252Bof%252B4%25252C5-fused%252Bpyridazinones%252Bas%252Bhistamine%252BH3%252Breceptor%252Bantagonists%26aulast%3DTao%26aufirst%3DMing%26date%3D2011%26volume%3D21%26issue%3D20%26spage%3D6126%26epage%3D6130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Babu G.  Sundar</span>, <span class="hlFld-ContribAuthor ">Thomas  Bailey</span>, <span class="hlFld-ContribAuthor ">Edward  Bacon</span>, <span class="hlFld-ContribAuthor ">Lisa  Aimone</span>, <span class="hlFld-ContribAuthor ">Zeqi  Huang</span>, <span class="hlFld-ContribAuthor ">Jacquelyn  Lyons</span>, <span class="hlFld-ContribAuthor ">Rita  Raddatz</span>, <span class="hlFld-ContribAuthor ">Robert  Hudkins</span>. </span><span class="cited-content_cbyCitation_article-title">Amine-constrained pyridazinone histamine H3 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (18)
                                     , 5543-5546. <a href="https://doi.org/10.1016/j.bmcl.2011.06.094" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.06.094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.06.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.06.094%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAmine-constrained%252Bpyridazinone%252Bhistamine%252BH3%252Breceptor%252Bantagonists%26aulast%3DSundar%26aufirst%3DBabu%2BG.%26date%3D2011%26volume%3D21%26issue%3D18%26spage%3D5543%26epage%3D5546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert L.  Hudkins</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Aimone</span>, <span class="hlFld-ContribAuthor ">Thomas R.  Bailey</span>, <span class="hlFld-ContribAuthor ">Robert J.  Bendesky</span>, <span class="hlFld-ContribAuthor ">Reddeppa reddy  Dandu</span>, <span class="hlFld-ContribAuthor ">Derek  Dunn</span>, <span class="hlFld-ContribAuthor ">John A.  Gruner</span>, <span class="hlFld-ContribAuthor ">Kurt A.  Josef</span>, <span class="hlFld-ContribAuthor ">Yin-Guo  Lin</span>, <span class="hlFld-ContribAuthor ">Jacquelyn  Lyons</span>, <span class="hlFld-ContribAuthor ">Val R.  Marcy</span>, <span class="hlFld-ContribAuthor ">Joanne R.  Mathiasen</span>, <span class="hlFld-ContribAuthor ">Babu G.  Sundar</span>, <span class="hlFld-ContribAuthor ">Ming  Tao</span>, <span class="hlFld-ContribAuthor ">Allison L.  Zulli</span>, <span class="hlFld-ContribAuthor ">Rita  Raddatz</span>, <span class="hlFld-ContribAuthor ">Edward R.  Bacon</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of pyridazin-3-one derivatives as potent, selective histamine H3 receptor inverse agonists with robust wake activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (18)
                                     , 5493-5497. <a href="https://doi.org/10.1016/j.bmcl.2011.06.108" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.06.108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.06.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.06.108%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bpyridazin-3-one%252Bderivatives%252Bas%252Bpotent%25252C%252Bselective%252Bhistamine%252BH3%252Breceptor%252Binverse%252Bagonists%252Bwith%252Brobust%252Bwake%252Bactivity%26aulast%3DHudkins%26aufirst%3DRobert%2BL.%26date%3D2011%26volume%3D21%26issue%3D18%26spage%3D5493%26epage%3D5497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/medium/jm-2011-00401v_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200401v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/medium/jm-2011-00401v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of representative H<sub>3</sub>R antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200401v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/medium/jm-2011-00401v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200401v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, 3-bromo-1-chloropropane, acetone, 65 Â°C, 99%; (b) CHOCO<sub>2</sub>HÂ·H<sub>2</sub>O, HOAc, 100 Â°C; (c) N<sub>2</sub>H<sub>4</sub>âH<sub>2</sub>O, 35â66%, two steps; (d) (<i>R</i>)-2-methylpyrrolidine, NaI, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 80 Â°C, 41%; (e) <b>9a</b> (<i>S</i>)-2-methylpyrrolidine, NaI, CH<sub>3</sub>CN, reflux, 93%; <b>9b</b> pyrrolidine, NaI, CH<sub>3</sub>CN, reflux, 72%; <b>9c</b> morpholine, NaI, CH<sub>3</sub>CN, reflux, 85%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/medium/jm-2011-00401v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200401v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-bromo-3-chloropropane, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN; (b) (<i>R</i>)-2-methylpyrrolidine, NaI, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 80 Â°C, 65%, two steps; (c) Pd(OAc)<sub>2</sub>, Ph<sub>3</sub>P, 3,6-dichloropyridazine, THF, EtOH, 80 Â°C, 90%; (d) HOAc, NaOAc 115 Â°C, 86%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/medium/jm-2011-00401v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200401v&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>15a</b> MeNHNH<sub>2</sub>; <b>15b</b> EtNHNH<sub>2</sub>; <b>15c</b><i>i</i>-PrNHNH<sub>2</sub>; <b>15d</b> PhNHNH<sub>2</sub>; <b>15e</b> BnNHNH<sub>2</sub>, 2-propanol, reflux; (b) MnO<sub>2</sub>, xylenes, 155 Â°C; (c) Cu(II)Cl<sub>2</sub>, CH<sub>3</sub>CN, reflux, 71â94%, two steps; (d) BBr<sub>3</sub>, DCM, 5 Â°C â room temp, 92â98%; (e) K<sub>2</sub>CO<sub>3</sub>, 3-bromo-1-chloropropane, acetone, 65 Â°C, 78â92%; (f) (<i>R</i>)-2-methylpyrrolidine, NaI, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN 80 Â°C, 48â88%; (g) <b>20a</b> piperidine, 71%; <b>20b</b> (<i>S</i>)-1-pyrrolidin-2-yl-methanol, 53%; <b>20c</b> (<i>R</i>)-1-pyrrolidin-2-yl-methanol, 50%.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/medium/jm-2011-00401v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200401v&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (PPh<sub>3</sub>)<sub>4</sub>Pd(0), K<sub>2</sub>CO<sub>3</sub>, 2-hydroxymethyl-5-iodo-2<i>H</i>-pyridazin-3-one, DME, reflux 48 h, 63%.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/medium/jm-2011-00401v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200401v/production/images/large/jm-2011-00401v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200401v&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, 3-bromo-1-chloropropane, acetone, 65 Â°C, 92%; (b) (<i>R</i>)-2-methylpyrrolidine, NaI, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN 80 Â°C, 97%; (c) 2<i>H</i>-pyridazin-3-one, Cu(0), pyr, reflux 18 h, 36%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i61">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15714" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15714" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 35 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Arrang, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbarg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J. C.</span><span> </span><span class="NLM_article-title">Auto-inhibition of brain histamine release mediated by a novel class (H<sub>3</sub>) of histamine receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">832</span><span class="NLM_x">â</span> <span class="NLM_lpage">837</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1038%2F302832a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=6188956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADyaL3sXitFSmsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=1983&pages=832-837&author=J.+M.+Arrangauthor=M.+Garbargauthor=J.+C.+Schwartz&title=Auto-inhibition+of+brain+histamine+release+mediated+by+a+novel+class+%28H3%29+of+histamine+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Autoinhibition of brain histamine release mediated by a novel class (H3) of histamine receptor</span></div><div class="casAuthors">Arrang, Jean Michel; Garbarg, Monique; Schwartz, Jean Charles</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5911</span>),
    <span class="NLM_cas:pages">832-7</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The K+-induced release of 3H-labeled histamine (I)  [51-45-6] from rat cerebral cortex slices was inhibited by exogenous I, suggesting the presence of histaminic receptors by which this compd. can control its own release.  Although NÎ±-methylhistamine  [673-50-7] and NÎ±,NÎ±-dimethylhistamine  [673-46-1] also inhibited [3H]-I release, a no. of compds. known to exhibit agonist activities of H1 or H2 receptors had no significant effect.  Consequently, autoinhibition of I release by the brain is apparently mediated by a type of receptor (histaminic H3) that is clearly different from H1 and H2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpu3HYACgLprVg90H21EOLACvtfcHk0linJ_FDVq-Jow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXitFSmsbc%253D&md5=891b1e95467aa9213317c930f12bf3b7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F302832a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F302832a0%26sid%3Dliteratum%253Aachs%26aulast%3DArrang%26aufirst%3DJ.%2BM.%26aulast%3DGarbarg%26aufirst%3DM.%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26atitle%3DAuto-inhibition%2520of%2520brain%2520histamine%2520release%2520mediated%2520by%2520a%2520novel%2520class%2520%2528H3%2529%2520of%2520histamine%2520receptor%26jtitle%3DNature%26date%3D1983%26volume%3D302%26spage%3D832%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roland, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyati, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huvar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlander, M. G.</span><span> </span><span class="NLM_article-title">Cloning and functional expression of the human histamine H<sub>3</sub> receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1101</span><span class="NLM_x">â</span> <span class="NLM_lpage">1107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1124%2Fmol.55.6.1101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=10347254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADyaK1MXjsVOksb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=1101-1107&author=T.+W.+Lovenbergauthor=B.+L.+Rolandauthor=S.+J.+Wilsonauthor=X.+Jiangauthor=J.+Pyatiauthor=A.+Huvarauthor=M.+R.+Jacksonauthor=M.+G.+Erlander&title=Cloning+and+functional+expression+of+the+human+histamine+H3+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and functional expression of the human histamine H3 receptor</span></div><div class="casAuthors">Lovenberg, Timothy W.; Roland, Barbara L.; Wilson, Sandy J.; Jiang, Xiaoxia; Pyati, Jayashree; Huvar, Arne; Jackson, Michael R.; Erlander, Mark G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1101-1107</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Histamine regulates neurotransmitter release in the central and peripheral nervous systems through H3 presynaptic receptors.  The existence of the histamine H3 receptor was demonstrated pharmacol. 15 yr ago, yet despite intensive efforts, its mol. identity has remained elusive.  As part of a directed effort to discover novel G protein-coupled receptors through homol. searching of expressed sequence tag databases, we identified a partial clone (GPCR97) that had significant homol. to biogenic amine receptors.  The GPCR97 clone was used to probe a human thalamus library, which resulted in the isolation of a full-length clone encoding a putative G protein-coupled receptor.  Homol. anal. showed the highest similarity to MV muscarinic acetylcholine receptors and overall low homol. to all other biogenic amine receptors.  Transfection of GPCR97 into a variety of cell lines conferred an ability to inhibit forskolin-stimulated cAMP formation in response to histamine, but not to acetylcholine or any other biogenic amine.  Subsequent anal. revealed a pharmacol. profile practically indistinguishable from that for the histamine H3 receptor.  In situ hybridization in rat brain revealed high levels of mRNA in all neuronal systems (such as the cerebral cortex, the thalamus, and the caudate nucleus) previously assocd. with H3 receptor function.  Its widespread and abundant neuronal expression in the brain highlights the significance of histamine as a general neurotransmitter modulator.  The availability of the human H3 receptor cDNA should greatly aid in the development of chem. and biol. reagents, allowing a greater appreciation of the role of histamine in brain function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokl8o0_LbHs7Vg90H21EOLACvtfcHk0ljzP7xQVEG3Qw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjsVOksb8%253D&md5=62250ade28417ca835b6a85be5bebec2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fmol.55.6.1101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.55.6.1101%26sid%3Dliteratum%253Aachs%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DRoland%26aufirst%3DB.%2BL.%26aulast%3DWilson%26aufirst%3DS.%2BJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DPyati%26aufirst%3DJ.%26aulast%3DHuvar%26aufirst%3DA.%26aulast%3DJackson%26aufirst%3DM.%2BR.%26aulast%3DErlander%26aufirst%3DM.%2BG.%26atitle%3DCloning%2520and%2520functional%2520expression%2520of%2520the%2520human%2520histamine%2520H3%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D1999%26volume%3D55%26spage%3D1101%26epage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chazot, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenton, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J.</span><span> </span><span class="NLM_article-title">Molecular and biochemical pharmacology of the histamine H4 receptor</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="NLM_x">â</span> <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1111%2Fj.1476-5381.2009.00250.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=19413568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVWlsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2009&pages=14-23&author=R.+Leursauthor=P.+L.+Chazotauthor=F.+C.+Shentonauthor=H.+D.+Limauthor=I.+J.+de+Esch&title=Molecular+and+biochemical+pharmacology+of+the+histamine+H4+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular and biochemical pharmacology of the histamine H4 receptor</span></div><div class="casAuthors">Leurs, Rob; Chazot, Paul L.; Shenton, Fiona C.; Lim, Herman D.; de Esch, Iwan J. P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-23</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The elucidation of the human genome has had a major impact on histamine receptor research.  The identification of the human H4 receptor by several groups has been instrumental for a new appreciation of the role of histamine in the modulation of immune function.  In this review, we summarize the historical developments and the mol. and biochem. pharmacol. of the H4 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPKXOJ1f6Ka7Vg90H21EOLACvtfcHk0ljzP7xQVEG3Qw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVWlsrc%253D&md5=a091124eaeae2a088845cd64da627293</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00250.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00250.x%26sid%3Dliteratum%253Aachs%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DChazot%26aufirst%3DP.%2BL.%26aulast%3DShenton%26aufirst%3DF.%2BC.%26aulast%3DLim%26aufirst%3DH.%2BD.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%26atitle%3DMolecular%2520and%2520biochemical%2520pharmacology%2520of%2520the%2520histamine%2520H4%2520receptor%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D157%26spage%3D14%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_contrib-group">Zampeli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiligada, E.</span><span> </span><span class="NLM_article-title">The role of histamine H4 receptor in immune and inflammatory disorders</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">â</span> <span class="NLM_lpage">33</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1111%2Fj.1476-5381.2009.00151.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=19309354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVWls74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2009&pages=24-33&author=E.+Zampeliauthor=E.+Tiligada&title=The+role+of+histamine+H4+receptor+in+immune+and+inflammatory+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The role of histamine H4 receptor in immune and inflammatory disorders</span></div><div class="casAuthors">Zampeli, E.; Tiligada, E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-33</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Since its discovery at the beginning of the 20th century, histamine has been established to play a pathophysiol. regulatory role in cellular events through binding to four types of G-protein-coupled histamine receptors that are differentially expressed in various cell types.  The discovery, at the turn of the millennium, that the histamine H4 receptor is largely expressed in hemopoietic cells as well as its chemotactic properties designate its regulatory role in the immune system.  H4 receptors modulate eosinophil migration and selective recruitment of mast cells leading to amplification of histamine-mediated immune responses and eventually to chronic inflammation.  H4 receptor involvement in dendritic cell activation and T cell differentiation documents its immunomodulatory function.  The characterization of the H4 as the immune system histamine receptor directed growing attention towards its therapeutic exploitation in inflammatory disorders, such as allergy, asthma, chronic pruritus and autoimmune diseases.  The efficacy of a no. of H4 receptor ligands has been evaluated in in vivo and in vitro animal models of disease and in human biol. samples.  However, before reaching decisive conclusions on H4 receptor pathophysiol. functions and therapeutic exploitation, identification of genetic polymorphisms and interspecies differences in its relative actions and pharmacol. profile need to be addressed and taken into consideration.  Despite certain variations in the reported findings, the available data strongly point to the H4 receptor as a novel target for the pharmacol. modulation of histamine-transferred immune signals and offer an optimistic perspective for the therapeutic exploitation of this promising new drug target in inflammatory disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAW6UpRFCXFLVg90H21EOLACvtfcHk0li1ozPN3Nqh9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVWls74%253D&md5=e850c2e825c0c62b59927854ccfb35c2</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00151.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00151.x%26sid%3Dliteratum%253Aachs%26aulast%3DZampeli%26aufirst%3DE.%26aulast%3DTiligada%26aufirst%3DE.%26atitle%3DThe%2520role%2520of%2520histamine%2520H4%2520receptor%2520in%2520immune%2520and%2520inflammatory%2520disorders%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D157%26spage%3D24%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_contrib-group">Oda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morikawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuho, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, S.</span><span> </span><span class="NLM_article-title">Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">36781</span><span class="NLM_x">â</span> <span class="NLM_lpage">36786</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1074%2Fjbc.M006480200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=10973974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD3cXoslWlsrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=36781-36786&author=T.+Odaauthor=N.+Morikawaauthor=Y.+Saitoauthor=Y.+Masuhoauthor=S.+Matsumoto&title=Molecular+cloning+and+characterization+of+a+novel+type+of+histamine+receptor+preferentially+expressed+in+leukocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes</span></div><div class="casAuthors">Oda, Tamaki; Morikawa, Noriyuki; Saito, Yoko; Masuho, Yasuhiko; Matsumoto, Shun-Ichiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">36781-36786</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Recently cDNA encoding the histamine H3 receptor was isolated after 15 yr of considerable research.  However, several studies have proposed heterogeneity of the H3 receptor.  We report here the mol. cloning and characterization of a novel type of histamine receptor.  A novel orphan G-protein-coupled receptor named GPRv53 was obtained through a search of the human genomic DNA data base and analyzed by rapid amplification of cDNA ends (RACE).  GPRv53 possessed the features of biol. amine receptors and had the highest homol. with H3 receptor among known G-protein-coupled receptors.  Mammalian cells expressing GPRv53 were demonstrated to bind and respond to histamine in a concn.-dependent manner.  In functional assays, not only an H3 receptor agonist, R-(Î±)-methylhistamine, but also a H3 receptor antagonist, clobenpropit, and a neuroleptic, clozapine, activated GPRv53-expressing cells.  Tissue distribution anal. revealed that expression of GPRv53 is localized in the peripheral blood leukocytes, spleen, thymus, and colon, which was totally different from the H3 receptor, whose expression was restricted to the brain.  The discovery of the GPRv53 receptor will open a new phase of research on the physiol. role of histamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDi7OAeZ5Y9bVg90H21EOLACvtfcHk0li1ozPN3Nqh9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXoslWlsrs%253D&md5=1c5ef920f061561b6cc2dcf920d1f259</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M006480200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M006480200%26sid%3Dliteratum%253Aachs%26aulast%3DOda%26aufirst%3DT.%26aulast%3DMorikawa%26aufirst%3DN.%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DMasuho%26aufirst%3DY.%26aulast%3DMatsumoto%26aufirst%3DS.%26atitle%3DMolecular%2520cloning%2520and%2520characterization%2520of%2520a%2520novel%2520type%2520of%2520histamine%2520receptor%2520preferentially%2520expressed%2520in%2520leukocytes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D36781%26epage%3D36786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3d"><span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keseru, G. M.</span><span> </span><span class="NLM_article-title">Histamine H4 receptor ligands and their potential therapeutic applications</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">â</span> <span class="NLM_lpage">135</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1517%2F13543770802691085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=19441913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVClu7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=119-135&author=R.+Kissauthor=G.+M.+Keseru&title=Histamine+H4+receptor+ligands+and+their+potential+therapeutic+applications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3dR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Histamine H4 receptor ligands and their potential therapeutic applications</span></div><div class="casAuthors">Kiss, Robert; Keseru, Gyorgy M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-135</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The histamine H4 receptor (H4R) was first cloned in 2000.  As a new member of the histamine receptor family it was of great interest and a promising drug target for the treatment of inflammatory diseases.  Recent studies suggest that H4 antagonists have therapeutic potential, even in several pain conditions.  Initially, pharmacol. processes mediated by H4R were analyzed primarily by non-selective H4 ligands.  Since then, some highly potent and selective H4 antagonists have been reported by different groups.  Several companies are working on the development of potent H4 antagonists, although the no. of published patent applications is still low.  This review aims to give an overview of the ligands acting on H4R, this is drawn from published in papers and patent applications.  Anal. of scaffolds possessing significant H4 activity and review of their therapeutic potential.  The pharmacol. of currently available selective H4 ligands suggests therapeutic utility for H4 antagonists in inflammatory conditions as well as in chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6vhvbflM7ZLVg90H21EOLACvtfcHk0li1ozPN3Nqh9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVClu7s%253D&md5=ee1ede069edacbe85f30f111ab438e1c</span></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=10.1517%2F13543770802691085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770802691085%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DHistamine%2520H4%2520receptor%2520ligands%2520and%2520their%2520potential%2520therapeutic%2520applications%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D119%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_contrib-group">Bongers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span> </span><span class="NLM_article-title">Molecular aspects of the histamine H<sub>3</sub> receptor</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1195</span><span class="NLM_x">â</span> <span class="NLM_lpage">1204</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2007&pages=1195-1204&author=G.+Bongersauthor=R.+A.+Bakkerauthor=R.+Leurs&title=Molecular+aspects+of+the+histamine+H3+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBongers%26aufirst%3DG.%26aulast%3DBakker%26aufirst%3DR.%2BA.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DMolecular%2520aspects%2520of%2520the%2520histamine%2520H3%2520receptor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D73%26spage%3D1195%26epage%3D1204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_contrib-group">Wulff, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastrup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimvall, K.</span><span> </span><span class="NLM_article-title">Characteristics of recombinantly expressed rat and human histamine H<sub>3</sub> receptors</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">453</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">â</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1016%2FS0014-2999%2802%2902382-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=12393057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVChtL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=453&publication_year=2002&pages=33-41&author=B.+S.+Wulffauthor=S.+Hastrupauthor=K.+Rimvall&title=Characteristics+of+recombinantly+expressed+rat+and+human+histamine+H3+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Characteristics of recombinantly expressed rat and human histamine H3 receptors</span></div><div class="casAuthors">Wulff, Birgitte S.; Hastrup, Sven; Rimvall, Karin</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">453</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-41</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Human and rat histamine H3 receptors were recombinantly expressed and characterized using receptor binding and a functional cAMP assay.  Seven of nine agonists had similar affinities and potencies at the rat and human histamine H3 receptor.  S-Î±-methylhistamine had a significantly higher affinity and potency at the human than rat receptor, and for 4-[(1R*,2R*)-2-(5,5-dimethyl-1-hexynyl)cyclopropyl]-1H-imidazole (Perceptin) the preference was the reverse.  Only two of six antagonists had similar affinities and potencies at the human and the rat histamine H3 receptor.  Ciproxifan, thioperamide and ((1R*,2R*)-trans-2-imidazol-4-ylcyclopropyl) (cyclohexylmethoxy) carboxamide (GT2394) had significantly higher affinities and potencies at the rat than at the human histamine H3 receptor, while for N-(4-chlorobenzyl)-N-(7-pyrrolodin-1-ylheptyl)guanidine (JB98064) the preference was the reverse.  All antagonists also showed potent inverse agonism properties.  Iodoproxyfan, Perceptin, proxyfan and GR175737, compds. previously described as histamine H3 receptor antagonists, acted as full or partial agonists at both the rat and the human histamine H3 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopMFBIvhcSgbVg90H21EOLACvtfcHk0lhiuXaDpAkZkA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVChtL0%253D&md5=1abed9da8f107ceaa8f2dbd094a9e186</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2902382-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252902382-8%26sid%3Dliteratum%253Aachs%26aulast%3DWulff%26aufirst%3DB.%2BS.%26aulast%3DHastrup%26aufirst%3DS.%26aulast%3DRimvall%26aufirst%3DK.%26atitle%3DCharacteristics%2520of%2520recombinantly%2520expressed%2520rat%2520and%2520human%2520histamine%2520H3%2520receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D453%26spage%3D33%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="note"><p class="first last">Reviews: </p></div><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmerman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J.</span><span> </span><span class="NLM_article-title">The histamine H<sub>3</sub> receptor: from gene cloning to H<sub>3</sub> receptor drugs</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">â</span> <span class="NLM_lpage">120</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1038%2Fnrd1631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=15665857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpt1Wlsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=107-120&author=R.+Leursauthor=R.+A.+Bakkerauthor=H.+Timmermanauthor=I.+J.+de+Esch&title=The+histamine+H3+receptor%3A+from+gene+cloning+to+H3+receptor+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The histamine H3 receptor: from gene cloning to H3 receptor drugs</span></div><div class="casAuthors">Leurs, Rob; Bakker, Remko A.; Timmerman, Henk; de Esch, Iwan J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-120</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the cloning of the histamine H3 receptor cDNA in 1999 by Lovenberg and coworkers, this histamine receptor has gained the interest of many pharmaceutical companies as a potential drug target for the treatment of various important disorders, including obesity, attention-deficit hyperactivity disorder, Alzheimer's disease, schizophrenia, as well as for myocardial ischemia, migraine and inflammatory diseases.  Here, the authors discuss relevant information on this target protein and describe the development of various H3 receptor agonists and antagonists, and their effects in preclin. animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS284dYZ2NqrVg90H21EOLACvtfcHk0lhiuXaDpAkZkA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpt1Wlsw%253D%253D&md5=78f1127c7e8fb9abd416dae666f5bcfe</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1038%2Fnrd1631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1631%26sid%3Dliteratum%253Aachs%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DBakker%26aufirst%3DR.%2BA.%26aulast%3DTimmerman%26aufirst%3DH.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%26atitle%3DThe%2520histamine%2520H3%2520receptor%253A%2520from%2520gene%2520cloning%2520to%2520H3%2520receptor%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D107%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_contrib-group">Wijtmans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I.</span><span> </span><span class="NLM_article-title">Histamine H<sub>3</sub> receptor ligands break ground in a remarkable plethora of therapeutic areas</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">â</span> <span class="NLM_lpage">985</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=967-985&author=M.+Wijtmansauthor=R.+Leursauthor=I.+de+Esch&title=Histamine+H3+receptor+ligands+break+ground+in+a+remarkable+plethora+of+therapeutic+areas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWijtmans%26aufirst%3DM.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3Dde%2BEsch%26aufirst%3DI.%26atitle%3DHistamine%2520H3%2520receptor%2520ligands%2520break%2520ground%2520in%2520a%2520remarkable%2520plethora%2520of%2520therapeutic%2520areas%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2007%26volume%3D16%26spage%3D967%26epage%3D985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowart, M. D.</span><span> </span><span class="NLM_article-title">Histamine H<sub>3</sub> receptor antagonists: preclinical promise for treating obesity and cognitive disorders</span> <span class="citation_source-journal">Mol. Interventions</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">â</span> <span class="NLM_lpage">88</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=77-88&author=T.+A.+Esbenshadeauthor=G.+B.+Foxauthor=M.+D.+Cowart&title=Histamine+H3+receptor+antagonists%3A+preclinical+promise+for+treating+obesity+and+cognitive+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DFox%26aufirst%3DG.%2BB.%26aulast%3DCowart%26aufirst%3DM.%2BD.%26atitle%3DHistamine%2520H3%2520receptor%2520antagonists%253A%2520preclinical%2520promise%2520for%2520treating%2520obesity%2520and%2520cognitive%2520disorders%26jtitle%3DMol.%2520Interventions%26date%3D2006%26volume%3D6%26spage%3D77%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browman, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strakhova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowart, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brioni, J. D.</span><span> </span><span class="NLM_article-title">The histamine H<sub>3</sub> receptor: an attractive target for the treatment of cognitive disorders</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">1166</span><span class="NLM_x">â</span> <span class="NLM_lpage">1181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1038%2Fbjp.2008.147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=18469850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVCjtL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2008&pages=1166-1181&author=T.+A.+Esbenshadeauthor=K.+E.+Browmanauthor=R.+S.+Bitnerauthor=M.+Strakhovaauthor=M.+D.+Cowartauthor=J.+D.+Brioni&title=The+histamine+H3+receptor%3A+an+attractive+target+for+the+treatment+of+cognitive+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The histamine H3 receptor: an attractive target for the treatment of cognitive disorders</span></div><div class="casAuthors">Esbenshade, T. A.; Browman, K. E.; Bitner, R. S.; Strakhova, M.; Cowart, M. D.; Brioni, J. D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1166-1181</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The histamine H3 receptor, first described in 1983 as a histamine autoreceptor and later shown to also function as a heteroreceptor that regulates the release of other neurotransmitters, has been the focus of research by numerous labs. as it represents an attractive drug target for a no. of indications including cognition.  The purpose of this review is to acquaint the reader with the current understanding of H3 receptor localization and function as a modulator of neurotransmitter release and its effects on cognitive processes, as well as to provide an update on selected H3 antagonists in various states of preclin. and clin. advancement.  Blockade of centrally localized H3 receptors by selective H3 receptor antagonists has been shown to enhance the release of neurotransmitters such as histamine, ACh, dopamine and norepinephrine, among others, which play important roles in cognitive processes.  The cognitive-enhancing effects of H3 antagonists across multiple cognitive domains in a wide no. of preclin. cognition models also bolster confidence in this therapeutic approach for the treatment of attention deficit hyperactivity disorder, Alzheimer's disease and schizophrenia.  However, although a no. of clin. studies examg. the efficacy of H3 receptor antagonists for a variety of cognitive disorders are currently underway, no clin. proof of concept for an H3 receptor antagonist has been reported to date.  The discovery of effective H3 antagonists as therapeutic agents for the novel treatment of cognitive disorders will only be accomplished through continued research efforts that further our insights into the functions of the H3 receptor.  British Journal of Pharmacol. (2008) 154, 1166-1181; doi:10.1038/bjp.2008.147; published online 12 May 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2N2Dg3cdZfrVg90H21EOLACvtfcHk0lhiuXaDpAkZkA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVCjtL4%253D&md5=05bcda7b1140e9d16b4ca4072902d925</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.147%26sid%3Dliteratum%253Aachs%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DBrowman%26aufirst%3DK.%2BE.%26aulast%3DBitner%26aufirst%3DR.%2BS.%26aulast%3DStrakhova%26aufirst%3DM.%26aulast%3DCowart%26aufirst%3DM.%2BD.%26aulast%3DBrioni%26aufirst%3DJ.%2BD.%26atitle%3DThe%2520histamine%2520H3%2520receptor%253A%2520an%2520attractive%2520target%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D154%26spage%3D1166%26epage%3D1181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5e"><span><span class="NLM_contrib-group">Hudkins, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raddatz, R.</span><span> </span><span class="NLM_article-title">Recent advances in drug discovery of histamine H<sub>3</sub> antagonist</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">â</span> <span class="NLM_lpage">63</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=49-63&author=R.+L.+Hudkinsauthor=R.+Raddatz&title=Recent+advances+in+drug+discovery+of+histamine+H3+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26aulast%3DRaddatz%26aufirst%3DR.%26atitle%3DRecent%2520advances%2520in%2520drug%2520discovery%2520of%2520histamine%2520H3%2520antagonist%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2007%26volume%3D42%26spage%3D49%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5f"><span><span class="NLM_contrib-group">Sander, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kottke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, H.</span><span> </span><span class="NLM_article-title">Histamine H<sub>3</sub> receptor antagonists go to clinics</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2163</span><span class="NLM_x">â</span> <span class="NLM_lpage">2181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1248%2Fbpb.31.2163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=19043195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Kmsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=2163-2181&author=K.+Sanderauthor=T.+Kottkeauthor=H.+Stark&title=Histamine+H3+receptor+antagonists+go+to+clinics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5fR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Histamine H3 receptor antagonists go to clinics</span></div><div class="casAuthors">Sander, Kerstin; Kottke, Tim; Stark, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2163-2181</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A review.  Within the recent years novel lead optimizations for histamine H3 receptor antagonists made their way from bench to bedside.  Structure-activity relationships, cross-affinities and side effects as well as pharmacokinetic profiling will be discussed on selected promising compd. series.  Due to diversity in potential therapeutic applications and in some cases a controversial debate, different indications will be highlighted with the potential and the problems of the test compds., e.g. sleep-wake disorders, attention-deficient hyperactivity disorder, epilepsy, cognitive impairment, schizophrenia, obesity and neuropathic pain.  First data published on clin. trials phase II (IIb) are presented showing proof of concept of H3 receptor antagonists in narcolepsy and photoinduced epilepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJWogrOu3mmbVg90H21EOLACvtfcHk0liCKopfFwuabw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Kmsbs%253D&md5=b816371be0c006bef83d279a426fee45</span></div><a href="/servlet/linkout?suffix=cit5f&amp;dbid=16384&amp;doi=10.1248%2Fbpb.31.2163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.31.2163%26sid%3Dliteratum%253Aachs%26aulast%3DSander%26aufirst%3DK.%26aulast%3DKottke%26aufirst%3DT.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DHistamine%2520H3%2520receptor%2520antagonists%2520go%2520to%2520clinics%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2008%26volume%3D31%26spage%3D2163%26epage%3D2181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5g"><span><span class="NLM_contrib-group">Brioni, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrison, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitner, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowart, M. D.</span><span> </span><span class="NLM_article-title">Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimerâs disease</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">â</span> <span class="NLM_lpage">46</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1124%2Fjpet.110.166876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=20864505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1ektw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=38-46&author=J.+D.+Brioniauthor=T.+A.+Esbenshadeauthor=T.+R.+Garrisonauthor=S.+R.+Bitnerauthor=M.+D.+Cowart&title=Discovery+of+histamine+H3+antagonists+for+the+treatment+of+cognitive+disorders+and+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5gR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer's disease</span></div><div class="casAuthors">Brioni, Jorge D.; Esbenshade, Tim A.; Garrison, Tiffany Runyan; Bitner, Scott R.; Cowart, Marlon D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-46</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  H3 antagonists increase the release of brain histamine, acetylcholine, noradrenaline, and dopamine, neurotransmitters that are known to modulate cognitive processes.  The ability to release brain histamine supports the effect on attention and vigilance, but histamine also modulates other cognitive domains such as short-term and long-term memory.  A no. of H3 antagonists, including 1-{3-[3-(4-chlorophenyl)propoxy]propyl}piperidine hydrochloride (BF2.649), (1R,3R)-N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]cyclobutane-1-carboxamide (PF-03654746), 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-pyridinecarboxamide hydrochloride (GSK189254), MK-0249 (structure not yet disclosed), JNJ-17216498 (structure not yet disclosed), and ABT-288 (structure not yet disclosed), have advanced to the clin. area for the potential treatment of human cognitive disorders.  H3 antagonists exhibited wake-promoting effects in humans and efficacy in narcoleptic patients, indicating target engagement, but some of them were not efficacious in patients suffering from attention-deficit hyperactivity disorder and schizophrenic patients.  Preclin. studies have also shown that H3 antagonists activate intracellular signaling pathways that may improve cognitive efficacy and disease-modifying effects in Alzheimer's disease.  Ongoing clin. studies will be able to det. the utility of H3 antagonists for the treatment of cognitive disorders in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHvanX-UatFbVg90H21EOLACvtfcHk0liCKopfFwuabw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1ektw%253D%253D&md5=d8f3f6997a6b9c96be5e6eb836bd2951</span></div><a href="/servlet/linkout?suffix=cit5g&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.166876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.166876%26sid%3Dliteratum%253Aachs%26aulast%3DBrioni%26aufirst%3DJ.%2BD.%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DGarrison%26aufirst%3DT.%2BR.%26aulast%3DBitner%26aufirst%3DS.%2BR.%26aulast%3DCowart%26aufirst%3DM.%2BD.%26atitle%3DDiscovery%2520of%2520histamine%2520H3%2520antagonists%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26spage%3D38%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5h"><span><span class="NLM_contrib-group">Raddatz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudkins, R. L.</span><span> </span><span class="NLM_article-title">Histamine H3 antagonists for treatment of cognitive deficits in CNS diseases</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">â</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5h&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.2174%2F156802610790411027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5h&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=20166960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5h&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFajsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=153-169&author=R.+Raddatzauthor=M.+Taoauthor=R.+L.+Hudkins&title=Histamine+H3+antagonists+for+treatment+of+cognitive+deficits+in+CNS+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5hR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Histamine H3 antagonists for treatment of cognitive deficits in CNS diseases</span></div><div class="casAuthors">Raddatz, Rita; Tao, Ming; Hudkins, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-169</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The H3 histamine receptor is expressed in many brain regions, including those involved in sleep/wake regulation and cognitive functions.  Inhibition of the H3 receptor leads to increased release of multiple neurotransmitters in these regions, making this receptor an ideal target for the potential enhancement of arousal and/or cognitive processes.  The high interest level by several pharmaceutical companies in H3 receptors as potential drug targets has produced rapid advancement in novel compd. series with different properties, providing a variety of preclin. tools as well as advancing several candidates into clin. trials.  Multiple chemotypes have demonstrated efficacy in preclin. models covering a range of cognitive deficits, suggesting the potential value of H3 antagonists as cognition enhancers in a variety of disease states.  These studies have revealed the actions of this class of compds. at the cellular, neuronal systems and behavioral levels.  Recently, compds. with improved selectivity, pharmacokinetics and preclin. safety profiles have advanced into clin. trials for a no. of potential indications.  The results of these clin. trials are eagerly awaited and will increase our understanding of the properties of H3 receptor antagonists that will provide therapeutic value.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5LHkk08wu0rVg90H21EOLACvtfcHk0liCKopfFwuabw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFajsro%253D&md5=c0168541e8407860144a7266a7555acd</span></div><a href="/servlet/linkout?suffix=cit5h&amp;dbid=16384&amp;doi=10.2174%2F156802610790411027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610790411027%26sid%3Dliteratum%253Aachs%26aulast%3DRaddatz%26aufirst%3DR.%26aulast%3DTao%26aufirst%3DM.%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26atitle%3DHistamine%2520H3%2520antagonists%2520for%2520treatment%2520of%2520cognitive%2520deficits%2520in%2520CNS%2520diseases%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D153%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5i"><span><span class="NLM_contrib-group">Berlin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lera Ruiz, M.</span><span> </span><span class="NLM_article-title">Histamine H(3) receptor as a drug discovery target</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">â</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100064d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=26-53&author=M.+Berlinauthor=C.+W.+Boyceauthor=M.+de+Lera+Ruiz&title=Histamine+H%283%29+receptor+as+a+drug+discovery+target"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5i&amp;dbid=16384&amp;doi=10.1021%2Fjm100064d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100064d%26sid%3Dliteratum%253Aachs%26aulast%3DBerlin%26aufirst%3DM.%26aulast%3DBoyce%26aufirst%3DC.%2BW.%26aulast%3Dde%2BLera%2BRuiz%26aufirst%3DM.%26atitle%3DHistamine%2520H%25283%2529%2520receptor%2520as%2520a%2520drug%2520discovery%2520target%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D26%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5j"><span><span class="NLM_contrib-group">Celanire, F.; Lebon, F.; Stark, H.</span><span> </span><span class="NLM_article-title">Drug Discovery: From Hits to Clinical Candidates</span>. In  <span class="citation_source-book">The Third Histamine Receptor: Selective Ligands as Potential Therapeutic Agents in CNS Disorders</span>; <span class="NLM_contrib-group">Vohora, D.</span>, Ed.; <span class="NLM_publisher-name">CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=F.+Celanire&author=F.+Lebon&author=H.+Starkauthor=D.+Vohora&title=The+Third+Histamine+Receptor%3A+Selective+Ligands+as+Potential+Therapeutic+Agents+in+CNS+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCelanire%26aufirst%3DF.%26atitle%3DDrug%2520Discovery%253A%2520From%2520Hits%2520to%2520Clinical%2520Candidates%26btitle%3DThe%2520Third%2520Histamine%2520Receptor%253A%2520Selective%2520Ligands%2520as%2520Potential%2520Therapeutic%2520Agents%2520in%2520CNS%2520Disorders%26aulast%3DVohora%26aufirst%3DD.%26pub%3DCRC%2520Press%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5k"><span> Thompson Reuters Integrity, Bavisant, Entry 470497,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Thompson+Reuters+Integrity%2C+Bavisant%2C+Entry+470497%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5k&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5l"><span> See trials NCT00675090, NCT00420420, NCT00506077, NCT00531752; <a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+See+trials+NCT00675090%2C+NCT00420420%2C+NCT00506077%2C+NCT00531752%3B+www.clinicaltrials.gov."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Arrang, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morisset, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gbahou, F.</span><span> </span><span class="NLM_article-title">Constitutive activity of the histamine H<sub>3</sub> receptor</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">â</span> <span class="NLM_lpage">357</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=350-357&author=J.+M.+Arrangauthor=S.+Morissetauthor=F.+Gbahou&title=Constitutive+activity+of+the+histamine+H3+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArrang%26aufirst%3DJ.%2BM.%26aulast%3DMorisset%26aufirst%3DS.%26aulast%3DGbahou%26aufirst%3DF.%26atitle%3DConstitutive%2520activity%2520of%2520the%2520histamine%2520H3%2520receptor%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D350%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Morisset, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouleau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligneau, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gbahou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tardivel-Lacombe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schunack, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganellin, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrang, J. M.</span><span> </span><span class="NLM_article-title">High constitutive activity of native H<sub>3</sub> receptors regulates histamine neurons in brain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">860</span><span class="NLM_x">â</span> <span class="NLM_lpage">864</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1038%2F35048583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=11130725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtl2lsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=860-864&author=S.+Morissetauthor=A.+Rouleauauthor=X.+Ligneauauthor=F.+Gbahouauthor=J.+Tardivel-Lacombeauthor=H.+Starkauthor=W.+Schunackauthor=C.+R.+Ganellinauthor=J.+C.+Schwartzauthor=J.+M.+Arrang&title=High+constitutive+activity+of+native+H3+receptors+regulates+histamine+neurons+in+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">High constitutive activity of native H3 receptors regulates histamine neurons in brain</span></div><div class="casAuthors">Morisset, Severine; Rouleau, Agnes; Lineau, Xavier; Gbahou, Florence; Tardivel-Lacombe, Joil; Stark, Holger; Schunack, Walter; Ganellin, C. Robin; Schwartz, Jean-Charles; Arrang, Jean-Michel</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6814</span>),
    <span class="NLM_cas:pages">860-864</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Some G-protein-coupled receptors display 'constitutive activity', i.e., spontaneous activity in the absence of agonist.  This means that a proportion of the receptor population spontaneously undergoes an allosteric transition, leading to a conformation that can bind G proteins.  The process has been shown to occur with recombinant receptors expressed at high d., and/or mutated, but also non-mutated recombinant receptors expressed at physiol. concns.  Transgenic mice that express a constitutively active mutant of the Î²2-adrenergic receptor display cardiac anomalies; and spontaneous receptor mutations leading to constitutive activity are at the origin of some human disease.  Nevertheless, this process has not previously been found to occur in animal expressing normal levels of receptor.  Here we show that two isoforms of the recombinant rat H3 receptor display high constitutive activity.  Using drugs that abrogate this activity ('inverse antagonists') and a drug that opposes both agonists and inverse agonists ('neutral antagonist'), we show that constitutive activity of native H3 receptors is present in rodent brain and that it controls histaminergic neuron activity in vivo.  Inverse agonists may therefore find therapeutic applications, even in the case of diseases involving non-mutated receptors expressed at normal levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ND0ffL4qKLVg90H21EOLACvtfcHk0liLB0mEAA49Vw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtl2lsw%253D%253D&md5=8d2a24b002e41a6e1d8fca67707e86d6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F35048583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35048583%26sid%3Dliteratum%253Aachs%26aulast%3DMorisset%26aufirst%3DS.%26aulast%3DRouleau%26aufirst%3DA.%26aulast%3DLigneau%26aufirst%3DX.%26aulast%3DGbahou%26aufirst%3DF.%26aulast%3DTardivel-Lacombe%26aufirst%3DJ.%26aulast%3DStark%26aufirst%3DH.%26aulast%3DSchunack%26aufirst%3DW.%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26aulast%3DArrang%26aufirst%3DJ.%2BM.%26atitle%3DHigh%2520constitutive%2520activity%2520of%2520native%2520H3%2520receptors%2520regulates%2520histamine%2520neurons%2520in%2520brain%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D860%26epage%3D864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Wieland, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bongers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamatodani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menge, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmerman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span> </span><span class="NLM_article-title">Constitutive activity of histamine h(3) receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H(3) antagonists</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">â</span> <span class="NLM_lpage">914</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=11714875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovVCktrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2001&pages=908-914&author=K.+Wielandauthor=G.+Bongersauthor=Y.+Yamamotoauthor=T.+Hashimotoauthor=A.+Yamatodaniauthor=W.+M.+Mengeauthor=H.+Timmermanauthor=T.+W.+Lovenbergauthor=R.+Leurs&title=Constitutive+activity+of+histamine+h%283%29+receptors+stably+expressed+in+SK-N-MC+cells%3A+display+of+agonism+and+inverse+agonism+by+H%283%29+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Constitutive activity of histamine H3 receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H3 antagonists</span></div><div class="casAuthors">Wieland, Kerstin; Bongers, Gerold; Yamamoto, Yumiko; Hashimoto, Takeshi; Yamatodani, Atsushi; Menge, Wiro M. B. P.; Timmerman, Henk; Lovenberg, Timothy W.; Leurs, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">908-914</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Agonist-independent activity of G-protein-coupled receptor, also referred to as constitutive activity, is a well-documented phenomenon and has been reported recently for both the histamine H1 and H2 receptors.  Using SK-N-MC cell lines stably expressing the human and rat H3 receptors at physiol. receptor densities (500-600 fmol/mg of protein), we show that both the rat and human H3 receptors show a high degree of constitutive activity.  The forskolin-mediated cAMP prodn. in SK-N-MC cells is inhibited strongly upon expression of the G1-coupled H3 receptor.  The cAMP prodn. can be further inhibited upon agonist stimulation of the H3 receptor and can be enhanced by a variety of H3 antagonists acting as inverse agonists at the H3 receptor.  Thioperamide, clobenpropit, and iodophenpropit raise the cAMP levels in SK-N-MC cells with potencies that match their receptor binding affinities.  Surprisingly, impentamine and burimamide act as effective H3 agonists.  Modification of the amine group of impentamine dramatically affected the pharmacol. activity of the ligand.  Receptor affinity was reduced slightly for most impentamine analogs, but the functional activity of the ligands varied from agonist to neutral antagonist and inverse agonist, indicating that subtle changes in the chem. structures of impentamine analogs have major impact on the (de)activation steps of the H3 receptor.  In conclusion, upon stable expression of the rat and human H3 receptor in SK-N-MC cells constitutive receptor activity is detected.  In this exptl. system, H3 receptors ligands, previously identified as H3 antagonists, cover the whole spectrum of pharmacol. activities, ranging from full inverse agonists to agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQLJVmRiEDBrVg90H21EOLACvtfcHk0liLB0mEAA49Vw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovVCktrk%253D&md5=1a3268a54761aa35466cd46908212311</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWieland%26aufirst%3DK.%26aulast%3DBongers%26aufirst%3DG.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DT.%26aulast%3DYamatodani%26aufirst%3DA.%26aulast%3DMenge%26aufirst%3DW.%2BM.%26aulast%3DTimmerman%26aufirst%3DH.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DConstitutive%2520activity%2520of%2520histamine%2520h%25283%2529%2520receptors%2520stably%2520expressed%2520in%2520SK-N-MC%2520cells%253A%2520display%2520of%2520agonism%2520and%2520inverse%2520agonism%2520by%2520H%25283%2529%2520antagonists%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D299%26spage%3D908%26epage%3D914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Schwartz, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morisset, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouleau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligneau, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gbahou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tardivel-Lacombe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schunack, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganellin, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrang, J. M.</span><span> </span><span class="NLM_article-title">Therapeutic implications of constitutive activity of receptors: the example of the histamine H<sub>3</sub> receptor</span> <span class="citation_source-journal">J. Neural Transm., Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1007%2F978-3-7091-6020-6_1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=12830926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1ClsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=1-16&author=J.+C.+Schwartzauthor=S.+Morissetauthor=A.+Rouleauauthor=X.+Ligneauauthor=F.+Gbahouauthor=J.+Tardivel-Lacombeauthor=H.+Starkauthor=W.+Schunackauthor=C.+R.+Ganellinauthor=J.+M.+Arrang&title=Therapeutic+implications+of+constitutive+activity+of+receptors%3A+the+example+of+the+histamine+H3+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic implications of constitutive activity of receptors: the example of the histamine H3 receptor</span></div><div class="casAuthors">Schwartz, J.-C.; Morisset, S.; Rouleau, A.; Ligneau, X.; Gbahou, F.; Tardivel-Lacombe, J.; Stark, H.; Schunack, W.; Ganellin, C. R.; Arrang, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neural Transmission, Supplement</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">Neuropsychopharmacology</span>),
    <span class="NLM_cas:pages">1-16</span>CODEN:
                <span class="NLM_cas:coden">JNTSD4</span>;
        ISSN:<span class="NLM_cas:issn">0303-6995</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag Wien</span>)
        </div><div class="casAbstract">A review.  Some G-protein-coupled receptors display constitutive activity, that is spontaneous activity in the absence of agonist: a proportion of the receptor population adopts a conformation that can bind and activate G proteins.  Whereas this was mainly shown to occur with recombinant or pathol. mutated receptors, the physiol. relevance of the process has remained debated.  We have addressed this question in the case of the histamine H3 receptor, a presynaptic inhibitory receptor regulating histamine release in brain.  Having identified a neutral antagonist and inverse agonists with variable intrinsic activity, we show that the native H3 receptor in brain displays high constitutive activity in vitro and, in vivo, controls the release of endogenous histamine.  This implies that inverse agonists with high intrinsic activity should be preferred for therapeutic application as "cognitive enhancers" in several psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL7nl3ktp80rVg90H21EOLACvtfcHk0liZkF94nhhrQg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1ClsrY%253D&md5=1469b883ec83b60f59be86791e45b359</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2F978-3-7091-6020-6_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-7091-6020-6_1%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26aulast%3DMorisset%26aufirst%3DS.%26aulast%3DRouleau%26aufirst%3DA.%26aulast%3DLigneau%26aufirst%3DX.%26aulast%3DGbahou%26aufirst%3DF.%26aulast%3DTardivel-Lacombe%26aufirst%3DJ.%26aulast%3DStark%26aufirst%3DH.%26aulast%3DSchunack%26aufirst%3DW.%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26aulast%3DArrang%26aufirst%3DJ.%2BM.%26atitle%3DTherapeutic%2520implications%2520of%2520constitutive%2520activity%2520of%2520receptors%253A%2520the%2520example%2520of%2520the%2520histamine%2520H3%2520receptor%26jtitle%3DJ.%2520Neural%2520Transm.%252C%2520Suppl.%26date%3D2003%26volume%3D64%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Reasor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastings, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, R. G.</span><span> </span><span class="NLM_article-title">Drug-induced phospholipidosis: issues and future directions</span> <span class="citation_source-journal">Expert Opin. Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">â</span> <span class="NLM_lpage">583</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1517%2F14740338.5.4.567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=16774494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD28XmslSksL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=567-583&author=M.+J.+Reasorauthor=K.+L.+Hastingsauthor=R.+G.+Ulrich&title=Drug-induced+phospholipidosis%3A+issues+and+future+directions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced phospholipidosis: issues and future directions</span></div><div class="casAuthors">Reasor, Mark J.; Hastings, Kenneth L.; Ulrich, Roger G.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Safety</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">567-583</span>CODEN:
                <span class="NLM_cas:coden">EODSA9</span>;
        ISSN:<span class="NLM_cas:issn">1474-0338</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Numerous drugs contg. a cationic amphiphilic structure are capable of inducing phospholipidosis in cells under conditions of in vivo administration or ex vivo incubation.  The principal characteristics of this condition include the reversible accumulation of polar phospholipids in assocn. with the development of unicentric or multicentric lamellated bodies within cells.  There is an abundance of data providing an understanding of potential mechanisms for the induction of phospholipidosis; however, the process is likely to be complex and may differ from one drug to another.  The functional consequences of the presence of this condition on cellular or tissue function are not well understood.  The general consensus is that the condition is an adaptive response rather than a toxicol. manifestation; however, addnl. studies to examine this question are needed.  Until this issue is resolved, concerns about phospholipidosis will continue to exist at regulatory agencies.  Procedures for the screening of potential phospholipogenic candidate compds. are available.  In contrast, a clear need exists for the identification of valid biomarkers to assess the development of phospholipidosis in preclin. and clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwYtmd7pqUebVg90H21EOLACvtfcHk0liZkF94nhhrQg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmslSksL8%253D&md5=a2801d85bc4f1730f69272eaea3ce17b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1517%2F14740338.5.4.567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14740338.5.4.567%26sid%3Dliteratum%253Aachs%26aulast%3DReasor%26aufirst%3DM.%2BJ.%26aulast%3DHastings%26aufirst%3DK.%2BL.%26aulast%3DUlrich%26aufirst%3DR.%2BG.%26atitle%3DDrug-induced%2520phospholipidosis%253A%2520issues%2520and%2520future%2520directions%26jtitle%3DExpert%2520Opin.%2520Drug%2520Saf.%26date%3D2006%26volume%3D5%26spage%3D567%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_contrib-group">Stark, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kathmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlicker, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schunack, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlegel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span> </span><span class="NLM_article-title">Medicinal chemical and pharmacological aspects of imidazole-containing histamine H<sub>3</sub> receptor antagonists</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">965</span><span class="NLM_x">â</span> <span class="NLM_lpage">977</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=965-977&author=H.+Starkauthor=M.+Kathmannauthor=E.+Schlickerauthor=W.+Schunackauthor=B.+Schlegelauthor=W.+Sippl&title=Medicinal+chemical+and+pharmacological+aspects+of+imidazole-containing+histamine+H3+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStark%26aufirst%3DH.%26aulast%3DKathmann%26aufirst%3DM.%26aulast%3DSchlicker%26aufirst%3DE.%26aulast%3DSchunack%26aufirst%3DW.%26aulast%3DSchlegel%26aufirst%3DB.%26aulast%3DSippl%26aufirst%3DW.%26atitle%3DMedicinal%2520chemical%2520and%2520pharmacological%2520aspects%2520of%2520imidazole-containing%2520histamine%2520H3%2520receptor%2520antagonists%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D965%26epage%3D977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span> </span><span class="NLM_article-title">Recent medicinal chemistry of the histamine H<sub>3</sub> receptor</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">â</span> <span class="NLM_lpage">206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1016%2FS0079-6468%2805%2944405-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=16697898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktVShtb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2006&pages=181-206&author=M.+A.+Letavicauthor=A.+J.+Barbierauthor=C.+A.+Dvorakauthor=N.+I.+Carruthers&title=Recent+medicinal+chemistry+of+the+histamine+H3+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Recent medicinal chemistry of the histamine H3 receptor</span></div><div class="casAuthors">Letavic, Michael A.; Barbier, Ann J.; Dvorak, Curt A.; Carruthers, Nicholas I.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">181-206</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review on the new biol. insights on H3 receptor, its clin. applications, the histamine H3 receptor antagonists/inverse agonists and its mol. modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNLHHd2A-5RrVg90H21EOLACvtfcHk0liZkF94nhhrQg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktVShtb0%253D&md5=c891bdacacb2ca1f14254bff9c5b8432</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2805%2944405-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252805%252944405-7%26sid%3Dliteratum%253Aachs%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DBarbier%26aufirst%3DA.%2BJ.%26aulast%3DDvorak%26aufirst%3DC.%2BA.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26atitle%3DRecent%2520medicinal%2520chemistry%2520of%2520the%2520histamine%2520H3%2520receptor%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D44%26spage%3D181%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_contrib-group">Stocking, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Histamine H<sub>3</sub> antagonists as wake-promoting and pro-cognitive agents</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">988</span><span class="NLM_x">â</span> <span class="NLM_lpage">1002</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.2174%2F156802608784936728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=18673168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1OhtLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=988-1002&author=E.+M.+Stockingauthor=M.+A.+Letavic&title=Histamine+H3+antagonists+as+wake-promoting+and+pro-cognitive+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Histamine H3 antagonists as wake-promoting and pro-cognitive agents</span></div><div class="casAuthors">Stocking, Emily M.; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">988-1002</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The histamine H3 receptor is a pre-synaptic auto- and hetero-receptor that controls the release of histamine and a variety of other neurotransmitters in the brain.  As such, modulation of the histamine H3 receptor is expected to affect wake via control of the release of histamine and to affect cognition via regulation of several other neurotransmitters including acetylcholine and norepinephrine.  Over the last several years numerous pre-clin. studies have shown that histamine H3 antagonists promote wakefulness, improve cognition, and in some cases affect food intake.  Based on the interest level generated from these early pharmacol. studies, and following the cloning and expression of the human histamine H3 receptor, many pharmaceutical companies began drug discovery programs aimed at the identification of histamine H3 antagonists suitable for human clin. trials.  These efforts have led to many new chemotypes, and several promising compds. have recently entered the clinic for a variety of conditions, including ADHD, Narcolepsy, EDS assocd. with Narcolepsy, Cognitive disorders and Schizophrenia.  Recent efforts towards the identification and pharmacol. characterization of novel histamine H3 antagonists will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3QHZ_tij6x7Vg90H21EOLACvtfcHk0lhFASCeSwj2og"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1OhtLg%253D&md5=278487f221ed3b58c2467ccd181c4032</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.2174%2F156802608784936728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608784936728%26sid%3Dliteratum%253Aachs%26aulast%3DStocking%26aufirst%3DE.%2BM.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DHistamine%2520H3%2520antagonists%2520as%2520wake-promoting%2520and%2520pro-cognitive%2520agents%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D988%26epage%3D1002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_contrib-group">Cowart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altenbach, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faghih, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, A. A.</span><span> </span><span class="NLM_article-title">Medicinal chemistry and biological properties of non-imidazole histamine H<sub>3</sub> antagonists</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">â</span> <span class="NLM_lpage">992</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=979-992&author=M.+Cowartauthor=R.+Altenbachauthor=L.+Blackauthor=R.+Faghihauthor=C.+Zhaoauthor=A.+A.+Hancock&title=Medicinal+chemistry+and+biological+properties+of+non-imidazole+histamine+H3+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCowart%26aufirst%3DM.%26aulast%3DAltenbach%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DL.%26aulast%3DFaghih%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DHancock%26aufirst%3DA.%2BA.%26atitle%3DMedicinal%2520chemistry%2520and%2520biological%2520properties%2520of%2520non-imidazole%2520histamine%2520H3%2520antagonists%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D979%26epage%3D992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_contrib-group">Berlin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, C. W.</span><span> </span><span class="NLM_article-title">Recent advances in the development of histamine H<sub>3</sub> antagonists</span> <span class="citation_source-journal">Exp. Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">â</span> <span class="NLM_lpage">687</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1517%2F13543776.17.6.675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=20144064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntFWqt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=675-687&author=M.+Berlinauthor=C.+W.+Boyce&title=Recent+advances+in+the+development+of+histamine+H3+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the development of histamine H3 antagonists</span></div><div class="casAuthors">Berlin, Michael; Boyce, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">675-687</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The histamine H3 receptor is involved in the central and peripheral regulation of levels of histamine and other neurotransmitters (e.g., acetylcholine, noradrenaline, dopamine, serotonin and GABA), which sets it up as a target in the treatment of various CNS (e.g., depression, schizophrenia, ADHD, dementia, neuropathic pain and sleep disorders), metabolic syndrome (e.g., obesity) and allergic disorders.  Novel chem. series from the most recent 2 years of patent literature have been reviewed.  While overall structural diversity is moderate, these represent or relate to some of the compds. progressing through clin. trials (e.g., GSK-189254).  However, an H3 receptor drug still has yet to reach the market.  Patenting activity is likely to remain high in the near future, bolstered by the com. promise of potential H3 receptor drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyL2NJ-m4DTbVg90H21EOLACvtfcHk0lhFASCeSwj2og"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntFWqt7k%253D&md5=28f8904ef061f9660e7e1fb890cde061</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1517%2F13543776.17.6.675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.17.6.675%26sid%3Dliteratum%253Aachs%26aulast%3DBerlin%26aufirst%3DM.%26aulast%3DBoyce%26aufirst%3DC.%2BW.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520histamine%2520H3%2520antagonists%26jtitle%3DExp.%2520Opin.%2520Ther.%2520Pat.%26date%3D2007%26volume%3D17%26spage%3D675%26epage%3D687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baranowski, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witte, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faghih, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennani, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, A. A.</span><span> </span><span class="NLM_article-title">Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H<sub>3</sub> receptor antagonist</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">â</span> <span class="NLM_lpage">945</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2004&pages=933-945&author=T.+A.+Esbenshadeauthor=G.+B.+Foxauthor=K.+M.+Kruegerauthor=J.+L.+Baranowskiauthor=T.+R.+Millerauthor=C.+H.+Kangauthor=L.+I.+Dennyauthor=D.+G.+Witteauthor=B.+B.+Yaoauthor=J.+B.+Panauthor=R.+Faghihauthor=Y.+L.+Bennaniauthor=M.+Williamsauthor=A.+A.+Hancock&title=Pharmacological+and+behavioral+properties+of+A-349821%2C+a+selective+and+potent+human+histamine+H3+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DFox%26aufirst%3DG.%2BB.%26aulast%3DKrueger%26aufirst%3DK.%2BM.%26aulast%3DBaranowski%26aufirst%3DJ.%2BL.%26aulast%3DMiller%26aufirst%3DT.%2BR.%26aulast%3DKang%26aufirst%3DC.%2BH.%26aulast%3DDenny%26aufirst%3DL.%2BI.%26aulast%3DWitte%26aufirst%3DD.%2BG.%26aulast%3DYao%26aufirst%3DB.%2BB.%26aulast%3DPan%26aufirst%3DJ.%2BB.%26aulast%3DFaghih%26aufirst%3DR.%26aulast%3DBennani%26aufirst%3DY.%2BL.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DHancock%26aufirst%3DA.%2BA.%26atitle%3DPharmacological%2520and%2520behavioral%2520properties%2520of%2520A-349821%252C%2520a%2520selective%2520and%2520potent%2520human%2520histamine%2520H3%2520receptor%2520antagonist%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2004%26volume%3D68%26spage%3D933%26epage%3D945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Hancock, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faghih, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowart, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, P. B.</span><span> </span><span class="NLM_article-title">In vitro optimization of structure activity relationships of analogues of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H<sub>3</sub> receptor antagonists</span> <span class="citation_source-journal">Basic Clin. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">â</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1111%2Fj.1742-7843.2004.950307.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=15447739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosFyiu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2004&pages=144-152&author=A.+A.+Hancockauthor=M.+S.+Diehlauthor=R.+Faghihauthor=E.+N.+Bushauthor=K.+M.+Kruegerauthor=G.+Krishnaauthor=T.+R.+Millerauthor=D.+M.+Wilcoxauthor=P.+Nguyenauthor=J.+K.+Prattauthor=M.+D.+Cowartauthor=T.+A.+Esbenshadeauthor=P.+B.+Jacobson&title=In+vitro+optimization+of+structure+activity+relationships+of+analogues+of+A-331440+combining+radioligand+receptor+binding+assays+and+micronucleus+assays+of+potential+antiobesity+histamine+H3+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro optimization of structure activity relationships of analogs of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H3 receptor antagonists</span></div><div class="casAuthors">Hancock, Arthur A.; Diehl, Marilyn S.; Faghih, Ramin; Bush, Eugene N.; Krueger, Kathleen M.; Krishna, Gopala; Miller, Thomas R.; Wilcox, Denise M.; Nguyen, Phong; Pratt, John K.; Cowart, Marlon D.; Eshenshade, Timothy A.; Jacobson, Peer B.</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">144-152</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A-331440 {4'-[3-(3(R)-(dimethylamino)-pyrrolidin-1-yl)-propoxy]-biphenyl-4-carbonitrile}, a potent and selective antagonist of histamine H3 receptors, yielded pos. results in an in vitro micronucleus assay, predictive of genotoxicity in vivo.  Because this compd. has highly favorable properties and potential as an antiobesity agent, new compds. of this general chem. class were sought that would retain or improve upon the high potency and selectivity of A-331440 for H3 receptors, but would lack the potential for genotoxicity obtained with that compd.  Our working hypothesis was that the biphenyl rings in A-331440 might contribute to interactions with DNA and thereby predispose toward genotoxicity.  Toward this end, several analogs were prepd., with substituents introduced onto the biaryl ring to alter the orientation, electronegativity, and polarity of this moiety, and were tested for their radioligand binding potency and selectivity and their propensity to induce genotoxicity in the in vitro micronucleus assay.  Using this strategy, novel compds. were discovered that retained or improved upon the potency and selectivity of A-331440 for H3 receptors and were devoid of genotoxicity in vitro.  Of these, the simple mono- and di-fluorinated analogs (A-417022 [4'-{3-[(3R)-3-(dimethylamino)-1-pyrrolidinyl]propoxy}-3'-fluoro-1,1'-biphenyl-4-carbonitrile] and A-423579 [4'-{3-[(3R)-3-(dimethylamino)-1-pyrrolidinyl]-propoxy}-3',5'-difluoro-1,1'-biphenyl-4-carbonitrile] resp.) were found to bind to H3 receptors at least as potently as A-331440, while lacking genotoxicity in the micronucleus assay.  The reason of the lack of genotoxicity of the fluorinated analogs is unclear, but is esp. noteworthy in light of the general principle that fluorine and hydrogen are very similar in size.  Therefore, these fluorinated analogs of A-331440 represented the most potent and potentially safest compds. for further evaluation as antiobesity leads.  Preliminary findings with one of these examples, A-417022, in a mouse model of obesity are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsB-CdUg04qLVg90H21EOLACvtfcHk0lgmqyZCVORnJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosFyiu7o%253D&md5=dd639fa35ed75d531d83b6fc8f662087</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-7843.2004.950307.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-7843.2004.950307.x%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DA.%2BA.%26aulast%3DDiehl%26aufirst%3DM.%2BS.%26aulast%3DFaghih%26aufirst%3DR.%26aulast%3DBush%26aufirst%3DE.%2BN.%26aulast%3DKrueger%26aufirst%3DK.%2BM.%26aulast%3DKrishna%26aufirst%3DG.%26aulast%3DMiller%26aufirst%3DT.%2BR.%26aulast%3DWilcox%26aufirst%3DD.%2BM.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DPratt%26aufirst%3DJ.%2BK.%26aulast%3DCowart%26aufirst%3DM.%2BD.%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DJacobson%26aufirst%3DP.%2BB.%26atitle%3DIn%2520vitro%2520optimization%2520of%2520structure%2520activity%2520relationships%2520of%2520analogues%2520of%2520A-331440%2520combining%2520radioligand%2520receptor%2520binding%2520assays%2520and%2520micronucleus%2520assays%2520of%2520potential%2520antiobesity%2520histamine%2520H3%2520receptor%2520antagonists%26jtitle%3DBasic%2520Clin.%2520Pharmacol.%2520Toxicol.%26date%3D2004%26volume%3D95%26spage%3D144%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_contrib-group">Cowart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faghih, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gfesser, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennani, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, A. A.</span><span> </span><span class="NLM_article-title">4-(2-[2-(2(<i>R</i>)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H<sub>3</sub> receptor antagonists potently enhance cognition and attention</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">â</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040118g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=38-55&author=M.+Cowartauthor=R.+Faghihauthor=M.+P.+Curtisauthor=G.+A.+Gfesserauthor=Y.+L.+Bennaniauthor=L.+A.+Blackauthor=L.+Panauthor=K.+C.+Marshauthor=J.+P.+Sullivanauthor=T.+A.+Esbenshadeauthor=G.+B.+Foxauthor=A.+A.+Hancock&title=4-%282-%5B2-%282%28R%29-methylpyrrolidin-1-yl%29ethyl%5Dbenzofuran-5-yl%29benzonitrile+and+related+2-aminoethylbenzofuran+H3+receptor+antagonists+potently+enhance+cognition+and+attention"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1021%2Fjm040118g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040118g%26sid%3Dliteratum%253Aachs%26aulast%3DCowart%26aufirst%3DM.%26aulast%3DFaghih%26aufirst%3DR.%26aulast%3DCurtis%26aufirst%3DM.%2BP.%26aulast%3DGfesser%26aufirst%3DG.%2BA.%26aulast%3DBennani%26aufirst%3DY.%2BL.%26aulast%3DBlack%26aufirst%3DL.%2BA.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DFox%26aufirst%3DG.%2BB.%26aulast%3DHancock%26aufirst%3DA.%2BA.%26atitle%3D4-%25282-%255B2-%25282%2528R%2529-methylpyrrolidin-1-yl%2529ethyl%255Dbenzofuran-5-yl%2529benzonitrile%2520and%2520related%25202-aminoethylbenzofuran%2520H3%2520receptor%2520antagonists%2520potently%2520enhance%2520cognition%2520and%2520attention%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D38%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witte, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennani, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowart, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, A. A.</span><span> </span><span class="NLM_article-title">Pharmacological properties of ABT-239 [4-(2-{2-[(2<i>R</i>)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H<sub>3</sub> receptor antagonist with drug-like properties</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">â</span> <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1124%2Fjpet.104.078303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=15608078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlSnsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2005&pages=165-175&author=T.+A.+Esbenshadeauthor=G.+B.+Foxauthor=K.+M.+Kruegerauthor=T.+R.+Millerauthor=C.+H.+Kangauthor=L.+I.+Dennyauthor=D.+G.+Witteauthor=B.+B.+Yaoauthor=L.+Panauthor=J.+Wetterauthor=K.+Marshauthor=Y.+L.+Bennaniauthor=M.+D.+Cowartauthor=J.+P.+Sullivanauthor=A.+A.+Hancock&title=Pharmacological+properties+of+ABT-239+%5B4-%282-%7B2-%5B%282R%29-2-Methylpyrrolidinyl%5Dethyl%7D-benzofuran-5-yl%29benzonitrile%5D%3A+I.+Potent+and+selective+histamine+H3+receptor+antagonist+with+drug-like+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties</span></div><div class="casAuthors">Esbenshade, Timothy A.; Fox, Gerard B.; Krueger, Kathleen M.; Miller, Thomas R.; Kang, Chae Hee; Denny, Lynne I.; Witte, David G.; Yao, Betty B.; Pan, Liping; Wetter, Jill; Marsh, Kennan; Bennani, Youssef L.; Cowart, Marlon D.; Sullivan, James P.; Hancock, Arthur A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">165-175</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Histamine H3 receptor antagonists are being developed to treat a variety of neurol. and cognitive disorders that may be ameliorated by enhancement of central neurotransmitter release.  Here, we present the in vitro pharmacol. and in vivo pharmacokinetic profiles for the nonimidazole, benzofuran ligand ABT-239 [4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile] and compare it with several previously described imidazole and nonimidazole H3 receptor antagonists.  ABT-239 binds to recombinant human and rat H3 receptors with high affinity, with pKi values of 9.4 and 8.9, resp., and is over 1000-fold selective vs. human H1, H2, and H4 histamine receptors.  ABT-239 is a potent H3 receptor antagonist at recombinant human and rat receptors, reversing agonist-induced changes in cAMP formation (pKb = 7.9 and 7.6, resp.), guanosine 5'-O-(3-[35S]thio) triphosphate ([35S]GTPÎ³S) binding (pKb = 9.0 and 8.3, resp.), and calcium mobilization (human pKb = 7.9).  ABT-239 also competitively reversed histamine-mediated inhibition of [3H]histamine release from rat brain cortical synaptosomes (pKb = 7.7) and agonist-induced inhibition of contractile responses in elec. field stimulated guinea pig ileal segments (pA2 = 8.7).  Addnl., ABT-239 is a potent inverse agonist, inhibiting constitutive [35S]GTPÎ³S binding at both rat and human H3 receptors with resp. pEC50 values of 8.9 and 8.2.  ABT-239 demonstrates good pharmacokinetic characteristics in rat, dog, and monkey with t1/2 values ranging from 4 to 29 h, corresponding with clearance values and metabolic turnover in liver microsomes from these species, and good oral bioavailability ranging from 52 to 89%.  Thus, ABT-239 is a selective, nonimidazole H3 receptor antagonist/inverse agonist with similar high potency in both human and rat and favorable drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowcC95NH2bcLVg90H21EOLACvtfcHk0lgmqyZCVORnJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlSnsL0%253D&md5=33248c15c96745da445a14853461c019</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.078303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.078303%26sid%3Dliteratum%253Aachs%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DFox%26aufirst%3DG.%2BB.%26aulast%3DKrueger%26aufirst%3DK.%2BM.%26aulast%3DMiller%26aufirst%3DT.%2BR.%26aulast%3DKang%26aufirst%3DC.%2BH.%26aulast%3DDenny%26aufirst%3DL.%2BI.%26aulast%3DWitte%26aufirst%3DD.%2BG.%26aulast%3DYao%26aufirst%3DB.%2BB.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DWetter%26aufirst%3DJ.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DBennani%26aufirst%3DY.%2BL.%26aulast%3DCowart%26aufirst%3DM.%2BD.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DHancock%26aufirst%3DA.%2BA.%26atitle%3DPharmacological%2520properties%2520of%2520ABT-239%2520%255B4-%25282-%257B2-%255B%25282R%2529-2-Methylpyrrolidinyl%255Dethyl%257D-benzofuran-5-yl%2529benzonitrile%255D%253A%2520I.%2520Potent%2520and%2520selective%2520histamine%2520H3%2520receptor%2520antagonist%2520with%2520drug-like%2520properties%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D313%26spage%3D165%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15c"><span><span class="NLM_contrib-group">Fox, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radek, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browman, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komater, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faghih, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drescher, K. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porsolt, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennani, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowart, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, A. A.</span><span> </span><span class="NLM_article-title">Pharmacological properties of ABT-239 [4-(2-{2-[(2<i>R</i>)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H<sub>3</sub> receptor antagonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">176</span><span class="NLM_x">â</span> <span class="NLM_lpage">190</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1124%2Fjpet.104.078402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=15608077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlSnsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2005&pages=176-190&author=G.+B.+Foxauthor=T.+A.+Esbenshadeauthor=J.+B.+Panauthor=R.+J.+Radekauthor=K.+M.+Kruegerauthor=B.+B.+Yaoauthor=K.+E.+Browmanauthor=M.+J.+Buckleyauthor=M.+E.+Ballardauthor=V.+A.+Komaterauthor=H.+Minerauthor=M.+Zhangauthor=R.+Faghihauthor=L.+E.+Rueterauthor=R.+S.+Bitnerauthor=K.+U.+Drescherauthor=J.+Wetterauthor=K.+Marshauthor=M.+Lemaireauthor=R.+D.+Porsoltauthor=Y.+L.+Bennaniauthor=J.+P.+Sullivanauthor=M.+D.+Cowartauthor=M.+W.+Deckerauthor=A.+A.+Hancock&title=Pharmacological+properties+of+ABT-239+%5B4-%282-%7B2-%5B%282R%29-2-methylpyrrolidinyl%5Dethyl%7D-benzofuran-5-yl%29benzonitrile%5D%3A+II.+neurophysiological+characterization+and+broad+preclinical+efficacy+in+cognition+and+schizophrenia+of+a+potent+and+selective+histamine+H3+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15cR"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist</span></div><div class="casAuthors">Fox, Gerard B.; Esbenshade, Timothy A.; Pan, Jia Bao; Radek, Richard J.; Krueger, Kathleen M.; Yao, Betty B.; Browman, Kaitlin E.; Buckley, Michael J.; Ballard, Michael E.; Komater, Victoria A.; Miner, Holly; Zhang, Min; Faghih, Ramin; Rueter, Lynne E.; Bitner, R. Scott; Drescher, Karla U.; Wetter, Jill; Marsh, Kennan; Lemaire, Martine; Porsolt, Roger D.; Bennani, Youssef L.; Sullivan, James P.; Cowart, Marlon D.; Decker, Michael W.; Hancock, Arthur A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">176-190</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Acute pharmacol. blockade of central histamine H3 receptors (H3Rs) enhances arousal/attention in rodents.  However, there is little information available for other behavioral domains or for repeated administration using selective compds.  ABT-239 [4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile] exemplifies such a selective, nonimidazole H3R antagonist with high affinity for rat (pKi = 8.9) and human (pKi = 9.5) H3Rs.  Acute functional blockade of central H3Rs was demonstrated by blocking the dipsogenia response to the selective H3R agonist (R)-Î±-methylhistamine in mice.  In cognition studies, acquisition of a five-trial, inhibitory avoidance test in rat pups was improved with ABT-239 (0.1-1.0 mg/kg), a 10- to 150-fold gain in potency, with similar efficacy, over previous antagonists such as thioperamide, ciproxifan, A-304121 [(4-(3-(4-((2R)-2-aminopropanoyl)-1-piperazinyl)propoxy)phenyl)(cyclopropyl) methanone], A-317920 [N-((1R)-2-(4-(3-(4-(cyclopropylcarbonyl)phenoxy)propyl)-1-piperazinyl)-1-methyl-2-oxoethyl)-2-furamide], and A-349821 [(4'-(3-((R,R)2,5-dimethyl-pyrrolidin-1-yl)-propoxy)-biphenyl-4-yl)- morpholin-4-yl-methanone].  Efficacy in this model was maintained for 3 to 6 h and following repeated dosing with ABT-239.  Social memory was also improved in adult (0.01-0.3 mg/kg) and aged (0.3-1.0 mg/kg) rats.  In schizophrenia models, ABT-239 improved gating deficits in DBA/2 mice using prepulse inhibition of startle (1.0-3.0 mg/kg) and N40 (1.0-10.0 mg/kg).  Furthermore, ABT-239 (1.0 mg/kg) attenuated methamphetamine-induced hyperactivity in mice.  In freely moving rat microdialysis studies, ABT-239 enhanced acetylcholine release (0.1-3.0 mg/kg) in adult rat frontal cortex and hippocampus and enhanced dopamine release in frontal cortex (3.0 mg/kg), but not striatum.  In summary, broad efficacy was obsd. with ABT-239 across animal models such that potential clin. efficacy may extend beyond disorders such as ADHD to include Alzheimer's disease and schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5hD1Q0ydnubVg90H21EOLACvtfcHk0liFTIqpumRibQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlSnsLo%253D&md5=437e154a172071e4c5d31e44134ab1b5</span></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.078402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.078402%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DG.%2BB.%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DPan%26aufirst%3DJ.%2BB.%26aulast%3DRadek%26aufirst%3DR.%2BJ.%26aulast%3DKrueger%26aufirst%3DK.%2BM.%26aulast%3DYao%26aufirst%3DB.%2BB.%26aulast%3DBrowman%26aufirst%3DK.%2BE.%26aulast%3DBuckley%26aufirst%3DM.%2BJ.%26aulast%3DBallard%26aufirst%3DM.%2BE.%26aulast%3DKomater%26aufirst%3DV.%2BA.%26aulast%3DMiner%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DFaghih%26aufirst%3DR.%26aulast%3DRueter%26aufirst%3DL.%2BE.%26aulast%3DBitner%26aufirst%3DR.%2BS.%26aulast%3DDrescher%26aufirst%3DK.%2BU.%26aulast%3DWetter%26aufirst%3DJ.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DLemaire%26aufirst%3DM.%26aulast%3DPorsolt%26aufirst%3DR.%2BD.%26aulast%3DBennani%26aufirst%3DY.%2BL.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DCowart%26aufirst%3DM.%2BD.%26aulast%3DDecker%26aufirst%3DM.%2BW.%26aulast%3DHancock%26aufirst%3DA.%2BA.%26atitle%3DPharmacological%2520properties%2520of%2520ABT-239%2520%255B4-%25282-%257B2-%255B%25282R%2529-2-methylpyrrolidinyl%255Dethyl%257D-benzofuran-5-yl%2529benzonitrile%255D%253A%2520II.%2520neurophysiological%2520characterization%2520and%2520broad%2520preclinical%2520efficacy%2520in%2520cognition%2520and%2520schizophrenia%2520of%2520a%2520potent%2520and%2520selective%2520histamine%2520H3%2520receptor%2520antagonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D313%26spage%3D176%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Hancock, A. A.</span><span> </span><span class="NLM_article-title">The challenge of drug discovery of a GPCR target: analysis of preclinical pharmacology of histamine H<sub>3</sub> antagonists/inverse agonists</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1103</span><span class="NLM_x">â</span> <span class="NLM_lpage">1113</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=1103-1113&author=A.+A.+Hancock&title=The+challenge+of+drug+discovery+of+a+GPCR+target%3A+analysis+of+preclinical+pharmacology+of+histamine+H3+antagonists%2Finverse+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DA.%2BA.%26atitle%3DThe%2520challenge%2520of%2520drug%2520discovery%2520of%2520a%2520GPCR%2520target%253A%2520analysis%2520of%2520preclinical%2520pharmacology%2520of%2520histamine%2520H3%2520antagonists%252Finverse%2520agonists%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2006%26volume%3D71%26spage%3D1103%26epage%3D1113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_contrib-group">Nagase, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitobe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takenaga, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, N.</span><span> </span><span class="NLM_article-title">Synthesis, structureâactivity relationships, and biological profiles of a quinazolinone class of histamine H<sub>3</sub> receptor inverse agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4780</span><span class="NLM_x">â</span> <span class="NLM_lpage">4789</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8003834" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4780-4789&author=T.+Nagaseauthor=T.+Mizutaniauthor=S.+Ishikawaauthor=E.+Sekinoauthor=T.+Sasakiauthor=T.+Fujimuraauthor=S.+Itoauthor=Y.+Mitobeauthor=Y.+Miyamotoauthor=R.+Yoshimotoauthor=T.+Tanakaauthor=A.+Ishiharaauthor=N.+Takenagaauthor=S.+Tokitaauthor=T.+Fukamiauthor=N.+Sato&title=Synthesis%2C+structure%E2%80%93activity+relationships%2C+and+biological+profiles+of+a+quinazolinone+class+of+histamine+H3+receptor+inverse+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Fjm8003834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8003834%26sid%3Dliteratum%253Aachs%26aulast%3DNagase%26aufirst%3DT.%26aulast%3DMizutani%26aufirst%3DT.%26aulast%3DIshikawa%26aufirst%3DS.%26aulast%3DSekino%26aufirst%3DE.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DFujimura%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DS.%26aulast%3DMitobe%26aufirst%3DY.%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DYoshimoto%26aufirst%3DR.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DIshihara%26aufirst%3DA.%26aulast%3DTakenaga%26aufirst%3DN.%26aulast%3DTokita%26aufirst%3DS.%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DN.%26atitle%3DSynthesis%252C%2520structure%25E2%2580%2593activity%2520relationships%252C%2520and%2520biological%2520profiles%2520of%2520a%2520quinazolinone%2520class%2520of%2520histamine%2520H3%2520receptor%2520inverse%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4780%26epage%3D4789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span>Thompson Reuters Integrity, MK-0249, Entry 433171,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Thompson+Reuters+Integrity%2C+MK-0249%2C+Entry+433171%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_contrib-group">Ligneau, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landais, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piriou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uguen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anaclet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burban, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrang, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J. C.</span><span> </span><span class="NLM_article-title">Brain histamine and schizophrenia: potential therapeutic applications of H<sub>3</sub> receptor inverse agonists studied with BF2.649</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1215</span><span class="NLM_x">â</span> <span class="NLM_lpage">1224</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2007&pages=1215-1224&author=X.+Ligneauauthor=L.+Landaisauthor=D.+Perrinauthor=J.+Piriouauthor=M.+Uguenauthor=E.+Denisauthor=P.+Robertauthor=R.+Parmentierauthor=C.+Anacletauthor=J.+S.+Linauthor=A.+Burbanauthor=J.+M.+Arrangauthor=J.+C.+Schwartz&title=Brain+histamine+and+schizophrenia%3A+potential+therapeutic+applications+of+H3+receptor+inverse+agonists+studied+with+BF2.649"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLigneau%26aufirst%3DX.%26aulast%3DLandais%26aufirst%3DL.%26aulast%3DPerrin%26aufirst%3DD.%26aulast%3DPiriou%26aufirst%3DJ.%26aulast%3DUguen%26aufirst%3DM.%26aulast%3DDenis%26aufirst%3DE.%26aulast%3DRobert%26aufirst%3DP.%26aulast%3DParmentier%26aufirst%3DR.%26aulast%3DAnaclet%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DJ.%2BS.%26aulast%3DBurban%26aufirst%3DA.%26aulast%3DArrang%26aufirst%3DJ.%2BM.%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26atitle%3DBrain%2520histamine%2520and%2520schizophrenia%253A%2520potential%2520therapeutic%2520applications%2520of%2520H3%2520receptor%2520inverse%2520agonists%2520studied%2520with%2520BF2.649%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D73%26spage%3D1215%26epage%3D1224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_contrib-group">Ligneau, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landais, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camelin, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calmels, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrebi-Bertrand, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecomte, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anaclet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertaina-Anglade, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">la Rochelle, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">dâAniello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouleau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gbahou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrang, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganellin, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schunack, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J. C.</span><span> </span><span class="NLM_article-title">BF2.649 [1-{3-[3-(4-chlorophenyl)-propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H<sub>3</sub> receptor: preclinical pharmacology</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">â</span> <span class="NLM_lpage">75</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1124%2Fjpet.106.111039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=17005916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsFChsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=365-75&author=X.+Ligneauauthor=D.+Perrinauthor=L.+Landaisauthor=J.+C.+Camelinauthor=T.+P.+Calmelsauthor=I.+Berrebi-Bertrandauthor=J.+M.+Lecomteauthor=R.+Parmentierauthor=C.+Anacletauthor=J.+S.+Linauthor=V.+Bertaina-Angladeauthor=C.+D.+la+Rochelleauthor=F.+d%E2%80%99Anielloauthor=A.+Rouleauauthor=F.+Gbahouauthor=J.+M.+Arrangauthor=C.+R.+Ganellinauthor=H.+Starkauthor=W.+Schunackauthor=J.+C.+Schwartz&title=BF2.649+%5B1-%7B3-%5B3-%284-chlorophenyl%29-propoxy%5Dpropyl%7Dpiperidine%2C+hydrochloride%5D%2C+a+nonimidazole+inverse+agonist%2Fantagonist+at+the+human+histamine+H3+receptor%3A+preclinical+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">BF2.649 [1-{3-[3-(4-chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: preclinical pharmacology</span></div><div class="casAuthors">Ligneau, X.; Perrin, D.; Landais, L.; Camelin, J.-C.; Calmels, T. P. G.; Berrebi-Bertrand, I.; Lecomte, J.-M.; Parmentier, R.; Anaclet, C.; Lin, J.-S.; Bertaina-Anglade, V.; la Rochelle, C. Drieu; d'Aniello, F.; Rouleau, A.; Gbahou, F.; Arrang, J.-M.; Ganellin, C. R.; Stark, H.; Schunack, W.; Schwartz, J.-C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">365-375</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Histamine H3 receptor inverse agonists are known to enhance the activity of histaminergic neurons in brain and thereby promote vigilance and cognition.  1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride (BF2.649) is a novel, potent, and selective nonimidazole inverse agonist at the recombinant human H3 receptor.  On the stimulation of guanosine 5'-O-(3-[35S]thio)triphosphate binding to this receptor, BF2.649 behaved as a competitive antagonist with a Ki value of 0.16 nM and as an inverse agonist with an EC50 value of 1.5 nM and an intrinsic activity â¼50% higher than that of ciproxifan.  Its in vitro potency was â¼6 times lower at the rodent receptor.  In mice, the oral bioavailability coeff., i.e., the ratio of plasma areas under the curve after oral and i.v. administrations, resp., was 84%.  BF2.649 dose dependently enhanced tele-methylhistamine levels in mouse brain, an index of histaminergic neuron activity, with an ED50 value of 1.6 mg/kg p.o., a response that persisted after repeated administrations for 17 days.  In rats, the drug enhanced dopamine and acetylcholine levels in microdialyzates of the prefrontal cortex.  In cats, it markedly enhanced wakefulness at the expense of sleep states and also enhanced fast cortical rhythms of the EEG, known to be assocd. with improved vigilance.  On the two-trial object recognition test in mice, a promnesiant effect was shown regarding either scopolamine-induced or natural forgetting.  These preclin. data suggest that BF2.649 is a valuable drug candidate to be developed in wakefulness or memory deficits and other cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKmA7knKGrp7Vg90H21EOLACvtfcHk0linnpJd7YZ0fA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsFChsA%253D%253D&md5=592d569ec46591850fcd1dde58be3ff7</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.111039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.111039%26sid%3Dliteratum%253Aachs%26aulast%3DLigneau%26aufirst%3DX.%26aulast%3DPerrin%26aufirst%3DD.%26aulast%3DLandais%26aufirst%3DL.%26aulast%3DCamelin%26aufirst%3DJ.%2BC.%26aulast%3DCalmels%26aufirst%3DT.%2BP.%26aulast%3DBerrebi-Bertrand%26aufirst%3DI.%26aulast%3DLecomte%26aufirst%3DJ.%2BM.%26aulast%3DParmentier%26aufirst%3DR.%26aulast%3DAnaclet%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DJ.%2BS.%26aulast%3DBertaina-Anglade%26aufirst%3DV.%26aulast%3Dla%2BRochelle%26aufirst%3DC.%2BD.%26aulast%3Dd%25E2%2580%2599Aniello%26aufirst%3DF.%26aulast%3DRouleau%26aufirst%3DA.%26aulast%3DGbahou%26aufirst%3DF.%26aulast%3DArrang%26aufirst%3DJ.%2BM.%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26aulast%3DStark%26aufirst%3DH.%26aulast%3DSchunack%26aufirst%3DW.%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26atitle%3DBF2.649%2520%255B1-%257B3-%255B3-%25284-chlorophenyl%2529-propoxy%255Dpropyl%257Dpiperidine%252C%2520hydrochloride%255D%252C%2520a%2520nonimidazole%2520inverse%2520agonist%252Fantagonist%2520at%2520the%2520human%2520histamine%2520H3%2520receptor%253A%2520preclinical%2520pharmacology%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D365%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_contrib-group">Medhurst, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkins, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresford, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brackenborough, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calver, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cilia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluderay, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crook, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gartlon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heslop, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacroix, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martyn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ociepka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schogger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southam, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stean, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trail, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadsworth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wald, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolley, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. M.</span><span> </span><span class="NLM_article-title">GSK189254, a novel H<sub>3</sub> receptor antagonist that binds to histamine H3 receptors in Alzheimerâs disease brain and improves cognitive performance in preclinical models</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">1032</span><span class="NLM_x">â</span> <span class="NLM_lpage">1045</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1124%2Fjpet.107.120311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=17327487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFeqs74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=1032-1045&author=A.+D.+Medhurstauthor=A.+R.+Atkinsauthor=I.+J.+Beresfordauthor=K.+Brackenboroughauthor=M.+A.+Briggsauthor=A.+R.+Calverauthor=J.+Ciliaauthor=J.+E.+Cluderayauthor=B.+Crookauthor=J.+B.+Davisauthor=R.+K.+Davisauthor=R.+P.+Davisauthor=L.+A.+Dawsonauthor=A.+G.+Foleyauthor=J.+Gartlonauthor=M.+I.+Gonzalezauthor=T.+Heslopauthor=W.+D.+Hirstauthor=C.+Jenningsauthor=D.+N.+Jonesauthor=L.+P.+Lacroixauthor=A.+Martynauthor=S.+Ociepkaauthor=A.+Rayauthor=C.+M.+Reganauthor=J.+C.+Robertsauthor=J.+Schoggerauthor=E.+Southamauthor=T.+O.+Steanauthor=B.+K.+Trailauthor=N.+Uptonauthor=G.+Wadsworthauthor=J.+A.+Waldauthor=T.+Whiteauthor=J.+Witheringtonauthor=M.+L.+Woolleyauthor=A.+Worbyauthor=D.+M.+Wilson&title=GSK189254%2C+a+novel+H3+receptor+antagonist+that+binds+to+histamine+H3+receptors+in+Alzheimer%E2%80%99s+disease+brain+and+improves+cognitive+performance+in+preclinical+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models</span></div><div class="casAuthors">Medhurst, Andrew D.; Atkins, Alan R.; Beresford, Isabel J.; Brackenborough, Kim; Briggs, Michael A.; Calver, Andrew R.; Cilia, Jackie; Cluderay, Jane E.; Crook, Barry; Davis, John B.; Davis, Rebecca K.; Davis, Robert P.; Dawson, Lee A.; Foley, Andrew G.; Gartlon, Jane; Gonzalez, M. Isabel; Heslop, Teresa; Hirst, Warren D.; Jennings, Carol; Jones, Declan N. C.; Lacroix, Laurent P.; Martyn, Abbe; Ociepka, Sandrine; Ray, Alison; Regan, Ciaran M.; Roberts, Jennifer C.; Schogger, Joanne; Southam, Eric; Stean, Tania O.; Trail, Brenda K.; Upton, Neil; Wadsworth, Graham; Wald, Jeffrey A.; White, Trevor; Witherington, Jason; Woolley, Marie L.; Worby, Angela; Wilson, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1032-1045</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">6[(3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-pyridinecarboxamide hydrochloride (GSK189254) is a novel histamine H3 receptor antagonist with high affinity for human (pKi = 9.59-9.90) and rat (pKi = 8.51-9.17) H3 receptors.  GSK189254 is >10,000-fold selective for human H3 receptors vs. other targets tested, and it exhibited potent functional antagonism (pA2 = 9.06 vs. agonist-induced changes in cAMP) and inverse agonism [pIC50 = 8.20 vs. basal guanosine 5'-O-(3-[35S]thio)triphosphate binding] at the human recombinant H3 receptor.  In vitro autoradiog. demonstrated specific [3H]GSK189254 binding in rat and human brain areas, including cortex and hippocampus.  In addn., dense H3 binding was detected in medial temporal cortex samples from severe cases of Alzheimer's disease, suggesting for the first time that H3 receptors are preserved in late-stage disease.  After oral administration, GSK189254 inhibited cortical ex vivo R-(-)-Î±-methyl[imidazole-2,5(n)-3H]histamine dihydrochloride ([3H]R-Î±-methylhistamine) binding (ED50 = 0.17 mg/kg) and increased c-Fos immunoreactivity in prefrontal and somatosensory cortex (3 mg/kg).  Microdialysis studies demonstrated that GSK189254 (0.3-3 mg/kg p.o.) increased the release of acetylcholine, noradrenaline, and dopamine in the anterior cingulate cortex and acetylcholine in the dorsal hippocampus.  Functional antagonism of central H3 receptors was demonstrated by blockade of R-Î±-methylhistamine-induced dipsogenia in rats (ID50 = 0.03 mg/kg p.o.).  GSK189254 significantly improved performance of rats in diverse cognition paradigms, including passive avoidance (1 and 3 mg/kg p.o.), water maze (1 and 3 mg/kg p.o.), object recognition (0.3 and 1 mg/kg p.o.), and attentional set shift (1 mg/kg p.o.).  These data suggest that GSK189254 may have therapeutic potential for the symptomatic treatment of dementia in Alzheimer's disease and other cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1RSEKGEQaDbVg90H21EOLACvtfcHk0linnpJd7YZ0fA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFeqs74%253D&md5=c72dfbcb1db4f56cda723eff6b0f0e85</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.120311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.120311%26sid%3Dliteratum%253Aachs%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DAtkins%26aufirst%3DA.%2BR.%26aulast%3DBeresford%26aufirst%3DI.%2BJ.%26aulast%3DBrackenborough%26aufirst%3DK.%26aulast%3DBriggs%26aufirst%3DM.%2BA.%26aulast%3DCalver%26aufirst%3DA.%2BR.%26aulast%3DCilia%26aufirst%3DJ.%26aulast%3DCluderay%26aufirst%3DJ.%2BE.%26aulast%3DCrook%26aufirst%3DB.%26aulast%3DDavis%26aufirst%3DJ.%2BB.%26aulast%3DDavis%26aufirst%3DR.%2BK.%26aulast%3DDavis%26aufirst%3DR.%2BP.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DFoley%26aufirst%3DA.%2BG.%26aulast%3DGartlon%26aufirst%3DJ.%26aulast%3DGonzalez%26aufirst%3DM.%2BI.%26aulast%3DHeslop%26aufirst%3DT.%26aulast%3DHirst%26aufirst%3DW.%2BD.%26aulast%3DJennings%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DD.%2BN.%26aulast%3DLacroix%26aufirst%3DL.%2BP.%26aulast%3DMartyn%26aufirst%3DA.%26aulast%3DOciepka%26aufirst%3DS.%26aulast%3DRay%26aufirst%3DA.%26aulast%3DRegan%26aufirst%3DC.%2BM.%26aulast%3DRoberts%26aufirst%3DJ.%2BC.%26aulast%3DSchogger%26aufirst%3DJ.%26aulast%3DSoutham%26aufirst%3DE.%26aulast%3DStean%26aufirst%3DT.%2BO.%26aulast%3DTrail%26aufirst%3DB.%2BK.%26aulast%3DUpton%26aufirst%3DN.%26aulast%3DWadsworth%26aufirst%3DG.%26aulast%3DWald%26aufirst%3DJ.%2BA.%26aulast%3DWhite%26aufirst%3DT.%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DWoolley%26aufirst%3DM.%2BL.%26aulast%3DWorby%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26atitle%3DGSK189254%252C%2520a%2520novel%2520H3%2520receptor%2520antagonist%2520that%2520binds%2520to%2520histamine%2520H3%2520receptors%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520brain%2520and%2520improves%2520cognitive%2520performance%2520in%2520preclinical%2520models%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D321%26spage%3D1032%26epage%3D1045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span> Thompson Reuters Integrity, GSK-189254, Entry 376370,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Thompson+Reuters+Integrity%2C+GSK-189254%2C+Entry+376370%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_contrib-group">Wermuth, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlewer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourguignon, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maghioros, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouchet, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moire, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worms, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biziere, K.</span><span> </span><span class="NLM_article-title">3-Aminopyridazine derivatives with atypical antidepressant, serotonergic, and dopaminergic activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">528</span><span class="NLM_x">â</span> <span class="NLM_lpage">537</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00123a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=528-537&author=C.+G.+Wermuthauthor=G.+Schlewerauthor=J.+J.+Bourguignonauthor=G.+Maghiorosauthor=M.+J.+Bouchetauthor=C.+Moireauthor=J.+P.+Kanauthor=P.+Wormsauthor=K.+Biziere&title=3-Aminopyridazine+derivatives+with+atypical+antidepressant%2C+serotonergic%2C+and+dopaminergic+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1021%2Fjm00123a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00123a004%26sid%3Dliteratum%253Aachs%26aulast%3DWermuth%26aufirst%3DC.%2BG.%26aulast%3DSchlewer%26aufirst%3DG.%26aulast%3DBourguignon%26aufirst%3DJ.%2BJ.%26aulast%3DMaghioros%26aufirst%3DG.%26aulast%3DBouchet%26aufirst%3DM.%2BJ.%26aulast%3DMoire%26aufirst%3DC.%26aulast%3DKan%26aufirst%3DJ.%2BP.%26aulast%3DWorms%26aufirst%3DP.%26aulast%3DBiziere%26aufirst%3DK.%26atitle%3D3-Aminopyridazine%2520derivatives%2520with%2520atypical%2520antidepressant%252C%2520serotonergic%252C%2520and%2520dopaminergic%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D528%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_contrib-group">Coates, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKillop, A.</span><span> </span><span class="NLM_article-title">One-pot preparation of 6-substituted 3(2<i>H</i>)-pyridazinones from ketones</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_fpage">334</span><span class="NLM_x">â</span> <span class="NLM_lpage">342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1055%2Fs-1993-25861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADyaK3sXisFCrt7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&pages=334-342&author=W.+J.+Coatesauthor=A.+McKillop&title=One-pot+preparation+of+6-substituted+3%282H%29-pyridazinones+from+ketones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">One-pot preparation of 6-substituted 3(2H)-pyridazinones from ketones</span></div><div class="casAuthors">Coates, W. J.; McKillop, A.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">334-42</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">A one-pot process for the prepn. of 6-phenyl-3(2H)-pyridazinone from acetophenone and glyoxylic acid has been investigated and shown to have wide utility in the prepn. of 6- and 5,6-substituted 3(2H)-pyridazinones.  Limitations to the process encountered with 2'-hydroxyacetophenone and with basic heteroarom. ketones have been overcome, and the processes described offer the rapid and efficient synthesis of many 6-substituted pyridazinones from readily available ketones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUXtHqDnNY2LVg90H21EOLACvtfcHk0ljEJsG32glyAQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXisFCrt7w%253D&md5=7fa145eb5b58dd9f6b1700cd961336e4</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1055%2Fs-1993-25861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1993-25861%26sid%3Dliteratum%253Aachs%26aulast%3DCoates%26aufirst%3DW.%2BJ.%26aulast%3DMcKillop%26aufirst%3DA.%26atitle%3DOne-pot%2520preparation%2520of%25206-substituted%25203%25282H%2529-pyridazinones%2520from%2520ketones%26jtitle%3DSynthesis%26date%3D1993%26spage%3D334%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Curran, W. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, A.</span><span> </span><span class="NLM_article-title">6-Phenyl-4,5-dihydro-3(2<i>H</i>)-pyridazinones. A series of hypotensive agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">â</span> <span class="NLM_lpage">281</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00249a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1974&pages=273-281&author=W.+V.+Curranauthor=A.+Ross&title=6-Phenyl-4%2C5-dihydro-3%282H%29-pyridazinones.+A+series+of+hypotensive+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm00249a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00249a004%26sid%3Dliteratum%253Aachs%26aulast%3DCurran%26aufirst%3DW.%2BV.%26aulast%3DRoss%26aufirst%3DA.%26atitle%3D6-Phenyl-4%252C5-dihydro-3%25282H%2529-pyridazinones.%2520A%2520series%2520of%2520hypotensive%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1974%26volume%3D17%26spage%3D273%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_contrib-group">Sircar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duell, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristol, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. B.</span><span> </span><span class="NLM_article-title">Cardiotonic agents. 2. Synthesis and structureâactivity relationships of 4,5-dihydro-6-[4-(1<i>H</i>-imidazol-1-yl)phenyl]-3(2<i>H</i>)-pyridazinones: a new class of positive inotropic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1405</span><span class="NLM_x">â</span> <span class="NLM_lpage">1413</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00148a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=1405-1413&author=I.+Sircarauthor=B.+L.+Duellauthor=G.+Bobowskiauthor=J.+A.+Bristolauthor=D.+B.+Evans&title=Cardiotonic+agents.+2.+Synthesis+and+structure%E2%80%93activity+relationships+of+4%2C5-dihydro-6-%5B4-%281H-imidazol-1-yl%29phenyl%5D-3%282H%29-pyridazinones%3A+a+new+class+of+positive+inotropic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fjm00148a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00148a006%26sid%3Dliteratum%253Aachs%26aulast%3DSircar%26aufirst%3DI.%26aulast%3DDuell%26aufirst%3DB.%2BL.%26aulast%3DBobowski%26aufirst%3DG.%26aulast%3DBristol%26aufirst%3DJ.%2BA.%26aulast%3DEvans%26aufirst%3DD.%2BB.%26atitle%3DCardiotonic%2520agents.%25202.%2520Synthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%25204%252C5-dihydro-6-%255B4-%25281H-imidazol-1-yl%2529phenyl%255D-3%25282H%2529-pyridazinones%253A%2520a%2520new%2520class%2520of%2520positive%2520inotropic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1985%26volume%3D28%26spage%3D1405%26epage%3D1413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_contrib-group">Sotelo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravina, E.</span><span> </span><span class="NLM_article-title">Efficient aromatization of 4,5-dihydro-3(2<i>H</i>)-pyridazinone substituted at 5 position by using anhydrous copper chloride</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">7</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1080%2F00397910008087285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtVSrtb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2000&pages=1-7&author=E.+Soteloauthor=E.+Ravina&title=Efficient+aromatization+of+4%2C5-dihydro-3%282H%29-pyridazinone+substituted+at+5+position+by+using+anhydrous+copper+chloride"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient aromatization of 4,5-dihydro-3(2H)-pyridazinones substituted at 5 position by using anhydrous copper(II) chloride</span></div><div class="casAuthors">Sotelo, Eddy; Ravina, Enrique</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">An efficient conversion of 5-substituted-4,5-dihydro-3(2H)-pyridazinones, e.g. I, into their corresponding dehydrogenated derivs. was achieved by treatment with anhyd. copper(II) chloride in acetonitrile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1-dh7DTR7fLVg90H21EOLACvtfcHk0lgKlJZiJSDJCA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtVSrtb0%253D&md5=fa6bf2391659d2b8c6ae80dfc8e9fa7c</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1080%2F00397910008087285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910008087285%26sid%3Dliteratum%253Aachs%26aulast%3DSotelo%26aufirst%3DE.%26aulast%3DRavina%26aufirst%3DE.%26atitle%3DEfficient%2520aromatization%2520of%25204%252C5-dihydro-3%25282H%2529-pyridazinone%2520substituted%2520at%25205%2520position%2520by%2520using%2520anhydrous%2520copper%2520chloride%26jtitle%3DSynth.%2520Commun.%26date%3D2000%26volume%3D30%26spage%3D1%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_contrib-group">Kodavanti, U. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehendale, H. M.</span><span> </span><span class="NLM_article-title">Cationic amphiphilic drugs and phospholipid storage disorder</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">â</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=2080227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADyaK3MXksVWjtbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1990&pages=327-354&author=U.+P.+Kodavantiauthor=H.+M.+Mehendale&title=Cationic+amphiphilic+drugs+and+phospholipid+storage+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Cationic amphiphilic drugs and phospholipid storage disorder</span></div><div class="casAuthors">Kodavanti, Urmila P.; Mehendale, Harihara M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">327-54</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    </div><div class="casAbstract">A review with â¼300 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeDCq1uXj7fLVg90H21EOLACvtfcHk0lgKlJZiJSDJCA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXksVWjtbk%253D&md5=2025601b772b06756c57559565810c73</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKodavanti%26aufirst%3DU.%2BP.%26aulast%3DMehendale%26aufirst%3DH.%2BM.%26atitle%3DCationic%2520amphiphilic%2520drugs%2520and%2520phospholipid%2520storage%2520disorder%26jtitle%3DPharmacol.%2520Rev.%26date%3D1990%26volume%3D42%26spage%3D327%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_contrib-group">Ploemen, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Sandt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Burgsteden, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saleminki, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Esch, E.</span><span> </span><span class="NLM_article-title">Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines</span> <span class="citation_source-journal">Exp. Toxicol. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">â</span> <span class="NLM_lpage">355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=15088636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFGltL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=347-355&author=J.+P.+Ploemenauthor=J.+Kelderauthor=T.+Hafmansauthor=H.+van+de+Sandtauthor=J.+A.+van+Burgstedenauthor=P.+J.+Saleminkiauthor=E.+van+Esch&title=Use+of+physicochemical+calculation+of+pKa+and+CLogP+to+predict+phospholipidosis-inducing+potential%3A+a+case+study+with+structurally+related+piperazines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines</span></div><div class="casAuthors">Ploemen, Jan-Peter H. T. M.; Kelder, Jan; Hafmans, Theo; van de Sandt, Han; van Burgsteden, Johan A.; Salemink, Paul J. M.; van Esch, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">347-355</span>CODEN:
                <span class="NLM_cas:coden">ETPAEK</span>;
        ISSN:<span class="NLM_cas:issn">0940-2993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Several cationic amphiphilic compds. are known to induce phospholipidosis, a condition primarily characterized by excessive accumulation of phospholipids in different cell types, giving the affected cells a finely foamy appearance.  Excessive storage of lamellar membranous intralysosomal inclusion bodies is the hallmark for phospholipidosis on the electron microscopic level.  In case of alveolar phospholipidosis, foamy macrophages accumulate within the alveolar spaces of the lung.  Based on such findings in a one-year toxicity study with gepirone in rats, we studied the mol. properties of this compd. and compds. suspected of being phospholipidosis inducers by means of physicochem. calcns.  Physicochem. mol. calcns. of mol. wt., ClogP (partition coeff. octanol/water), logD at pH 7.4, and pKa were performed, for the cationic amphiphilic compds. chlorpromazine, amiodarone, imipramine, propranolol and fluoxetine, and for the structurally related compds. 1-phenylpiperazine (1-PHP), gepirone (and its major metabolites, 3-OH-gepirone and 1-pyrimidinylpiperazine [1-PP]), and buspirone.  ClogP and calcd. pKa cluster differently for the amphiphilic drugs compared to the chem. series of piperazines.  In line with this anal., lamellar inclusion bodies were found in an in vitro validation expt. in the human monoblastoid cell line U-937, incubated for 96 h at 10 Î¼g/mL with cationic amphiphilic drugs (amiodarone, imipramine, or propranolol).  No such lamellar inclusion bodies were seen for any of the compds. from the chem. series of piperazines including gepirone and its metabolites.  The data presented support the use of simple physicochem. calcns. of ClogP and pKa to discriminate rapidly between compds. suspected of being phospholipidosis inducers.  Finally, the discriminative power of these physicochem. ClogP and pKa calcns. to predict phospholipidosis-inducing potential was further validated by extension of the set of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-qnA3_zghvbVg90H21EOLACvtfcHk0lgKlJZiJSDJCA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFGltL0%253D&md5=caf5e68d3d5356dfef1cc29dbaf5ca87</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPloemen%26aufirst%3DJ.%2BP.%26aulast%3DKelder%26aufirst%3DJ.%26aulast%3DHafmans%26aufirst%3DT.%26aulast%3Dvan%2Bde%2BSandt%26aufirst%3DH.%26aulast%3Dvan%2BBurgsteden%26aufirst%3DJ.%2BA.%26aulast%3DSaleminki%26aufirst%3DP.%2BJ.%26aulast%3Dvan%2BEsch%26aufirst%3DE.%26atitle%3DUse%2520of%2520physicochemical%2520calculation%2520of%2520pKa%2520and%2520CLogP%2520to%2520predict%2520phospholipidosis-inducing%2520potential%253A%2520a%2520case%2520study%2520with%2520structurally%2520related%2520piperazines%26jtitle%3DExp.%2520Toxicol.%2520Pathol.%26date%3D2004%26volume%3D55%26spage%3D347%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Bacon, E. R.; Bailey, T. R.; Becknell, N. C.; Chatterjee, S.; Dunn, D.; Hostetler, G. A.; Hudkins, R. L.; Josef, K. A.; Knutsen, L.; Tao, M.; Zulli, A. L.</span>US2010273779,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bacon%2C+E.+R.%3B+Bailey%2C+T.+R.%3B+Becknell%2C+N.+C.%3B+Chatterjee%2C+S.%3B+Dunn%2C+D.%3B+Hostetler%2C+G.+A.%3B+Hudkins%2C+R.+L.%3B+Josef%2C+K.+A.%3B+Knutsen%2C+L.%3B+Tao%2C+M.%3B+Zulli%2C+A.+L.US2010273779%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBacon%26aufirst%3DE.%2BR.%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">â</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eYWRv_pErDKybntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_contrib-group">Lesson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concept on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">â</span> <span class="NLM_lpage">890</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Lessonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concept+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLesson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concept%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25c"><span><span class="NLM_contrib-group">Perola, E.</span><span> </span><span class="NLM_article-title">An analysis of the binding efficiencies of drugs and their leads in successful drug discovery program</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2986</span><span class="NLM_x">â</span> <span class="NLM_lpage">2997</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100118x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2986-2997&author=E.+Perola&title=An+analysis+of+the+binding+efficiencies+of+drugs+and+their+leads+in+successful+drug+discovery+program"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=10.1021%2Fjm100118x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100118x%26sid%3Dliteratum%253Aachs%26aulast%3DPerola%26aufirst%3DE.%26atitle%3DAn%2520analysis%2520of%2520the%2520binding%2520efficiencies%2520of%2520drugs%2520and%2520their%2520leads%2520in%2520successful%2520drug%2520discovery%2520program%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2986%26epage%3D2997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_contrib-group">Menear, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adcock, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockcroft, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copsey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cranston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillon, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drzewiecki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javaid, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerrigan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knights, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, V. M.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâConnor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M.</span><span> </span><span class="NLM_article-title">4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2<i>H</i>-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6581</span><span class="NLM_x">â</span> <span class="NLM_lpage">6591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8001263" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6581-6591&author=K.+A.+Menearauthor=C.+Adcockauthor=R.+Boulterauthor=X.+L.+Cockcroftauthor=L.+Copseyauthor=A.+Cranstonauthor=K.+J.+Dillonauthor=J.+Drzewieckiauthor=S.+Garmanauthor=S.+Gomezauthor=H.+Javaidauthor=F.+Kerriganauthor=C.+Knightsauthor=A.+Lauauthor=V.+M.+Lohauthor=I.+T.+Matthewsauthor=S.+Mooreauthor=M.+J.+O%E2%80%99Connorauthor=G.+C.+Smithauthor=N.+M.+Martin&title=4-%5B3-%284-Cyclopropanecarbonylpiperazine-1-carbonyl%29-4-fluorobenzyl%5D-2H-phthalazin-1-one%3A+a+novel+bioavailable+inhibitor+of+poly%28ADP-ribose%29+polymerase-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1021%2Fjm8001263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8001263%26sid%3Dliteratum%253Aachs%26aulast%3DMenear%26aufirst%3DK.%2BA.%26aulast%3DAdcock%26aufirst%3DC.%26aulast%3DBoulter%26aufirst%3DR.%26aulast%3DCockcroft%26aufirst%3DX.%2BL.%26aulast%3DCopsey%26aufirst%3DL.%26aulast%3DCranston%26aufirst%3DA.%26aulast%3DDillon%26aufirst%3DK.%2BJ.%26aulast%3DDrzewiecki%26aufirst%3DJ.%26aulast%3DGarman%26aufirst%3DS.%26aulast%3DGomez%26aufirst%3DS.%26aulast%3DJavaid%26aufirst%3DH.%26aulast%3DKerrigan%26aufirst%3DF.%26aulast%3DKnights%26aufirst%3DC.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DLoh%26aufirst%3DV.%2BM.%26aulast%3DMatthews%26aufirst%3DI.%2BT.%26aulast%3DMoore%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DG.%2BC.%26aulast%3DMartin%26aufirst%3DN.%2BM.%26atitle%3D4-%255B3-%25284-Cyclopropanecarbonylpiperazine-1-carbonyl%2529-4-fluorobenzyl%255D-2H-phthalazin-1-one%253A%2520a%2520novel%2520bioavailable%2520inhibitor%2520of%2520poly%2528ADP-ribose%2529%2520polymerase-1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6581%26epage%3D6591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_contrib-group">Hoelder, S.; Mueller, G.; Schoenafinger, K.; Will, D. W.; Matter, H.; Bossart, M.</span><span> </span><span class="NLM_article-title">Preparation of Pyridazinones as Glycogen Synthase Kinase-3 Beta Inhibitors for Pharmaceutical Uses</span>. WO2005111018,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=S.+Hoelder&author=G.+Mueller&author=K.+Schoenafinger&author=D.+W.+Will&author=H.+Matter&author=M.+Bossart&title=Preparation+of+Pyridazinones+as+Glycogen+Synthase+Kinase-3+Beta+Inhibitors+for+Pharmaceutical+Uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DPreparation%2520of%2520Pyridazinones%2520as%2520Glycogen%2520Synthase%2520Kinase-3%2520Beta%2520Inhibitors%2520for%2520Pharmaceutical%2520Uses%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Yazdanian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glynn, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawi, A.</span><span> </span><span class="NLM_article-title">Correlating partitioning and caco-2 cell permeability of structurally diverse small molecular weight compounds</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1490</span><span class="NLM_x">â</span> <span class="NLM_lpage">1494</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1023%2FA%3A1011930411574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=9755906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADyaK1cXmtFyhu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1998&pages=1490-1494&author=M.+Yazdanianauthor=S.+L.+Glynnauthor=J.+L.+Wrightauthor=A.+Hawi&title=Correlating+partitioning+and+caco-2+cell+permeability+of+structurally+diverse+small+molecular+weight+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds</span></div><div class="casAuthors">Yazdanian, Mehran; Glynn, Susan L.; Wright, James L.; Hawi, Amale</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1490-1494</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Plenum Publishing Corp.</span>)
        </div><div class="casAbstract">Caco-2 cell permeability coeffs. for 51 structurally diverse small mol. wt. compds. were measured and correlated to distribution coeffs. in three distinct solvent systems: octanol, hexadecane, and propylene glycol dipelargonate (PGDP).  There were no simple math. correlations between Caco-2 cell permeability coeffs. and partitioning values for all solvent systems.  In general, however, the more lipophilic compds. had higher cellular permeability coeffs.  It was possible to det. an approx. distribution coeff. value above which all compds. were highly cell permeable for all the solvent systems.  These were in logarithmic units 0.5, -1.0, and 0 for octanol, hexadecane, and PGDP solvent systems, resp.  Below these distribution coeffs., as the compds. became more hydrophilic, there was absolutely no trend in the data.  This study reinforces the tenet that single phys. parameters such as partitioning values can only be used to quant. det. Caco-2 cell permeability, and cannot be used as surrogate markers of in vivo intestinal permeability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4HU14sQxafLVg90H21EOLACvtfcHk0lh8rifJunqi5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtFyhu7c%253D&md5=08831ac873445016aa618a112202af15</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1023%2FA%3A1011930411574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1011930411574%26sid%3Dliteratum%253Aachs%26aulast%3DYazdanian%26aufirst%3DM.%26aulast%3DGlynn%26aufirst%3DS.%2BL.%26aulast%3DWright%26aufirst%3DJ.%2BL.%26aulast%3DHawi%26aufirst%3DA.%26atitle%3DCorrelating%2520partitioning%2520and%2520caco-2%2520cell%2520permeability%2520of%2520structurally%2520diverse%2520small%2520molecular%2520weight%2520compounds%26jtitle%3DPharm.%2520Res.%26date%3D1998%26volume%3D15%26spage%3D1490%26epage%3D1494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_contrib-group">Summerfield, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Carmen Osuna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalding, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span> </span><span class="NLM_article-title">Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">1282</span><span class="NLM_x">â</span> <span class="NLM_lpage">1290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1124%2Fjpet.105.092916" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=16330496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1SgsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2006&pages=1282-1290&author=S.+G.+Summerfieldauthor=A.+J.+Stevensauthor=L.+Cutlerauthor=M.+del+Carmen+Osunaauthor=B.+Hammondauthor=S.+P.+Tangauthor=A.+Herseyauthor=D.+J.+Spaldingauthor=P.+Jeffrey&title=Improving+the+in+vitro+prediction+of+in+vivo+central+nervous+system+penetration%3A+integrating+permeability%2C+P-glycoprotein+efflux%2C+and+free+fractions+in+blood+and+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain</span></div><div class="casAuthors">Summerfield, Scott G.; Stevens, Alexander J.; Cutler, Leanne; Osuna, Maria del Carmen; Hammond, Beverley; Tang, Sac-Pham; Hersey, Ann; Spalding, David J.; Jeffrey, Phil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1282-1290</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">This work examines the inter-relationship between the unbound drug fractions in blood and brain homogenate, passive membrane permeability, P-glycoprotein (Pgp) efflux ratio, and log octanol/water partition coeffs. (cLogP) in detg. the extent of central nervous system (CNS) penetration obsd. in vivo.  The present results demonstrate that compds. often considered to be Pgp substrates in rodents (efflux ratio greater than 5 in multidrug resistant Madin-Darby canine kidney cells) with poor passive permeability may still exhibit reasonable CNS penetration in vivo; i.e., where the unbound fractions and non-specific tissue binding act as a compensating force.  In these instances, the efflux ratio and in vitro blood-brain partition ratio may be used to predict the in vivo blood-brain ratio.  This relationship may be extended to account for the differences in CNS penetration obsd. in vivo between mdr1a/b wild type and knockout mice.  In some instances, cross-species differences that might initially seem to be related to differing transporter expression can be rationalized from knowledge of unbound fractions alone.  The results presented in this article suggest that the information exists to provide a coherent picture of the nature of CNS penetration in the drug discovery setting, allowing the focus to be shifted away from understanding CNS penetration toward the more important aspect of understanding CNS efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZMb2mL7xQC7Vg90H21EOLACvtfcHk0lghBNgEzrqqsg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1SgsL0%253D&md5=02b6cbbcde6738e7f6802d223b889261</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.092916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.092916%26sid%3Dliteratum%253Aachs%26aulast%3DSummerfield%26aufirst%3DS.%2BG.%26aulast%3DStevens%26aufirst%3DA.%2BJ.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3Ddel%2BCarmen%2BOsuna%26aufirst%3DM.%26aulast%3DHammond%26aufirst%3DB.%26aulast%3DTang%26aufirst%3DS.%2BP.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DSpalding%26aufirst%3DD.%2BJ.%26aulast%3DJeffrey%26aufirst%3DP.%26atitle%3DImproving%2520the%2520in%2520vitro%2520prediction%2520of%2520in%2520vivo%2520central%2520nervous%2520system%2520penetration%253A%2520integrating%2520permeability%252C%2520P-glycoprotein%2520efflux%252C%2520and%2520free%2520fractions%2520in%2520blood%2520and%2520brain%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D316%26spage%3D1282%26epage%3D1290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_contrib-group">Kalvass, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassidy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollack, G. M.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and pharmacodynamics of seven opioids in P-glycoprotein-competent mice: assessment of unbound brain EC50, u and correlation of in vitro, preclinical, and clinical data</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">323</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">â</span> <span class="NLM_lpage">355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1124%2Fjpet.107.119560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=17646430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFahsb%252FN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2007&pages=346-355&author=J.+C.+Kalvassauthor=E.+R.+Olsonauthor=M.+P.+Cassidyauthor=D.+E.+Selleyauthor=G.+M.+Pollack&title=Pharmacokinetics+and+pharmacodynamics+of+seven+opioids+in+P-glycoprotein-competent+mice%3A+assessment+of+unbound+brain+EC50%2C+u+and+correlation+of+in+vitro%2C+preclinical%2C+and+clinical+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28bR"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and pharmacodynamics of seven opioids in P-glycoprotein-competent mice: assessment of unbound brain EC50,u and correlation of in vitro, preclinical, and clinical data</span></div><div class="casAuthors">Kalvass, J. Cory; Olson, Emily R.; Cassidy, Michael P.; Selley, Dana E.; Pollack, Gary M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">346-355</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">This study was conducted to assess the utility of unbound brain EC50 (EC50,u) as a measure of in vivo potency for centrally active drugs.  Seven Î¼-opioid agonists (alfentanil, fentanyl, loperamide, methadone, meperidine, morphine, and sufentanil) were selected as model central nervous system drugs because they elicit a readily measurable central effect (antinociception) and their clin. pharmacokinetics/pharmacodynamics are well understood.  Mice received an equipotent s.c. dose of one of the model opioids.  The time course of antinociception and the serum and brain concns. were detd.  A pharmacokinetic/pharmacodynamic model was used to est. relevant parameters.  In vitro measures of opioid binding affinity (Ki) and functional activity [EC50 for agonist stimulated guanosine 5'-O-(3-[35S]thio)triphosphate binding] and relevant clin. parameters were obtained to construct in vitro-to-preclin. and preclin.-to-clin. correlations.  The strongest in vitro-to-in vivo correlation was obsd. between Ki and unbound brain EC50,u (r2 â¼ 0.8).  A strong correlation between mouse serum and human plasma EC50 was obsd. (r2 = 0.949); the correlation was improved when cor. for protein binding (r2 = 0.995).  Clin. equipotent i.v. dose was only moderately related to Ki.  However, ests. of ED50 and EC50 (total serum, unbound serum, total brain, and unbound brain) were significant predictors of clin. equipotent i.v. dose; the best correlation was obsd. for brain EC50,u (r2 = 0.982).  For each opioid, brain equilibration half-life in mice was almost identical to the plasma effect-site equilibration half-life measured clin.  These results indicate that the mouse is a good model for opioid human brain disposition and clin. pharmacol. and that superior in vitro-to-preclin. and preclin.-to-clin. correlations can be achieved with relevant unbound concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_E2A6_UTPA7Vg90H21EOLACvtfcHk0lghBNgEzrqqsg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFahsb%252FN&md5=589fda7ce9d453d14f428c599a3640e5</span></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.119560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.119560%26sid%3Dliteratum%253Aachs%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DOlson%26aufirst%3DE.%2BR.%26aulast%3DCassidy%26aufirst%3DM.%2BP.%26aulast%3DSelley%26aufirst%3DD.%2BE.%26aulast%3DPollack%26aufirst%3DG.%2BM.%26atitle%3DPharmacokinetics%2520and%2520pharmacodynamics%2520of%2520seven%2520opioids%2520in%2520P-glycoprotein-competent%2520mice%253A%2520assessment%2520of%2520unbound%2520brain%2520EC50%252C%2520u%2520and%2520correlation%2520of%2520in%2520vitro%252C%2520preclinical%252C%2520and%2520clinical%2520data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D323%26spage%3D346%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silber, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rance, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wastall, P.</span><span> </span><span class="NLM_article-title">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">â</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=9336307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=46-58&author=R.+S.+Obachauthor=J.+G.+Baxterauthor=T.+E.+Listonauthor=B.+M.+Silberauthor=B.+C.+Jonesauthor=F.+MacIntyreauthor=D.+J.+Ranceauthor=P.+Wastall&title=The+prediction+of+human+pharmacokinetic+parameters+from+preclinical+and+in+vitro+metabolism+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span></div><div class="casAuthors">Obach, R. Scott; Baxter, James G.; Liston, Theodore E.; Silber, B. Michael; Jones, Barry C.; Macintyre, Flona; Rance, David J.; Wastall, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-58</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 35 refs.  We describe a comprehensive retrospective anal. in which the abilities of several methods by which human pharmacokinetic parameters are predicted from preclin. pharmacokinetic data and/or in vitro metab. data were assessed.  The prediction methods examd. included both methods from the scientific literature as well as some described in this report for the first time.  Four methods were examd. for their ability to predict human vol. of distribution.  Three were highly predictive, yielding, on av., predictions that were within 60% to 90% of actual values.  Twelve methods were assessed for their utility in predicting clearance.  The most successful allometric scaling method yielded clearance predictions that were, on av., within 80% of actual values.  The best methods in which in vitro metab. data from human liver microsomes were scaled to in vivo clearance values yielded predicted clearance values that were, on av., within 70% to 80% of actual values.  Human t1/2 was predicted by combining predictions of human vol. of distribution and clearance.  The best t1/2 prediction methods successfully assigned compds. to appropriate dosing regimen categories (e.g., once daily, twice daily and so forth) 70% to 80% of the time.  In addn., correlations between human t1/2 and t1/2 values from preclin. species were also generally successful (72-87%) when used to predict human dosing regimens.  In summary, this retrospective anal. has identified several approaches by which human pharmacokinetic data can be predicted from preclin. data.  Such approaches should find utility in the drug discovery and development processes in the identification and selection of compds. that will possess appropriate pharmacokinetic characteristics in humans for progression to clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAngniZ4izLVg90H21EOLACvtfcHk0lghBNgEzrqqsg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D&md5=68d1910d925e26ec4a8ef23043ffb1ed</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DBaxter%26aufirst%3DJ.%2BG.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DJones%26aufirst%3DB.%2BC.%26aulast%3DMacIntyre%26aufirst%3DF.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26aulast%3DWastall%26aufirst%3DP.%26atitle%3DThe%2520prediction%2520of%2520human%2520pharmacokinetic%2520parameters%2520from%2520preclinical%2520and%2520in%2520vitro%2520metabolism%2520data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D46%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Raucy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warfe, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yueh, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S. W.</span><span> </span><span class="NLM_article-title">A cell-based reporter gene assay for determining induction of CYP3A4 in a high-volume system</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">412</span><span class="NLM_x">â</span> <span class="NLM_lpage">423</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1124%2Fjpet.102.038653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=12235278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsV2qtrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=412-423&author=J.+Raucyauthor=L.+Warfeauthor=M.+F.+Yuehauthor=S.+W.+Allen&title=A+cell-based+reporter+gene+assay+for+determining+induction+of+CYP3A4+in+a+high-volume+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A cell-based reporter gene assay for determining induction of CYP3A4 in a high-volume system</span></div><div class="casAuthors">Raucy, Judy; Warfe, Lyndon; Yueh, Mei-Fei; Allen, Scott W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">412-423</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Assessing the inducibility of CYP3A4 by various xenobiotics can predict potential drug interactions.  In the present investigation, human hepatoma cells were stably integrated with either the CYP3A4 enhancer region and a luciferase reporter gene or the CYP3A4-luciferase construct and the human pregnane X receptor (PXR).  Several colonies contg. one to three copies of luciferase per cell were identified by Southern blot anal.  Those transformants producing high luciferase activity in response to rifampicin were used to standardize a 96-well plate screening system with minimal inter- and intraplate variability.  Standardization also consisted of assessing viability of cells cultured in medium contg. various serum concns.  In cells maintained for 48 h in medium with less than 5% serum, a significant (p < 0.01) decline was obsd. in viability accompanied by altered induction.  A defined serum-free medium also produced less viable cells but did not alter the inductive response.  Treatment of transformants with various concns. of rifampicin produced a dose-response curve with maximal induction at 10 Î¼M (5.6Â±0.18- and 2.1Â±0.3-fold above DMSO (DMSO)-treated cells in transformants with and without PXR, resp.).  Of addnl. agents examd. for their ability to induce CYP3A4, omeprazole (200 Î¼M) was the most potent inducer (12.8Â±1.9- and 2.4Â±0.2-fold above DMSO-treated cells in transformants with and without PXR, resp.).  Mifepristone and mevastatin produced modest induction (â¼3-fold) in the cell line contg. exogenous PXR, but produced less than 1.2-fold increases in cells lacking PXR.  Thus, only potent inducers can be identified in the cell line without PXR.  In contrast, cells contg. the receptor can be used to rank CYP3A4 induction.  Because a high vol. of chems. can be readily and accurately screened for their ability to induce CYP3A4 with this format, such a system could be valuable in the initial stages of preclin. drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodZyXqBDWRWLVg90H21EOLACvtfcHk0lhctUq2Fsg3xg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsV2qtrc%253D&md5=433cb89b72745771e8df9c07df65632f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.038653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.038653%26sid%3Dliteratum%253Aachs%26aulast%3DRaucy%26aufirst%3DJ.%26aulast%3DWarfe%26aufirst%3DL.%26aulast%3DYueh%26aufirst%3DM.%2BF.%26aulast%3DAllen%26aufirst%3DS.%2BW.%26atitle%3DA%2520cell-based%2520reporter%2520gene%2520assay%2520for%2520determining%2520induction%2520of%2520CYP3A4%2520in%2520a%2520high-volume%2520system%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D412%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Lagrutta, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepakova, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salata, J. J.</span><span> </span><span class="NLM_article-title">The hERG channel and risk of drug-acquired cardiac arrhythmia: an overview</span> <span class="citation_source-journal">Curr. Top Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1102</span><span class="NLM_x">â</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.2174%2F156802608785700016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=18782006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsrjK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1102-1112&author=A.+A.+Lagruttaauthor=E.+S.+Trepakovaauthor=J.+J.+Salata&title=The+hERG+channel+and+risk+of+drug-acquired+cardiac+arrhythmia%3A+an+overview"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The hERG channel and risk of drug-acquired cardiac arrhythmia: an overview</span></div><div class="casAuthors">Lagrutta, Armando A.; Trepakova, Elena S.; Salata, Joseph J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1102-1112</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">This review summarizes current knowledge of the cardiac rapidly activating delayed rectifier potassium current (IKr), and its connection to drug-acquired QT prolongation and the assocd. risk of ventricular arrhythmia and fibrillation.  The mol. characterization of hERG as the structural correlate of IKr and the link between inherited long QT and the KCNH2 gene (hERG), have facilitated mechanistic studies of drug-acquired QT prolongation.  The development of high throughput assays to evaluate drug effects on hERG has provided an avenue to det. structure-activity relations (SAR) within chem. series.  More than 10 years of collective data and structural considerations support the notion that hERG is an unusually promiscuous target among potassium channels, but that defining SAR within a chem. series is a viable strategy to reduce or eliminate hERG activity.  Despite a crit. need to minimize drug effects on hERG, one should always keep in mind that hERG is not the only structural correlate of QT prolongation, and that QT prolongation is a sub-optimal biomarker for ventricular arrhythmia and fibrillation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoixN90Myu6bVg90H21EOLACvtfcHk0lhctUq2Fsg3xg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsrjK&md5=31c03ae1d1c67bf8f85d804c7b2fe2d2</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F156802608785700016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608785700016%26sid%3Dliteratum%253Aachs%26aulast%3DLagrutta%26aufirst%3DA.%2BA.%26aulast%3DTrepakova%26aufirst%3DE.%2BS.%26aulast%3DSalata%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520hERG%2520channel%2520and%2520risk%2520of%2520drug-acquired%2520cardiac%2520arrhythmia%253A%2520an%2520overview%26jtitle%3DCurr.%2520Top%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1102%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Clapham, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilpatrick, G. J.</span><span> </span><span class="NLM_article-title">Histamine H<sub>3</sub> receptor-mediated modulation of water consumption in the rat</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">232</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">â</span> <span class="NLM_lpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1016%2F0014-2999%2893%2990733-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=8384565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADyaK3sXhvVCit7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=1993&pages=99-103&author=J.+Claphamauthor=G.+J.+Kilpatrick&title=Histamine+H3+receptor-mediated+modulation+of+water+consumption+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Histamine H3 receptor-mediated modulation of water consumption in the rat</span></div><div class="casAuthors">Clapham, Jane; Kilpatrick, Gavin J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-103</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The effect of the selective H3 receptor agonist (R)-Î±-methylhistamine and antagonist thioperamide on water consumption in the rat were examd.  (R)-Î±-Methylhistamine (0.1-20 mg/kg, i.p.) evoked a dose-dependent increase in water consumption, the max. effect being 310% above the vehicle control response.  Thioperamide (0.2, 2, and 10 mg/kg, i.p.) alone had no effect on water consumption.  However, the stimulatory effect of (R)-Î±-methylhistamine on water consumption was antagonized by thioperamide in a dose-dependent manner, whereas the H1 receptor antagonist mepyramine and the H2 receptor antagonist loxtidine were without effect.  Thus, the H3 receptor may play a role in the regulation of water consumption in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWYx3RqmLBR7Vg90H21EOLACvtfcHk0lhctUq2Fsg3xg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhvVCit7w%253D&md5=1e1caf0a00bcccbc9f32e2ff157325f7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2893%2990733-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252893%252990733-X%26sid%3Dliteratum%253Aachs%26aulast%3DClapham%26aufirst%3DJ.%26aulast%3DKilpatrick%26aufirst%3DG.%2BJ.%26atitle%3DHistamine%2520H3%2520receptor-mediated%2520modulation%2520of%2520water%2520consumption%2520in%2520the%2520rat%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D232%26spage%3D99%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Fox, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radek, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esbenshade, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faghih, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennani, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, A. A.</span><span> </span><span class="NLM_article-title">Two novel and selective nonimidazole H<sub>3</sub> receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterization</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">â</span> <span class="NLM_lpage">908</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1124%2Fjpet.102.047241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=12606600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1SnsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2003&pages=897-908&author=G.+B.+Foxauthor=J.+B.+Panauthor=R.+J.+Radekauthor=A.+M.+Lewisauthor=R.+S.+Bitnerauthor=T.+A.+Esbenshadeauthor=R.+Faghihauthor=Y.+L.+Bennaniauthor=M.+Williamsauthor=B.+B.+Yaoauthor=M.+W.+Deckerauthor=A.+A.+Hancock&title=Two+novel+and+selective+nonimidazole+H3+receptor+antagonists+A-304121+and+A-317920%3A+II.+In+vivo+behavioral+and+neurophysiological+characterization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterization</span></div><div class="casAuthors">Fox, Gerard B.; Pan, Jia Bao; Radek, Richard J.; Lewis, Angela M.; Bitner, R. Scott; Esbenshade, Timothy A.; Faghih, Ramin; Bennani, Youssef L.; Williams, Michael; Yao, Betty B.; Decker, Michael W.; Hancock, Arthur A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">897-908</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Pharmacol. blockade of central histamine H3 receptors (H3Rs) enhances cognition in rodents and offers promise for the clin. treatment of neurol. disorders.  However, many previously characterized H3R antagonists are either not selective for H3Rs or have potentially significant tolerability issues.  Here, we present in vivo behavioral and neurophysiol. data for two novel and selective H3R antagonists with improved safety indexes.  Functional blockade of central H3Rs was first demonstrated for A-304121 [(4-(3-(4-((2R)-2-aminopropanoyl)-1-piperazinyl)propoxy)phenyl)cyclopropylmethanone] (1 mg/kg) and A-317920 [N-((1R)-2-(4-(3-(4-(cyclopropylcarbonyl)phenoxy)propyl) -1-piperazinyl)-1-methyl-2-oxo-ethyl)-2-furamide] (0.45 mg/kg) by significantly attenuating an acute dipsogenia response to the selective H3R agonist (R)-Î±-methylhistamine [(R)-Î±-MeHA].  Cognitive performance was improved in a five-trial rat pup avoidance test following administration of A-304121 (10 mg/kg) or A-317920 (3 mg/kg), with efficacy comparable with previously published observations for ref. H3R antagonists thioperamide (10 mg/kg), ciproxifan (3 mg/kg), and GT-2331 [(1R,2R)-4-(2-(5,5-dimethylhex-1-ynyl)cyclopropyl)imidazole] (1 mg/kg).  Social memory was also significantly enhanced in the adult rat with A-304121 (3, 10 mg/kg) and A-317920 (1, 3 mg/kg) at doses that produced no significant change in EEG slow-wave amplitude activity.  Relative therapeutic indexes (Tls) of 30 and 42 were estd. for A-304121 and A-317920, resp., by comparing doses producing adverse effects in general observation studies with potency in inhibitory avoidance, which were superior to Tls of 8, 10, and 18 obsd. for the ref. antagonists thioperamide, ciproxifan, and GT-2331, resp.  A-304121 and A-317920 represent a series of novel, H3R-selective piperazine amides that enhance cognition in vivo, which could offer advantages over existing H3R antagonists or cognition-enhancing agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-leHeQZ5WiLVg90H21EOLACvtfcHk0lhVWxx1ScE1FQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1SnsL0%253D&md5=359e981ceb5c192d61e0029bacb0f817</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.047241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.047241%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DG.%2BB.%26aulast%3DPan%26aufirst%3DJ.%2BB.%26aulast%3DRadek%26aufirst%3DR.%2BJ.%26aulast%3DLewis%26aufirst%3DA.%2BM.%26aulast%3DBitner%26aufirst%3DR.%2BS.%26aulast%3DEsbenshade%26aufirst%3DT.%2BA.%26aulast%3DFaghih%26aufirst%3DR.%26aulast%3DBennani%26aufirst%3DY.%2BL.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DYao%26aufirst%3DB.%2BB.%26aulast%3DDecker%26aufirst%3DM.%2BW.%26aulast%3DHancock%26aufirst%3DA.%2BA.%26atitle%3DTwo%2520novel%2520and%2520selective%2520nonimidazole%2520H3%2520receptor%2520antagonists%2520A-304121%2520and%2520A-317920%253A%2520II.%2520In%2520vivo%2520behavioral%2520and%2520neurophysiological%2520characterization%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D305%26spage%3D897%26epage%3D908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Raddatz, R.; Hudkins, R. L.; Mathiasen, J. R.; Gruner, J. A.; Le, S.; Schaffhauser, H.; Bozyczko-Coyne, D.; Marino, M. J.; Ator, M. A.; Bacon, E. R.; Mallamo, J. P.; Williams, M.</span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Raddatz%2C+R.%3B+Hudkins%2C+R.+L.%3B+Mathiasen%2C+J.+R.%3B+Gruner%2C+J.+A.%3B+Le%2C+S.%3B+Schaffhauser%2C+H.%3B+Bozyczko-Coyne%2C+D.%3B+Marino%2C+M.+J.%3B+Ator%2C+M.+A.%3B+Bacon%2C+E.+R.%3B+Mallamo%2C+J.+P.%3B+Williams%2C+M.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DRaddatz%26aufirst%3DR." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Irwin, S.</span><span> </span><span class="NLM_article-title">Comprehensive observational assessment: Ia. A systematic quantitative procedure for assessing the behavioural and physiologic state of the mouse</span> <span class="citation_source-journal">Psychopharmacologia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">â</span> <span class="NLM_lpage">257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm200401v&amp;key=10.1007%2FBF00401402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm200401v&amp;key=5679627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm200401v&amp;key=1%3ACAS%3A280%3ADyaF1M%252FgtlCiuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1968&pages=222-257&author=S.+Irwin&title=Comprehensive+observational+assessment%3A+Ia.+A+systematic+quantitative+procedure+for+assessing+the+behavioural+and+physiologic+state+of+the+mouse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse</span></div><div class="casAuthors">Irwin S</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacologia</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">222-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQae8F3n8PRtf6AExegM5LLfW6udTcc2eZnhKFvlCA9Abntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF1M%252FgtlCiuw%253D%253D&md5=37ab1a9fa105ba776dbd68650fd9edbf</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1007%2FBF00401402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00401402%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DS.%26atitle%3DComprehensive%2520observational%2520assessment%253A%2520Ia.%2520A%2520systematic%2520quantitative%2520procedure%2520for%2520assessing%2520the%2520behavioural%2520and%2520physiologic%2520state%2520of%2520the%2520mouse%26jtitle%3DPsychopharmacologia%26date%3D1968%26volume%3D13%26spage%3D222%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-5"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i58"><a href="/doi/suppl/10.1021/jm200401v">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_14657"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis results of <b>8a</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200401v/suppl_file/jm200401v_si_001.pdf">jm200401v_si_001.pdf (19.02 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm200401v&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm200401v%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-13%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm200401v" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67993fc8fdac21d6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
